{"meta":{"query_hash":"2d921af8bae2","filters":{"venue":"JAMA Oncology"},"cohort_total":219,"direct_labels_cover":4,"predictions_cover":219,"exported":219,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/2d921af8bae2","api":"https://metacan.xera.ac/api/v1/cohort?venue=JAMA+Oncology"},"results":[{"id":"W1480334271","doi":"10.1001/jamaoncol.2015.2239","title":"Effects of a High vs Moderate Volume of Aerobic Exercise on Adiposity Outcomes in Postmenopausal Women","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Alberta; Alberta Cancer Foundation; University of Calgary","funders":"University of Alberta; Alberta Health Services; Eli Lilly and Company","keywords":"Medicine; Body mass index; Aerobic exercise; Waist; Interquartile range; Internal medicine; Breast cancer; Waist–hip ratio; Body fat percentage; Cancer","score_opus":0.013680576565805758,"score_gpt":0.2893089354087831,"score_spread":0.2756283588429774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480334271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99769515,0.0015664527,0.00003858787,0.00011008712,0.000027839587,0.00009300727,0.00005996314,0.0000070137685,0.00040185833],"genre_scores_gemma":[0.9987626,0.00049422006,0.00015891907,0.00012724515,0.000044475673,0.00008310631,0.00007495331,0.0000011007644,0.00025341508],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99972564,0.00011072275,0.000026374459,0.00003415795,0.000052864067,0.000050258997],"domain_scores_gemma":[0.9995974,0.000111928864,0.000094536495,0.000027827731,0.000026629232,0.00014177647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008177353,0.0003086922,0.0005884029,0.00017425316,0.00022948679,0.00038347984,0.00029748783,0.00056225446,0.0012744847],"category_scores_gemma":[0.0011473869,0.00019879587,0.0006938765,0.00018421722,0.00030677288,0.00014215913,0.0002308003,0.0006128577,0.00011774987],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.79105216,0.0268344,0.054903533,0.0012573813,0.004125536,0.00007392355,0.00022062362,0.0008992953,0.010135397,0.00010490335,0.0008217003,0.109571256],"study_design_scores_gemma":[0.17856468,0.28009665,0.53300387,0.0002757872,0.0032719746,0.00008799101,0.00018580999,0.0009886838,0.0017840966,0.0003183854,0.0013934919,0.000028587128],"about_ca_topic_score_codex":0.0042716097,"about_ca_topic_score_gemma":0.010142053,"teacher_disagreement_score":0.0042716097,"about_ca_system_score_codex":0.00039418068,"about_ca_system_score_gemma":0.00062260247,"threshold_uncertainty_score":0.008493483},"labels":[],"label_agreement":null},{"id":"W1961570053","doi":"10.1001/jamaoncol.2015.1333","title":"Genomic Profiling","year":2015,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Leukemia and Lymphoma Society; Damon Runyon Cancer Research Foundation; National Cancer Institute; National Science Foundation; Prostate Cancer Foundation; Weill Cornell Medical College; U.S. Department of Defense","keywords":"Humanities; Philosophy; Physics","score_opus":0.020649862484884686,"score_gpt":0.28348847576283914,"score_spread":0.26283861327795444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1961570053","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10158952,0.071349025,0.18917355,0.019907486,0.0080174655,0.0037927742,0.12959215,0.0125747565,0.46400324],"genre_scores_gemma":[0.33160394,0.04093707,0.09439285,0.01587931,0.002082057,0.004173447,0.15946898,0.0031924495,0.3482699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984634,0.00019328581,0.00010013324,0.0005347501,0.0005197027,0.00018887263],"domain_scores_gemma":[0.998713,0.00018526969,0.00010202479,0.00026453985,0.00054711825,0.0001880389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011044677,0.0009794235,0.0010709445,0.0027643498,0.0013785016,0.002639031,0.0009935304,0.0017540499,0.0573841],"category_scores_gemma":[0.0036439989,0.00048211342,0.00109372,0.002155373,0.0005281775,0.001009045,0.0016671132,0.0019755475,0.03557702],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013428407,0.00022824579,0.039346784,0.0017964842,0.00028244287,0.006330428,0.0010468941,0.0014155315,0.09831703,0.014976218,0.3178233,0.5170938],"study_design_scores_gemma":[0.00010430379,0.00021786804,0.02033548,0.00054140406,0.0001842439,0.010324812,0.00059608265,0.0017756174,0.028447589,0.004912901,0.9324765,0.00008324425],"about_ca_topic_score_codex":0.0044080326,"about_ca_topic_score_gemma":0.005630289,"teacher_disagreement_score":0.0573841,"about_ca_system_score_codex":0.0010311758,"about_ca_system_score_gemma":0.0016795932,"threshold_uncertainty_score":0.19196898},"labels":[],"label_agreement":null},{"id":"W2020095621","doi":"10.1001/jamaoncol.2015.0387","title":"5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Maisonneuve-Rosemont; McGill University; Jewish General Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Prostate cancer; Cancer; Hazard ratio; Internal medicine; Proportional hazards model; Cohort; Cohort study; Propensity score matching; Oncology; Retrospective cohort study; Confidence interval","score_opus":0.01920276632136555,"score_gpt":0.32753211426995127,"score_spread":0.30832934794858574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020095621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934969,0.0039261943,0.00046807417,0.00026408938,0.000026628293,0.000019983785,0.0011958041,0.000013782047,0.0005885297],"genre_scores_gemma":[0.99850744,0.0005601986,0.00019880767,0.000042222884,0.000039191258,0.0000106224325,0.0004573106,0.000002372331,0.00018184299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99928695,0.00026191762,0.00007555784,0.0001487474,0.00016430578,0.00006264556],"domain_scores_gemma":[0.99772304,0.0005457168,0.0012253828,0.000170044,0.00016528594,0.0001704418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012908415,0.00021,0.00029496217,0.00049178937,0.00028227537,0.00062682293,0.00040664422,0.00040586712,0.0013830509],"category_scores_gemma":[0.0048928037,0.00025010091,0.00069609104,0.0009540398,0.00019010872,0.00036493797,0.0003762521,0.0007026648,0.00017075666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016096358,0.00003315073,0.9979838,0.000023948385,0.00015271369,0.0000196209,0.000026973363,0.000117076925,0.000041690677,0.000016684104,0.000095523144,0.0013278116],"study_design_scores_gemma":[0.000016158952,0.000121980294,0.99832016,0.000017492335,0.00014703744,0.00016134356,0.000053048596,0.0007464094,0.000059369526,0.000051679963,0.00030071478,0.0000045520906],"about_ca_topic_score_codex":0.0062272563,"about_ca_topic_score_gemma":0.0060402118,"teacher_disagreement_score":0.0062272563,"about_ca_system_score_codex":0.0003337312,"about_ca_system_score_gemma":0.00055721524,"threshold_uncertainty_score":0.0123820305},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2043881730","doi":"10.1001/jamaoncol.2015.0197","title":"Germline<i>TP53</i>Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Microsatellite instability; MUTYH; Colorectal cancer; Germline mutation; Family history; Germline; Lynch syndrome; Cancer; Population; Genetic testing; Oncology; Internal medicine; Cancer registry; Genetics; DNA mismatch repair; Mutation; Biology; Microsatellite; Gene; Allele","score_opus":0.019329175602541052,"score_gpt":0.30515829414331114,"score_spread":0.2858291185407701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043881730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999161,0.00010456456,0.000047598132,0.000021677472,0.000002269602,0.00000920072,0.00040667556,0.0000043869927,0.00024265036],"genre_scores_gemma":[0.99952066,0.000055614557,0.00007751382,0.000012103457,0.000003755184,0.000007484702,0.00027272792,0.00000108976,0.000049145296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994241,0.00014378231,0.00007332485,0.00017249059,0.000098935474,0.00008753251],"domain_scores_gemma":[0.9974739,0.00038307335,0.0014899581,0.00016911478,0.00020726956,0.0002766918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077838,0.00019817134,0.00027856746,0.0010099626,0.00045873385,0.00045660048,0.00035489077,0.0003591724,0.0016629694],"category_scores_gemma":[0.0036274372,0.0002000398,0.00026237764,0.0011647192,0.00022610946,0.00036623413,0.00034684813,0.0003207123,0.00021895592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004054476,0.000013312643,0.9991086,0.0000047443345,0.000010963252,0.00018427995,0.0000368192,0.000020168662,0.00012303598,0.0000049095174,0.000072709074,0.00037997813],"study_design_scores_gemma":[0.0000071492263,0.000067416586,0.99821883,0.0000073976958,0.000026227985,0.001135105,0.00013860084,0.00015139568,0.000099259785,0.000009769374,0.00013493627,0.0000038127607],"about_ca_topic_score_codex":0.012318509,"about_ca_topic_score_gemma":0.012422293,"teacher_disagreement_score":0.012318509,"about_ca_system_score_codex":0.00031002177,"about_ca_system_score_gemma":0.000540976,"threshold_uncertainty_score":0.024493635},"labels":[],"label_agreement":null},{"id":"W2105956673","doi":"10.1001/jamaoncol.2014.168","title":"Hereditary Diffuse Gastric Cancer Syndrome","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Wnt/β-catenin signaling in development and cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":687,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dr. H. Bliss Murphy Cancer Centre; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital; Vancouver General Hospital; Occupational Cancer Research Centre; McGill University Health Centre; University of British Columbia; BC Cancer Agency","funders":"National Institute for Health and Care Research; Cancer Research UK","keywords":"Germline mutation; Medicine; Breast cancer; Cancer; Penetrance; CHEK2; Proband; Genetics; Oncology; Mutation; CDH1; Genetic testing; Internal medicine; Biology; Gene","score_opus":0.025806393917823713,"score_gpt":0.2901571075128544,"score_spread":0.2643507135950307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105956673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901647,0.0015768546,0.0010884474,0.0003345008,0.000046702215,0.000035976343,0.0008599479,0.000114261726,0.005778521],"genre_scores_gemma":[0.9980944,0.00035848134,0.00035890928,0.00007972175,0.000020915526,0.000006477647,0.0002705995,0.0000054794077,0.0008050633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999887,0.000011926398,0.0000073234355,0.000042056974,0.000025569761,0.000026063886],"domain_scores_gemma":[0.99981564,0.000052609346,0.00004883793,0.000010375947,0.000019968866,0.000052469957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008413496,0.0007612456,0.00029292706,0.0006686004,0.0003752393,0.00017431348,0.00016889173,0.00034491782,0.0049335263],"category_scores_gemma":[0.0007058225,0.00009880492,0.00016853283,0.0006822356,0.0003785764,0.000109246794,0.00035380878,0.0002364456,0.00031926262],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043835674,0.000066609,0.53535527,0.0004166566,0.00026044305,0.37245062,0.0010042501,0.00046078177,0.03466342,0.0019269607,0.0070713367,0.045885302],"study_design_scores_gemma":[0.000049785296,0.00013217739,0.41475844,0.0000636485,0.00009578054,0.57502735,0.000217221,0.00041307384,0.0022837801,0.00041797015,0.0065277833,0.000013084326],"about_ca_topic_score_codex":0.0024264455,"about_ca_topic_score_gemma":0.0030082748,"teacher_disagreement_score":0.0049335263,"about_ca_system_score_codex":0.00033401864,"about_ca_system_score_gemma":0.00023095288,"threshold_uncertainty_score":0.016504347},"labels":[],"label_agreement":null},{"id":"W2148287035","doi":"10.1001/jamaoncol.2015.0735","title":"The Global Burden of Cancer 2013","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2758,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; University of Toronto; Health Canada; University of Ottawa","funders":"University of Colorado School of Medicine, Anschutz Medical Campus; National Institute of Environmental Health Sciences; Barts and The London School of Medicine and Dentistry; Wageningen University and Research; Institute of Infection and Immunity; Allergan; Mekelle University; Addis Ababa University; Università di Bologna; National Center of Neurology and Psychiatry; Universitetet i Bergen; Sahlgrenska Akademin; University of Hong Kong; Northwestern University; Universiti Tunku Abdul Rahman; Göteborgs Universitet; Kyung Hee University; National Research University Higher School of Economics; University of Queensland; Public Health Foundation of India; National Heart, Lung, and Blood Institute; Tehran University of Medical Sciences and Health Services; Australian National University; Genentech; University of Oxford; James Cook University; Wellcome Trust; University College London; Istituto di Ricerche Farmacologiche Mario Negri - IRCCS; National Institute for Health and Care Research; University of the Philippines; Institute for Health Metrics and Evaluation; Northumbria University; Faculty of Medicine and Health, University of Sydney; Philipps-Universität Marburg; Health Canada; Harvard University; Jackson State University; Karolinska Institutet; Bill and Melinda Gates Foundation; Rijksuniversiteit Groningen; Faculty of Medicine, University of British Columbia; National Institutes of Health; Regeneron Pharmaceuticals; Arak University of Medical Sciences; U.S. Department of Veterans Affairs","keywords":"Medicine; Cancer; MEDLINE; Internal medicine","score_opus":0.10981261299171613,"score_gpt":0.4293837995996755,"score_spread":0.31957118660795936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2148287035","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003799678,0.4787147,0.005941059,0.1122299,0.026636912,0.001310089,0.051634304,0.0019897206,0.31774366],"genre_scores_gemma":[0.0432157,0.63623035,0.009566285,0.039899062,0.016241007,0.0018674717,0.06600077,0.00044416345,0.18653524],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99807274,0.00043277934,0.00016517476,0.00026221632,0.0007826202,0.00028446002],"domain_scores_gemma":[0.99843067,0.00018293154,0.00023726735,0.00007110015,0.00086341676,0.00021468358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017867329,0.0009108863,0.001391572,0.0018369263,0.00078261766,0.0040306034,0.0014881209,0.0024577957,0.09547324],"category_scores_gemma":[0.004379086,0.00039812067,0.0012301772,0.0036194592,0.0006506376,0.0016309369,0.0031206494,0.0034858517,0.04605956],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004402108,0.00002670584,0.0012596409,0.002129349,0.00008860293,0.00010530962,0.000060542385,0.0001306013,0.00024377416,0.0033080943,0.6946869,0.29791656],"study_design_scores_gemma":[0.00001644296,0.000023017386,0.0022080839,0.0016958617,0.000050822797,0.00027046734,0.00006622571,0.0000680787,0.00007678603,0.0015021401,0.9940123,0.000009783098],"about_ca_topic_score_codex":0.009096304,"about_ca_topic_score_gemma":0.006891253,"teacher_disagreement_score":0.09547324,"about_ca_system_score_codex":0.0023648636,"about_ca_system_score_gemma":0.008220027,"threshold_uncertainty_score":0.31938976},"labels":[],"label_agreement":null},{"id":"W2168590528","doi":"10.1001/jamaoncol.2015.103","title":"Active Surveillance in Prostate Cancer","year":2015,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Prostate cancer; Prostate; MEDLINE; Oncology; Gynecology; Internal medicine","score_opus":0.033394488229505845,"score_gpt":0.34510457709868136,"score_spread":0.3117100888691755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168590528","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029081595,0.024482632,0.000091366936,0.95952487,0.0066834292,0.000013362186,0.000056913643,0.000025456997,0.0062138196],"genre_scores_gemma":[0.05218794,0.029195435,0.00018414801,0.8536152,0.060604557,0.00004241342,0.000098237,0.000020977712,0.0040511135],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984181,0.0006341714,0.0001569061,0.00016192975,0.0004124478,0.0002164953],"domain_scores_gemma":[0.99653083,0.0019417965,0.00033676127,0.00011146105,0.00042704615,0.0006521119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020973354,0.00031840242,0.0007696699,0.0008012334,0.0021635199,0.0015507259,0.0007890674,0.011904226,0.0024796757],"category_scores_gemma":[0.01618284,0.00033891012,0.00066449255,0.00062134874,0.0012096305,0.0018888696,0.00091977447,0.012242111,0.0012849646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001628822,0.0000903518,0.008516864,0.00026111965,0.000037352853,0.0035033065,0.00030524225,0.00013965963,0.00044463217,0.0034917642,0.90358543,0.07946132],"study_design_scores_gemma":[0.00052380934,0.0006346589,0.038375005,0.005582685,0.00018332817,0.030495327,0.0014975008,0.001881364,0.0007491822,0.024862586,0.8950771,0.00013745608],"about_ca_topic_score_codex":0.005465474,"about_ca_topic_score_gemma":0.008225499,"teacher_disagreement_score":0.011904226,"about_ca_system_score_codex":0.0024683294,"about_ca_system_score_gemma":0.0019839155,"threshold_uncertainty_score":0.01790911},"labels":[],"label_agreement":null},{"id":"W2175480754","doi":"10.1001/jamaoncol.2015.4685","title":"PD-L1 Testing in Cancer","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Oncology; Internal medicine","score_opus":0.12754339395627157,"score_gpt":0.3985948787585825,"score_spread":0.27105148480231095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2175480754","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.41157943,0.18368222,0.008910539,0.12275286,0.0075336793,0.00031334502,0.0060766665,0.0012626671,0.25788856],"genre_scores_gemma":[0.95429903,0.017372718,0.0033913609,0.013050413,0.002193521,0.00010448905,0.001998319,0.0000582204,0.0075318627],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99906033,0.00035759908,0.00009068309,0.00012345925,0.00018813086,0.00017986188],"domain_scores_gemma":[0.99725586,0.0012199804,0.0003602376,0.00015190779,0.0006398336,0.00037227088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013932169,0.00030408346,0.00047673009,0.0009967183,0.00055553264,0.0016294973,0.0006060552,0.00081231975,0.0048865136],"category_scores_gemma":[0.0062537016,0.00020028753,0.00036343953,0.0009877011,0.000506472,0.0011226989,0.0006226927,0.0016781706,0.001340706],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013171486,0.00027459481,0.24995822,0.00057417934,0.00016485709,0.0010753539,0.000115531526,0.0016552592,0.0022541815,0.0043787975,0.117699355,0.62053263],"study_design_scores_gemma":[0.00082881347,0.003033746,0.28888056,0.0029609539,0.0009218031,0.016234647,0.001383099,0.01848093,0.028814793,0.043030806,0.5952918,0.00013811437],"about_ca_topic_score_codex":0.0018858927,"about_ca_topic_score_gemma":0.0031854557,"teacher_disagreement_score":0.0048865136,"about_ca_system_score_codex":0.0015689894,"about_ca_system_score_gemma":0.001171914,"threshold_uncertainty_score":0.016346991},"labels":[],"label_agreement":null},{"id":"W2190282709","doi":"10.1001/jamaoncol.2015.5208","title":"Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA","year":2015,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":343,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Germline; Genetics; Medicine; Germline mutation; Gene; Cancer; Allele; Mendelian inheritance; Exome sequencing; Biology; Phenotype; Mutation","score_opus":0.030588858083084876,"score_gpt":0.2934010566878006,"score_spread":0.2628121986047157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190282709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604475,0.00040155835,0.0024627997,0.000028975714,0.000006772766,0.000025543632,0.00022298055,0.000013600941,0.0007930125],"genre_scores_gemma":[0.9988475,0.000102134814,0.00074619456,0.000018474526,0.00000436796,0.000009419232,0.00016542866,0.0000026300138,0.00010385061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815446,0.0005879018,0.00015481345,0.00058506883,0.00041609578,0.00010161748],"domain_scores_gemma":[0.9977805,0.0011609582,0.000630563,0.00021063045,0.000121335914,0.00009601097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020725736,0.00020309887,0.00020344461,0.0008937696,0.00015579582,0.00034568153,0.00029543557,0.000250901,0.0016236556],"category_scores_gemma":[0.0077718683,0.00017301264,0.00018769735,0.0006125426,0.00035434242,0.00024141734,0.0004126386,0.00016741504,0.00022967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035809487,0.000019907133,0.9789202,0.000043253578,0.000078853634,0.0009928865,0.00012488166,0.00060435804,0.0063534738,0.0002518813,0.00013196346,0.01212018],"study_design_scores_gemma":[0.000049528004,0.0005899311,0.9601979,0.000057586843,0.00013942737,0.01804961,0.00029449657,0.0053719035,0.011660886,0.0011470936,0.0024293861,0.000012232903],"about_ca_topic_score_codex":0.0012481118,"about_ca_topic_score_gemma":0.0012547248,"teacher_disagreement_score":0.0020725736,"about_ca_system_score_codex":0.00025110753,"about_ca_system_score_gemma":0.0001594819,"threshold_uncertainty_score":0.010960937},"labels":[],"label_agreement":null},{"id":"W2228606564","doi":"10.1001/jamaoncol.2015.5076","title":"Translational Childhood Cancer Genomics","year":2016,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.010100925778794421,"score_gpt":0.26591677338671055,"score_spread":0.25581584760791615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228606564","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031481285,0.010243043,0.0039605782,0.5866478,0.026726259,0.00023545811,0.00226001,0.0016490376,0.36512974],"genre_scores_gemma":[0.07202677,0.030790897,0.012374428,0.2864703,0.036895722,0.0005520077,0.005275489,0.0009549219,0.5546595],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994381,0.00017783855,0.000035554447,0.0000732138,0.00016182443,0.00011355397],"domain_scores_gemma":[0.9978654,0.00061463,0.00006765377,0.00026805067,0.0002977615,0.0008865549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001583679,0.0003692869,0.0002716719,0.00057509576,0.0011013917,0.0017443857,0.0006594842,0.0026993195,0.112652995],"category_scores_gemma":[0.0053471425,0.00023883961,0.0003462409,0.00041078136,0.0005738969,0.0011970174,0.0016641017,0.0042357463,0.039257906],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017838893,0.000026367696,0.00068291026,0.00003840317,0.00000349419,0.0005600441,0.000057938418,0.00003560208,0.00031562167,0.0034204782,0.93506944,0.05977181],"study_design_scores_gemma":[0.000016086757,0.000020145839,0.0009261771,0.00010392112,0.000002878539,0.001595078,0.00008162746,0.000082306746,0.00025310135,0.004294321,0.9926198,0.000004612279],"about_ca_topic_score_codex":0.0018310089,"about_ca_topic_score_gemma":0.0050078672,"teacher_disagreement_score":0.112652995,"about_ca_system_score_codex":0.0015438271,"about_ca_system_score_gemma":0.0018598913,"threshold_uncertainty_score":0.3768618},"labels":[],"label_agreement":null},{"id":"W2255009384","doi":"10.1001/jamaoncol.2015.4395","title":"Differing Perspectives on Breast Cancer Chemoprevention—Reply","year":2016,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Breast cancer; Internal medicine; Psychiatry; Cancer","score_opus":0.006445882364539007,"score_gpt":0.2700140490861776,"score_spread":0.2635681667216386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2255009384","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015869191,0.00070127315,0.0000343903,0.99136084,0.0072334358,0.0000033521019,0.000024930778,0.00001340254,0.00046970614],"genre_scores_gemma":[0.0020596737,0.0011233267,0.000116965275,0.9739897,0.020971945,0.000018316401,0.000019544135,0.000013538757,0.0016868815],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977806,0.0006406525,0.00039621818,0.00031169236,0.0005636586,0.00030716657],"domain_scores_gemma":[0.98887384,0.0069880877,0.00049294473,0.00030261435,0.0019332101,0.0014093216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046857414,0.0009067476,0.0013797685,0.00076497585,0.0032994102,0.0031539972,0.0022484986,0.040539708,0.009210423],"category_scores_gemma":[0.023844266,0.0008055665,0.0012795116,0.00092376396,0.003062457,0.0072084162,0.0021629569,0.040851936,0.0065404642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034160683,0.000027164535,0.000630874,0.000047037465,0.000009376557,0.00064170605,0.0001803846,0.0000400543,0.00007988076,0.0011828099,0.98973733,0.007389197],"study_design_scores_gemma":[0.00014927262,0.00009770473,0.0026580084,0.0005629558,0.000045927332,0.0045536803,0.0021910488,0.00048484726,0.00035700836,0.012100472,0.97663945,0.00015971709],"about_ca_topic_score_codex":0.00541276,"about_ca_topic_score_gemma":0.0062134587,"teacher_disagreement_score":0.040539708,"about_ca_system_score_codex":0.002664756,"about_ca_system_score_gemma":0.003023021,"threshold_uncertainty_score":0.030811965},"labels":[],"label_agreement":null},{"id":"W2283816551","doi":"10.1001/jamaoncol.2015.6113","title":"Association of Pathologic Complete Response to Neoadjuvant Therapy in HER2-Positive Breast Cancer With Long-Term Outcomes","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":375,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University; University of Ottawa; BC Cancer Agency; McGill University; University of Calgary; St. Michael's Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Hazard ratio; Neoadjuvant therapy; Randomized controlled trial; Cancer; Clinical trial; Lapatinib; Trastuzumab; Confidence interval","score_opus":0.03141613759811938,"score_gpt":0.362242651247462,"score_spread":0.3308265136493426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283816551","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02001829,0.9700749,0.0012507972,0.0037054631,0.00038511265,0.0008032597,0.0023632974,0.00002015194,0.0013787114],"genre_scores_gemma":[0.5593934,0.41686383,0.007371257,0.0061260615,0.0023187313,0.003912063,0.0031338567,0.000044425444,0.0008363385],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9619083,0.019490337,0.011725382,0.0021209882,0.0043959827,0.00035901417],"domain_scores_gemma":[0.6077439,0.31317464,0.06631994,0.004897654,0.0070112613,0.00085260737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.047319286,0.0006451246,0.0037802856,0.003292089,0.0003263365,0.0026469384,0.001208903,0.0018780456,0.005382972],"category_scores_gemma":[0.1728763,0.00041428825,0.0056190533,0.005838444,0.0011343072,0.0029772285,0.00088251976,0.0017243039,0.00033535206],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073500643,0.00018015776,0.081761606,0.71346843,0.06786446,0.0002352956,0.0004378166,0.0008270187,0.00046878448,0.0016217106,0.005345002,0.12043961],"study_design_scores_gemma":[0.006197911,0.0038252345,0.2539845,0.4702706,0.21776187,0.001277228,0.00093436387,0.0018549316,0.0009435345,0.008178633,0.03451756,0.0002535472],"about_ca_topic_score_codex":0.0017356368,"about_ca_topic_score_gemma":0.0035998193,"teacher_disagreement_score":0.047319286,"about_ca_system_score_codex":0.002084461,"about_ca_system_score_gemma":0.003641363,"threshold_uncertainty_score":0.25025123},"labels":[],"label_agreement":null},{"id":"W2290458471","doi":"10.1001/jamaoncol.2015.6479","title":"Oncologic Drugs Advisory Committee Recommendations and Approval of Cancer Drugs by the US Food and Drug Administration","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Advisory committee; Food and drug administration; Family medicine; Drug approval; Clinical trial; Drug; Pharmacology; Internal medicine","score_opus":0.23354803218996642,"score_gpt":0.5189264427589264,"score_spread":0.28537841056895996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2290458471","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6444826,0.015651772,0.01329917,0.17077954,0.0019085582,0.0022181815,0.003588803,0.00016958198,0.14790183],"genre_scores_gemma":[0.96963084,0.0034668634,0.0076399995,0.010457391,0.0015023354,0.0011095903,0.0008783544,0.000055732522,0.0052589704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.81591624,0.13379888,0.015231846,0.004444431,0.026893308,0.0037152336],"domain_scores_gemma":[0.43082914,0.34474748,0.17796053,0.011547036,0.025504282,0.009411474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.08409985,0.00022032112,0.00030065418,0.0022545722,0.0028181875,0.002702073,0.0011303767,0.0022144923,0.007276229],"category_scores_gemma":[0.36253828,0.00040095474,0.00044596114,0.0028650314,0.0022963742,0.0026116997,0.003927158,0.0028756096,0.0011193847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012387579,0.0003519403,0.59742653,0.003567461,0.00023424835,0.0009969241,0.03091261,0.0009338274,0.0018784171,0.012913177,0.10545551,0.24409059],"study_design_scores_gemma":[0.00012245127,0.00036965375,0.6527722,0.0031538296,0.00013905406,0.0010688475,0.023554558,0.0018121831,0.001845391,0.0067095463,0.30827585,0.00017641595],"about_ca_topic_score_codex":0.0062910523,"about_ca_topic_score_gemma":0.010201314,"teacher_disagreement_score":0.08409985,"about_ca_system_score_codex":0.0035449245,"about_ca_system_score_gemma":0.009515535,"threshold_uncertainty_score":0.44476783},"labels":[],"label_agreement":null},{"id":"W2395076114","doi":"10.1001/jamaoncol.2016.0732","title":"Analysis of Body Mass Index and Mortality in Patients With Colorectal Cancer Using Causal Diagrams","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":184,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Underweight; Body mass index; Colorectal cancer; Population; Hazard ratio; Retrospective cohort study; Internal medicine; Cancer; Cohort study; Surgery; Overweight; Confidence interval","score_opus":0.018779623621373136,"score_gpt":0.3317732007112069,"score_spread":0.3129935770898338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395076114","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44967568,0.015888114,0.5150659,0.0050022355,0.0003257145,0.0009886104,0.007780693,0.001053024,0.0042200848],"genre_scores_gemma":[0.9353644,0.002679907,0.05826092,0.00020511681,0.00017916012,0.0005135437,0.0022025905,0.000039061157,0.0005552086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97717154,0.019113984,0.00090531266,0.0014513265,0.00110411,0.00025378139],"domain_scores_gemma":[0.6888531,0.28812963,0.015902162,0.0041957875,0.002227722,0.0006916925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030047214,0.0010528137,0.0011969255,0.009249398,0.000740699,0.0023363726,0.0012484441,0.001157306,0.005254366],"category_scores_gemma":[0.14093968,0.0008960903,0.0043080663,0.0049313707,0.0010315508,0.0026713465,0.0017408851,0.0010819652,0.00025794026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00090071204,0.00024343113,0.7780053,0.0011853927,0.009073462,0.00040110748,0.00056245964,0.11188572,0.00014717777,0.035997923,0.001997252,0.05960001],"study_design_scores_gemma":[0.00045114424,0.00036633515,0.090563454,0.0006962614,0.0047048167,0.00056616234,0.0004198231,0.7776027,0.00025014783,0.118607275,0.0056543956,0.00011756294],"about_ca_topic_score_codex":0.013072459,"about_ca_topic_score_gemma":0.008317049,"teacher_disagreement_score":0.030047214,"about_ca_system_score_codex":0.0017383811,"about_ca_system_score_gemma":0.0020014227,"threshold_uncertainty_score":0.1589067},"labels":[],"label_agreement":null},{"id":"W2403998898","doi":"10.1001/jamaoncol.2016.0494","title":"Genomic Alterations in Cell-Free DNA and Enzalutamide Resistance in Castration-Resistant Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":384,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"National Cancer Institute","keywords":"Enzalutamide; Prostate cancer; Medicine; Interquartile range; Oncology; Internal medicine; Cell-free fetal DNA; Prostate-specific antigen; Cancer; Androgen deprivation therapy; Androgen receptor; Biology; Genetics","score_opus":0.02452938334777873,"score_gpt":0.3308476599576475,"score_spread":0.30631827660986877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403998898","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813867,0.00077124574,0.000252586,0.00003513399,0.0000019377633,0.000013437026,0.00040899718,0.000014845614,0.0003631405],"genre_scores_gemma":[0.9991486,0.00016229723,0.00018416593,0.000026127705,0.0000020778414,0.000006860399,0.000253175,0.0000019608324,0.000214721],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99986064,0.000028346187,0.000009179063,0.000038795966,0.00004517184,0.000017847698],"domain_scores_gemma":[0.99973327,0.000054351018,0.0001228763,0.000013040053,0.00003770207,0.00003882959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016347297,0.0001594185,0.00017899263,0.00073316507,0.0001485457,0.00033157467,0.0001807006,0.00018726206,0.0013354098],"category_scores_gemma":[0.0005689616,0.00012711805,0.00007679101,0.0005800983,0.00022154415,0.00011643025,0.00016323714,0.00016366948,0.00009703413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013605175,0.00010108497,0.9322835,0.00012799741,0.00011470988,0.00067917065,0.00023207706,0.00061488675,0.039010495,0.000058631842,0.00025779541,0.025159076],"study_design_scores_gemma":[0.000012790684,0.0002035912,0.9960433,0.0000070458577,0.000024140936,0.0008190669,0.00008796439,0.00024236011,0.0021428908,0.000030039011,0.0003825535,0.0000042722368],"about_ca_topic_score_codex":0.009839244,"about_ca_topic_score_gemma":0.023632538,"teacher_disagreement_score":0.009839244,"about_ca_system_score_codex":0.00056126685,"about_ca_system_score_gemma":0.00048571412,"threshold_uncertainty_score":0.019563913},"labels":[],"label_agreement":null},{"id":"W2409177147","doi":"10.1001/jamaoncol.2016.0149","title":"Radical Cystectomy and the Multidisciplinary Management of Muscle-Invasive Bladder Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.019787550496334384,"score_gpt":0.3232224669575325,"score_spread":0.3034349164611981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409177147","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.21997303,0.5301126,0.0022756488,0.1376782,0.0037528102,0.00009307865,0.00025688834,0.00021278014,0.105644904],"genre_scores_gemma":[0.8105068,0.16415294,0.0018265581,0.008021713,0.0054796636,0.000057109588,0.00017948278,0.000025351193,0.009750328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997209,0.0001068617,0.000019251043,0.000026890288,0.00006211617,0.00006391192],"domain_scores_gemma":[0.9990995,0.000250573,0.00017327775,0.000017787333,0.000047888552,0.00041095985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006416524,0.00014242425,0.00016654794,0.0004436319,0.00047661038,0.00049408065,0.0002799183,0.00049951434,0.0068341424],"category_scores_gemma":[0.0025004095,0.00010043166,0.000329603,0.00044452443,0.0004469793,0.00058847334,0.00064336514,0.0012307175,0.00043600323],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054773345,0.0005684554,0.0560762,0.0011884293,0.00014485366,0.0072295265,0.000713742,0.001209148,0.0009185642,0.003718009,0.11085967,0.8168256],"study_design_scores_gemma":[0.00035360677,0.0021952,0.6063183,0.0048203175,0.00020514327,0.0827472,0.004629787,0.001515849,0.00090152747,0.010552018,0.28560153,0.00015946609],"about_ca_topic_score_codex":0.0031191348,"about_ca_topic_score_gemma":0.014472316,"teacher_disagreement_score":0.0068341424,"about_ca_system_score_codex":0.0007003837,"about_ca_system_score_gemma":0.001953682,"threshold_uncertainty_score":0.022862494},"labels":[],"label_agreement":null},{"id":"W2540613192","doi":"10.1001/jamaoncol.2016.4877","title":"Systemic Therapy for Previously Untreated Advanced <i>BRAF</i>-Mutated Melanoma","year":2016,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Hazard ratio; Oncology; Internal medicine; Melanoma; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; Adverse effect; MEK inhibitor; Progression-free survival; Overall survival; Cancer research; MAPK/ERK pathway","score_opus":0.028164773284773216,"score_gpt":0.3337088176855344,"score_spread":0.30554404440076116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540613192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003565024,0.99260956,0.0004404268,0.00096261606,0.00038365173,0.0005138162,0.0004474485,0.000015440093,0.0010619403],"genre_scores_gemma":[0.1266354,0.8632406,0.0032283713,0.003131457,0.0012305552,0.0014590443,0.00052747823,0.000017637238,0.00052942656],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98988277,0.0059925867,0.0023761217,0.0005981555,0.0010248505,0.00012557376],"domain_scores_gemma":[0.9620815,0.03016008,0.0060050916,0.00038676706,0.0011505095,0.00021599772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010649672,0.0009750605,0.006457215,0.0022463708,0.00026102926,0.002238083,0.00086285645,0.0016769496,0.0042391447],"category_scores_gemma":[0.03772457,0.0004234585,0.007275024,0.0021681169,0.00060083665,0.0014275502,0.0005091208,0.0017771891,0.00033840872],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006304733,0.00011400321,0.0021537635,0.7904836,0.06015549,0.00012213776,0.00009728602,0.00048219296,0.00066534313,0.000663262,0.004377108,0.1343811],"study_design_scores_gemma":[0.023156038,0.0063490155,0.012633293,0.5759154,0.33508885,0.00068077334,0.0003227634,0.0012205861,0.0015156504,0.0038977484,0.039109625,0.00011027996],"about_ca_topic_score_codex":0.0023824638,"about_ca_topic_score_gemma":0.004886287,"teacher_disagreement_score":0.010649672,"about_ca_system_score_codex":0.0016268094,"about_ca_system_score_gemma":0.0025279531,"threshold_uncertainty_score":0.0563215},"labels":[],"label_agreement":null},{"id":"W2546973056","doi":"10.1001/jamaoncol.2016.4884","title":"Association of Polymorphisms in <i>FCGR2A</i> and <i>FCGR3A</i> With Degree of Trastuzumab Benefit in the Adjuvant Treatment of ERBB2/HER2–Positive Breast Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":113,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; U.S. Department of Health and Human Services","keywords":"Medicine; Trastuzumab; Internal medicine; Oncology; Breast cancer; Regimen; Cyclophosphamide; Cohort; Cancer; Chemotherapy","score_opus":0.02793474528304624,"score_gpt":0.3318939157411339,"score_spread":0.3039591704580877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546973056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989427,0.00030114775,0.00017784772,0.000045766552,0.000005035855,0.000013875127,0.0002428705,0.0000026210796,0.00026815612],"genre_scores_gemma":[0.9995523,0.00005320892,0.000097852375,0.00003763379,0.00000896117,0.000008133646,0.00016774217,0.0000023934804,0.000071697184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99942374,0.00022844503,0.000067758,0.00014835462,0.00008072865,0.000050880604],"domain_scores_gemma":[0.99889565,0.0003827219,0.00048873347,0.00011823077,0.000036694746,0.00007797544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011148704,0.00020846487,0.00024776784,0.00026744636,0.00020766103,0.0003102657,0.00022848076,0.00039152562,0.0008617489],"category_scores_gemma":[0.0017255684,0.00012625298,0.00035945073,0.00048606796,0.00037251605,0.00013402964,0.00011711126,0.00036256414,0.00009974514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069908286,0.00013660482,0.9769693,0.000032201173,0.0007309063,0.00017133314,0.000060314353,0.0005577818,0.008721365,0.00011253406,0.0002538225,0.0052631083],"study_design_scores_gemma":[0.00033021253,0.0007436492,0.99531305,0.000010947914,0.0003681506,0.0005546221,0.000031100295,0.00063257763,0.001350192,0.00011597798,0.0005409913,0.000008528724],"about_ca_topic_score_codex":0.0030238733,"about_ca_topic_score_gemma":0.0033033343,"teacher_disagreement_score":0.0030238733,"about_ca_system_score_codex":0.00025297928,"about_ca_system_score_gemma":0.00024240218,"threshold_uncertainty_score":0.0060124993},"labels":[],"label_agreement":null},{"id":"W2560322684","doi":"10.1001/jamaoncol.2016.5688","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":6310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Ottawa Hospital; University of British Columbia","funders":"National Heart, Lung, and Blood Institute; Medical Research Council; Audrey and Theodor Geisel School of Medicine at Dartmouth; Norris Cotton Cancer Center; University of California, Irvine; Tehran University of Medical Sciences and Health Services; National Institutes of Health; Western Sydney University; Mekelle University; Universität Ulm; Addis Ababa University; Northumbria University; University of Gondar; National Research University Higher School of Economics; Seoul National University; Universidade do Porto; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; University of Haifa; Jimma University; Haramaya University; Universitetet i Bergen; Samfundet Folkhälsan; Shiraz University of Medical Sciences; University Of Nigeria Nsukka; Inyuvesi Yakwazulu-Natali; Massachusetts General Hospital; Universidade Federal de Minas Gerais; Wuhan University; National Center for Chronic Disease Prevention and Health Promotion; Jordan University of Science and Technology; Ahmadu Bello University; Fudan University; Universität Bielefeld; Kosin University; Umweltbundesamt; Newcastle University; United Nations Population Fund; Karolinska Institutet; Yonsei University; Pacific Institute for Research and Evaluation; Birzeit University; Trường Đại học Duy Tân; Iran University of Medical Sciences; Curtin University of Technology; Dartmouth College; Centers for Disease Control and Prevention; National Institute on Minority Health and Health Disparities; Jackson State University; Johns Hopkins University; Alborz University of Medical Sciences; National Institute for Health and Care Research; World Health Organization; Shiraz University","keywords":"Medicine; Years of potential life lost; Demography; Cancer; Life expectancy; Population; Cancer registry; Incidence (geometry); Lung cancer; Mortality rate; Gerontology; Environmental health; Surgery; Oncology; Internal medicine","score_opus":0.11305784042264108,"score_gpt":0.4077724964717964,"score_spread":0.29471465604915537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2560322684","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015540562,0.881336,0.0009996968,0.0030963935,0.000448739,0.00033758066,0.092375256,0.00010502686,0.0057607912],"genre_scores_gemma":[0.1687265,0.7560357,0.0031311603,0.0018145875,0.00047663995,0.0011275242,0.06583821,0.000033311262,0.002816466],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978071,0.00048303482,0.0005180547,0.00027534098,0.0007901086,0.0001264427],"domain_scores_gemma":[0.9969008,0.00039162918,0.0012069582,0.000045596622,0.0013069246,0.00014818544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024875754,0.0006041114,0.0010854743,0.0058725635,0.0003070892,0.0008263387,0.0007019118,0.00039787023,0.0031199742],"category_scores_gemma":[0.008345196,0.0003123748,0.0025807188,0.008826184,0.00026958348,0.00092616555,0.0010203642,0.00090160995,0.0005851124],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060186797,0.000062555635,0.2207491,0.110582456,0.008183082,0.00012699516,0.00049254636,0.0023933009,0.00032538056,0.002156175,0.22160637,0.43272018],"study_design_scores_gemma":[0.00031500607,0.00037428807,0.5996193,0.066055216,0.013238791,0.00072111236,0.0011333228,0.0014573277,0.0005541318,0.00204187,0.3143757,0.00011395344],"about_ca_topic_score_codex":0.061960198,"about_ca_topic_score_gemma":0.12188993,"teacher_disagreement_score":0.061960198,"about_ca_system_score_codex":0.0027774705,"about_ca_system_score_gemma":0.003854521,"threshold_uncertainty_score":0.123199105},"labels":[],"label_agreement":null},{"id":"W2566317011","doi":"10.1001/jamaoncol.2016.5478","title":"The <i>KRAS</i>-Variant and Cetuximab Response in Head and Neck Squamous Cell Cancer","year":2016,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Dental and Craniofacial Research; National Cancer Institute","keywords":"Cetuximab; KRAS; Medicine; Oncology; Internal medicine; Head and neck squamous-cell carcinoma; Head and neck cancer; Cancer; Colorectal cancer; Radiation therapy","score_opus":0.020109965153768745,"score_gpt":0.3258279171779345,"score_spread":0.3057179520241658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566317011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976761,0.0007194095,0.0002630261,0.00007238573,0.000012362676,0.00013592273,0.00049067906,0.0000059093063,0.0006242933],"genre_scores_gemma":[0.9989021,0.0001255862,0.00019069551,0.000058470996,0.000009629767,0.000092048256,0.00040348875,0.0000028512811,0.00021501655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926585,0.00036159938,0.00009667589,0.000116275565,0.00011989118,0.00003973034],"domain_scores_gemma":[0.9988789,0.00046529918,0.00040959296,0.000076136486,0.00008233385,0.000087773995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020738917,0.00015571488,0.00035494711,0.00029320476,0.00015388281,0.0003030245,0.0002820327,0.000441687,0.002303358],"category_scores_gemma":[0.0025891685,0.00014456557,0.00040592943,0.00045114118,0.00019050158,0.00020797926,0.00022757414,0.0002860266,0.00026406735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011672548,0.00022168324,0.9706243,0.00021215042,0.00031240977,0.000101886166,0.000050408264,0.0004949583,0.0019526244,0.000050404997,0.00048373247,0.013822836],"study_design_scores_gemma":[0.00052227103,0.0029635238,0.99248123,0.00003229836,0.0002481201,0.00042243305,0.00004739242,0.0010628749,0.0011713936,0.00009450787,0.0009457067,0.0000082993365],"about_ca_topic_score_codex":0.0007569156,"about_ca_topic_score_gemma":0.0014445459,"teacher_disagreement_score":0.002303358,"about_ca_system_score_codex":0.0003179459,"about_ca_system_score_gemma":0.0004386122,"threshold_uncertainty_score":0.01096797},"labels":[],"label_agreement":null},{"id":"W2574800639","doi":"10.1001/jamaoncol.2016.6020","title":"Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Calgary","funders":"National Cancer Institute","keywords":"Medicine; Temozolomide; Recursive partitioning; Oncology; Hazard ratio; Proportional hazards model; Internal medicine; Survivin; Immunohistochemistry; Glioblastoma; Multivariate analysis; Glioma; Confidence interval; Cancer research; Radiation therapy; Cancer","score_opus":0.03271598446077441,"score_gpt":0.3546530358862001,"score_spread":0.3219370514254257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2574800639","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49601066,0.0010202328,0.49724296,0.0019398432,0.00009605818,0.00031117583,0.00093538646,0.000596049,0.0018475845],"genre_scores_gemma":[0.9462255,0.00035645592,0.048566755,0.00017895376,0.00006883181,0.0003889027,0.0012459807,0.00007417282,0.0028943948],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99903,0.000563203,0.000029458635,0.00018576822,0.00008836187,0.00010324749],"domain_scores_gemma":[0.9973883,0.0017086626,0.00034905248,0.000098030636,0.00035761367,0.00009828291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035198808,0.001046466,0.0012702951,0.0009725324,0.00047437495,0.0010190329,0.0014043688,0.00064732635,0.0014448782],"category_scores_gemma":[0.004785883,0.00037426275,0.0015355912,0.00036247188,0.0004909128,0.0006002205,0.0006996615,0.0012934487,0.00046499717],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003360388,0.000116024414,0.023346849,0.000057855766,0.00037262356,0.00022442297,0.00018532499,0.9322745,0.0015870783,0.006223873,0.0020147585,0.03326069],"study_design_scores_gemma":[0.000013054018,0.000036190755,0.0020726074,0.0000054470206,0.00003148914,0.000028430759,0.00001136305,0.9952579,0.00006575003,0.0022687244,0.00020028287,0.000008677179],"about_ca_topic_score_codex":0.022271333,"about_ca_topic_score_gemma":0.01584383,"teacher_disagreement_score":0.022271333,"about_ca_system_score_codex":0.0015199793,"about_ca_system_score_gemma":0.0014459353,"threshold_uncertainty_score":0.04428339},"labels":[],"label_agreement":null},{"id":"W2586519388","doi":"10.1001/jamaoncol.2016.6728","title":"Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":126,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"National Cancer Institute; U.S. Department of Veterans Affairs","keywords":"Medicine; GiST; Imatinib mesylate; Internal medicine; Imatinib; Oncology; Clinical trial; Clinical endpoint; PDGFRA; Randomized controlled trial; Survival rate; Gastroenterology; Stromal cell","score_opus":0.08707842160318213,"score_gpt":0.35515958213784143,"score_spread":0.2680811605346593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2586519388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887446,0.0036827354,0.0022156585,0.00024444907,0.00008881425,0.000089452544,0.002190219,0.000033399494,0.0027106213],"genre_scores_gemma":[0.9971564,0.0002531422,0.0007126038,0.000079603175,0.000041259045,0.00008617792,0.0013009184,0.000010888628,0.0003589305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99524814,0.0018789017,0.00089991605,0.000514042,0.0011304594,0.00032857264],"domain_scores_gemma":[0.97629607,0.00970011,0.008011377,0.0014979267,0.0030601914,0.001434341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00907755,0.00035189287,0.00058881333,0.0010833704,0.0003201322,0.0009499513,0.00054471876,0.0008090374,0.001929695],"category_scores_gemma":[0.016576076,0.00017276815,0.00044682363,0.0007044338,0.00037441903,0.0009293464,0.000614416,0.00083353685,0.0005122513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011112848,0.00029355256,0.96554804,0.00011484506,0.00054350024,0.00014934146,0.00008987562,0.0006217095,0.0025708193,0.000084191524,0.00050485006,0.018366372],"study_design_scores_gemma":[0.00017797122,0.0048958007,0.98400795,0.00004854598,0.00055027986,0.0007017283,0.00012497287,0.0024758084,0.004419985,0.0002487763,0.0023121012,0.000036081816],"about_ca_topic_score_codex":0.00023625989,"about_ca_topic_score_gemma":0.00060209783,"teacher_disagreement_score":0.00907755,"about_ca_system_score_codex":0.0004902694,"about_ca_system_score_gemma":0.00027686416,"threshold_uncertainty_score":0.04800725},"labels":[],"label_agreement":null},{"id":"W2592294322","doi":"10.1001/jamaoncol.2016.5945","title":"Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Telomeres, Telomerase, and Senescence","field":"Medicine","cited_by":529,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; Public Health Ontario; University of Toronto; Mount Sinai Hospital","funders":"National Institute of General Medical Sciences; National Human Genome Research Institute; National Health and Medical Research Council; National Center for Advancing Translational Sciences; Medical Research Council; National Heart, Lung, and Blood Institute; Anschutz Medical Campus, University of Colorado; Health Research Council of New Zealand; University of Texas Health Science Center at San Antonio; University of California, San Diego; National Institutes of Health; Bundesministerium für Bildung und Forschung; National Institute for Health and Care Research; Vincent Fairfax Family Foundation; World Health Organization; Wellcome Trust; Cancer Research UK; Morehouse School of Medicine; Johns Hopkins University; National Jewish Health; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; National Institute of Neurological Disorders and Stroke; British Heart Foundation; University of Pittsburgh; University of Minnesota; Brigham and Women's Hospital; Canadian Institutes of Health Research; Cancerfonden; NHLBI Division of Intramural Research; Motor Neurone Disease Association; National Institute of Arthritis and Musculoskeletal and Skin Diseases; National Institute of Diabetes and Digestive and Kidney Diseases; Temple University; South London and Maudsley NHS Foundation Trust; Deutsche Forschungsgemeinschaft; National Cancer Institute; University of Bristol; GlaxoSmithKline; King's College London; World Cancer Research Fund; American Heart Association","keywords":"Medicine; Telomere; Cancer; Oncology; Internal medicine; Genetics; DNA; Biology","score_opus":0.014487709622223592,"score_gpt":0.3185083507505348,"score_spread":0.30402064112831123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592294322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9442385,0.029530408,0.012111126,0.0017138254,0.00017709198,0.00017253244,0.008858738,0.00010499689,0.0030928554],"genre_scores_gemma":[0.9924936,0.002659259,0.0028291915,0.0001311694,0.00008937072,0.0000569866,0.0015023259,0.000011394646,0.0002266644],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99506205,0.002309813,0.000850035,0.0009426328,0.0007095477,0.00012587474],"domain_scores_gemma":[0.9693637,0.016844602,0.010585621,0.001932188,0.00089740736,0.00037642624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066635385,0.00027905923,0.00045829083,0.0015090924,0.00021285651,0.00055585813,0.0005610759,0.00043301517,0.002740161],"category_scores_gemma":[0.030562004,0.00019360946,0.0013125569,0.0026590226,0.0005579686,0.0005553029,0.0005240164,0.0006396787,0.00015013014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092916354,0.000029530893,0.97712874,0.0010080974,0.0031732088,0.00008534216,0.00008584556,0.00064458634,0.00078983,0.0004732237,0.00037826283,0.015274291],"study_design_scores_gemma":[0.000102414895,0.00040877485,0.9918275,0.00027720406,0.0018709821,0.00044406886,0.00007980188,0.001088548,0.0006559114,0.0016339171,0.0015897593,0.00002107841],"about_ca_topic_score_codex":0.0017395722,"about_ca_topic_score_gemma":0.0021850565,"teacher_disagreement_score":0.0066635385,"about_ca_system_score_codex":0.00033116274,"about_ca_system_score_gemma":0.00066257274,"threshold_uncertainty_score":0.03524065},"labels":[],"label_agreement":null},{"id":"W2607785336","doi":"10.1001/jamaoncol.2017.0502","title":"Association Between <i>SLC16A5</i> Genetic Variation and Cisplatin-Induced Ototoxic Effects in Adult Patients With Testicular Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver General Hospital; BC Cancer Agency; Princess Margaret Cancer Centre; University of Toronto; BC Children's Hospital; University Health Network; University of British Columbia","funders":"","keywords":"Medicine; Testicular cancer; Interquartile range; Cisplatin; Pharmacogenomics; Internal medicine; Oncology; Odds ratio; Ototoxicity; Chemotherapy; Cancer; Pharmacogenetics; Bioinformatics; Genotype; Pharmacology; Genetics; Biology; Gene","score_opus":0.01883450593665139,"score_gpt":0.29155629906533276,"score_spread":0.2727217931286814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2607785336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989115,0.00018476883,0.00012503861,0.00004058012,0.000003377234,0.000011091945,0.00047491567,0.0000037849275,0.00024504142],"genre_scores_gemma":[0.9995437,0.000046964506,0.00009007193,0.000024140674,0.0000038200387,0.0000047321364,0.00023204206,0.0000010903194,0.000053344636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974006,0.000040216866,0.000038690938,0.00008368743,0.000058841382,0.0000383662],"domain_scores_gemma":[0.99928963,0.0001272902,0.00036624068,0.000045585737,0.000085050764,0.00008627387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000264473,0.00016390452,0.00019178262,0.00029349368,0.00027403136,0.00025792303,0.00020494104,0.00018690673,0.0017966569],"category_scores_gemma":[0.0011365587,0.00008588845,0.00022481856,0.00059618504,0.000236504,0.00012595045,0.00016922735,0.00021452601,0.00012197042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094206036,0.000008151612,0.9976357,0.000009275615,0.000039958297,0.00011278072,0.000036541915,0.00003731605,0.00091701356,0.000013825374,0.000089736815,0.0010054505],"study_design_scores_gemma":[0.0000100972175,0.0000894939,0.99851197,0.0000059212834,0.000032063042,0.000706673,0.00007462122,0.00014049777,0.00022520595,0.000018761191,0.000182204,0.0000024379146],"about_ca_topic_score_codex":0.017269172,"about_ca_topic_score_gemma":0.02594601,"teacher_disagreement_score":0.017269172,"about_ca_system_score_codex":0.0003758325,"about_ca_system_score_gemma":0.00046595375,"threshold_uncertainty_score":0.034337282},"labels":[],"label_agreement":null},{"id":"W2613162682","doi":"10.1001/jamaoncol.2017.0751","title":"Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":317,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Genome British Columbia","funders":"","keywords":"Medicine; Prostate cancer; Retrospective cohort study; Androgen deprivation therapy; Oncology; Internal medicine; Prospective cohort study; Prostate; Subtyping; Metastasis; Cancer; Pathology","score_opus":0.03806270671449913,"score_gpt":0.35084125963257196,"score_spread":0.3127785529180728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613162682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99834764,0.00049627497,0.00037807212,0.000054158318,0.000005919479,0.000006382794,0.0003312029,0.000007872503,0.00037233846],"genre_scores_gemma":[0.9991567,0.00007413907,0.00019177246,0.00001719138,0.0000062579866,0.000003185513,0.00048656424,0.0000022389981,0.00006190382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99949455,0.00015704098,0.000070245456,0.00010739834,0.0001121845,0.000058503672],"domain_scores_gemma":[0.9981652,0.00044906524,0.0006919618,0.00024363479,0.00019849442,0.00025171402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000981666,0.00018195168,0.00029544288,0.00054537435,0.00024716547,0.00061101525,0.00027719486,0.000355998,0.0010804855],"category_scores_gemma":[0.003116482,0.00010864529,0.00025049466,0.0005349605,0.0002733227,0.00027641605,0.00037614524,0.00037994538,0.00018922548],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010724203,0.000004850074,0.9975821,0.000004622076,0.000029392973,0.000011259009,0.000007929578,0.00004841089,0.00041917054,0.000010680544,0.000043823144,0.001730353],"study_design_scores_gemma":[0.000004525762,0.00007262119,0.9982046,0.0000068381046,0.000034710734,0.00033927202,0.000058109526,0.00071205193,0.00029598194,0.000054958946,0.00021279414,0.0000035635596],"about_ca_topic_score_codex":0.0016297679,"about_ca_topic_score_gemma":0.003580124,"teacher_disagreement_score":0.0016297679,"about_ca_system_score_codex":0.00018568039,"about_ca_system_score_gemma":0.0003316357,"threshold_uncertainty_score":0.0051915646},"labels":[],"label_agreement":null},{"id":"W2740476111","doi":"10.1001/jamaoncol.2017.2085","title":"Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency; University of Ottawa; Ottawa Hospital; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Lapatinib; Taxane; Trastuzumab; Oncology; Internal medicine; Metastatic breast cancer; Breast cancer; Docetaxel; Tumor-infiltrating lymphocytes; Cancer; Immunotherapy","score_opus":0.01663913112658683,"score_gpt":0.33253364601581675,"score_spread":0.3158945148892299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740476111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770796,0.0013279277,0.00012668587,0.000103775674,0.00001095558,0.00002970094,0.00020632568,0.0000060092684,0.00048061385],"genre_scores_gemma":[0.9993468,0.00014437726,0.00011799473,0.000032334563,0.00001992808,0.000015772199,0.00020267506,0.000001001201,0.000119187556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99974614,0.000108064916,0.000018592009,0.000046180347,0.00004426845,0.00003674648],"domain_scores_gemma":[0.9989864,0.00033947913,0.0002744341,0.000049932994,0.000102338476,0.0002474803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012146842,0.00035931318,0.0002890776,0.00030681325,0.00020016437,0.00038181353,0.00031336898,0.00036384753,0.0009132292],"category_scores_gemma":[0.0025259699,0.00009801674,0.00021724676,0.00032011786,0.00031487833,0.00027650144,0.00024920187,0.0004460319,0.00013728734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005212232,0.00014095282,0.97438735,0.00005563376,0.00011640864,0.000046365847,0.00003525135,0.00075282564,0.000815951,0.000018326533,0.00033288178,0.018085895],"study_design_scores_gemma":[0.00053274224,0.0027146335,0.9905973,0.000040755338,0.0002787011,0.0003279755,0.00010278325,0.0033887855,0.00076996227,0.00018779415,0.0010456955,0.000012889123],"about_ca_topic_score_codex":0.003684557,"about_ca_topic_score_gemma":0.008763202,"teacher_disagreement_score":0.003684557,"about_ca_system_score_codex":0.00046231595,"about_ca_system_score_gemma":0.00051770627,"threshold_uncertainty_score":0.0073261857},"labels":[],"label_agreement":null},{"id":"W2740889547","doi":"10.1001/jamaoncol.2017.2023","title":"Demonstrating Noninferiority of Accelerated Radiotherapy With Panitumumab vs Standard Radiotherapy With Cisplatin in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma—Reply","year":2017,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Oncology; Radiation therapy; Internal medicine; Cisplatin; Panitumumab; Head and neck squamous-cell carcinoma; Head and neck; Stage (stratigraphy); Head and neck cancer; Overall survival; Cetuximab; Chemotherapy; Surgery; Cancer","score_opus":0.02526348135416973,"score_gpt":0.3141709108334444,"score_spread":0.28890742947927467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2740889547","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029244588,0.0013992913,0.00023614371,0.97065824,0.023321897,0.000043039552,0.0007046816,0.000060019334,0.000652237],"genre_scores_gemma":[0.015239558,0.00078038697,0.0005316874,0.9525307,0.028467197,0.00018137878,0.00018823466,0.00005391229,0.0020269786],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935422,0.00368903,0.0010034754,0.0006254608,0.00080541207,0.0003345039],"domain_scores_gemma":[0.9334956,0.05648227,0.0023723894,0.0015390143,0.0047197514,0.0013909173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01562754,0.0006120501,0.0019942988,0.00074097613,0.0015110667,0.0015310622,0.0020976837,0.016628517,0.0062546856],"category_scores_gemma":[0.07413662,0.0006405208,0.0017221508,0.0009820211,0.0022433964,0.0021150713,0.0010790789,0.018476104,0.0035574532],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018298705,0.00010890493,0.0077144452,0.00029773678,0.00027556746,0.0007047967,0.00022080513,0.00016456515,0.0003756681,0.0013146551,0.96646065,0.020532312],"study_design_scores_gemma":[0.00781273,0.0035904057,0.04242146,0.001204048,0.0026391295,0.0035974095,0.00208577,0.0036074398,0.0049540396,0.021318715,0.9061064,0.0006623783],"about_ca_topic_score_codex":0.003527759,"about_ca_topic_score_gemma":0.0046848366,"teacher_disagreement_score":0.016628517,"about_ca_system_score_codex":0.0020653787,"about_ca_system_score_gemma":0.0027604287,"threshold_uncertainty_score":0.08264738},"labels":[],"label_agreement":null},{"id":"W2743199111","doi":"10.1001/jamaoncol.2017.2319","title":"Association of Systemic Inflammation and Sarcopenia With Survival in Nonmetastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":424,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Sarcopenia; Internal medicine; Body mass index; Cancer; Colorectal cancer; Systemic inflammation; Overweight; Oncology; Inflammation; Surrogate endpoint; Prospective cohort study; Gastroenterology","score_opus":0.029169919706434427,"score_gpt":0.3635976434972987,"score_spread":0.3344277237908643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2743199111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988244,0.00044001025,0.00006362017,0.000056629433,0.00000481391,0.0000044619155,0.00037582841,0.000003061294,0.00022723844],"genre_scores_gemma":[0.9995284,0.000078373036,0.000045526504,0.000009147007,0.000006933239,0.0000037959287,0.00026030137,4.6541012e-7,0.00006703703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997805,0.000062082734,0.000024827803,0.000054624215,0.00004409578,0.000033880962],"domain_scores_gemma":[0.99904007,0.00013261633,0.0005194245,0.000049949394,0.00011336789,0.00014452869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039516436,0.00017579988,0.00023359776,0.00031029707,0.00018355953,0.0002575397,0.00014481183,0.00020234945,0.0011699843],"category_scores_gemma":[0.001426584,0.00011873294,0.00021529442,0.0005461271,0.00017176747,0.00017580726,0.00022447437,0.0002747838,0.000093501985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007014232,0.000008211523,0.99911755,0.000007933797,0.000017782433,0.000012901548,0.0000056041204,0.000025290014,0.00005498776,0.0000021683175,0.00005024577,0.00062716124],"study_design_scores_gemma":[0.0000053237345,0.000060375118,0.9995871,0.000003750108,0.00001526164,0.00008095473,0.000016430302,0.00014941674,0.000021255883,0.0000060121642,0.00005307556,0.0000010536046],"about_ca_topic_score_codex":0.0026795785,"about_ca_topic_score_gemma":0.0058402764,"teacher_disagreement_score":0.0026795785,"about_ca_system_score_codex":0.00017871892,"about_ca_system_score_gemma":0.00022350415,"threshold_uncertainty_score":0.0053279996},"labels":[],"label_agreement":null},{"id":"W2753140990","doi":"10.1001/jamaoncol.2017.2579","title":"Effect of Modified Vaccinia Ankara–5T4 and Low-Dose Cyclophosphamide on Antitumor Immunity in Metastatic Colorectal Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"Academy of Medical Sciences; Cancer Research UK; Wellcome Trust","keywords":"Medicine; Cyclophosphamide; Colorectal cancer; Randomized controlled trial; Internal medicine; Clinical endpoint; Modified vaccinia Ankara; Chemotherapy; Oncology; Vaccinia; Cancer; Gastroenterology","score_opus":0.013369444290487666,"score_gpt":0.3174498981780427,"score_spread":0.30408045388755506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2753140990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979261,0.00092805724,0.00013766637,0.0001348702,0.000104484345,0.00034133927,0.000043694385,0.000018983948,0.00036477332],"genre_scores_gemma":[0.9982445,0.0004283962,0.00042652423,0.00012547444,0.0000891439,0.00028127345,0.00007783771,0.000003029752,0.00032385957],"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9994635,0.00030139615,0.00004022419,0.000065739965,0.000039851868,0.00008931959],"domain_scores_gemma":[0.9990664,0.00029041964,0.00019302424,0.000061308085,0.000028154329,0.00036073785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012337134,0.00068013027,0.0013614058,0.00029942903,0.00026170755,0.00051412283,0.00059883314,0.00077184616,0.0021071236],"category_scores_gemma":[0.001277026,0.00040354114,0.0008548431,0.00023150623,0.0008237314,0.000534583,0.0003676477,0.0016042298,0.0001852821],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.86508036,0.04888913,0.0026415002,0.00055839954,0.000741208,0.00009180741,0.00007194441,0.0013732599,0.0322578,0.00021181928,0.0006954858,0.047387343],"study_design_scores_gemma":[0.31741068,0.6655448,0.006090677,0.000043147124,0.00062273105,0.00012943636,0.000028902485,0.0019420716,0.0073759775,0.00015413872,0.0006386789,0.000018745732],"about_ca_topic_score_codex":0.00050311495,"about_ca_topic_score_gemma":0.0014025198,"teacher_disagreement_score":0.0021071236,"about_ca_system_score_codex":0.0005091007,"about_ca_system_score_gemma":0.0010195611,"threshold_uncertainty_score":0.007049024},"labels":[],"label_agreement":null},{"id":"W2761031851","doi":"10.1001/jamaoncol.2017.3055","title":"The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2020,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Hospital for Sick Children; SickKids Foundation; University of Manitoba","funders":"Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Johns Hopkins Bloomberg School of Public Health; Rede de Química e Tecnologia; Western Sydney University; Ingham Institute for Applied Medical Research; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Universität Ulm; Laboratório Associado para a Química Verde; Golestan University of Medical Sciences; National Research University Higher School of Economics; Texas Children's Hospital; Universitetet i Oslo; Universitetet i Bergen; Jimma University; Haramaya University; Seoul National University; Alborz University of Medical Sciences; Mekelle University; Queensland University of Technology; Universität Bielefeld; Public Health Foundation of India; Karolinska Institutet; Yonsei University; All-India Institute of Medical Sciences; Iran University of Medical Sciences; Wuhan University; Jordan University of Science and Technology; Johns Hopkins University; University of Washington; Imperial College London; Inyuvesi Yakwazulu-Natali; Fogarty International Center; Universidade do Porto; Uniwersytet Jagielloński Collegium Medicum; Case Western Reserve University; Tehran University of Medical Sciences and Health Services; Norwegian Institute of Public Health; Centers for Disease Control and Prevention; Jackson State University; Universitetet i Tromsø; Universität Basel; College of Medicine, Seoul National University; Sabin Vaccine Institute","keywords":"Medicine; Years of potential life lost; Life expectancy; Liver cancer; Cancer; Incidence (geometry); Mortality rate; Demography; Disease burden; Standardized mortality ratio; Population; Environmental health; Internal medicine","score_opus":0.1713678529679771,"score_gpt":0.40534369956053434,"score_spread":0.23397584659255724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761031851","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08921859,0.635354,0.005568743,0.028424209,0.0029384503,0.00037471636,0.21813704,0.0004362617,0.019548057],"genre_scores_gemma":[0.5340471,0.36261877,0.0064074215,0.010307499,0.0025009369,0.0005902594,0.07958955,0.00010304378,0.003835311],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983961,0.00047142085,0.00035411198,0.00026395495,0.00038043965,0.00013405578],"domain_scores_gemma":[0.9980956,0.000343546,0.00070699665,0.00007825195,0.0006506531,0.00012508538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002006794,0.00043546344,0.00063743425,0.0023521741,0.00026977505,0.00094421324,0.0005760152,0.0004846301,0.0063106106],"category_scores_gemma":[0.0064254445,0.00026070792,0.0020180466,0.004076229,0.00033013697,0.0010562973,0.0015227274,0.0008506933,0.0009371105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007675144,0.00005179924,0.22016843,0.04924389,0.004899247,0.0002596231,0.0010863709,0.0026664182,0.0009191184,0.0061219656,0.20738888,0.50642675],"study_design_scores_gemma":[0.00016008313,0.00030531953,0.5734108,0.030097434,0.0053745112,0.001338242,0.0014693061,0.0019885094,0.0009336218,0.0057908176,0.37900302,0.00012828593],"about_ca_topic_score_codex":0.05087737,"about_ca_topic_score_gemma":0.07784421,"teacher_disagreement_score":0.05087737,"about_ca_system_score_codex":0.0021616719,"about_ca_system_score_gemma":0.0039295126,"threshold_uncertainty_score":0.10116243},"labels":[],"label_agreement":null},{"id":"W2765953690","doi":"10.1001/jamaoncol.2017.3290","title":"Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":404,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Royal Alexandra Hospital; Vancouver General Hospital; Alberta Health Services; University of British Columbia; University of Calgary","funders":"National Center for Advancing Translational Sciences; Cancer Research UK; National Cancer Institute; National Center for Research Resources; Fogarty International Center; Francis Crick Institute","keywords":"Medicine; Tumor-infiltrating lymphocytes; Serous fluid; Oncology; CD8; Internal medicine; Ovarian cancer; Survival analysis; Immunotherapy; Cancer; Immune system; Immunology","score_opus":0.01761508240589437,"score_gpt":0.30840041665345425,"score_spread":0.29078533424755987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765953690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99933213,0.00020891405,0.00009311591,0.0000350937,0.0000029665075,0.000004224762,0.00014391627,0.0000062083222,0.00017334273],"genre_scores_gemma":[0.99968445,0.000027891292,0.000041807587,0.000011150194,0.0000031457644,0.000003980155,0.00013620532,0.000001275336,0.00009011589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997042,0.00012188013,0.000024405428,0.000067172405,0.0000384921,0.00004377967],"domain_scores_gemma":[0.99792236,0.0008919522,0.0005865774,0.00029556153,0.00012089999,0.00018266728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00096672936,0.0000986446,0.00018506862,0.00022013739,0.00011810555,0.0002615459,0.00016337028,0.0003254982,0.0016051946],"category_scores_gemma":[0.002688135,0.00011031856,0.00024937847,0.00023094582,0.00017300222,0.0001682058,0.0002104235,0.00025325004,0.00015900223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030064916,0.000061089,0.9883475,0.000020440913,0.00011756732,0.000045325283,0.00003060744,0.00056394923,0.0020417955,0.000021720345,0.00014574348,0.0055978284],"study_design_scores_gemma":[0.000038442806,0.0007189,0.99772996,0.000003117892,0.00004419211,0.00012525427,0.00003860733,0.0006607002,0.00038244555,0.000054683806,0.00020107275,0.0000026129392],"about_ca_topic_score_codex":0.00071602495,"about_ca_topic_score_gemma":0.0009029903,"teacher_disagreement_score":0.0016051946,"about_ca_system_score_codex":0.00019046852,"about_ca_system_score_gemma":0.00013711334,"threshold_uncertainty_score":0.005369842},"labels":[],"label_agreement":null},{"id":"W2770798942","doi":"10.1001/jamaoncol.2017.3776","title":"Association of Ipilimumab With Safety and Antitumor Activity in Women With Metastatic or Recurrent Human Papillomavirus–Related Cervical Carcinoma","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":162,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University Hospital; Juravinski Cancer Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Ottawa Hospital; University Health Network","funders":"","keywords":"Medicine; Ipilimumab; Response Evaluation Criteria in Solid Tumors; Internal medicine; Cervical cancer; Oncology; Cancer; Immunotherapy; Clinical trial; Phases of clinical research","score_opus":0.022603644146138538,"score_gpt":0.31995943085534284,"score_spread":0.2973557867092043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770798942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99588794,0.0023598438,0.00017824584,0.00027399155,0.000024530023,0.000061188206,0.00022426031,0.000015915874,0.00097414845],"genre_scores_gemma":[0.99922717,0.0001941674,0.00006502119,0.000094925286,0.0000384875,0.000028112601,0.00012745667,0.0000031058678,0.00022158505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99938893,0.00022637508,0.000050120896,0.00012508298,0.00011956555,0.00008987635],"domain_scores_gemma":[0.9965244,0.0015724011,0.0009481792,0.00029809505,0.00024674702,0.0004101869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017603408,0.00028211984,0.00051123864,0.000261913,0.00028266018,0.0004619545,0.00025638603,0.0006430807,0.0020341084],"category_scores_gemma":[0.0075124544,0.00019161958,0.00046827318,0.00033043046,0.000326635,0.0003707662,0.00022230358,0.00082000555,0.00017976282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.052783024,0.0010329859,0.86662227,0.00020584169,0.0007474238,0.00039691667,0.00018011386,0.00058653683,0.0055302433,0.00010017065,0.0009495574,0.07086509],"study_design_scores_gemma":[0.0037202819,0.039891873,0.94572276,0.000045745852,0.0011077514,0.0014332915,0.00010364368,0.002003684,0.0022445088,0.000258849,0.0034481946,0.000019386294],"about_ca_topic_score_codex":0.0005097033,"about_ca_topic_score_gemma":0.00056505133,"teacher_disagreement_score":0.0020341084,"about_ca_system_score_codex":0.0004657577,"about_ca_system_score_gemma":0.000530275,"threshold_uncertainty_score":0.0093096495},"labels":[],"label_agreement":null},{"id":"W2770975168","doi":"10.1001/jamaoncol.2017.5029","title":"Vemurafenib for <i>BRAF</i> V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis","year":2017,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"National Cancer Institute","keywords":"Vemurafenib; Medicine; V600E; Langerhans cell histiocytosis; Internal medicine; Progression-free survival; Melanoma; Oncology; Adverse effect; Positron emission tomography; Dermatology; Cancer research; Radiology; Chemotherapy; Disease; Mutation; Metastatic melanoma","score_opus":0.030770526430371405,"score_gpt":0.3246722442241393,"score_spread":0.2939017177937679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770975168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960109,0.00202798,0.00029063638,0.00007067153,0.000018155315,0.00031026307,0.00035162104,0.000013026435,0.0009067963],"genre_scores_gemma":[0.99824524,0.00041681022,0.0003872625,0.00010729664,0.000033313936,0.00012514136,0.000436108,0.0000028627608,0.00024592038],"study_design_codex":"observational","study_design_gemma":"case_report","domain_scores_codex":[0.9996227,0.00015698488,0.000058835656,0.00005470051,0.000045789016,0.000060991002],"domain_scores_gemma":[0.99944097,0.00012301588,0.00023679751,0.000027179756,0.000032397802,0.00013951547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009810934,0.00030630996,0.0006952258,0.00023772592,0.00016394517,0.00040953743,0.00028337768,0.00025022184,0.0013932057],"category_scores_gemma":[0.0008207904,0.00013612263,0.0004271224,0.00025798476,0.00017506053,0.0003627149,0.0003062816,0.00040742918,0.00011937412],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.32457718,0.009344036,0.34607825,0.0024146228,0.003084564,0.0019927374,0.00018346179,0.0020500193,0.07232429,0.0007364391,0.0045031356,0.23271127],"study_design_scores_gemma":[0.12239891,0.17729107,0.6449559,0.00026692968,0.0021484536,0.008629409,0.00020624457,0.0039499644,0.02475904,0.0006722586,0.014647696,0.00007416843],"about_ca_topic_score_codex":0.00029102527,"about_ca_topic_score_gemma":0.0007857412,"teacher_disagreement_score":0.0013932057,"about_ca_system_score_codex":0.00027773637,"about_ca_system_score_gemma":0.00040464732,"threshold_uncertainty_score":0.0051885843},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2793000264","doi":"10.1001/jamaoncol.2017.5808","title":"Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institutes of Health; Active Biotech; Astellas Pharma; Eisai; Ipsen; Clovis Oncology; Advanced Accelerator Applications; Endocyte; Gilead Sciences; Genentech; Valeant Pharmaceuticals International; Sanofi; GlaxoSmithKline; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Prostate cancer; Enzalutamide; Oncology; Internal medicine; Progression-free survival; Clinical endpoint; Clinical trial; Placebo; Discontinuation; Cancer; Chemotherapy; Pathology","score_opus":0.04999381704449428,"score_gpt":0.4252381961655681,"score_spread":0.37524437912107383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793000264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93196267,0.050089404,0.0089683635,0.0016622269,0.0003441382,0.0020374123,0.0019990664,0.000086132204,0.0028505966],"genre_scores_gemma":[0.99156207,0.0021625112,0.0036574362,0.0006030061,0.00022562065,0.0008119056,0.0006196068,0.000010976211,0.00034677333],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9672454,0.02967245,0.0009756847,0.0006869927,0.001271076,0.00014834551],"domain_scores_gemma":[0.9687482,0.020987388,0.0074640554,0.0014203854,0.00087156484,0.0005083267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.052605513,0.0007672339,0.0012025996,0.00069571234,0.00019333535,0.00097119896,0.0006726409,0.0007721691,0.0010527861],"category_scores_gemma":[0.032671325,0.00023743733,0.0026901644,0.00090531894,0.0009236056,0.0006317614,0.0007054244,0.0015026025,0.000088643006],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.42162815,0.0029447975,0.29558256,0.010097838,0.025587106,0.0002696026,0.0003706085,0.026582088,0.012560341,0.0024908534,0.0046565607,0.19722949],"study_design_scores_gemma":[0.056379233,0.16211902,0.69730395,0.0018823658,0.013595158,0.00078549917,0.00019133632,0.034280993,0.012887706,0.005246256,0.015078701,0.00024971087],"about_ca_topic_score_codex":0.00068402436,"about_ca_topic_score_gemma":0.0021301352,"teacher_disagreement_score":0.052605513,"about_ca_system_score_codex":0.0005158532,"about_ca_system_score_gemma":0.0017579609,"threshold_uncertainty_score":0.27820784},"labels":[],"label_agreement":null},{"id":"W2793364080","doi":"10.1001/jamaoncol.2018.0013","title":"Safety and Efficacy of Pembrolizumab Monotherapy in Patients With Previously Treated Advanced Gastric and Gastroesophageal Junction Cancer","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":1812,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Genentech; Daiichi Sankyo Europe; Gilead Sciences; National Cancer Institute; Sirtex Medical; Five Prime Therapeutics; Ipsen; Eli Lilly and Company; Ono Pharmaceutical; Astellas Pharma; Yakult Honsha; Sanofi; Kyowa Hakko Kirin; MacroGenics; Arog Pharmaceuticals; Pfizer; Incyte; Halozyme; Amgen; Celgene; Bristol-Myers Squibb; AstraZeneca; Chugai Pharmaceutical; Agios Pharmaceuticals","keywords":"Medicine; Pembrolizumab; Internal medicine; Cancer; Cohort; Response Evaluation Criteria in Solid Tumors; Progressive disease; Clinical endpoint; Gastroenterology; Surgery; Disease; Immunotherapy; Clinical trial","score_opus":0.008114240074526269,"score_gpt":0.2647737009068763,"score_spread":0.25665946083235003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2793364080","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977991,0.0014642027,0.00007355161,0.000062361636,0.000009743126,0.000041692223,0.00017122983,0.000004789498,0.00037323908],"genre_scores_gemma":[0.9989791,0.00037207722,0.00012398475,0.00009152967,0.000022067004,0.00003224416,0.00028002335,0.000001455646,0.00009750784],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99951077,0.00021384207,0.000055328288,0.00008640685,0.00009734672,0.00003632735],"domain_scores_gemma":[0.9988059,0.00027787473,0.00059542974,0.000053943735,0.00007551801,0.00019140681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014424642,0.00026458196,0.0007563896,0.00026072955,0.00032571054,0.0004973903,0.00020066541,0.00043870253,0.001054125],"category_scores_gemma":[0.001970434,0.00017882478,0.0005807354,0.0003536081,0.00026557012,0.00049346976,0.00019834773,0.00053407735,0.00022558188],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06281703,0.0023134474,0.8667809,0.00035783413,0.0014322472,0.00046136518,0.0001939721,0.0010262874,0.012908457,0.000046562138,0.0010391825,0.050622802],"study_design_scores_gemma":[0.008330817,0.04299608,0.94036144,0.00007138257,0.0007037877,0.0013823009,0.00013886749,0.0016983201,0.002055922,0.000063289845,0.002169608,0.000028272165],"about_ca_topic_score_codex":0.00035981604,"about_ca_topic_score_gemma":0.0009622854,"teacher_disagreement_score":0.0014424642,"about_ca_system_score_codex":0.00042561328,"about_ca_system_score_gemma":0.0004201813,"threshold_uncertainty_score":0.00762856},"labels":[],"label_agreement":null},{"id":"W2800412330","doi":"10.1001/jamaoncol.2018.0211","title":"Hormone Replacement Therapy After Oophorectomy and Breast Cancer Risk Among <i>BRCA1</i> Mutation Carriers","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":172,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Sunnybrook Health Science Centre; University of Toronto; Women's College Hospital; Public Health Ontario","funders":"","keywords":"Medicine; Breast cancer; Hazard ratio; Oophorectomy; Ovarian cancer; Prospective cohort study; Internal medicine; Hormone replacement therapy (female-to-male); Gynecology; Family history; Cancer; Proportional hazards model; Oncology; BRCA mutation; Cohort; Cohort study; Obstetrics; Surgery; Hysterectomy; Confidence interval","score_opus":0.006555885125884231,"score_gpt":0.27597025544227166,"score_spread":0.26941437031638743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2800412330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994536,0.00026345553,0.000012834453,0.000017160039,0.0000024955484,0.0000034735756,0.00014964846,9.650187e-7,0.00009623187],"genre_scores_gemma":[0.9994375,0.00015888426,0.00004332331,0.000016319538,0.00000494425,0.000005565909,0.00018921074,7.6800046e-7,0.00014349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998135,0.00003508734,0.000020839558,0.000042685922,0.000042408705,0.000045454097],"domain_scores_gemma":[0.99905735,0.00013544211,0.0005544213,0.000036556525,0.000064630025,0.00015163345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046512013,0.00013902453,0.00020641953,0.0004741783,0.00028944082,0.00041763572,0.0002098829,0.00025393188,0.0009919764],"category_scores_gemma":[0.0013863418,0.00017610523,0.000297246,0.0006036326,0.00014533653,0.00023446356,0.00017253356,0.00032676428,0.00013094736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008101705,0.000018061133,0.99924016,0.0000033803947,0.000015185099,0.000023127479,0.000018033026,0.000007462228,0.00006906835,0.000002605911,0.000027086662,0.00049498363],"study_design_scores_gemma":[0.0000072122634,0.00009153228,0.9995078,0.0000053914523,0.000025994363,0.00012685741,0.000051719388,0.000057980607,0.000035726098,0.000004339667,0.0000842603,0.0000011490325],"about_ca_topic_score_codex":0.008517502,"about_ca_topic_score_gemma":0.010390898,"teacher_disagreement_score":0.008517502,"about_ca_system_score_codex":0.00030632195,"about_ca_system_score_gemma":0.00039473572,"threshold_uncertainty_score":0.016935825},"labels":[],"label_agreement":null},{"id":"W2805212882","doi":"10.1001/jamaoncol.2018.2254","title":"Association of Exercise With Mortality in Adult Survivors of Childhood Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":155,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Interquartile range; Cancer; National Death Index; Population; Cohort study; Internal medicine; Hazard ratio; Incidence (geometry); Mortality rate; Pediatrics; Confidence interval","score_opus":0.018558042344005526,"score_gpt":0.33453772707503426,"score_spread":0.3159796847310287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805212882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985489,0.00067024597,0.00008724926,0.00006750728,0.0000037480286,0.0000047876474,0.00040559063,0.0000042817464,0.00020768201],"genre_scores_gemma":[0.9992453,0.00022281175,0.000059964226,0.000012198968,0.0000060418247,0.000004336414,0.00038314165,0.0000010135502,0.00006521314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996753,0.000085664025,0.000037444726,0.00007622321,0.000072949566,0.000052492167],"domain_scores_gemma":[0.9987425,0.00017434977,0.0007651904,0.000069186404,0.00011970424,0.0001291244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042903706,0.00016898339,0.00018172088,0.0004275098,0.00013148249,0.00026938078,0.00021029996,0.00024682164,0.00072353386],"category_scores_gemma":[0.0021505735,0.00011127279,0.00025455825,0.0006761086,0.00014905991,0.00021150045,0.00029689452,0.00032514744,0.0000619683],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024341767,0.0000071017835,0.99891055,0.0000059419503,0.00003009863,0.000009113863,0.000010019678,0.000032902357,0.000035962006,0.0000034780112,0.000030696487,0.0008997879],"study_design_scores_gemma":[0.0000011059203,0.000021139715,0.9997937,0.000002815002,0.000007807878,0.000032416716,0.000015440712,0.00007292037,0.000013980362,0.0000041071626,0.000033952478,5.312502e-7],"about_ca_topic_score_codex":0.0071452106,"about_ca_topic_score_gemma":0.012849078,"teacher_disagreement_score":0.0071452106,"about_ca_system_score_codex":0.00021839172,"about_ca_system_score_gemma":0.00021364907,"threshold_uncertainty_score":0.014207184},"labels":[],"label_agreement":null},{"id":"W2808333976","doi":"10.1001/jamaoncol.2018.0775","title":"Association of <i>ERBB</i> Mutations With Clinical Outcomes of Afatinib- or Erlotinib-Treated Patients With Lung Squamous Cell Carcinoma","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Afatinib; Medicine; Erlotinib; Oncology; Internal medicine; Lung cancer; Gefitinib; Basal cell; Carcinoma; ErbB; Epidermal growth factor receptor; Cancer","score_opus":0.015937738691310308,"score_gpt":0.3583568929958549,"score_spread":0.34241915430454456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2808333976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99835336,0.0005466678,0.000114399,0.000057666846,0.000010073455,0.00012401397,0.00033265844,0.000005323542,0.0004558131],"genre_scores_gemma":[0.9988901,0.00009298237,0.00012812405,0.00008174275,0.000028138196,0.00011420264,0.0005226773,0.0000018652289,0.00014023687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884677,0.0006372467,0.00010242883,0.00020429627,0.00011686255,0.0000925093],"domain_scores_gemma":[0.9986487,0.00041822385,0.00054165995,0.00009436151,0.000083359715,0.00021377872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024335957,0.00028641138,0.00075224595,0.00019478508,0.00021784082,0.00056452345,0.00039646274,0.000441771,0.0013338246],"category_scores_gemma":[0.0018556868,0.0001701256,0.0009221885,0.0002759342,0.00038165777,0.00033264488,0.00024292787,0.0005892793,0.00015843833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40108833,0.0019669926,0.55100036,0.00050832896,0.0036884085,0.000095903524,0.00007634779,0.0015070974,0.008595564,0.00011474559,0.0010486566,0.030309258],"study_design_scores_gemma":[0.05525312,0.06643971,0.8656805,0.00007807162,0.003297587,0.00035653816,0.00009193736,0.0022078797,0.0041808467,0.0003128976,0.0020622462,0.000038552178],"about_ca_topic_score_codex":0.00041367917,"about_ca_topic_score_gemma":0.0014111894,"teacher_disagreement_score":0.0024335957,"about_ca_system_score_codex":0.0005065932,"about_ca_system_score_gemma":0.0005148432,"threshold_uncertainty_score":0.012870252},"labels":[],"label_agreement":null},{"id":"W2809263049","doi":"10.1001/jamaoncol.2018.1771","title":"Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Institutes of Health; Hellenic Health Foundation; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Umeå Universitet; Medical Research Council; Samfundet Folkhälsan; Graduate School of Public Health, University of Pittsburgh; Karolinska Institutet; National Cancer Institute; University of Toronto; National University of Singapore; University of Oxford; Norges Teknisk-Naturvitenskapelige Universitet; Deutsches Krebsforschungszentrum; University of Pittsburgh; Duke-NUS Medical School; Imperial College London; Universitetet i Oslo; Helsingin Yliopisto; Universiteit Utrecht; World Health Organization; Aarhus Universitet; University of Southern California","keywords":"Medicine; Body mass index; Breast cancer; Oncology; Gynecology; Cancer; Association (psychology); Internal medicine; Obstetrics; Gerontology","score_opus":0.009468008879487547,"score_gpt":0.2933573706393742,"score_spread":0.28388936175988666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809263049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975466,0.0012902735,0.00021954259,0.00003813452,0.000009224128,0.000009480626,0.00054917217,0.000008903006,0.00032867474],"genre_scores_gemma":[0.99915814,0.0002104531,0.00013570726,0.000014645081,0.000013411018,0.00000856124,0.00032996672,0.0000023759108,0.00012658829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955136,0.00012330702,0.00004815124,0.00015571555,0.00007448534,0.00004693437],"domain_scores_gemma":[0.99850404,0.00029398192,0.0007334974,0.00021826016,0.00012286915,0.00012737706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012287193,0.0002704936,0.00036027253,0.0006570056,0.00028077606,0.00044238774,0.00037009435,0.000323749,0.0010927655],"category_scores_gemma":[0.0033079123,0.00025795327,0.00061342336,0.00082288374,0.0001643109,0.00025589345,0.00033553946,0.0002616644,0.00012967027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014206534,0.0000070767414,0.998841,0.0000069860553,0.00017042184,0.000014435436,0.000019657053,0.000023813405,0.00012249123,0.0000065195486,0.000027943368,0.00061762065],"study_design_scores_gemma":[0.000004845578,0.000050866456,0.999529,0.000003390206,0.00008952894,0.000051595747,0.000023389814,0.0001158943,0.000039273353,0.000012976681,0.000077828394,0.0000014417709],"about_ca_topic_score_codex":0.004192468,"about_ca_topic_score_gemma":0.005087779,"teacher_disagreement_score":0.004192468,"about_ca_system_score_codex":0.00014314395,"about_ca_system_score_gemma":0.00022939187,"threshold_uncertainty_score":0.008336127},"labels":[],"label_agreement":null},{"id":"W2810247444","doi":"10.1001/jamaoncol.2018.1977","title":"Association of<i>MGMT</i>Promoter Methylation Status With Survival Outcomes in Patients With High-Risk Glioma Treated With Radiotherapy and Temozolomide","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Notre-Dame; Toronto General Hospital; Cancer Care Ontario","funders":"National Cancer Institute","keywords":"Temozolomide; Medicine; Oncology; Glioma; Radiation therapy; Internal medicine; Glioblastoma; Methylation; Cancer research; Gene","score_opus":0.007310149578843544,"score_gpt":0.26220942388373286,"score_spread":0.25489927430488935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810247444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99964106,0.00012837001,0.000015348214,0.000033164826,0.0000017629058,0.000004542565,0.00005375247,0.0000016163176,0.0001203069],"genre_scores_gemma":[0.9997905,0.000039782106,0.000024012525,0.000014647922,0.0000055490823,0.0000056597105,0.000079924124,6.378217e-7,0.000039202565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998293,0.000063125764,0.000015077924,0.000027761524,0.000029605697,0.000035153476],"domain_scores_gemma":[0.9994672,0.00009514723,0.00028072693,0.000019508418,0.000029204639,0.00010831124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041627223,0.00012569573,0.0003039565,0.00024898598,0.00015089898,0.00024350687,0.00017782854,0.00021216008,0.00073282066],"category_scores_gemma":[0.0010992849,0.00009993451,0.00021049836,0.0003097346,0.00020313934,0.00015931988,0.00015181514,0.00024138854,0.000101362806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003066546,0.000107031585,0.99000335,0.00001685028,0.00008256299,0.00007154757,0.000034602104,0.00014509671,0.0013977388,0.000009616101,0.00017643481,0.0048886924],"study_design_scores_gemma":[0.0001445583,0.0013971388,0.997024,0.00000551105,0.00007564073,0.00026510458,0.000049857346,0.000360305,0.00041252957,0.000023821942,0.00023844138,0.000003116646],"about_ca_topic_score_codex":0.0012868433,"about_ca_topic_score_gemma":0.0023811439,"teacher_disagreement_score":0.0012868433,"about_ca_system_score_codex":0.0003591358,"about_ca_system_score_gemma":0.00027322836,"threshold_uncertainty_score":0.0026056767},"labels":[],"label_agreement":null},{"id":"W2810342468","doi":"10.1001/jamaoncol.2018.1812","title":"Tucatinib Combined With Ado-Trastuzumab Emtansine in Advanced <i>ERBB2/HER2</i>-Positive Metastatic Breast Cancer","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":165,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Bausch Health (Canada); London Health Sciences Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Trastuzumab emtansine; Trastuzumab; Metastatic breast cancer; Taxane; Internal medicine; Adverse effect; Breast cancer; Pharmacokinetics; Oncology; Pertuzumab; Cancer; Response Evaluation Criteria in Solid Tumors; Capecitabine; Gastroenterology; Pharmacology; Progressive disease; Chemotherapy; Colorectal cancer","score_opus":0.025182949452053863,"score_gpt":0.39367988303731133,"score_spread":0.3684969335852575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810342468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967315,0.0022011257,0.000089685076,0.00008574508,0.000024602881,0.0002163259,0.000095442956,0.000011433875,0.00054415996],"genre_scores_gemma":[0.99786526,0.0010954518,0.0002340297,0.00009883505,0.000046682366,0.00014336295,0.00018677897,0.0000023780922,0.00032719548],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997682,0.00010818609,0.000023629957,0.000033729444,0.000034534816,0.000031760395],"domain_scores_gemma":[0.99975854,0.000045306275,0.000082574865,0.000015643996,0.000017520628,0.00008043334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007274245,0.00033898282,0.0010421656,0.00022010191,0.00019896863,0.00046387815,0.0002761882,0.00035364486,0.0012968533],"category_scores_gemma":[0.00063982804,0.00017077554,0.00042401833,0.00023801917,0.00024354288,0.0003813752,0.00017674902,0.0006624199,0.00020764854],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5652175,0.03021937,0.037398804,0.0019476322,0.0022607425,0.00041107167,0.00027829784,0.0037242197,0.07317595,0.0002957855,0.003549868,0.2815208],"study_design_scores_gemma":[0.27522534,0.6127869,0.0803413,0.0001876172,0.0014465348,0.0012001274,0.00014096938,0.004739548,0.016733842,0.00021695074,0.0069372677,0.0000435667],"about_ca_topic_score_codex":0.0005640147,"about_ca_topic_score_gemma":0.0021912062,"teacher_disagreement_score":0.0012968533,"about_ca_system_score_codex":0.00042473074,"about_ca_system_score_gemma":0.0006637416,"threshold_uncertainty_score":0.0043383837},"labels":[],"label_agreement":null},{"id":"W2884733293","doi":"10.1001/jamaoncol.2018.2428","title":"Follow-up Recommendations for Completely Resected Gastroenteropancreatic Neuroendocrine Tumors","year":2018,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Ottawa; University of Toronto; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Neuroendocrine tumors; MEDLINE; Multidisciplinary approach; General surgery; Oncology; Internal medicine; Intensive care medicine","score_opus":0.14259627281744186,"score_gpt":0.44755826398915516,"score_spread":0.3049619911717133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884733293","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00096372206,0.9697,0.0022759365,0.016636861,0.0020324173,0.0003925212,0.0008313133,0.00008248436,0.007084753],"genre_scores_gemma":[0.0071468446,0.9645533,0.013545532,0.008949025,0.00065760064,0.00054439384,0.0016231309,0.000020814377,0.0029592651],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9976527,0.0007676771,0.00082441495,0.00011769117,0.0005481934,0.00008936829],"domain_scores_gemma":[0.9935307,0.0032568162,0.0012105715,0.00014187815,0.0016457078,0.0002143786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040632915,0.00061739626,0.001304434,0.0031783734,0.00041348557,0.00087017956,0.0021485505,0.0021048828,0.003944337],"category_scores_gemma":[0.01504783,0.00032608773,0.001943004,0.0022074003,0.00036025126,0.0014212434,0.00069437135,0.0022884193,0.0015375123],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010637434,0.00007086869,0.001127267,0.04480593,0.0003057211,0.00039527589,0.00034484948,0.00040712734,0.00047012328,0.003143847,0.15254238,0.79628026],"study_design_scores_gemma":[0.00013684778,0.00010260574,0.003857555,0.12439349,0.0009898577,0.0014343794,0.00037138857,0.00018112104,0.0003933179,0.0038948855,0.86419857,0.00004591868],"about_ca_topic_score_codex":0.0040118326,"about_ca_topic_score_gemma":0.010727554,"teacher_disagreement_score":0.0040632915,"about_ca_system_score_codex":0.0009624665,"about_ca_system_score_gemma":0.004410775,"threshold_uncertainty_score":0.021489024},"labels":[],"label_agreement":null},{"id":"W2893903454","doi":"10.1001/jamaoncol.2018.4039","title":"Tenofovir vs Entecavir for Hepatocellular Carcinoma Prevention in Patients With Chronic Hepatitis B","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Internal medicine; Psychiatry","score_opus":0.019552385490580828,"score_gpt":0.27654457821241896,"score_spread":0.25699219272183815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2893903454","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3715184,0.067663506,0.0002098765,0.4394337,0.012995732,0.00023433175,0.0015898885,0.000103151004,0.10625147],"genre_scores_gemma":[0.86800474,0.016828272,0.00056771183,0.086761065,0.01291462,0.00017476844,0.0005086149,0.000028332717,0.014211868],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9996512,0.00016478662,0.000060094342,0.000024462528,0.000045575973,0.000053953463],"domain_scores_gemma":[0.9984315,0.0008901166,0.00017793871,0.000029036728,0.00012685431,0.00034446846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073679077,0.00013312645,0.0004931291,0.0003162445,0.0005372984,0.00056700537,0.00021948892,0.0013624551,0.010180569],"category_scores_gemma":[0.006014567,0.00011092499,0.0003934407,0.00053888094,0.00019519523,0.0006540069,0.00017044904,0.0015911683,0.00091246335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027929388,0.0009224907,0.14642626,0.0014645108,0.00041316697,0.011215801,0.0005832486,0.0004146808,0.0009583123,0.0017844483,0.4314066,0.37648103],"study_design_scores_gemma":[0.032602295,0.0142657645,0.40975434,0.0077253925,0.0019815497,0.033108085,0.0032250884,0.003074938,0.0027915179,0.01038896,0.48091918,0.00016287633],"about_ca_topic_score_codex":0.0025197074,"about_ca_topic_score_gemma":0.0073058694,"teacher_disagreement_score":0.010180569,"about_ca_system_score_codex":0.0009958327,"about_ca_system_score_gemma":0.00092339475,"threshold_uncertainty_score":0.03405738},"labels":[],"label_agreement":null},{"id":"W2898717093","doi":"10.1001/jamaoncol.2018.4628","title":"Safety and Efficacy of Durvalumab With or Without Tremelimumab in Patients With PD-L1–Low/Negative Recurrent or Metastatic HNSCC","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":310,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute; National Institute for Health and Care Research","keywords":"Tremelimumab; Durvalumab; Medicine; Internal medicine; Head and neck squamous-cell carcinoma; Tolerability; Oncology; Immunotherapy; Adverse effect; Cancer; Head and neck cancer; Nivolumab; Ipilimumab","score_opus":0.021322078231398343,"score_gpt":0.31950666701340313,"score_spread":0.29818458878200477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898717093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975138,0.0012726409,0.000101494545,0.00009548762,0.000033061096,0.00014383029,0.0001805647,0.000020544885,0.00063861447],"genre_scores_gemma":[0.9985273,0.00042803882,0.00024999568,0.000107775784,0.000052053485,0.000113391645,0.00022053944,0.0000035600167,0.00029731297],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995546,0.00021123466,0.00003609363,0.00007247522,0.000059997892,0.00006550425],"domain_scores_gemma":[0.999443,0.00014365194,0.00016159435,0.000047104648,0.00003262069,0.00017206962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00118837,0.00045389775,0.0012062197,0.00019749586,0.0002477558,0.00044608163,0.0004342166,0.0005069992,0.0014168918],"category_scores_gemma":[0.0011613301,0.00028024035,0.0009232699,0.00022662293,0.00044627686,0.0005038958,0.00014925076,0.0010850262,0.00030832455],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7706699,0.013533817,0.02620109,0.0007458853,0.0015656942,0.0002612752,0.00015888017,0.0019333125,0.03365868,0.0001855456,0.002360218,0.14872584],"study_design_scores_gemma":[0.3610873,0.53633565,0.0810749,0.000101922844,0.0024054584,0.0008453731,0.000107421736,0.0038318955,0.010093875,0.00017371771,0.0038912387,0.000051306357],"about_ca_topic_score_codex":0.0008918674,"about_ca_topic_score_gemma":0.0035785388,"teacher_disagreement_score":0.0014168918,"about_ca_system_score_codex":0.0008998369,"about_ca_system_score_gemma":0.0011652485,"threshold_uncertainty_score":0.0065287948},"labels":[],"label_agreement":null},{"id":"W2904240523","doi":"10.1001/jamaoncol.2018.6012","title":"Assessment of<i>ERBB2</i>/<i>HER2</i>Status in<i>HER2</i>-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines","year":2018,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Fluorescence in situ hybridization; Clinical trial; Cohort; Clinical Oncology; Fish <Actinopterygii>; Cancer; Chromosome; Gene","score_opus":0.013110897557483323,"score_gpt":0.3339736071521035,"score_spread":0.32086270959462015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904240523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99378407,0.00043303822,0.00084370223,0.00009155262,0.0000112045855,0.00013929134,0.00097374537,0.000021088734,0.00370227],"genre_scores_gemma":[0.9977348,0.00017281597,0.0010045855,0.000086852415,0.000012993745,0.000053013442,0.00071087334,0.000008521645,0.00021552197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99931216,0.00017677309,0.00015356364,0.00011933287,0.00015724862,0.00008087305],"domain_scores_gemma":[0.99822265,0.00033598515,0.0008013633,0.00012414991,0.00032337444,0.0001925196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012338609,0.00025793508,0.00024061097,0.0011770003,0.00030149004,0.00045056673,0.00039774872,0.0002665724,0.0017903552],"category_scores_gemma":[0.0025792145,0.00012990888,0.00019140811,0.0006955423,0.0007194246,0.00042256873,0.00046528445,0.0002762511,0.00039681344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013245725,0.000016306392,0.9949575,0.000028012026,0.00001255222,0.00039467795,0.000040874773,0.00005498324,0.0016279054,0.00004950458,0.0002968369,0.0023882652],"study_design_scores_gemma":[0.000036020712,0.00043055863,0.9783167,0.000048827573,0.00009075793,0.011669915,0.0004228555,0.0006132781,0.005025526,0.00016516155,0.0031667682,0.000013490117],"about_ca_topic_score_codex":0.0012382882,"about_ca_topic_score_gemma":0.0022453845,"teacher_disagreement_score":0.0017903552,"about_ca_system_score_codex":0.00032502002,"about_ca_system_score_gemma":0.00051756395,"threshold_uncertainty_score":0.0065253377},"labels":[],"label_agreement":null},{"id":"W2905463162","doi":"10.1001/jamaoncol.2018.5877","title":"Assessment of Frequency and Reporting of Changes in Cancer Trial Design After Initiation of Patient Accrual","year":2018,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"Vetenskapsrådet; National Natural Science Foundation of China","keywords":"Medicine; Accrual; Clinical trial; Research design; Clinical study design; Oncology; Drug trial; Internal medicine; Statistics; Accounting","score_opus":0.665240267925091,"score_gpt":0.6166713619402905,"score_spread":0.04856890598480046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905463162","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2512447,0.010131968,0.09687506,0.5142221,0.013047996,0.009029931,0.027859753,0.0022659749,0.07532248],"genre_scores_gemma":[0.784059,0.0024931638,0.059171144,0.123189926,0.0060939174,0.011835255,0.00486046,0.00062673853,0.0076702544],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.43317783,0.3916671,0.08805469,0.010312387,0.0727175,0.0040705083],"domain_scores_gemma":[0.06986042,0.59885305,0.20247999,0.071351245,0.054825116,0.0026302456],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3848148,0.0003855623,0.00091561244,0.0062050754,0.0018505722,0.004973366,0.002206215,0.006393353,0.0040721563],"category_scores_gemma":[0.8336029,0.0008111997,0.0012090534,0.009070423,0.0024872452,0.0052406783,0.0031091769,0.0063717435,0.002454069],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008807206,0.0004403078,0.33926645,0.0019917833,0.0006892872,0.0005934235,0.0063910536,0.0017588225,0.0013146416,0.013797459,0.21492976,0.41001987],"study_design_scores_gemma":[0.0026453868,0.004721064,0.5014271,0.0053501287,0.0007980297,0.0041797026,0.004815031,0.024328435,0.009706621,0.04193852,0.39923608,0.0008538762],"about_ca_topic_score_codex":0.0033095586,"about_ca_topic_score_gemma":0.0038152568,"teacher_disagreement_score":0.6151852,"about_ca_system_score_codex":0.00768047,"about_ca_system_score_gemma":0.006201298,"threshold_uncertainty_score":0.7586329},"labels":[],"label_agreement":null},{"id":"W2907028960","doi":"10.1001/jamaoncol.2018.5904","title":"Association of Patient Sex With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Advanced Cancers","year":2019,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":302,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunotherapy; Hazard ratio; Meta-analysis; Internal medicine; Randomized controlled trial; Observational study; Clinical trial; Oncology; MEDLINE; Cancer; Confidence interval","score_opus":0.018362684288729527,"score_gpt":0.32044378403258034,"score_spread":0.30208109974385083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907028960","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07042504,0.92504054,0.001196488,0.0009076711,0.00039631798,0.000121248944,0.0009167032,0.000024880366,0.0009709953],"genre_scores_gemma":[0.82247925,0.17234059,0.0018824795,0.0011431826,0.0007280034,0.00022718603,0.0008060096,0.000030785457,0.00036261076],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.98932225,0.005904243,0.0021648682,0.0013145175,0.001043072,0.00025112682],"domain_scores_gemma":[0.96621966,0.026550807,0.005135803,0.0009829531,0.0008325119,0.00027831644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0137315905,0.0011939984,0.0041421996,0.002263214,0.0003800457,0.002347907,0.0009293389,0.0012910161,0.0019128524],"category_scores_gemma":[0.034177404,0.0005606653,0.021330839,0.003103914,0.0005904703,0.0012336381,0.00068891695,0.0013809563,0.00012608214],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010329639,0.000079428435,0.13306154,0.06657441,0.7498436,0.00015929842,0.00014259535,0.0015490684,0.00064530724,0.00034620237,0.0009882773,0.036280654],"study_design_scores_gemma":[0.0018162637,0.0012499795,0.105320506,0.010201646,0.87449217,0.00038771555,0.000119962264,0.0011155687,0.0006291006,0.0012890826,0.0033246304,0.000053503034],"about_ca_topic_score_codex":0.0019022061,"about_ca_topic_score_gemma":0.0027948217,"teacher_disagreement_score":0.0137315905,"about_ca_system_score_codex":0.0007307342,"about_ca_system_score_gemma":0.0009922491,"threshold_uncertainty_score":0.07262045},"labels":[],"label_agreement":null},{"id":"W2909664909","doi":"10.1001/jamaoncol.2018.6908","title":"Association Between Invasive Lobular Breast Cancer and Mutations in the Mismatch Repair Gene <i>MSH6</i>","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Breast cancer; MEDLINE; Internal medicine; Psychiatry; Cancer","score_opus":0.02186519730483698,"score_gpt":0.29666452917169733,"score_spread":0.27479933186686034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2909664909","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23541856,0.003334449,0.0007259996,0.5786643,0.010036596,0.00015579013,0.001634311,0.00021902507,0.16981098],"genre_scores_gemma":[0.7970368,0.003224591,0.0013209743,0.119910575,0.024590615,0.000099473415,0.00062791177,0.00009175017,0.053097166],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9995147,0.00011889082,0.000057908288,0.000077315715,0.0001266993,0.000104519306],"domain_scores_gemma":[0.9982346,0.00092129817,0.00020957892,0.00006972628,0.00022973595,0.00033494606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045629352,0.00037265723,0.00046344992,0.0011872279,0.001574918,0.0006656243,0.00037007668,0.0041334657,0.015851943],"category_scores_gemma":[0.0037795622,0.00029506034,0.00045430099,0.001170593,0.00062079204,0.00071269285,0.00028039538,0.002809413,0.0028474366],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006420189,0.00046571164,0.2949276,0.00022675458,0.00012367898,0.30425805,0.0007621364,0.00075087004,0.0025322814,0.0030770113,0.36723843,0.02499551],"study_design_scores_gemma":[0.00039516468,0.000537345,0.30827373,0.00083326723,0.00024101684,0.5450115,0.0021241324,0.005572612,0.0012367843,0.008345891,0.1273047,0.00012389524],"about_ca_topic_score_codex":0.007881605,"about_ca_topic_score_gemma":0.010717893,"teacher_disagreement_score":0.015851943,"about_ca_system_score_codex":0.001087273,"about_ca_system_score_gemma":0.00087662047,"threshold_uncertainty_score":0.053030014},"labels":[],"label_agreement":null},{"id":"W2914132252","doi":"10.1001/jamaoncol.2018.6631","title":"Methodology Flaws and Implications of a Complementary Medicine Study","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry; Law","score_opus":0.2537361593006372,"score_gpt":0.47629790789540294,"score_spread":0.22256174859476574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914132252","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11874485,0.025518129,0.26370955,0.39877027,0.06243183,0.055539016,0.005769919,0.00095401215,0.06856244],"genre_scores_gemma":[0.5884903,0.0030482844,0.20160867,0.1417685,0.0060843476,0.05280702,0.0007359296,0.00040120122,0.0050557735],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.20160522,0.64540124,0.07578716,0.015338545,0.058999278,0.002868504],"domain_scores_gemma":[0.07795875,0.8068275,0.024577528,0.043281764,0.045257382,0.0020970532],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6933956,0.0014420165,0.0021716023,0.008051364,0.0044591837,0.0073877703,0.0060385833,0.0056868535,0.008403249],"category_scores_gemma":[0.8959679,0.0015163487,0.0039042523,0.0069414154,0.009838961,0.0054770038,0.004556025,0.005446164,0.001609725],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007041709,0.0015321078,0.15909871,0.021523716,0.012233363,0.0045627956,0.042837262,0.0022883464,0.0011969325,0.20377848,0.18535332,0.35855335],"study_design_scores_gemma":[0.0077934633,0.00355864,0.09039232,0.0530164,0.013028253,0.0059943106,0.019678697,0.022945946,0.0077409563,0.34025115,0.43497524,0.00062462984],"about_ca_topic_score_codex":0.008887465,"about_ca_topic_score_gemma":0.0096708415,"teacher_disagreement_score":0.3066044,"about_ca_system_score_codex":0.010376067,"about_ca_system_score_gemma":0.018621491,"threshold_uncertainty_score":0.37809783},"labels":[],"label_agreement":null},{"id":"W2918886543","doi":"10.1001/jamaoncol.2019.0022","title":"<i>CHEK2</i> Alleles Predispose to Renal Cancer in Poland","year":2019,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; Psychiatry","score_opus":0.012722114216908269,"score_gpt":0.3065758528575868,"score_spread":0.29385373864067854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2918886543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.632746,0.0024304348,0.0015749742,0.25520095,0.0028135746,0.0001175102,0.0014978222,0.00029233858,0.10332643],"genre_scores_gemma":[0.95013124,0.001160706,0.00073070097,0.02776639,0.0017172579,0.000030248348,0.00019832178,0.000063178275,0.018202016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99976856,0.000037545917,0.000034492172,0.00005031031,0.00004477116,0.00006428015],"domain_scores_gemma":[0.99945396,0.00019456889,0.00010350913,0.00005049032,0.00007271867,0.00012476301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022276548,0.00019347144,0.00024936468,0.00074167794,0.00089373253,0.0005687152,0.00020358007,0.0019543746,0.0075180847],"category_scores_gemma":[0.0027024855,0.00017652637,0.00027888635,0.0005920657,0.00042320826,0.00059016846,0.00039648786,0.0013250483,0.0012124024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007181811,0.00016320443,0.47888175,0.00019262992,0.00010180078,0.31125683,0.0014091466,0.0005513705,0.0042812526,0.0046453904,0.16263346,0.035164926],"study_design_scores_gemma":[0.0001946744,0.00020910785,0.330453,0.00040132814,0.00014794602,0.5579878,0.0030051917,0.003411857,0.002046393,0.010322715,0.09173848,0.00008150511],"about_ca_topic_score_codex":0.0066332784,"about_ca_topic_score_gemma":0.0070732934,"teacher_disagreement_score":0.0075180847,"about_ca_system_score_codex":0.0006534916,"about_ca_system_score_gemma":0.00043394143,"threshold_uncertainty_score":0.025150478},"labels":[],"label_agreement":null},{"id":"W2925055605","doi":"10.1001/jamaoncol.2019.0054","title":"The Role of Disease Label in Patient Perceptions and Treatment Decisions in the Setting of Low-Risk Malignant Neoplasms","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; University Health Network; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Disease; MEDLINE; Malignant disease; Intensive care medicine; Oncology; Internal medicine; Cancer","score_opus":0.0632828586419593,"score_gpt":0.3961007150998496,"score_spread":0.3328178564578903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925055605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962298,0.00025773607,0.0007685649,0.0014490439,0.000016391774,0.000032651078,0.00002431472,0.0000035244807,0.0012180001],"genre_scores_gemma":[0.9991416,0.00006518995,0.0005336069,0.0001909141,0.000009562205,0.000012842125,0.000009183824,0.0000010045021,0.000036199788],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9730251,0.023704,0.0007328178,0.00051373756,0.0015764349,0.00044783266],"domain_scores_gemma":[0.92650044,0.05727542,0.01174685,0.0011112455,0.0012641308,0.0021018966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02144537,0.00022013046,0.00031242453,0.0005317952,0.0008056889,0.0021850045,0.00032403835,0.0010853776,0.0028428016],"category_scores_gemma":[0.07984717,0.00025838404,0.00073501334,0.0003921242,0.0021136657,0.0015617388,0.0012137301,0.0014462838,0.00020835179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051573743,0.002086665,0.88161635,0.0005550649,0.00056164904,0.000543049,0.02027663,0.0023719622,0.0025334551,0.0029043464,0.0013222818,0.08007107],"study_design_scores_gemma":[0.0010209554,0.006497086,0.9080151,0.0008607581,0.0005428019,0.0018270283,0.039526604,0.021116108,0.002326349,0.012258366,0.005697691,0.00031112312],"about_ca_topic_score_codex":0.0012293316,"about_ca_topic_score_gemma":0.0018857735,"teacher_disagreement_score":0.02144537,"about_ca_system_score_codex":0.0011637588,"about_ca_system_score_gemma":0.0010610351,"threshold_uncertainty_score":0.1134153},"labels":[],"label_agreement":null},{"id":"W2937981811","doi":"10.1001/jamaoncol.2018.7147","title":"Current Landscape of Immunotherapy in Breast Cancer","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":409,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Institutes of Health","keywords":"Medicine; Breast cancer; Immunotherapy; Oncology; Clinical trial; Cancer; Immune checkpoint; Internal medicine; Tumor microenvironment","score_opus":0.012827140362133293,"score_gpt":0.32467049464520614,"score_spread":0.31184335428307286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2937981811","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018720739,0.9652074,0.00041879795,0.029791377,0.002376743,0.000011630098,0.00004512352,0.000027508193,0.0019341683],"genre_scores_gemma":[0.0048657088,0.9682028,0.0011384956,0.016532386,0.008007137,0.000051015875,0.00011197711,0.000012129727,0.0010783707],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99796546,0.00088736706,0.00027844115,0.00023647564,0.00047241285,0.00015988434],"domain_scores_gemma":[0.9912764,0.0052267453,0.00073742884,0.00024298651,0.0018007552,0.00071573094],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054617296,0.0006370373,0.0012811188,0.0015877692,0.0007899228,0.003725225,0.0011032815,0.0034714958,0.009209931],"category_scores_gemma":[0.008396029,0.00029400285,0.0008527482,0.0019152728,0.0019909618,0.0062786667,0.0016386579,0.005676496,0.0032242814],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002742526,0.00010656623,0.0007831584,0.010760483,0.00008346017,0.00016128938,0.00013529067,0.00045343352,0.0010110684,0.017962085,0.11539001,0.85287887],"study_design_scores_gemma":[0.0000508888,0.00023195558,0.00094319537,0.009868426,0.00010210489,0.00071859674,0.00025175538,0.00027412985,0.0002510498,0.019132888,0.9681483,0.000026811684],"about_ca_topic_score_codex":0.0008660916,"about_ca_topic_score_gemma":0.0016670909,"teacher_disagreement_score":0.009209931,"about_ca_system_score_codex":0.001899889,"about_ca_system_score_gemma":0.004688264,"threshold_uncertainty_score":0.030810297},"labels":[],"label_agreement":null},{"id":"W2955638704","doi":"10.1001/jamaoncol.2019.1867","title":"Looking Forward, Not Backward, on Watch and Wait for Rectal Cancer","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.024328073687890535,"score_gpt":0.345970239144727,"score_spread":0.3216421654568365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955638704","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057467524,0.018498156,0.0044726697,0.15806322,0.020303026,0.00019065087,0.003156009,0.004221008,0.7336277],"genre_scores_gemma":[0.29901966,0.023123823,0.009231778,0.09337798,0.011759571,0.00020560922,0.0019143735,0.0012698321,0.5600973],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998282,0.000040625957,0.000009321844,0.00001486571,0.000036268222,0.0000707045],"domain_scores_gemma":[0.9990095,0.00020523161,0.000084162006,0.000025930065,0.000088504625,0.00058668916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032851347,0.00019959967,0.00023195673,0.00031396945,0.0008335519,0.0009062095,0.00025651144,0.00075546757,0.1875641],"category_scores_gemma":[0.003670892,0.000119378,0.00029597263,0.00023501164,0.0002989692,0.0013099631,0.0007059708,0.001328753,0.055299107],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014447267,0.00006451913,0.004739412,0.00010797783,0.000011666432,0.00051167037,0.00020326208,0.00002279248,0.00037390465,0.00033818957,0.89606637,0.09741581],"study_design_scores_gemma":[0.00011941403,0.00047993095,0.028550033,0.0009564225,0.0000600057,0.00827136,0.0022197051,0.00019786204,0.000952384,0.0022000202,0.9559193,0.00007350762],"about_ca_topic_score_codex":0.002431188,"about_ca_topic_score_gemma":0.011167885,"teacher_disagreement_score":0.1875641,"about_ca_system_score_codex":0.00026629324,"about_ca_system_score_gemma":0.00062941475,"threshold_uncertainty_score":0.6274644},"labels":[],"label_agreement":null},{"id":"W2959096163","doi":"10.1001/jamaoncol.2019.1588","title":"Durvalumab With or Without Tremelimumab for Patients With Metastatic Pancreatic Ductal Adenocarcinoma","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":765,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute; AstraZeneca","keywords":"Durvalumab; Medicine; Tremelimumab; Gemcitabine; Internal medicine; Population; Combination therapy; Oncology; Surgery; Cancer; Immunotherapy; Ipilimumab; Nivolumab","score_opus":0.031134347711250843,"score_gpt":0.3374684671745833,"score_spread":0.30633411946333244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2959096163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922131,0.004770249,0.0002469216,0.00041301062,0.00009188501,0.00034340768,0.00021940413,0.000032953507,0.0016690512],"genre_scores_gemma":[0.9970192,0.0012469603,0.00050389074,0.00023831677,0.00006733737,0.00017084798,0.00015405036,0.00000395704,0.00059551216],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9997347,0.00011730872,0.000026086895,0.00004720867,0.000035140198,0.000039534323],"domain_scores_gemma":[0.99970394,0.00006876717,0.00008056867,0.000020652455,0.000017237302,0.00010873228],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073037663,0.00031420303,0.0009330782,0.00017223653,0.00020508215,0.00052333425,0.00027308328,0.00037734013,0.0020454514],"category_scores_gemma":[0.000833218,0.00019768332,0.00066683575,0.0002046577,0.00027083606,0.00056953053,0.00019721285,0.0009898301,0.00028838392],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.524036,0.019373555,0.05068102,0.0016873517,0.0028761844,0.0007458244,0.00022741653,0.0027630534,0.043812577,0.00045110335,0.0050748084,0.3482711],"study_design_scores_gemma":[0.38635466,0.47271493,0.09353223,0.00021221218,0.0031389515,0.0019953987,0.00020429237,0.0054030465,0.016797632,0.0005596327,0.019037092,0.000049866347],"about_ca_topic_score_codex":0.00032734984,"about_ca_topic_score_gemma":0.0017799167,"teacher_disagreement_score":0.0020454514,"about_ca_system_score_codex":0.0004875884,"about_ca_system_score_gemma":0.00093585474,"threshold_uncertainty_score":0.0068427324},"labels":[],"label_agreement":null},{"id":"W2976453465","doi":"10.1001/jamaoncol.2019.3338","title":"The Value of Progression-Free Survival as a Treatment End Point Among Patients With Advanced Cancer","year":2019,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Surrogate endpoint; MEDLINE; Progression-free survival; Cancer; Meta-analysis; Oncology; Internal medicine; Intensive care medicine; Overall survival","score_opus":0.11490236358128177,"score_gpt":0.48394285602300235,"score_spread":0.3690404924417206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2976453465","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008502067,0.98523617,0.0003070753,0.0039042314,0.00021187459,0.000099094075,0.000270116,0.000003157205,0.0014662183],"genre_scores_gemma":[0.3359339,0.6536079,0.002609071,0.005988292,0.0008007177,0.0004486347,0.0003754204,0.000009113833,0.00022685324],"study_design_codex":"systematic_review","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.95935744,0.02763329,0.0070370114,0.001314893,0.0043445984,0.00031277916],"domain_scores_gemma":[0.81459975,0.15363792,0.024753254,0.0011515684,0.005263467,0.000594081],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.026463022,0.0006439056,0.0031467092,0.0037498837,0.00045815326,0.004784527,0.001224158,0.0022700701,0.00230041],"category_scores_gemma":[0.1515361,0.00039101945,0.0035322958,0.004574131,0.0018353331,0.0047826245,0.0012637832,0.0031557383,0.00018704115],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021934207,0.00013467752,0.032002185,0.6359667,0.018037807,0.0001921519,0.0024398896,0.00068497966,0.000333188,0.0038709454,0.004586151,0.29955792],"study_design_scores_gemma":[0.0013142962,0.002096958,0.06104917,0.8301469,0.03991597,0.0013537797,0.0043764254,0.0007007507,0.00071966817,0.010803505,0.0473142,0.00020830595],"about_ca_topic_score_codex":0.002895068,"about_ca_topic_score_gemma":0.004825124,"teacher_disagreement_score":0.97353697,"about_ca_system_score_codex":0.0023967242,"about_ca_system_score_gemma":0.0039888816,"threshold_uncertainty_score":0.13995147},"labels":[],"label_agreement":null},{"id":"W2989825979","doi":"10.1001/jamaoncol.2019.5098","title":"<i>Listeria</i> Susceptibility in Patients With Multiple Myeloma Receiving Daratumumab-Based Therapy","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Daratumumab; Listeria; Multiple myeloma; Listeria monocytogenes; Oncology; Internal medicine; MEDLINE; Bortezomib","score_opus":0.019006791030601954,"score_gpt":0.2983351776100454,"score_spread":0.2793283865794435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2989825979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97423005,0.011064836,0.00036705495,0.00452275,0.00027909077,0.00009805,0.0010893458,0.00007810886,0.008270768],"genre_scores_gemma":[0.9952408,0.0014318145,0.00059079984,0.001261241,0.00012577637,0.00003943766,0.00044219443,0.000008849062,0.0008591452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996246,0.00013648607,0.00003660307,0.000043806966,0.00007240167,0.000085990025],"domain_scores_gemma":[0.9989944,0.00019827056,0.0004530363,0.00004334517,0.00013531197,0.0001757007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000472719,0.00020906162,0.0004153257,0.00023679821,0.00044183986,0.00066842866,0.0002352549,0.00035428503,0.003231629],"category_scores_gemma":[0.0028119748,0.000114826566,0.0006191284,0.00037119447,0.00011616499,0.00028601463,0.00030774338,0.00083840627,0.00045510544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013399561,0.0010463557,0.77369666,0.0005752556,0.0010383971,0.00016330554,0.00016130912,0.000320597,0.0029458,0.00024291137,0.016095506,0.19031441],"study_design_scores_gemma":[0.0016992238,0.006071245,0.97014856,0.00051572244,0.001731802,0.0010077193,0.00036146247,0.0013691355,0.0025372042,0.0008869684,0.013639773,0.00003120323],"about_ca_topic_score_codex":0.0025277403,"about_ca_topic_score_gemma":0.0034919179,"teacher_disagreement_score":0.003231629,"about_ca_system_score_codex":0.00048777252,"about_ca_system_score_gemma":0.0005552629,"threshold_uncertainty_score":0.010810852},"labels":[],"label_agreement":null},{"id":"W2991564522","doi":"10.1001/jamaoncol.2018.2706","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016","year":2018,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":1542,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Ottawa Hospital; University of Manitoba","funders":"Medical Research Council; College of Medicine, Seoul National University; University of California, Irvine; Laboratório Associado para a Química Verde; Western Sydney University; Alborz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; University of Peradeniya; Helsingin Yliopisto; National Research University Higher School of Economics; Christian Medical College, Vellore; Tampereen Yliopisto; University of Haifa; Universitair Medisch Centrum Groningen; Haramaya University; Inyuvesi Yakwazulu-Natali; University of Gondar; Universidade Federal de Minas Gerais; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Mazandaran University of Medical Sciences; Samara University; United Nations Population Fund; Karolinska Institutet; Universidade do Porto; Seoul National University; Rijksuniversiteit Groningen; National Institute for Health and Care Research; Jordan University of Science and Technology; University of Oxford; Samfundet Folkhälsan; Maragheh University of Medical Sciences; Fudan University; Ahmadu Bello University; Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu; Trường Đại học Duy Tân; Iran University of Medical Sciences; Rede de Química e Tecnologia; University of West Florida; National Cancer Institute; University College London; Mekelle University; Arabian Gulf University; Case Western Reserve University; Universitetet i Tromsø; Baqiyatallah University of Medical Sciences; Imperial College London; Johns Hopkins University; Curtin University of Technology; University of Washington; Aarhus Universitet; United Arab Emirates University; Jackson State University; Korea University; South African Medical Research Council; King's College London; Public Health Foundation of India; Universität Bielefeld; Kosin University; Ball State University; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Years of potential life lost; Cancer; Population; Disease burden; Global health; Demography; Epidemiology; Incidence (geometry); Environmental health; Gerontology; Public health; Life expectancy; Pathology; Internal medicine","score_opus":0.1869459352406655,"score_gpt":0.4487672438435223,"score_spread":0.2618213086028568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991564522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003628628,0.9805453,0.0002596872,0.0013587573,0.00018349277,0.00008583434,0.012276843,0.00001812206,0.0016433941],"genre_scores_gemma":[0.052085787,0.9390046,0.00078974053,0.0006314599,0.00019093532,0.00022725154,0.00654944,0.000007848238,0.00051299745],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974234,0.00066512165,0.00068330235,0.00025069618,0.00086675776,0.00011067498],"domain_scores_gemma":[0.9963553,0.0010858811,0.0013036286,0.000052253563,0.0010893908,0.00011356139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003024053,0.00065310526,0.0015143321,0.006121571,0.00023260608,0.0011018205,0.0007087512,0.00051776995,0.0019614059],"category_scores_gemma":[0.010746471,0.0003740596,0.002941776,0.010850424,0.00038856157,0.0010106305,0.0008962811,0.0009177388,0.0003798637],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006012309,0.00004006505,0.10128518,0.2875152,0.012640518,0.00014531547,0.00036482306,0.0015388128,0.00024669184,0.0017898995,0.06625402,0.5275783],"study_design_scores_gemma":[0.0004704753,0.000587814,0.36049762,0.23241062,0.039584454,0.0013456275,0.0016506324,0.0012833285,0.00072331534,0.0030386222,0.358267,0.00014054493],"about_ca_topic_score_codex":0.039917912,"about_ca_topic_score_gemma":0.0774721,"teacher_disagreement_score":0.039917912,"about_ca_system_score_codex":0.0026059947,"about_ca_system_score_gemma":0.00461797,"threshold_uncertainty_score":0.079371154},"labels":[],"label_agreement":null},{"id":"W2997720498","doi":"10.1001/jamaoncol.2019.5570","title":"Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":436,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"Pharmacyclics; Genentech; Merck Canada; Deutschen Konsortium für Translationale Krebsforschung; Radboud Universitair Medisch Centrum; Melanoma Institute Australia; Amgen; Radboud Universiteit; Universitat de Barcelona; Astellas Pharma; Les Laboratories Pierre Fabre; European Organisation for Research and Treatment of Cancer; SkylineDx; Sun Pharma; Peter MacCallum Cancer Centre; Syndax Pharmaceuticals; Regeneron Pharmaceuticals; Endocyte; Array BioPharma; Aix-Marseille Université; InflaRx; Pfizer; Incyte; F. Hoffmann-La Roche; Sanofi; GlaxoSmithKline; NeraCare; University of Sydney; Medizinischen Hochschule Hannover; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Pembrolizumab; Internal medicine; Adverse effect; Placebo; Randomized controlled trial; Clinical trial; Melanoma; Oncology; Surgery; Cancer; Immunotherapy; Pathology","score_opus":0.014428608379705823,"score_gpt":0.2701461534137153,"score_spread":0.25571754503400945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2997720498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99503314,0.0024936239,0.0002812408,0.00023612262,0.00017548433,0.00061528897,0.00042735413,0.000014638337,0.00072307774],"genre_scores_gemma":[0.997221,0.00043594735,0.00027286392,0.00027055695,0.00017446809,0.0007539578,0.00029205595,0.0000032822768,0.0005758494],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9984315,0.0008792738,0.00016121665,0.00028718796,0.00010916488,0.0001316437],"domain_scores_gemma":[0.99752444,0.0009097889,0.00087782845,0.00015534378,0.00010774839,0.00042485987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025722256,0.0005970428,0.00190792,0.00028607898,0.0002634638,0.00053741597,0.0004025092,0.0011566591,0.0030776132],"category_scores_gemma":[0.0044112504,0.00040804758,0.0018340993,0.00026495103,0.00050057605,0.0006055988,0.00029877116,0.0013257015,0.00032438204],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96614176,0.0024678938,0.015418152,0.00034265354,0.0015609578,0.000031810843,0.000038995462,0.00019981115,0.001449115,0.000051465762,0.00039096305,0.011906347],"study_design_scores_gemma":[0.6279935,0.25570235,0.10661034,0.00013387512,0.0038528794,0.00015402878,0.00006722316,0.0019434654,0.0013436711,0.0005480651,0.0015968324,0.00005382188],"about_ca_topic_score_codex":0.00032946662,"about_ca_topic_score_gemma":0.0005292928,"teacher_disagreement_score":0.0030776132,"about_ca_system_score_codex":0.0003434517,"about_ca_system_score_gemma":0.0004864749,"threshold_uncertainty_score":0.013603389},"labels":[],"label_agreement":null},{"id":"W3000043704","doi":"10.1001/jamaoncol.2019.5559","title":"Association Between 21-Gene Assay Recurrence Score and Locoregional Recurrence Rates in Patients With Node-Positive Breast Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Cancer Institute; National Institutes of Health; Genomic Health","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer recurrence; Cancer","score_opus":0.013472572159005458,"score_gpt":0.26638401579031185,"score_spread":0.2529114436313064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000043704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989436,0.00048850017,0.00007289054,0.0000443731,0.000005383212,0.0000064258143,0.00022827108,0.0000043346254,0.0002062216],"genre_scores_gemma":[0.9993063,0.00008557077,0.00006589406,0.000017653272,0.0000144901305,0.000008207358,0.00038702288,0.0000018840216,0.000112909904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995166,0.00016414885,0.00006168427,0.00009300237,0.00011009685,0.00005446043],"domain_scores_gemma":[0.9971943,0.0007563955,0.0014403367,0.00018662863,0.00019849757,0.00022388881],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093981135,0.0001889698,0.00027706617,0.0005322605,0.00013803344,0.00032531022,0.00027319737,0.0003284402,0.0011080502],"category_scores_gemma":[0.0045627314,0.00013677565,0.00038736404,0.00046887793,0.00015341384,0.00026448056,0.00020380088,0.00039890365,0.00018169127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004111866,0.00002300796,0.99770063,0.000006633823,0.00006155177,0.00002233731,0.000009128513,0.00005573423,0.00012511734,0.000006704938,0.000093434785,0.0014844267],"study_design_scores_gemma":[0.000046856498,0.00032151205,0.9985298,0.0000044186745,0.00007797982,0.00025861312,0.000022765842,0.0004130864,0.00010137552,0.000018165023,0.0002009873,0.0000045526904],"about_ca_topic_score_codex":0.0011814181,"about_ca_topic_score_gemma":0.0021481856,"teacher_disagreement_score":0.0011814181,"about_ca_system_score_codex":0.00018864613,"about_ca_system_score_gemma":0.00017932421,"threshold_uncertainty_score":0.004970312},"labels":[],"label_agreement":null},{"id":"W3008735477","doi":"10.1001/jamaoncol.2019.6716","title":"Global Retinoblastoma Presentation and Analysis by National Income Level","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Ocular Oncology and Treatments","field":"Medicine","cited_by":369,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine; Hospital for Sick Children","funders":"Cliniques Universitaires Saint-Luc; Emory Eye Center; NIH Clinical Center; National Cancer Institute; Faculty of Medicine and Health, University of Sydney; School of Medicine, Shanghai Jiao Tong University; College of Medicine, University of Cincinnati; Université de Paris; Servicio Andaluz de Salud; Universitas Andalas; Centre hospitalier universitaire Sainte-Justine; Masarykova Univerzita; Dali University; Universitas Airlangga; University of Cape Town; Hospital for Sick Children; Addis Ababa University; Anna University; Université Mohammed V de Rabat; Aarhus Universitet; University of Ghana; Prince of Songkla University; Jimma University; Hospital Infantil de México Federico Gómez; Università degli Studi di Padova; Universitas Udayana; Shanghai Jiao Tong University; Hacettepe Üniversitesi; Tel Aviv University; Seoul National University Hospital; Faculdade de Medicina da Universidade de São Paulo; Mahidol University; Hebrew University of Jerusalem; Universitätsklinikum Hamburg-Eppendorf; Universiteit Stellenbosch; Universidade de São Paulo; Chulalongkorn University; Centre Hospitalier Universitaire Vaudois; Northwestern University; Seoul National University; Helsingin Yliopisto; Semmelweis Egyetem; University of Cincinnati; Amsterdam University Medical Centers; Universitätsklinikum Essen; Birmingham Women's and Children's NHS Foundation Trust; Leonard M. Miller School of Medicine; Indus Hospital; University of Southern California; Children's Hospital Colorado; Cleveland Clinic; Hadassah Medical Organization; Guangxi Medical University; Iran University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Universidade de Coimbra; University of Miami; University of South Carolina; University of Louisville; Johns Hopkins University; Feinberg School of Medicine; Ankara Universitesi; Ege Üniversitesi; Università degli Studi di Siena; Chang Gung Medical Foundation; Children's Hospital Los Angeles; St. Jude Children's Research Hospital; Aarhus Universitetshospital; Universidad de Chile; Emory University; Inyuvesi Yakwazulu-Natali; University of Otago; Consejo Nacional de Investigaciones Científicas y Técnicas; Uniwersytet Jagielloński Collegium Medicum","keywords":"Medicine; Retinoblastoma; Interquartile range; Pediatrics; Cohort; Strabismus; Referral; Surgery; Internal medicine; Family medicine","score_opus":0.03398779889015197,"score_gpt":0.3545768754051521,"score_spread":0.3205890765150001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008735477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525034,0.00049888686,0.000103812476,0.00010987215,0.0000075895623,0.000019633273,0.0028175742,0.000017932014,0.0011743493],"genre_scores_gemma":[0.9977477,0.0001942671,0.000067839486,0.00003042862,0.000006843271,0.00002125093,0.0018085579,0.000006908318,0.000116097035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995994,0.00009268086,0.000057573427,0.00008951859,0.00006653059,0.00009431542],"domain_scores_gemma":[0.9985084,0.00017384074,0.0008432546,0.00009367923,0.00015326797,0.00022749478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071645185,0.00025785642,0.00035114825,0.0017475055,0.00026440594,0.0005235456,0.00030552858,0.00019415039,0.0026661113],"category_scores_gemma":[0.002420383,0.00016150484,0.0006706754,0.002206285,0.00031055542,0.0005736923,0.0009394147,0.00037915626,0.00040160486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035989397,0.000004156372,0.9990815,0.000007199541,0.00003367489,0.000030967512,0.000026030177,0.00004203119,0.00003110313,0.00001147004,0.00016473635,0.00053114066],"study_design_scores_gemma":[0.0000037386671,0.000025907451,0.99911255,0.000010072736,0.000021048974,0.00023495214,0.00020342275,0.00014260695,0.00002103549,0.000027133952,0.00019469822,0.0000027809763],"about_ca_topic_score_codex":0.005517782,"about_ca_topic_score_gemma":0.004938815,"teacher_disagreement_score":0.005517782,"about_ca_system_score_codex":0.00038630716,"about_ca_system_score_gemma":0.0003246905,"threshold_uncertainty_score":0.010971308},"labels":[],"label_agreement":null},{"id":"W30128482","doi":"10.1001/jamaoncol.2018.4091","title":"Using circles of support and accountability in China: prospects and problems","year":2010,"lang":"en","type":"dissertation","venue":"JAMA Oncology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Accountability; China; Political science; Law","score_opus":0.055439473072147256,"score_gpt":0.4587338958495721,"score_spread":0.40329442277742483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W30128482","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9588096,0.003325644,0.0003127905,0.021341475,0.00006757528,0.0000716571,0.00007180547,0.000020190562,0.01597922],"genre_scores_gemma":[0.99731463,0.00094257615,0.000181724,0.0003519682,0.000018359442,0.000022435775,0.000022000633,0.0000019338256,0.0011443284],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774146,0.000733782,0.00009733282,0.00016860577,0.0004684959,0.0007903242],"domain_scores_gemma":[0.9955544,0.0006687096,0.0011715351,0.00031563727,0.00092129176,0.0013685027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032186252,0.0002506392,0.00031443825,0.0021318987,0.0053290226,0.0037789694,0.0014032071,0.00079944,0.0027066732],"category_scores_gemma":[0.0044747693,0.00019995627,0.0002469198,0.004870578,0.0029638684,0.0034133482,0.002825516,0.0006333056,0.00011208896],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001254993,0.00030461172,0.62224627,0.00046092636,0.000056219542,0.0011153466,0.06794604,0.0008432199,0.00070647005,0.057593554,0.007961796,0.24064009],"study_design_scores_gemma":[0.00005764898,0.00033876224,0.7779597,0.00051452365,0.00007312869,0.00038381555,0.14605221,0.0031623594,0.00088483735,0.013298237,0.057175934,0.00009892631],"about_ca_topic_score_codex":0.17424275,"about_ca_topic_score_gemma":0.21595736,"teacher_disagreement_score":0.17424275,"about_ca_system_score_codex":0.0130224265,"about_ca_system_score_gemma":0.02150064,"threshold_uncertainty_score":0.34645706},"labels":[],"label_agreement":null},{"id":"W3013690193","doi":"10.1001/jamaoncol.2020.0167","title":"Double Counting of Patients in Meta-analyses of Observational Studies","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.4692503425462964,"score_gpt":0.4781352585005708,"score_spread":0.00888491595427443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013690193","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06436038,0.33252767,0.4236319,0.043641835,0.06052898,0.011493252,0.032603197,0.0049452065,0.02626755],"genre_scores_gemma":[0.7849441,0.02062396,0.13699767,0.020357704,0.006723151,0.016789678,0.0052905637,0.0013847396,0.0068884557],"study_design_codex":"meta_analysis","study_design_gemma":"not_applicable","domain_scores_codex":[0.5307165,0.3737561,0.055329707,0.025271442,0.013559891,0.0013663489],"domain_scores_gemma":[0.4454854,0.46189407,0.021187058,0.063206404,0.0068794675,0.0013476686],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19161683,0.0025594644,0.009228107,0.006004034,0.0015434303,0.004577233,0.0034323204,0.0047967695,0.0093868105],"category_scores_gemma":[0.48077095,0.0023443913,0.029430933,0.0071586804,0.0020253372,0.004463347,0.0031767043,0.0068374835,0.0011718012],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019551616,0.00017197418,0.07505878,0.07253619,0.60094064,0.0025706752,0.001281754,0.0042750305,0.0021054419,0.01362825,0.08603017,0.12184943],"study_design_scores_gemma":[0.017278716,0.0023071736,0.054451626,0.024999088,0.6207558,0.005922443,0.0008746944,0.025674399,0.005084646,0.108419076,0.13335252,0.0008798992],"about_ca_topic_score_codex":0.002583917,"about_ca_topic_score_gemma":0.004525273,"teacher_disagreement_score":0.9907719,"about_ca_system_score_codex":0.0017060278,"about_ca_system_score_gemma":0.002449044,"threshold_uncertainty_score":0.99688035},"labels":[],"label_agreement":null},{"id":"W3014602666","doi":"10.1001/jamaoncol.2020.0249","title":"Effect of Delayed Targeted Intraoperative Radiotherapy vs Whole-Breast Radiotherapy on Local Recurrence and Survival","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":106,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"St. Olavs Hospital Universitetssykehuset i Trondheim; Uniwersytet Medyczny w Lublinie; Universität des Saarlandes; University College London; University of Southern California; National Institute for Health and Care Research; Universitätsspital Zürich; Norges Teknisk-Naturvitenskapelige Universitet; University of Oxford","keywords":"Medicine; Lumpectomy; Radiation therapy; Mastectomy; Breast cancer; Randomized controlled trial; External beam radiotherapy; Surgery; Intraoperative radiotherapy; Cancer; Radiology; Brachytherapy; Internal medicine","score_opus":0.007730415757261636,"score_gpt":0.2830973617822725,"score_spread":0.2753669460250109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014602666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989837,0.00753383,0.00038665778,0.0004729801,0.0003543792,0.00042553415,0.00017038702,0.000023448034,0.0007957667],"genre_scores_gemma":[0.9966337,0.0010781672,0.00046172045,0.00029522544,0.00028936705,0.0005510522,0.00012475955,0.000006833766,0.0005592314],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99768984,0.0015483579,0.00015232607,0.00027851723,0.00013028305,0.00020071886],"domain_scores_gemma":[0.9923759,0.004905762,0.0014643002,0.00034706786,0.00014445455,0.0007624873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046379105,0.0009032863,0.0019046629,0.00029483202,0.00021692656,0.00080046407,0.0009956553,0.001581025,0.004644424],"category_scores_gemma":[0.0071583814,0.00033137685,0.0027110544,0.00024818938,0.0008250904,0.00092051097,0.00043940355,0.0019735224,0.00034271352],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9746592,0.0032934987,0.0022549785,0.0005267399,0.00089063053,0.000018250028,0.000019142492,0.00045737735,0.00077254634,0.00009168499,0.00018320227,0.016832875],"study_design_scores_gemma":[0.45474038,0.51997906,0.014500779,0.00024301681,0.0038037978,0.00011843772,0.000055752727,0.002478393,0.0025300966,0.0006660121,0.0008520675,0.000032245393],"about_ca_topic_score_codex":0.00036302584,"about_ca_topic_score_gemma":0.00059575186,"teacher_disagreement_score":0.004644424,"about_ca_system_score_codex":0.0006435086,"about_ca_system_score_gemma":0.0007453968,"threshold_uncertainty_score":0.024527907},"labels":[],"label_agreement":null},{"id":"W3016210953","doi":"10.1001/jamaoncol.2020.0237","title":"Durvalumab With or Without Tremelimumab vs Standard Chemotherapy in First-line Treatment of Metastatic Non–Small Cell Lung Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":628,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Center for Advancing Translational Sciences; AstraZeneca","keywords":"Durvalumab; Tremelimumab; Medicine; Internal medicine; Oncology; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Nivolumab; Ipilimumab","score_opus":0.03414082962539107,"score_gpt":0.3314500925352575,"score_spread":0.2973092629098664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016210953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953525,0.0025528255,0.00013907535,0.000267824,0.00015636734,0.00044435784,0.00019952767,0.000021896372,0.00086554314],"genre_scores_gemma":[0.9973978,0.0009148067,0.00032921825,0.00025350673,0.00009416749,0.0003203626,0.00020780136,0.000003768855,0.00047851118],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9994301,0.00032344493,0.000042103038,0.00007527592,0.000051575636,0.00007746911],"domain_scores_gemma":[0.9989492,0.0003687514,0.00026230124,0.00005993714,0.000041959152,0.000317794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015503524,0.00053899287,0.001429056,0.00030049085,0.00018816881,0.0007485724,0.000679396,0.0008124784,0.0024417185],"category_scores_gemma":[0.0017360896,0.0003020079,0.0012733648,0.00024925914,0.00053362036,0.0007490752,0.0002902848,0.0018037165,0.0002613834],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.95014435,0.006704144,0.0018545915,0.00047188686,0.0010478728,0.00003718399,0.000047680023,0.0009356353,0.002923021,0.0001482881,0.00059544074,0.035089914],"study_design_scores_gemma":[0.70686513,0.27613157,0.009794373,0.00007149402,0.0014842944,0.00012463011,0.000050037645,0.002114213,0.0019442906,0.00027081533,0.0011264442,0.000022696851],"about_ca_topic_score_codex":0.0007092695,"about_ca_topic_score_gemma":0.00254461,"teacher_disagreement_score":0.0024417185,"about_ca_system_score_codex":0.0010737143,"about_ca_system_score_gemma":0.0010927494,"threshold_uncertainty_score":0.008199096},"labels":[],"label_agreement":null},{"id":"W3021442601","doi":"10.1001/jamaoncol.2020.0910","title":"Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":398,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Canadian Red Cross Society; Dalhousie University; Moncton Hospital; Juravinski Cancer Centre; Ottawa Hospital; Saskatchewan Cancer Agency; St. John’s Health Sciences Centre; Université de Sherbrooke; Queen's University; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; Université Laval","funders":"Ipsen; Eisai; Celgene; Amgen","keywords":"Medicine; Microsatellite instability; Internal medicine; Colorectal cancer; Oncology; Cetuximab; Regorafenib; Tremelimumab; Irinotecan; Cancer; Ipilimumab; Immunotherapy","score_opus":0.005834023752853325,"score_gpt":0.27359923073120196,"score_spread":0.26776520697834866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3021442601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99236566,0.0050363326,0.00014621619,0.0004270686,0.0002651853,0.00044277858,0.00016449361,0.000032104883,0.0011201417],"genre_scores_gemma":[0.9972166,0.001085331,0.0004050008,0.00032801938,0.00020952238,0.00025633592,0.00014916009,0.0000041077606,0.00034575874],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993616,0.0003216605,0.000050752264,0.00010365208,0.00005762613,0.00010466527],"domain_scores_gemma":[0.99860746,0.0004327932,0.0002180539,0.00006584943,0.000054901273,0.0006209423],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013014557,0.0008660796,0.0020623568,0.00047280712,0.00032639314,0.0007479706,0.0006638802,0.0008232308,0.002812716],"category_scores_gemma":[0.0022928165,0.0003542732,0.001366181,0.00037731815,0.00059566076,0.00078415236,0.00041369608,0.0017838054,0.00029185298],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9168504,0.009102195,0.0037168022,0.0005821164,0.001481494,0.0000577775,0.000050941027,0.0012119574,0.0027636688,0.00006854988,0.0007708606,0.06334328],"study_design_scores_gemma":[0.4015201,0.56785834,0.022636104,0.00011587931,0.002416457,0.00013855599,0.00006192596,0.002025797,0.0014752084,0.00018764063,0.0015259776,0.000038027676],"about_ca_topic_score_codex":0.0015871957,"about_ca_topic_score_gemma":0.007538321,"teacher_disagreement_score":0.002812716,"about_ca_system_score_codex":0.0011693387,"about_ca_system_score_gemma":0.0015439469,"threshold_uncertainty_score":0.009409487},"labels":[],"label_agreement":null},{"id":"W3030472743","doi":"10.1001/jamaoncol.2020.2218","title":"Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":179,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sunitinib; Tolerability; Internal medicine; Renal cell carcinoma; Population; Oncology; Clinical endpoint; Cabozantinib; Expanded access; Clinical trial; Urology; Surgery; Adverse effect","score_opus":0.023545140243513205,"score_gpt":0.25515136495276947,"score_spread":0.23160622470925626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030472743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99631906,0.0020044814,0.000112455855,0.00017798609,0.00007945816,0.0003046739,0.00020382088,0.000031474647,0.00076658436],"genre_scores_gemma":[0.9984843,0.00037138254,0.00022972308,0.00017655641,0.00008377919,0.00020601043,0.00019088443,0.00000411263,0.00025312134],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99931514,0.0003838394,0.000064886284,0.00009796649,0.00005436239,0.00008386378],"domain_scores_gemma":[0.99893254,0.00034517274,0.00029692097,0.00006197947,0.000055197175,0.00030820706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023870913,0.0006468007,0.0018438157,0.00029230997,0.00028025854,0.0008441616,0.0004507171,0.0008277143,0.0020505064],"category_scores_gemma":[0.0019128906,0.00038040912,0.001664303,0.00025757923,0.0005069028,0.00079161825,0.0002967598,0.0014194389,0.0003254833],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91607934,0.010563608,0.012474482,0.00057161384,0.0011906879,0.000084623745,0.00012172822,0.0015615559,0.007646935,0.0001173291,0.0010525876,0.048535477],"study_design_scores_gemma":[0.37281784,0.57953906,0.037534237,0.00007896453,0.0014548205,0.00029444275,0.00010638817,0.003204041,0.0029137689,0.00032369327,0.0016904757,0.000042271662],"about_ca_topic_score_codex":0.00045051737,"about_ca_topic_score_gemma":0.0013315749,"teacher_disagreement_score":0.0023870913,"about_ca_system_score_codex":0.0008153217,"about_ca_system_score_gemma":0.0010171933,"threshold_uncertainty_score":0.012624323},"labels":[],"label_agreement":null},{"id":"W3030999222","doi":"10.1001/jamaoncol.2020.1271","title":"Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":215,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Université de Sherbrooke","funders":"National Center for Advancing Translational Sciences; National Institute of General Medical Sciences","keywords":"Medicine; Radiosurgery; Interquartile range; Lung cancer; Radiation therapy; Brain metastasis; Internal medicine; Prophylactic cranial irradiation; Oncology; Cohort; Retrospective cohort study; Cancer; Metastasis; Conventional PCI","score_opus":0.09586448013135285,"score_gpt":0.42618148420825736,"score_spread":0.3303170040769045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030999222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935741,0.0034871157,0.0006363377,0.0002233027,0.000048619862,0.000301827,0.0009087008,0.000030249135,0.00078975165],"genre_scores_gemma":[0.9978544,0.00059085875,0.0003811685,0.00010473531,0.00006278191,0.00015006833,0.00065942155,0.000007792577,0.00018869317],"study_design_codex":"observational","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9976555,0.0011056769,0.00022619375,0.00044828924,0.0004314524,0.00013279122],"domain_scores_gemma":[0.9931553,0.0021309226,0.0032208299,0.00041248623,0.000501865,0.00057857734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056967414,0.00046827496,0.0010064667,0.00034760917,0.00021605632,0.00071026006,0.0008530566,0.0005516288,0.0019010911],"category_scores_gemma":[0.01022354,0.0001852466,0.002831964,0.00042940228,0.00033243943,0.00082158745,0.0003747047,0.0007737211,0.0002482372],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14988886,0.003099867,0.6607717,0.0019377625,0.012980402,0.00013866655,0.00027371824,0.004054778,0.0033598493,0.00041992468,0.0021125874,0.16096173],"study_design_scores_gemma":[0.012249492,0.12541826,0.83907276,0.00036689173,0.00809693,0.0005028649,0.00019803285,0.006103999,0.0044803293,0.00055287656,0.0029048116,0.000052768053],"about_ca_topic_score_codex":0.0022252938,"about_ca_topic_score_gemma":0.0056698867,"teacher_disagreement_score":0.0056967414,"about_ca_system_score_codex":0.0016902819,"about_ca_system_score_gemma":0.0020356567,"threshold_uncertainty_score":0.030127645},"labels":[],"label_agreement":null},{"id":"W3032917453","doi":"10.1001/jamaoncol.2020.1694","title":"Survival After Minimally Invasive vs Open Radical Hysterectomy for Early-Stage Cervical Cancer","year":2020,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":209,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Cervical cancer; Observational study; Hysterectomy; Randomized controlled trial; Meta-analysis; Radical Hysterectomy; Confounding; Stage (stratigraphy); Surgery; Cancer; Internal medicine","score_opus":0.10949079119001927,"score_gpt":0.42479862671239965,"score_spread":0.3153078355223804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3032917453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017977545,0.9795569,0.0005111053,0.0005302174,0.0002810362,0.00011758089,0.00066748925,0.000013479423,0.00034468694],"genre_scores_gemma":[0.54668367,0.4464268,0.0022580933,0.0014111098,0.00092744426,0.00051187305,0.0013640474,0.000025606005,0.00039135886],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.9865876,0.0074519627,0.0029641674,0.0013160452,0.0014822831,0.00019804112],"domain_scores_gemma":[0.9598262,0.031239579,0.0068357736,0.0007712448,0.0010721498,0.00025509018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017059287,0.0010623357,0.00649016,0.0033128494,0.00023193461,0.0024353352,0.0012263288,0.0015312122,0.001959371],"category_scores_gemma":[0.048514005,0.000530208,0.02047173,0.0034400322,0.00055049884,0.0013439014,0.0009114319,0.0015106997,0.00013648278],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013358314,0.00008569376,0.0407348,0.28411508,0.6064059,0.00018373951,0.0002266629,0.0014417818,0.0005765991,0.0004808396,0.0013946336,0.05099593],"study_design_scores_gemma":[0.0035304786,0.0021759258,0.056053285,0.062418103,0.86776716,0.00033169464,0.0002409903,0.00083782594,0.0006009081,0.0015946368,0.004354089,0.00009480787],"about_ca_topic_score_codex":0.0025569494,"about_ca_topic_score_gemma":0.004403665,"teacher_disagreement_score":0.017059287,"about_ca_system_score_codex":0.0013755419,"about_ca_system_score_gemma":0.0015742802,"threshold_uncertainty_score":0.0902192},"labels":[],"label_agreement":null},{"id":"W3037873371","doi":"10.1001/jamaoncol.2020.1796","title":"Efficacy and Safety of Trastuzumab Emtansine Plus Capecitabine vs Trastuzumab Emtansine Alone in Patients With Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Capecitabine; Medicine; Metastatic breast cancer; Trastuzumab emtansine; Internal medicine; Trastuzumab; Oncology; Phases of clinical research; Breast cancer; Cancer; Gastroenterology; Chemotherapy","score_opus":0.019962352137295275,"score_gpt":0.31567226766944956,"score_spread":0.2957099155321543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3037873371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974673,0.0015455897,0.00010913905,0.000097502634,0.000040689858,0.00018787243,0.000109390174,0.000013507876,0.0004290382],"genre_scores_gemma":[0.99829525,0.00062720047,0.00021688007,0.00013724895,0.00007783981,0.00018464145,0.00018268898,0.0000032158887,0.0002750163],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99952674,0.000247284,0.000037998867,0.00006873872,0.00005443398,0.00006474623],"domain_scores_gemma":[0.9989699,0.00029984344,0.0003127411,0.000053749427,0.00003636886,0.00032749772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012955071,0.0005581771,0.0016195886,0.00034044767,0.00021131983,0.0005506491,0.0004056225,0.0006480254,0.0015355459],"category_scores_gemma":[0.0017932891,0.0002713408,0.0010072696,0.00032306142,0.00042106202,0.00062167214,0.00020778779,0.0015561677,0.00021850878],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8626672,0.017240405,0.013063305,0.00032305138,0.0014838761,0.00017675677,0.00012127999,0.0025751705,0.01642412,0.00013241539,0.0008328988,0.084959485],"study_design_scores_gemma":[0.2707265,0.67493224,0.044022806,0.000059455397,0.0013520699,0.00030146097,0.000045437602,0.0032603336,0.003761797,0.00021342133,0.0012942802,0.00003017211],"about_ca_topic_score_codex":0.00043277213,"about_ca_topic_score_gemma":0.0013413662,"teacher_disagreement_score":0.0016195886,"about_ca_system_score_codex":0.0008383968,"about_ca_system_score_gemma":0.0008041001,"threshold_uncertainty_score":0.006851375},"labels":[],"label_agreement":null},{"id":"W3038137802","doi":"10.1001/jamaoncol.2020.2404","title":"Covid-19 Pandemic—An Opportunity to Reduce and Eliminate Low-Value Practices in Oncology?","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Cancer Care Ontario","funders":"","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Pandemic; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Value (mathematics); MEDLINE; Betacoronavirus; Oncology; Coronavirus Infections; Internal medicine; Virology; Intensive care medicine; Outbreak; Infectious disease (medical specialty); Statistics","score_opus":0.35086257480534905,"score_gpt":0.5370751771833544,"score_spread":0.18621260237800535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038137802","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031946916,0.0032459837,0.00025472694,0.9731064,0.006373591,0.000022013024,0.00040747665,0.00007034614,0.013324845],"genre_scores_gemma":[0.098516054,0.011711746,0.002954756,0.86250925,0.014051402,0.0001388852,0.0009356748,0.00013997473,0.009042246],"study_design_codex":"not_applicable","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9910788,0.0023961517,0.0004350071,0.00044184315,0.0026751047,0.0029731563],"domain_scores_gemma":[0.9465185,0.008243701,0.0035859651,0.0015386192,0.0067612883,0.033351876],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011469726,0.0004819237,0.0005554789,0.0011900159,0.0033073938,0.008391064,0.0027429187,0.010713535,0.035047363],"category_scores_gemma":[0.04991269,0.00042014202,0.0012774008,0.0012042377,0.0046390817,0.007388172,0.009120305,0.013677965,0.0041358825],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017258553,0.00045114182,0.015922267,0.00033554513,0.000083953106,0.00029516793,0.0004987414,0.00028719,0.00044704782,0.05067665,0.83581334,0.095016286],"study_design_scores_gemma":[0.00023549801,0.00042570694,0.030171545,0.0023257646,0.000057659017,0.000337466,0.0041914796,0.00046030202,0.00051846914,0.03993778,0.9212006,0.00013781301],"about_ca_topic_score_codex":0.030490626,"about_ca_topic_score_gemma":0.073478974,"teacher_disagreement_score":0.9885303,"about_ca_system_score_codex":0.008973306,"about_ca_system_score_gemma":0.056657065,"threshold_uncertainty_score":0.11724508},"labels":[],"label_agreement":null},{"id":"W3038926436","doi":"10.1001/jamaoncol.2020.2134","title":"Characterization of the Cancer Spectrum in Men With Germline<i>BRCA1</i>and<i>BRCA2</i>Pathogenic Variants","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; University of Toronto; University Health Network; Centre hospitalier universitaire de Québec; Lunenfeld-Tanenbaum Research Institute; Mount Sinai Hospital","funders":"Klinisk Institut, Aalborg Universitet; Servicio Gallego de Salud; Lee Kong Chian School of Medicine, Nanyang Technological University; European Regional Development Fund; Medical Research Council; Canadian Institutes of Health Research; Manchester Biomedical Research Centre; Fox Chase Cancer Center; National Institutes of Health; Centro de Investigación Biomédica en Red de Cáncer; National Cancer Institute; Liga Portuguesa Contra o Cancro; National Institute of General Medical Sciences; Institut National Du Cancer; Tel Aviv University; Ministerio de Economía y Competitividad; Landspítali Háskólasjúkrahús; Aalborg Universitetshospital; Fondation ARC pour la Recherche sur le Cancer; Medizinische Universität Wien; Karolinska Institutet; Hungarian Scientific Research Fund; Gentofte Hospital; Nederlandse Organisatie voor Wetenschappelijk Onderzoek; Ministero della Salute; Generalitat de Catalunya; Associazione Italiana per la Ricerca sul Cancro; Aalborg Universitet; Deutsche Krebshilfe; National Breast Cancer Foundation; Seoul National University; Universität Wien; Cancer Australia; National Institute for Health and Care Research; Georgetown University; Nanyang Technological University; Centre Hospitalier Universitaire de Québec; Istituto Oncologico Veneto; Helsingin Yliopisto; Université Laval; Centres de Recerca de Catalunya; KWF Kankerbestrijding; Cancer Research UK; Memorial Sloan-Kettering Cancer Center; Wellcome Trust; College of Medicine, Seoul National University; Susan G. Komen for the Cure; National Cancer Centre of Singapore; Deutsches Krebsforschungszentrum; Università degli Studi di Firenze; Instituto de Investigación Sanitaria de Santiago de Compostela; Ministério da Ciência, Tecnologia e Inovação; Kansas Bioscience Authority; University of Chicago; Cancer Research Institute; Dr. Ralph and Marian Falk Medical Research Trust; Cancer Center, University of Kansas; Cancerfonden; Fundación Mutua Madrileña; Rigshospitalet; National Health and Medical Research Council; Fisher Center for Alzheimer's Research Foundation; Instituto de Salud Carlos III; Ohio State University; Institut Català de la Salut; University of Pennsylvania; European Commission; Breast Cancer Research Foundation","keywords":"Medicine; Germline; Cancer; BRCA2 Protein; Germline mutation; Oncology; Genetics; Mutation; Internal medicine; Gene; Biology","score_opus":0.01058025025450346,"score_gpt":0.2567594755809587,"score_spread":0.24617922532645523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038926436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990151,0.0002850103,0.000121600446,0.000040211624,0.0000031889883,0.000006222995,0.00025191825,0.0000025602599,0.00027413433],"genre_scores_gemma":[0.99946064,0.0000884202,0.00011526,0.000026540738,0.000007722978,0.0000044587878,0.00023238728,0.0000013844528,0.000063203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970406,0.00006503473,0.000026598264,0.000108904365,0.000051894625,0.000043570115],"domain_scores_gemma":[0.99909675,0.00015336063,0.00049001625,0.000062112624,0.000054543307,0.00014325147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055778306,0.00019371197,0.00021594984,0.00094108185,0.0003127923,0.00030160992,0.00028007984,0.00029708282,0.0012933415],"category_scores_gemma":[0.0015959677,0.00014316659,0.00026405024,0.0006798367,0.0003150453,0.0003398335,0.00036732157,0.00027880393,0.00014415495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005085868,0.0000074642116,0.998754,0.0000034745226,0.000010362478,0.00003861475,0.0000347062,0.000017187927,0.00037141397,0.000015271171,0.00003845713,0.0006581449],"study_design_scores_gemma":[0.0000033774595,0.0000484651,0.998923,0.0000042271545,0.000009111578,0.00062269036,0.000104359155,0.00008250129,0.00008160204,0.000029007999,0.000090204194,0.0000013642032],"about_ca_topic_score_codex":0.0024929212,"about_ca_topic_score_gemma":0.0032603785,"teacher_disagreement_score":0.0024929212,"about_ca_system_score_codex":0.000132743,"about_ca_system_score_gemma":0.00015900921,"threshold_uncertainty_score":0.004956782},"labels":[],"label_agreement":null},{"id":"W3044088237","doi":"10.1001/jamaoncol.2020.2485","title":"Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":225,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"U.S. Department of Defense","keywords":"Medicine; Grading (engineering); Biopsy; Prostate cancer; Prostate; Second opinion; Prostate biopsy; Radiology; Tumor grade; Medical physics; Cancer; Pathology; Internal medicine","score_opus":0.033228661469353424,"score_gpt":0.31262632328907225,"score_spread":0.2793976618197188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044088237","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40562743,0.000670678,0.58444107,0.00071040844,0.00014065222,0.00062947004,0.0008054405,0.004407908,0.0025669169],"genre_scores_gemma":[0.7278535,0.00015529004,0.26777712,0.00028425563,0.000031981486,0.0003653099,0.0019199457,0.000071752365,0.0015408369],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99874866,0.00038650783,0.00016599162,0.0003027957,0.00029774726,0.000098295866],"domain_scores_gemma":[0.996367,0.0013502901,0.00023710323,0.00027835384,0.0016514024,0.00011591283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042136568,0.0007493626,0.00044731563,0.0015695894,0.00043419612,0.0010406818,0.0012009792,0.001165375,0.0011248254],"category_scores_gemma":[0.009519185,0.0002749882,0.00054160546,0.00055182504,0.00033976338,0.00063766906,0.0010357887,0.0009630935,0.0005602292],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031580587,0.00052008725,0.0572788,0.00012626097,0.00020887674,0.00013891756,0.000109197266,0.15986127,0.014607049,0.0008951985,0.0051684915,0.7607701],"study_design_scores_gemma":[0.00002951499,0.00009290798,0.004960379,0.00002120774,0.000018108638,0.00005005027,0.00002164769,0.9889704,0.004681731,0.00058575853,0.0005595038,0.000008844327],"about_ca_topic_score_codex":0.007547552,"about_ca_topic_score_gemma":0.0068682646,"teacher_disagreement_score":0.007547552,"about_ca_system_score_codex":0.0011356127,"about_ca_system_score_gemma":0.0019565541,"threshold_uncertainty_score":0.02228421},"labels":[],"label_agreement":null},{"id":"W3089997034","doi":"10.1001/jamaoncol.2020.3949","title":"Survival and Outcomes After Noncompletion of Treatment for Anal Cancer","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.05276631449055629,"score_gpt":0.3421484084919138,"score_spread":0.2893820940013575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3089997034","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731357,0.001984781,0.00007658871,0.00841717,0.00035794344,0.000014507317,0.0027449701,0.00002701841,0.013241214],"genre_scores_gemma":[0.99530727,0.0004779716,0.000030203548,0.000939746,0.00022408467,0.000013778195,0.0013709071,0.000004598002,0.0016313075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956805,0.00010018124,0.000036493886,0.00005608629,0.00008064865,0.00015849681],"domain_scores_gemma":[0.9973769,0.000870917,0.00075147755,0.000093364215,0.00023982911,0.00066752563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003895047,0.000100237055,0.00023002438,0.0006988521,0.0004161262,0.00052406185,0.000258303,0.0008187867,0.005879452],"category_scores_gemma":[0.0056768833,0.00009940587,0.00048561572,0.0009857692,0.00020776023,0.00063227065,0.00031962962,0.0009898683,0.000807054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009187335,0.000107717846,0.9728094,0.000029826228,0.000059876646,0.0008119273,0.00012004253,0.00022890851,0.00006491112,0.00013334757,0.0096689295,0.01504648],"study_design_scores_gemma":[0.0000449806,0.00028612945,0.99512345,0.000043543507,0.000054941775,0.0012758239,0.00028674706,0.0003673106,0.00004526673,0.0004007391,0.0020563074,0.0000147609735],"about_ca_topic_score_codex":0.005894052,"about_ca_topic_score_gemma":0.008302863,"teacher_disagreement_score":0.005894052,"about_ca_system_score_codex":0.0008322512,"about_ca_system_score_gemma":0.0005274608,"threshold_uncertainty_score":0.019668758},"labels":[],"label_agreement":null},{"id":"W3090413519","doi":"10.1001/jamaoncol.2020.4564","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1212,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nivolumab; Ipilimumab; Tolerability; Internal medicine; Sorafenib; Hepatocellular carcinoma; Adverse effect; Randomized controlled trial; Surgery; Gastroenterology; Oncology; Cancer; Immunotherapy","score_opus":0.023995485520901996,"score_gpt":0.2317533058969982,"score_spread":0.2077578203760962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090413519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978688,0.0013466898,0.00008740079,0.00010095098,0.00003482304,0.0001366599,0.0001013372,0.000012075126,0.00031114963],"genre_scores_gemma":[0.9989911,0.00034005634,0.00012928223,0.00010732398,0.000055108198,0.00012294314,0.00011933117,0.0000018241245,0.00013304673],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9994438,0.00028645314,0.000050933184,0.000090416805,0.00005584439,0.000072573],"domain_scores_gemma":[0.9991223,0.00024751064,0.00024804348,0.00005616992,0.000039482085,0.00028645826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014297365,0.0004667157,0.0012886224,0.0003532481,0.00029322298,0.0005256838,0.00033200835,0.00057184463,0.0014757983],"category_scores_gemma":[0.0016800058,0.00036519117,0.0011581684,0.00030332804,0.00044348324,0.0004753037,0.0002542325,0.0008947503,0.00027755953],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.81778914,0.011523296,0.07341879,0.00046140415,0.0024353173,0.0001778841,0.00015339481,0.0016665824,0.010766295,0.00008501827,0.0011326455,0.08039024],"study_design_scores_gemma":[0.3518758,0.41454703,0.21862082,0.0001318819,0.0030745992,0.000555144,0.00012780858,0.0044369227,0.0038217586,0.00040584747,0.002335088,0.00006727888],"about_ca_topic_score_codex":0.0005196552,"about_ca_topic_score_gemma":0.0011353105,"teacher_disagreement_score":0.0014757983,"about_ca_system_score_codex":0.00072797236,"about_ca_system_score_gemma":0.0007731646,"threshold_uncertainty_score":0.0075612664},"labels":[],"label_agreement":null},{"id":"W3091620172","doi":"10.1001/jamaoncol.2020.3963","title":"Survival and Outcomes After Noncompletion of Treatment for Anal Cancer—Reply","year":2020,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Colorectal and Anal Carcinomas","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Medicine; Anal cancer; MEDLINE; Oncology; Cancer; Gynecology; Internal medicine","score_opus":0.0495800179343163,"score_gpt":0.33570046823075805,"score_spread":0.28612045029644173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091620172","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005148579,0.0006350463,0.000046598783,0.9808715,0.008108045,0.000013257102,0.0009181429,0.000048980062,0.0042099175],"genre_scores_gemma":[0.03665512,0.0009589497,0.00015770704,0.933735,0.01684044,0.000086879576,0.00068748475,0.000036628193,0.0108417915],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989473,0.00036864504,0.00014393457,0.00012206251,0.00021779096,0.00020020302],"domain_scores_gemma":[0.99376065,0.003906525,0.00041777713,0.00016194939,0.0010248937,0.0007282272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016892619,0.00034855923,0.0006235838,0.0005546229,0.001369769,0.0010134677,0.00070304057,0.013342374,0.008871024],"category_scores_gemma":[0.013730945,0.00031052908,0.0006895133,0.0008479903,0.0006594487,0.001280243,0.0005562906,0.00818335,0.005744228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020163377,0.000043580294,0.009820502,0.00004510997,0.000017398559,0.00064609444,0.00012196441,0.00006486228,0.00013075367,0.00047449302,0.98012024,0.0083133895],"study_design_scores_gemma":[0.0006917198,0.0006182492,0.11766181,0.0012621349,0.00023848464,0.0070524914,0.0029076952,0.002060975,0.0011869178,0.008485934,0.85753185,0.00030168425],"about_ca_topic_score_codex":0.01425285,"about_ca_topic_score_gemma":0.020120772,"teacher_disagreement_score":0.01425285,"about_ca_system_score_codex":0.0019270646,"about_ca_system_score_gemma":0.00215637,"threshold_uncertainty_score":0.029676497},"labels":[],"label_agreement":null},{"id":"W3093123863","doi":"10.1001/jamaoncol.2020.4630","title":"Multi-institutional Analysis of Prognostic Factors and Outcomes After Hypofractionated Stereotactic Radiotherapy to the Resection Cavity in Patients With Brain Metastases","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":77,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Radiosurgery; Radiation therapy; Interquartile range; Cohort; Retrospective cohort study; Dose fractionation; Surgery; Internal medicine","score_opus":0.025677227916149986,"score_gpt":0.3126175125691195,"score_spread":0.2869402846529695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093123863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956816,0.00007193633,0.000070476366,0.000012538174,0.0000017572517,0.0000048763272,0.0001945104,0.000002468842,0.0000731531],"genre_scores_gemma":[0.9995172,0.000023326185,0.00005442137,0.0000065931326,0.000004562994,0.000006622391,0.00035470288,0.0000015676484,0.000030923813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99957794,0.00011882081,0.000048783404,0.00011446496,0.000066000415,0.000073967596],"domain_scores_gemma":[0.9976803,0.00036617453,0.0013190331,0.00022380042,0.0001387159,0.0002718937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010598651,0.00027246564,0.00030517488,0.000828683,0.0003769148,0.00045261995,0.00047100685,0.0003081738,0.00096853584],"category_scores_gemma":[0.0021017073,0.00020262516,0.000528102,0.0010229972,0.0003286134,0.0005051719,0.0005582585,0.0003805152,0.00016217334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003221404,0.000019690873,0.99847203,0.0000044009075,0.00005350901,0.00004019904,0.000025263626,0.00012238794,0.00019726163,0.0000049070773,0.000044764343,0.0006934461],"study_design_scores_gemma":[0.000018751325,0.00017555628,0.99890745,0.0000027554001,0.000040090432,0.00021941982,0.00007308266,0.0002993664,0.00014857353,0.000015068564,0.00009553408,0.0000043140017],"about_ca_topic_score_codex":0.0024271936,"about_ca_topic_score_gemma":0.0040417057,"teacher_disagreement_score":0.0024271936,"about_ca_system_score_codex":0.00047482236,"about_ca_system_score_gemma":0.00035294448,"threshold_uncertainty_score":0.005605161},"labels":[],"label_agreement":null},{"id":"W3096193621","doi":"10.1001/jamaoncol.2020.5745","title":"Serial Screening for COVID-19 in Asymptomatic Patients Receiving Anticancer Therapy in the United Arab Emirates","year":2020,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Pacira BioSciences; Northwestern University; Intuitive Foundation; Pacira Pharmaceuticals; National Cancer Institute; Agency for Healthcare Research and Quality; Intuitive Surgical; American College of Surgeons","keywords":"Medicine; Coronavirus disease 2019 (COVID-19); Asymptomatic; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Cohort study; Betacoronavirus; MEDLINE; Cohort; Pandemic; Family medicine; Internal medicine; Virology; Outbreak; Disease; Infectious disease (medical specialty)","score_opus":0.15245498208069533,"score_gpt":0.4405189808179583,"score_spread":0.28806399873726296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3096193621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990965,0.00006303709,0.000028843455,0.000092358576,0.0000048790307,0.000015484218,0.00016543157,0.0000013323499,0.0005321267],"genre_scores_gemma":[0.99938715,0.0001045267,0.000076421384,0.00009927659,0.000006135576,0.0000126235755,0.00015243482,0.0000010826476,0.00016023873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99962187,0.000085367574,0.000030304407,0.000051723662,0.000062918254,0.00014777904],"domain_scores_gemma":[0.9992048,0.0000847642,0.00039977144,0.000037371035,0.00013925947,0.0001341023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048448547,0.00022997921,0.0002042822,0.0005891754,0.0006480183,0.0004901154,0.00032136086,0.0002904235,0.0010971449],"category_scores_gemma":[0.0022629006,0.00029184992,0.00023484523,0.00061755866,0.00024156747,0.00040447147,0.00057190383,0.00058115035,0.00014502961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044910175,0.00006084575,0.9981717,0.000007140263,0.000010064997,0.00008055189,0.00022338299,0.000013263882,0.00013872863,0.000020326444,0.00012501894,0.0011040557],"study_design_scores_gemma":[0.000008924763,0.0001964113,0.99771357,0.000015041858,0.0000136288745,0.0002966353,0.0012911758,0.00007728068,0.00006658232,0.000013668497,0.00030347117,0.0000035808798],"about_ca_topic_score_codex":0.044924393,"about_ca_topic_score_gemma":0.072292805,"teacher_disagreement_score":0.044924393,"about_ca_system_score_codex":0.00074717833,"about_ca_system_score_gemma":0.001305095,"threshold_uncertainty_score":0.089325786},"labels":[],"label_agreement":null},{"id":"W3118701973","doi":"10.1001/jamaoncol.2020.6789","title":"Frequency of and Factors Associated With Nonmedical Opioid Use Behavior Among Patients With Cancer Receiving Opioids for Cancer Pain","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences","keywords":"Medicine; Interquartile range; Cancer; Opioid; Internal medicine; Cancer pain; Inclusion and exclusion criteria; Physical therapy; Alternative medicine","score_opus":0.02420105981240075,"score_gpt":0.306094218075656,"score_spread":0.2818931582632553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3118701973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990627,0.00023346073,0.00003337004,0.00008135686,0.000006265137,0.0000098351675,0.0003296553,0.0000020604937,0.00024125962],"genre_scores_gemma":[0.999403,0.00009286382,0.0000516798,0.000034774785,0.000011342708,0.000012824958,0.00029293567,8.5938495e-7,0.00009968136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995654,0.00010108946,0.000082012266,0.00007489282,0.00009358738,0.000083087565],"domain_scores_gemma":[0.99778724,0.0004351605,0.0012496222,0.00008865298,0.00014158413,0.00029776915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046016747,0.00018174048,0.00026324735,0.00058808393,0.00038154915,0.00054599333,0.00030759026,0.0004522359,0.0021795346],"category_scores_gemma":[0.0029429973,0.00021645386,0.0003895615,0.00086456,0.00020396923,0.0005099584,0.00041655623,0.00062759017,0.00021740508],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019768257,0.000015224794,0.9995875,0.0000026520634,0.0000098874325,0.000006918826,0.000012723679,0.000007525299,0.000018728173,0.0000018221214,0.000026473117,0.00029086278],"study_design_scores_gemma":[0.0000033339202,0.00005036507,0.9996147,0.0000042380684,0.0000076080064,0.000060475097,0.00010652721,0.000083526014,0.000011192551,0.000003919823,0.000052497297,0.0000014736407],"about_ca_topic_score_codex":0.004892718,"about_ca_topic_score_gemma":0.009109341,"teacher_disagreement_score":0.004892718,"about_ca_system_score_codex":0.00035714475,"about_ca_system_score_gemma":0.0004648159,"threshold_uncertainty_score":0.009728432},"labels":[],"label_agreement":null},{"id":"W3128013781","doi":"10.1001/jamaoncol.2020.8017","title":"Evaluation of Efficacy and Safety of Nab-Paclitaxel vs Paclitaxel in Platinum-Refractory Metastatic Urothelial Cancer—Reply","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Queen's University; University Health Network","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; Internal medicine; Psychiatry","score_opus":0.06340154576612089,"score_gpt":0.37241622273889274,"score_spread":0.30901467697277185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3128013781","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010803574,0.0015218642,0.0001852635,0.96798396,0.014899926,0.00009811085,0.00070422015,0.000088957735,0.0037140953],"genre_scores_gemma":[0.046930812,0.0020426183,0.00068071054,0.90191805,0.03935647,0.00028426273,0.00042660444,0.00004642999,0.0083140535],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99852943,0.00053497317,0.0003619547,0.00014922234,0.00027670292,0.00014758109],"domain_scores_gemma":[0.9888355,0.007994635,0.00044538412,0.00022780734,0.0017799112,0.0007167681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028147534,0.00047806435,0.0009430526,0.0004648609,0.0012728567,0.0010205008,0.0009758696,0.012507649,0.005138972],"category_scores_gemma":[0.02066333,0.00030290554,0.0011386172,0.0006899212,0.0008099415,0.001309875,0.00034242935,0.008628072,0.002714899],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016501205,0.0002878903,0.008742809,0.0002492469,0.00011318298,0.0039989226,0.0002477071,0.0004108901,0.0006391592,0.0010407239,0.9466304,0.035988815],"study_design_scores_gemma":[0.004192508,0.0045267255,0.046690095,0.0009456101,0.00089910004,0.017984798,0.0018687029,0.0040868577,0.0041300864,0.012561856,0.9017765,0.00033724486],"about_ca_topic_score_codex":0.0047890795,"about_ca_topic_score_gemma":0.004291104,"teacher_disagreement_score":0.012507649,"about_ca_system_score_codex":0.0024915244,"about_ca_system_score_gemma":0.002072196,"threshold_uncertainty_score":0.018077314},"labels":[],"label_agreement":null},{"id":"W3129029771","doi":"10.1001/jamaoncol.2020.6752","title":"Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.04064746612541352,"score_gpt":0.3827713780327475,"score_spread":0.342123911907334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129029771","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022860174,0.07026573,0.002446941,0.8547649,0.046701975,0.00059639453,0.0011022657,0.0002418393,0.021594068],"genre_scores_gemma":[0.06749579,0.029478056,0.010001051,0.81028575,0.065177396,0.0018117717,0.00061816734,0.00070723385,0.014424743],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95504063,0.032338165,0.0044475133,0.0023715943,0.0042728144,0.0015292529],"domain_scores_gemma":[0.87091374,0.09597548,0.010056096,0.006894702,0.006490048,0.009669959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05879848,0.0010259687,0.0038588832,0.0016993895,0.0023415945,0.012516688,0.002021048,0.013189006,0.06644695],"category_scores_gemma":[0.21288018,0.0007160914,0.0037155908,0.0017891625,0.005081693,0.01834933,0.0025714955,0.018570997,0.01310997],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011833909,0.0003418155,0.0025444098,0.010217551,0.0033629318,0.0002269651,0.0005127005,0.00035616517,0.00039972743,0.042427022,0.6599509,0.26782596],"study_design_scores_gemma":[0.025455324,0.0023384101,0.0029138962,0.036886092,0.0054716226,0.00051614817,0.0010588596,0.0011664748,0.00077017705,0.14242317,0.780665,0.00033491052],"about_ca_topic_score_codex":0.0017827486,"about_ca_topic_score_gemma":0.003448466,"teacher_disagreement_score":0.06644695,"about_ca_system_score_codex":0.003947733,"about_ca_system_score_gemma":0.005388236,"threshold_uncertainty_score":0.31095976},"labels":[],"label_agreement":null},{"id":"W3133576100","doi":"10.1001/jamaoncol.2021.0019","title":"Assessment of Immune Checkpoint Inhibitors and Genomic Alterations by Body Mass Index in Advanced Renal Cell Carcinoma","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System; Juravinski Cancer Centre","funders":"Genentech; Ipsen; Pfizer; Bristol-Myers Squibb","keywords":"Medicine; Renal cell carcinoma; Body mass index; Clear cell renal cell carcinoma; Internal medicine; Oncology; Vascular endothelial growth factor; Immune checkpoint; Immune system; Carcinoma; Cancer research; Cancer; Immunotherapy; VEGF receptors; Immunology","score_opus":0.01056701007371909,"score_gpt":0.28577121943876493,"score_spread":0.27520420936504586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3133576100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954046,0.0021282856,0.00039020934,0.00008895033,0.000012956293,0.00004980951,0.00081055914,0.000012115375,0.0011025502],"genre_scores_gemma":[0.99730694,0.00059786893,0.00079206657,0.000098199474,0.000019092216,0.000048953185,0.00062134035,0.000004592465,0.0005108682],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99978656,0.00003867868,0.000018110066,0.00004767856,0.00007721175,0.000031765583],"domain_scores_gemma":[0.99959415,0.0000744572,0.00017650284,0.00002113219,0.00006221222,0.00007161928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034501302,0.00014081232,0.0002679908,0.00090639945,0.00020826996,0.00037350712,0.00019969809,0.00023213815,0.0014015563],"category_scores_gemma":[0.0008660486,0.00013580875,0.00020132908,0.00095992937,0.00017447927,0.00019602035,0.00018282679,0.00040011664,0.00019333554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020499376,0.00022662838,0.962016,0.00007829685,0.0001530864,0.00018624066,0.000068280206,0.00040472858,0.013843386,0.000072700605,0.00033942767,0.020561367],"study_design_scores_gemma":[0.000031420568,0.00061428937,0.99318355,0.0000120112345,0.00006519347,0.0004060803,0.0000772852,0.00086150016,0.0035441762,0.00010261196,0.001095353,0.0000063683356],"about_ca_topic_score_codex":0.0012449062,"about_ca_topic_score_gemma":0.0027542415,"teacher_disagreement_score":0.0014015563,"about_ca_system_score_codex":0.00030415857,"about_ca_system_score_gemma":0.0002312986,"threshold_uncertainty_score":0.0046886206},"labels":[],"label_agreement":null},{"id":"W3137427440","doi":"10.1001/jamaoncol.2021.0379","title":"Evolution of the Randomized Clinical Trial in the Era of Precision Oncology","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":202,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; NOSM University; Kingston Health Sciences Centre; Thunder Bay Regional Health Sciences Centre","funders":"","keywords":"Medicine; Randomized controlled trial; Internal medicine; Surrogate endpoint; Breast cancer; Oncology; Clinical endpoint; Colorectal cancer; Cohort; Lung cancer; Cancer","score_opus":0.5062045424251019,"score_gpt":0.6209226704404257,"score_spread":0.11471812801532377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137427440","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010129908,0.39442164,0.21841803,0.344237,0.020984083,0.0026768015,0.00086692104,0.00045169474,0.007813977],"genre_scores_gemma":[0.23179893,0.11335024,0.43214458,0.17474629,0.036174167,0.008715068,0.0006364498,0.0007881443,0.0016462188],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.2096371,0.67654383,0.050843246,0.019126583,0.042527325,0.0013218529],"domain_scores_gemma":[0.06764428,0.8466977,0.028815802,0.0307783,0.024080878,0.0019831809],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7043592,0.0015988444,0.009549882,0.011094639,0.0019492093,0.020149061,0.006473544,0.014272781,0.0038411678],"category_scores_gemma":[0.8001654,0.0022943201,0.005072177,0.016240159,0.03496675,0.029845852,0.008311215,0.02159214,0.0009859994],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005905099,0.0003756392,0.02191906,0.04133962,0.0078139,0.000319898,0.0051406114,0.005962398,0.00089876296,0.44119206,0.028799538,0.4403334],"study_design_scores_gemma":[0.0060127103,0.004220798,0.012819978,0.10626403,0.0041491655,0.0012092975,0.002436639,0.01804307,0.0016408381,0.6337883,0.2086543,0.0007609248],"about_ca_topic_score_codex":0.0028999434,"about_ca_topic_score_gemma":0.0020662125,"teacher_disagreement_score":0.29564083,"about_ca_system_score_codex":0.018372243,"about_ca_system_score_gemma":0.029200628,"threshold_uncertainty_score":0.36457783},"labels":[],"label_agreement":null},{"id":"W3162414274","doi":"10.1001/jamaoncol.2021.1359","title":"Central Nervous System–Specific Outcomes of Phase 3 Randomized Clinical Trials in Patients With Advanced Breast Cancer, Lung Cancer, and Melanoma","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; Juravinski Hospital; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Lung cancer; Melanoma; Oncology; Cancer; Internal medicine; Clinical trial; Central nervous system; Metastatic breast cancer; Randomized controlled trial; Cancer research","score_opus":0.034853460795665675,"score_gpt":0.41050362783154726,"score_spread":0.3756501670358816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3162414274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713154,0.009551017,0.0019190517,0.00063079345,0.00020405602,0.0019255046,0.010336156,0.000056707668,0.0040613175],"genre_scores_gemma":[0.98860836,0.001065836,0.0009969161,0.0007236534,0.00015379358,0.001326092,0.006517737,0.00003510177,0.0005724722],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98603463,0.009916076,0.0014477185,0.0011269306,0.0008542972,0.00062032894],"domain_scores_gemma":[0.9654214,0.015265011,0.012649135,0.003544881,0.0015299908,0.0015897027],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.018502045,0.00071970926,0.0014803199,0.0007353384,0.0005909106,0.0013054027,0.0007151752,0.00084254716,0.0034637162],"category_scores_gemma":[0.034290407,0.00036259214,0.0048433226,0.0009673891,0.00056745036,0.0012714935,0.0010996662,0.002024446,0.00042214352],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55300146,0.0028116086,0.3191445,0.0020393804,0.04863316,0.00018026421,0.00024466205,0.0020386686,0.0033056338,0.001470953,0.0117547875,0.05537487],"study_design_scores_gemma":[0.21964042,0.068428725,0.6452052,0.00083473406,0.03353589,0.0012328015,0.0003779217,0.005126437,0.004307229,0.0031981529,0.017920395,0.00019202435],"about_ca_topic_score_codex":0.00093618024,"about_ca_topic_score_gemma":0.002244357,"teacher_disagreement_score":0.99851966,"about_ca_system_score_codex":0.0006467353,"about_ca_system_score_gemma":0.001407886,"threshold_uncertainty_score":0.09784931},"labels":[],"label_agreement":null},{"id":"W3164251373","doi":"10.1001/jamaoncol.2021.1463","title":"Association of Molecular Subtypes With Differential Outcome to Apalutamide Treatment in Nonmetastatic Castration-Resistant Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Hazard ratio; Prostate cancer; Internal medicine; Oncology; Proportional hazards model; Enzalutamide; Cohort; Confidence interval; Cancer; Androgen receptor","score_opus":0.02506877602564506,"score_gpt":0.3563358219363845,"score_spread":0.33126704591073947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3164251373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989579,0.0005408592,0.00008204531,0.000022587676,0.0000049390974,0.000030523515,0.00019672979,0.000002877567,0.00016154225],"genre_scores_gemma":[0.9992994,0.00013713319,0.00012370935,0.00003193882,0.00001100248,0.000023123072,0.0002783917,0.0000011094861,0.00009424469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99965477,0.00013612723,0.00003550807,0.00007244765,0.00006434017,0.000036734753],"domain_scores_gemma":[0.9993963,0.00014453128,0.0002773925,0.000060569862,0.000027244485,0.00009397397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072531676,0.000215332,0.0005196723,0.00017469036,0.00015817492,0.00034353655,0.0002915626,0.00027992288,0.0011721641],"category_scores_gemma":[0.0009290184,0.00013771975,0.0005166215,0.00027685123,0.0002514446,0.00017990137,0.00013279985,0.000402871,0.00009306089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.076943226,0.0009923395,0.8719978,0.00022949005,0.0012072523,0.00015915591,0.000058453716,0.0006689362,0.010493192,0.00008538099,0.0004383425,0.03672649],"study_design_scores_gemma":[0.0029068294,0.008987084,0.98391193,0.000017320099,0.00048560643,0.00052555144,0.00004160062,0.00079710496,0.0016736926,0.00011770627,0.0005208413,0.000014608819],"about_ca_topic_score_codex":0.00063444255,"about_ca_topic_score_gemma":0.0018890406,"teacher_disagreement_score":0.0011721641,"about_ca_system_score_codex":0.00031933602,"about_ca_system_score_gemma":0.00039973846,"threshold_uncertainty_score":0.0039212704},"labels":[],"label_agreement":null},{"id":"W3176726648","doi":"10.1001/jamaoncol.2021.1516","title":"Adjuvant Zoledronate Therapy for Women With Breast Cancer—Effective Treatment or Fool’s Gold?","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Bone health and treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Adjuvant; Breast cancer; MEDLINE; Adjuvant therapy; Oncology; Medical physics; Cancer; Intensive care medicine; Internal medicine","score_opus":0.028488919355201585,"score_gpt":0.34469385056623747,"score_spread":0.3162049312110359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3176726648","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018802145,0.0017993198,0.00006828242,0.95706636,0.0109947575,0.00003287776,0.00025335955,0.00006299861,0.027841857],"genre_scores_gemma":[0.018159274,0.0037326375,0.00031754948,0.89259124,0.026351485,0.00007836881,0.0002548577,0.000059108734,0.05845539],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936527,0.00016155759,0.000063869156,0.0000496043,0.00021038974,0.00014938472],"domain_scores_gemma":[0.998621,0.00057597517,0.00009551479,0.00003504907,0.0002687491,0.0004037462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007796517,0.00032653974,0.00045581008,0.00051750004,0.001909051,0.0011448435,0.0005976204,0.012644931,0.02198648],"category_scores_gemma":[0.005853339,0.00027549756,0.0005151014,0.0005193336,0.00069201324,0.0012521531,0.000545826,0.008025064,0.010560718],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010684414,0.000055111377,0.0008807257,0.000042473446,0.000005526514,0.0010771459,0.000034593097,0.000042519405,0.00023127247,0.0010825457,0.9806732,0.015768105],"study_design_scores_gemma":[0.0003627551,0.00021163272,0.0062950514,0.00064214726,0.000029338515,0.003359939,0.00036527068,0.00051371485,0.00031190488,0.005286514,0.9825904,0.000031407235],"about_ca_topic_score_codex":0.008340952,"about_ca_topic_score_gemma":0.026062448,"teacher_disagreement_score":0.02198648,"about_ca_system_score_codex":0.002198917,"about_ca_system_score_gemma":0.0029383346,"threshold_uncertainty_score":0.07355213},"labels":[],"label_agreement":null},{"id":"W3180426532","doi":"10.1001/jamaoncol.2021.2140","title":"Practice Patterns and Outcomes of Novel Targeted Agents for the Treatment of <i>ERBB2</i>-Positive Metastatic Breast Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; CancerCare Manitoba; Queen's University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Metastatic breast cancer; Oncology; Breast cancer; Cancer; Internal medicine; Intensive care medicine","score_opus":0.08597336018157553,"score_gpt":0.4605725266895825,"score_spread":0.37459916650800695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3180426532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926358,0.0013137768,0.00026301033,0.0014476589,0.00001192153,0.00006650855,0.0023626988,0.000011369476,0.0018872498],"genre_scores_gemma":[0.9983354,0.00049609755,0.00017776078,0.00012384675,0.000009857396,0.0000335205,0.0006577884,0.0000032304472,0.00016244623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99762267,0.0004971306,0.00034744944,0.00047996177,0.00069735956,0.00035533062],"domain_scores_gemma":[0.98497355,0.0014723289,0.010812809,0.00033457825,0.0014060274,0.0010006786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014010979,0.00012041861,0.0002261101,0.0007689738,0.00042359333,0.000739814,0.0005608957,0.00037835032,0.0014755721],"category_scores_gemma":[0.012523272,0.00016315529,0.0002746544,0.0020327189,0.00044236518,0.00047912338,0.00061464065,0.00040581624,0.0001385752],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048681883,0.000020550118,0.9945891,0.000037069218,0.00003696275,0.000031035943,0.00028368647,0.00008024662,0.000051722844,0.00007010986,0.0005941032,0.0041566817],"study_design_scores_gemma":[0.000011052748,0.00003604176,0.99814487,0.000049300943,0.000016243373,0.00008244866,0.0005128,0.00035876504,0.000032459295,0.00005582566,0.0006950141,0.0000052272862],"about_ca_topic_score_codex":0.19025925,"about_ca_topic_score_gemma":0.29259068,"teacher_disagreement_score":0.19025925,"about_ca_system_score_codex":0.004582474,"about_ca_system_score_gemma":0.005929026,"threshold_uncertainty_score":0.37830365},"labels":[],"label_agreement":null},{"id":"W3186969757","doi":"10.1001/jamaoncol.2021.2318","title":"Addition of Metformin to Concurrent Chemoradiation in Patients With Locally Advanced Non–Small Cell Lung Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":95,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Hamilton Health Sciences","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Interquartile range; Hazard ratio; Metformin; Common Terminology Criteria for Adverse Events; Lung cancer; Chemoradiotherapy; Oncology; Clinical endpoint; Cancer; Surgery; Clinical trial; Confidence interval","score_opus":0.004354965336468148,"score_gpt":0.2483650140380045,"score_spread":0.24401004870153636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186969757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897007,0.00818592,0.00017646937,0.00034647508,0.00012594053,0.00036919874,0.00016983505,0.000018827832,0.0009066633],"genre_scores_gemma":[0.99688774,0.0017352864,0.00034956486,0.00024064672,0.00011720358,0.00022598261,0.00022376151,0.000002952835,0.00021682911],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99946755,0.0002540912,0.000068102854,0.00008581293,0.00007228358,0.0000520311],"domain_scores_gemma":[0.99933857,0.000206589,0.00024108149,0.00003355246,0.000032759654,0.00014737887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013568844,0.00040783858,0.0013279401,0.0003592909,0.00027073818,0.00059645926,0.00041537217,0.00057282357,0.001216271],"category_scores_gemma":[0.0021435614,0.00028121728,0.001197149,0.00048451877,0.00037644582,0.00061955577,0.00031402186,0.0011133193,0.00020013364],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.5545535,0.010924794,0.12593323,0.0023899477,0.0026817627,0.00032259707,0.00016580666,0.0027077766,0.007815819,0.00024732854,0.0023885712,0.2898689],"study_design_scores_gemma":[0.26587424,0.41391432,0.29458743,0.00058244675,0.0051743896,0.00077813026,0.0002328733,0.0058860844,0.0046730735,0.00063483557,0.0075694877,0.00009273711],"about_ca_topic_score_codex":0.0006927008,"about_ca_topic_score_gemma":0.0036160063,"teacher_disagreement_score":0.0013568844,"about_ca_system_score_codex":0.00088441756,"about_ca_system_score_gemma":0.0012540269,"threshold_uncertainty_score":0.007175982},"labels":[],"label_agreement":null},{"id":"W3191105813","doi":"10.1001/jamaoncol.2021.2697","title":"Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hearing, Cochlea, Tinnitus, Genetics","field":"Neuroscience","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children; BC Children's Hospital; University of British Columbia","funders":"Cancer Research UK","keywords":"Medicine; Context (archaeology); Ototoxicity; Hearing loss; Tinnitus; Intensive care medicine; Cancer; Clinical trial; Pediatric cancer; Audiology; Surgery; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.1561833292756699,"score_gpt":0.3740810340462203,"score_spread":0.21789770477055037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3191105813","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.018959062,0.07557799,0.10177812,0.682986,0.029100949,0.013357838,0.0045844456,0.0024125637,0.071243025],"genre_scores_gemma":[0.09256255,0.09169361,0.61027396,0.14847451,0.0076331645,0.021543074,0.008457838,0.00051856606,0.0188427],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.95420283,0.02166842,0.011438649,0.0015740203,0.0088348435,0.0022811668],"domain_scores_gemma":[0.8286491,0.058433313,0.01585922,0.0045665056,0.081729405,0.010762369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.05198019,0.001579615,0.0014540788,0.004740905,0.0018132369,0.0024474638,0.005585275,0.010742645,0.006866284],"category_scores_gemma":[0.119286574,0.00088873506,0.0042958395,0.0020298033,0.0018101989,0.0044383835,0.0040240623,0.009765193,0.0043081744],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003568525,0.00078283943,0.010664587,0.010941281,0.00023095019,0.0012088219,0.0031488508,0.0031184878,0.00359768,0.0060457326,0.58016545,0.3797385],"study_design_scores_gemma":[0.0008376022,0.00067746727,0.025437307,0.058194086,0.0008859561,0.002003023,0.0055361544,0.0028748747,0.003664009,0.015512261,0.88396627,0.00041095013],"about_ca_topic_score_codex":0.008222885,"about_ca_topic_score_gemma":0.011856785,"teacher_disagreement_score":0.05198019,"about_ca_system_score_codex":0.0038722297,"about_ca_system_score_gemma":0.023371631,"threshold_uncertainty_score":0.2749008},"labels":[],"label_agreement":null},{"id":"W3195999920","doi":"10.1001/jamaoncol.2021.3338","title":"Randomized Clinical Trials in the Era of Precision Oncology—The Role of End Points, Industry Funding, and Medical Writing Integrity","year":2021,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Internal medicine; Psychiatry","score_opus":0.1383174984120795,"score_gpt":0.4000104798995828,"score_spread":0.2616929814875033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195999920","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019179433,0.0029842467,0.00073174667,0.9867721,0.0062045944,0.00001970809,0.000049766575,0.000029929466,0.0030161664],"genre_scores_gemma":[0.02329239,0.009666426,0.006339134,0.85021704,0.10586107,0.0003079434,0.00008397019,0.00018082932,0.004051266],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.789544,0.15457995,0.019078376,0.0079252105,0.025926203,0.0029462005],"domain_scores_gemma":[0.11065222,0.8060106,0.026201153,0.018344443,0.027921414,0.010870132],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23051153,0.0006969104,0.002814652,0.0034779944,0.0040067905,0.019660732,0.0044715204,0.03256461,0.020830706],"category_scores_gemma":[0.71898955,0.0015235505,0.0020218128,0.00507545,0.018058624,0.018565234,0.0052843234,0.036657047,0.00677808],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005803366,0.000034108376,0.002040969,0.00073581614,0.00015091662,0.00057413895,0.0005187089,0.00034819698,0.000060897488,0.051172104,0.86818993,0.07559394],"study_design_scores_gemma":[0.0016106527,0.00022146663,0.0033400578,0.007173764,0.0002699546,0.002137335,0.0006654058,0.0036888833,0.000296365,0.30887052,0.6714981,0.00022746247],"about_ca_topic_score_codex":0.0036000162,"about_ca_topic_score_gemma":0.00462362,"teacher_disagreement_score":0.96743536,"about_ca_system_score_codex":0.012026338,"about_ca_system_score_gemma":0.025594844,"threshold_uncertainty_score":0.94891626},"labels":[],"label_agreement":null},{"id":"W3201585333","doi":"10.1001/jamaoncol.2021.3987","title":"Prognosis Associated With Luminal and Basal Subtypes of Metastatic Prostate Cancer","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Basal (medicine); Internal medicine; Oncology; Prostate; Pathology; Cancer; Biopsy","score_opus":0.03329409438283301,"score_gpt":0.352235723384815,"score_spread":0.318941629001982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3201585333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988288,0.00026884815,0.00013400635,0.00004630813,0.0000043365008,0.000004878933,0.00029033035,0.0000058726982,0.00041663565],"genre_scores_gemma":[0.99950767,0.000049971393,0.00004236696,0.000008179941,0.000005988923,0.000002252869,0.0003114052,0.0000015414879,0.00007069309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997253,0.000059942646,0.00002234802,0.000067215726,0.0000684216,0.00005675239],"domain_scores_gemma":[0.9987651,0.00014231013,0.00057368056,0.00008209899,0.00010041007,0.00033646138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048767368,0.00019166982,0.0002584003,0.0004629049,0.00031816302,0.00061247725,0.00027600024,0.00029246855,0.0015311474],"category_scores_gemma":[0.001700295,0.0001428655,0.00026354796,0.00051927887,0.0003546831,0.0003080184,0.00045836665,0.0003988924,0.00020570554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001124481,0.000004890717,0.9987884,0.000003178689,0.000019479838,0.00003231887,0.000011081856,0.000032154392,0.00017418478,0.000012377285,0.000047854515,0.0007615788],"study_design_scores_gemma":[0.000005029322,0.000061938255,0.9990073,0.0000035648268,0.000019333713,0.00043442694,0.000069211084,0.00017732166,0.00007490785,0.00005008532,0.000093695024,0.0000032215112],"about_ca_topic_score_codex":0.0017364987,"about_ca_topic_score_gemma":0.0027428807,"teacher_disagreement_score":0.0017364987,"about_ca_system_score_codex":0.00022751708,"about_ca_system_score_gemma":0.00030442662,"threshold_uncertainty_score":0.0051222444},"labels":[],"label_agreement":null},{"id":"W3202966447","doi":"10.1001/jamaoncol.2021.4531","title":"Incidence and Predictors of Second Primary Cancers in Patients With Neuroendocrine Tumors","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Incidence (geometry); Oncology; Internal medicine; Neuroendocrine tumors; Primary (astronomy)","score_opus":0.009036331980940648,"score_gpt":0.28587309050649645,"score_spread":0.2768367585255558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202966447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978277,0.00041952837,0.00006299314,0.000046182195,0.000010971325,0.000006911047,0.0009106618,0.0000047884205,0.0007102832],"genre_scores_gemma":[0.9989385,0.00019533955,0.000036809146,0.00001896459,0.000011160537,0.0000052620944,0.00061689917,0.0000027921974,0.00017417871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99964786,0.000040778228,0.00004227925,0.00008696312,0.00007945449,0.00010261496],"domain_scores_gemma":[0.9988117,0.00016121854,0.00050061935,0.0001467437,0.00012870107,0.00025109065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003073575,0.0002048623,0.00037721387,0.0006927595,0.00036519117,0.000629335,0.00033657812,0.00042414345,0.0017402894],"category_scores_gemma":[0.00169888,0.00036464463,0.0006252734,0.0009361459,0.00018413522,0.00055083784,0.00048920803,0.00088719564,0.0002827788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040249004,0.0000103833845,0.99940896,0.000002580393,0.000022393337,0.0000682534,0.000011636694,0.000019669618,0.0000768781,0.000008904574,0.000052161096,0.00027786306],"study_design_scores_gemma":[0.0000045577094,0.00005116014,0.9985644,0.000003758596,0.000019860401,0.00091352005,0.00011979479,0.00009874022,0.00004847085,0.000017452105,0.00015469221,0.0000036517147],"about_ca_topic_score_codex":0.007879398,"about_ca_topic_score_gemma":0.009621417,"teacher_disagreement_score":0.007879398,"about_ca_system_score_codex":0.00033912167,"about_ca_system_score_gemma":0.0004297233,"threshold_uncertainty_score":0.01566708},"labels":[],"label_agreement":null},{"id":"W3209267706","doi":"10.1001/jamaoncol.2021.5153","title":"Implications of Selection Bias Due to Delayed Study Entry in Clinical Genomic Studies","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Genetic Associations and Epidemiology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Milestone; Truncation (statistics); Lung cancer; Data set; Cancer; Survival analysis; Oncology; Internal medicine; Statistics","score_opus":0.07599562025519879,"score_gpt":0.41817460537246715,"score_spread":0.34217898511726835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3209267706","genre_codex":"methods","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18679552,0.05498215,0.4590613,0.23716109,0.018399935,0.009199801,0.007708245,0.001394753,0.025297187],"genre_scores_gemma":[0.84242594,0.0041514495,0.088432774,0.04959969,0.004816579,0.006154614,0.0012685173,0.00031943407,0.002830967],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.43907252,0.46449703,0.044993613,0.018263254,0.03028783,0.0028857612],"domain_scores_gemma":[0.14770018,0.7623668,0.042885553,0.034255613,0.010866621,0.0019253159],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.45626515,0.0009080384,0.0020423953,0.0031062963,0.002257278,0.0043561403,0.0037331937,0.003569366,0.0049496647],"category_scores_gemma":[0.7515471,0.00082338566,0.002329382,0.005272931,0.005465502,0.004082048,0.0032191025,0.0039900416,0.0007326192],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006290151,0.0003255735,0.50240606,0.006705128,0.006182649,0.0034910208,0.010737765,0.006432382,0.0010685171,0.09733656,0.0651687,0.2938555],"study_design_scores_gemma":[0.00479881,0.003140169,0.42934826,0.015461695,0.007175173,0.011571432,0.006550622,0.061160002,0.0053738407,0.3554024,0.099226676,0.0007909957],"about_ca_topic_score_codex":0.006454692,"about_ca_topic_score_gemma":0.006988537,"teacher_disagreement_score":0.54373485,"about_ca_system_score_codex":0.0038003905,"about_ca_system_score_gemma":0.006935521,"threshold_uncertainty_score":0.6705219},"labels":[],"label_agreement":null},{"id":"W3210203927","doi":"10.1001/jamaoncol.2021.4398","title":"Analysis of the Li-Fraumeni Spectrum Based on an International Germline <i>TP53</i> Variant Data Set","year":2021,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer-related Molecular Pathways","field":"Medicine","cited_by":146,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Li–Fraumeni syndrome; Germline; Genetics; Phenotype; Cancer; Medicine; Germline mutation; Biology; Gene; Mutation","score_opus":0.03520636438146082,"score_gpt":0.3412794353095997,"score_spread":0.3060730709281389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3210203927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92415607,0.00046565366,0.002357754,0.00019296419,0.000017676723,0.00012005941,0.07102978,0.000119380085,0.0015407029],"genre_scores_gemma":[0.85556805,0.00017554124,0.004800766,0.00007651144,0.000018381912,0.00021393859,0.1389273,0.000038039092,0.00018148855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709,0.00059713953,0.0005379073,0.0007852025,0.00064021023,0.00034965193],"domain_scores_gemma":[0.99131143,0.00401586,0.0020721862,0.0011345216,0.00093652186,0.0005294537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028240562,0.00051408244,0.0006790183,0.008044599,0.000621235,0.00095977937,0.0007817042,0.00037987332,0.002163178],"category_scores_gemma":[0.0132002495,0.00015417332,0.0009993365,0.0053096083,0.0003215849,0.00037292432,0.001137651,0.00050277816,0.00049700076],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000453627,0.000099699486,0.97760326,0.00014545865,0.0004485983,0.00061666325,0.00013356427,0.001686601,0.0018729772,0.0003533211,0.004186449,0.012399859],"study_design_scores_gemma":[0.000094123396,0.00014857721,0.97893494,0.000107794614,0.00037540292,0.0020775676,0.0004061695,0.008299299,0.0017733776,0.0005105236,0.0072413515,0.00003077973],"about_ca_topic_score_codex":0.011039993,"about_ca_topic_score_gemma":0.01152784,"teacher_disagreement_score":0.011039993,"about_ca_system_score_codex":0.00051485916,"about_ca_system_score_gemma":0.0011629077,"threshold_uncertainty_score":0.021951497},"labels":[],"label_agreement":null},{"id":"W3211488171","doi":"10.1001/jamaoncol.2019.2996","title":"Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017","year":2019,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2665,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Alberta; University of British Columbia; University of Toronto; Public Health Agency of Canada; Ottawa Hospital; University of Manitoba; Impact; McGill University; University of Calgary","funders":"Division of Cancer Epidemiology and Genetics, National Cancer Institute; National Cancer Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Invasive Fungi Research Center, Mazandaran University of Medical Sciences; Department of Medicine, Ottawa Hospital; Center for International Health; Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences; College of Medicine and Health Sciences, United Arab Emirates University; Gastrointestinal and Liver Diseases Research Center; Drug Applied Research Center, Tabriz University of Medical Sciences; Medical Research Council; Đại học Quốc gia Hà Nội; School of Public Health and Family Medicine, University of Cape Town; Comprehensive Cancer Center, University of Alabama at Birmingham; Injury Prevention Research Center; Wolkite University; Directorate for Biological Sciences; Debre Markos University; Damietta University; Universitair Ziekenhuis Antwerpen; Moscow Institute of Physics and Technology; Imam Abdulrahman Bin Faisal University; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Menzies Institute for Medical Research; Kurdistan University Of Medical Sciences; Lorestan University of Medical Sciences; Kwame Nkrumah University of Science and Technology; Universitas Hasanuddin; Savitribai Phule Pune University; McGill University; Alexandria University; Mansoura University; University of Peradeniya; Xiamen University; Universitas Airlangga; Universidad Autónoma de Sinaloa; Shahid Beheshti University of Medical Sciences; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Western Sydney University; Tartu Ülikool; College of Science and Engineering, University of Minnesota; Shiraz University of Medical Sciences; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Università degli Studi di Milano; Pomorski Uniwersytet Medyczny W Szczecinie; Qatar Foundation; Universidade Federal de Minas Gerais; University of Hail; Universidade do Porto; Virginia Commonwealth University; Università di Bologna; Baqiyatallah University of Medical Sciences; Shahrekord University of Medical Sciences; Chungnam National University Hospital; Universidad Nacional Autónoma de México; University of New South Wales; Kermanshah University of Medical Sciences; Birjand University of Medical Sciences; University of South Carolina; Pacific Institute for Research and Evaluation; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; University of Gondar; United Arab Emirates University; Instituto De Saúde Pública, Universidade do Porto; Ahvaz Jundishapur University of Medical Sciences; Mazandaran University of Medical Sciences; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; National Center of Neurology and Psychiatry; Mashhad University of Medical Sciences; Taipei Medical University; Tanta University; World Health Organization; Urmia University; Babol Noshirvani University of Technology; Hamadan University of Medical Sciences; Institute for Research in Fundamental Sciences; Inyuvesi Yakwazulu-Natali; Semmelweis Egyetem; University College London; Universiti Kebangsaan Malaysia; Hawassa University; Kuwait University; Tampereen Yliopisto; Tabriz University of Medical Sciences; Seoul National University Hospital; Tsinghua University; University of Cape Town; Khalifa University of Science, Technology and Research; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Frankfurt University of Applied Sciences; Kashan University of Medical Sciences; Karolinska Institutet; Kerman University of Medical Sciences; Public Health Agency of Canada; Madda Walabu University; Universidade Federal de Juiz de Fora; Institució Catalana de Recerca i Estudis Avançats; Rafsanjan University of Medical Sciences; United Nations Population Fund; Bushehr University of Medical Sciences; Kyung Hee University; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Sun Yat-sen University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Adigrat University; Morgan State University; Universitätsklinikum Heidelberg; Ottawa Hospital Research Institute; King Saud University; Ain Shams University; Cochrane South Africa; University of Toronto; Imperial College London; Public Health England; Queensland University of Technology; Cairo University; Laboratório Associado para a Química Verde; University of Health Sciences Lahore; Oklahoma State University; Flinders University; Monash University; Wuhan University; University of Washington; South African Medical Research Council; Universitas Negeri Semarang; Sydney Medical School; Newcastle University; Universitat de València; Helsingin Yliopisto; Delhi Technological University; Uniwersytet Jagielloński Collegium Medicum; Shiraz University; King's College London; McMaster University; University of Leicester; Sanjay Gandhi Postgraduate Institute of Medical Sciences; Krishna Institute Of Medical Sciences Deemed To Be University; Universität Ulm; University of Embu; Health Services Management Research Center; Dilla University; Maragheh University of Medical Sciences; Mekelle University; National Institutes of Health; Banaras Hindu University; Wollega University; University of Tabriz; Ahmadu Bello University; Brigham and Women's Hospital; Arak University of Medical Sciences; Rede de Química e Tecnologia; Radboud Universiteit; Aksum University; Islamic Azad University; West Virginia University; University of Health and Allied Sciences; A.T. Still University; Christian Medical College, Vellore; Curtin University of Technology; Universidade Federal de Santa Catarina; Amirkabir University of Technology; Applied Molecular Biosciences Unit; Iran University of Medical Sciences; Ekiti State University; Bahir Dar University; National Center for Child Health and Development; Sheffield Hallam University; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; Seattle Children's Research Institute; Deakin University; Public Health Agency; Eli Lilly and Company; Syddansk Universitet; Jimma University; Harvard University; Postgraduate Institute of Medical Education and Research, Chandigarh; Sveučilište u Zagrebu; Seoul National University; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; Division of Cardiothoracic Surgery, University of Colorado School of Medicine, Anschutz Medical Campus; University of Jiroft; Durban University of Technology; University of Texas at Austin; Bournemouth University; Trường Đại học Nguyễn Tất Thành; Chungnam National University; Addis Ababa University; Ball State University; Samara University; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Oklahoma; Wellcome Trust; Johns Hopkins University; Westfälische Wilhelms-Universität Münster; St. Jude Children's Research Hospital; Trường Đại học Duy Tân; Universidade de Brasília; Case Western Reserve University; Hamad Medical Corporation; Birmingham City University; School of Medicine, Boston University; Jackson State University; University of Tasmania; Alborz University of Medical Sciences; Northwestern University; University of West Florida; Isfahan University of Medical Sciences; Instituto de Salud Carlos III; San Diego State University","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Years of potential life lost; Demography; Gerontology; Life expectancy; Population; Environmental health; Internal medicine","score_opus":0.10922435704668773,"score_gpt":0.40194005345103223,"score_spread":0.29271569640434447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3211488171","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011511755,0.8859745,0.0017755807,0.010966203,0.001395812,0.0008313697,0.07934454,0.00006789031,0.008132317],"genre_scores_gemma":[0.15305781,0.7907284,0.00675446,0.0070074755,0.0011894124,0.0029268824,0.036654096,0.000051930067,0.0016296769],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9918018,0.0030197515,0.002201127,0.0005307868,0.0020839167,0.00036255902],"domain_scores_gemma":[0.9845509,0.00610195,0.003852939,0.00038521527,0.004794813,0.00031414593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01002433,0.0006859714,0.001417358,0.009820568,0.00029910944,0.0014239685,0.0011898114,0.0007427931,0.004037786],"category_scores_gemma":[0.034227133,0.00047759383,0.0040175486,0.015078512,0.00062061276,0.0014088202,0.0020415247,0.0013090869,0.0007459945],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055843045,0.00006225083,0.17914186,0.29005635,0.014498795,0.00014789907,0.00091689767,0.0021324244,0.0002612747,0.0036382875,0.14068517,0.36790046],"study_design_scores_gemma":[0.0003332382,0.00049363094,0.41441888,0.2117669,0.025009628,0.0005279817,0.0026853173,0.00075166964,0.0006537246,0.002443387,0.34078884,0.0001268361],"about_ca_topic_score_codex":0.062286697,"about_ca_topic_score_gemma":0.113696665,"teacher_disagreement_score":0.062286697,"about_ca_system_score_codex":0.0035505076,"about_ca_system_score_gemma":0.00774344,"threshold_uncertainty_score":0.12384832},"labels":[],"label_agreement":null},{"id":"W3212351387","doi":"10.1001/jamaoncol.2021.4337","title":"Treatment Selection in First-line Metastatic Renal Cell Carcinoma—The Contemporary Treatment Paradigm in the Age of Combination Therapy","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":64,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Clear cell renal cell carcinoma; Internal medicine; Targeted therapy; Immune checkpoint; Blockade; Biomarker; Immunotherapy; Cancer; Receptor","score_opus":0.14141519839767608,"score_gpt":0.3723387328481768,"score_spread":0.23092353445050073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3212351387","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005166118,0.99881905,0.00006882402,0.0006858293,0.00012301262,0.0000021388717,0.0000041506664,0.0000028570078,0.00024247388],"genre_scores_gemma":[0.0008993121,0.9978236,0.00014759705,0.00072764815,0.00027057616,0.0000071166614,0.000008143868,0.0000015193253,0.0001144796],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99936265,0.00029351446,0.00008814986,0.00007306223,0.00015307935,0.000029575262],"domain_scores_gemma":[0.9981193,0.0013458285,0.0002106887,0.000032599426,0.00024048603,0.000051007723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018085429,0.0005361501,0.0015970035,0.001104,0.0002158574,0.0012211581,0.0009665494,0.0013319111,0.0016717424],"category_scores_gemma":[0.0029769877,0.00019602278,0.0006441999,0.0014747664,0.0007494054,0.0015479856,0.00049336156,0.002396708,0.00062508305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079610254,0.00003364657,0.00016443575,0.019588053,0.00019051683,0.00007081405,0.0000662521,0.00060744555,0.00021937747,0.005680705,0.029857371,0.9434418],"study_design_scores_gemma":[0.000079052465,0.00022539806,0.0013025391,0.02629028,0.0004330925,0.001400001,0.00017235422,0.0003696491,0.00020203588,0.007654601,0.96183705,0.000033930595],"about_ca_topic_score_codex":0.0012678698,"about_ca_topic_score_gemma":0.0024062,"teacher_disagreement_score":0.0018085429,"about_ca_system_score_codex":0.0010714576,"about_ca_system_score_gemma":0.0015950067,"threshold_uncertainty_score":0.0095645785},"labels":[],"label_agreement":null},{"id":"W4200584507","doi":"10.1001/jamaoncol.2021.6987","title":"Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019","year":2021,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":2009,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary; University of Alberta; Alberta Health Services; McMaster University; Ottawa Hospital; Research Canada; University of British Columbia; University of Waterloo; University of Toronto","funders":"European and Developing Countries Clinical Trials Partnership; Division of Cancer Epidemiology and Genetics, National Cancer Institute; Division of Human Resource Development; Division of Mathematical Sciences; National Cancer Institute; National Heart, Lung, and Blood Institute; Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca; Erasmus Universitair Medisch Centrum Rotterdam; Amity Institute of Biotechnology, Amity University; Department of Medicine, University of Toronto; Gastrointestinal and Liver Diseases Research Center; Instituto de Salud Carlos III; Sydney Medical School; Medical Research Council; School of Public Health and Family Medicine, University of Cape Town; Lerner Research Institute, Cleveland Clinic; School of Medicine, University of Alabama at Birmingham; University of Texas Health Science Center at San Antonio; University of Oklahoma Health Sciences Center; University of Veterinary and Animal Sciences; Liverpool University Hospitals NHS Foundation Trust; George Institute for Global Health; King Faisal University; Université de Versailles Saint-Quentin-en-Yvelines; Ajman University; Laboratório Associado para a Química Verde; Cancer Research Center, Tehran University of Medical Sciences; Universidad Autónoma de Sinaloa; Department of Global Health and Population, Harvard T.H. Chan School of Public Health; Imam Abdulrahman Bin Faisal University; Centro de Desarrollo Urbano Sustentable; Alborz University of Medical Sciences; Alzahra University; Peking Union Medical College; University Of Nigeria Nsukka; Kurdistan University Of Medical Sciences; Walailak University; Novo Nordisk Fonden; National Center of Neurology and Psychiatry; Menofia University; Mekelle University; Universitas Airlangga; Tartu Ülikool; Universidad de Chile; University of Sulaimani; Universidade Federal de Minas Gerais; Universidad Nacional Autónoma de México; National Research University Higher School of Economics; Eastern Virginia Medical School; Amirkabir University of Technology; Universidade Federal de Santa Catarina; Ajou University; Technische Universität Berlin; Trakya Üniversitesi; Universidade do Porto; University of Tsukuba; University of Dhaka; Oulun Yliopisto; Biotechnology Research Center, Tabriz University of Medical Sciences; Hokkaido University; Università di Bologna; Universitatea de Medicină şi Farmacie \"Carol Davila\" Bucureşti; Golestan University of Medical Sciences; Shahid Beheshti University of Medical Sciences; Universitat de Barcelona; Göteborgs Universitet; Shahrekord University of Medical Sciences; Shahroud University of Medical Sciences; Babol University of Medical Sciences; Universitetet i Oslo; Rajshahi University; Autoritatea Natională pentru Cercetare Stiintifică; Kermanshah University of Medical Sciences; Faculdade de Medicina do ABC; Pacific Institute for Research and Evaluation; Gazi Üniversitesi; Qazvin University of Medical Sciences; Guilan University of Medical Sciences; Universitair Medisch Centrum Groningen; Shahrekord University; Ministry of Health and Medical Education; Haramaya University; Hamadan University of Medical Sciences; Moscow Institute of Physics and Technology; Emory University; Università di Catania; Zanjan University of Medical Sciences; United Arab Emirates University; University of Gondar; Harokopio University; University of Waterloo; Tabriz University of Medical Sciences; King Abdulaziz University; European Regional Development Fund; Karolinska Institutet; Federation University Australia; Bill and Melinda Gates Foundation; Institució Catalana de Recerca i Estudis Avançats; University of Alabama at Birmingham; Imperial College London; University of Toronto; Universitat de València; Inyuvesi Yakwazulu-Natali; Delhi Technological University; Cambridge University Hospitals; Universidad Nacional de Colombia; Gachon University; Seoul National University; University of Jordan; Tarbiat Modares University; Hacettepe Üniversitesi; U.S. Department of Veterans Affairs; Kosin University; Yonsei University; Rijksuniversiteit Groningen; Sharif University of Technology; Instituto Politécnico do Porto; University of Pennsylvania; National Taiwan Normal University; Cairo University; Université de Lausanne; Ottawa Hospital Research Institute; King Saud University; College of Science and Engineering, University of Minnesota; Maurice Wilkins Centre for Molecular Biodiscovery; Shiraz University of Medical Sciences; Ain Shams University; Universiti Sains Malaysia; Curtin University of Technology; Nankai University; Debre Tabor University; Universiteit Utrecht; Flinders University; Wuhan University; Alberta Health Services; University of Zanjan; University of Washington; Institut National de la Santé et de la Recherche Médicale; Deutsche Forschungsgemeinschaft; Amity University; Queensland University of Technology; Middlesex University; London South Bank University; Westfälische Wilhelms-Universität Münster; Indian Council of Medical Research; Uniwersytet Jagielloński Collegium Medicum; American Lebanese Syrian Associated Charities; Semmelweis Egyetem; University College London; Shiraz University; King's College London; University of Queensland; National Institute for Health and Care Research; Macquarie University; Katolicki Uniwersytet Lubelski Jana Pawla II; Student Research Committee, Tabriz University of Medical Sciences; La Trobe University; Università degli Studi di Napoli Federico II; World Health Organization; Ekiti State University; University of Alberta; Jordan University of Science and Technology; Hamad Bin Khalifa University; University of Cambridge; Kasturba Medical College, Manipal; Maragheh University of Medical Sciences; Tehran University of Medical Sciences and Health Services; University of Technology Sydney; University of Arkansas for Medical Sciences; South Eastern Sydney Local Health District; Mongolian National University of Medical Sciences; South African Medical Research Council; Mashhad University of Medical Sciences; Alexander von Humboldt-Stiftung; University of Southern California; Tribhuvan University; National Institutes of Health; Banaras Hindu University; National University of Singapore; Trường Đại học Nguyễn Tất Thành; University of Tabriz; Baki Dövlət Universiteti; European Commission; Ahmadu Bello University; James Cook University; Nord universitet; Public Health Foundation of India; Australian Catholic University; University of Cape Town; Khalifa University of Science, Technology and Research; University of Ottawa; National Institute for Medical Research Development; University of Alabama; National Authority for Scientific Research and Innovation; Barts Charity; Washington University in St. Louis; Monash University; University of Texas Health Science Center at Houston; China Medical University; Anglia Ruskin University; Jackson State University; Universidade de São Paulo; Universitatea din București; Universitas Ahmad Dahlan; Islamic Azad University; Technische Universität München; University of Colombo; Universidade Federal do Rio Grande do Sul; Arabian Gulf University; King Abdullah University of Science and Technology; Sanofi; University of Oxford; McMaster University; Deakin University; Universidade de Lisboa; Jazan University; University of Baghdad; University of Glasgow; Umeå Universitet; Moffitt Cancer Center; Taipei Medical University; Cleveland Clinic; London School of Hygiene and Tropical Medicine; Sveučilište u Zagrebu; Centre Hospitalier Universitaire Vaudois; Johns Hopkins University; Ohio State University; Alexandria University; Rush University; Bournemouth University; Case Western Reserve University; University of Central Florida; Wellcome Trust; Pomorski Uniwersytet Medyczny W Szczecinie; Università degli Studi di Milano; Universiti Brunei Darussalam; Coventry University; Bahir Dar University; National Center for Child Health and Development; Salahaddin University-Erbil; Durban University of Technology; Krishna Institute Of Medical Sciences Deemed To Be University; Fundação para a Ciência e a Tecnologia; Universidad de Antioquia; Xiamen University; Children's Hospital of Philadelphia; Wayne State University; Jimma University; Harvard University; Boston College; Iran University of Medical Sciences; Tulane University; Western Sydney University; Brown University; United Nations Population Fund; University of Oklahoma; Ochsner Health; Kerman University of Medical Sciences; Trường Đại học Duy Tân; Isfahan University of Medical Sciences","keywords":"Medicine; Cancer; Incidence (geometry); Cancer incidence; Gerontology; Demography; Years of potential life lost; Life expectancy; Internal medicine; Population; Environmental health","score_opus":0.15698928027793474,"score_gpt":0.4699616461180795,"score_spread":0.31297236584014476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200584507","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.023502707,0.78655255,0.0016130483,0.0038666613,0.0009940986,0.00032011495,0.17418386,0.00019863057,0.008768428],"genre_scores_gemma":[0.27345383,0.6187408,0.0030769524,0.0027974362,0.00079956144,0.0012497243,0.09630613,0.00005551976,0.0035200745],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9964773,0.0006880372,0.0008465839,0.00045487302,0.0013480863,0.00018499022],"domain_scores_gemma":[0.9954672,0.000857697,0.0017833143,0.000066376546,0.0016603478,0.00016503542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036831482,0.0006434384,0.0012633272,0.0064593293,0.000349345,0.0011513617,0.0008032925,0.0005340432,0.0041954513],"category_scores_gemma":[0.011584513,0.00033904554,0.0036684931,0.009539136,0.0003165489,0.0010561001,0.00095333863,0.0012606394,0.0009171448],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014129778,0.00008308623,0.32584208,0.0888988,0.019263662,0.00014865595,0.0004843575,0.0030748227,0.0002848116,0.0020019752,0.18925838,0.36924648],"study_design_scores_gemma":[0.00048613374,0.00049957365,0.6694257,0.04986548,0.0189733,0.000783593,0.0010361382,0.002184334,0.00049573346,0.0020194198,0.25407413,0.00015639975],"about_ca_topic_score_codex":0.04559824,"about_ca_topic_score_gemma":0.0737238,"teacher_disagreement_score":0.04559824,"about_ca_system_score_codex":0.0030080446,"about_ca_system_score_gemma":0.0029322933,"threshold_uncertainty_score":0.09066564},"labels":[],"label_agreement":null},{"id":"W4205157273","doi":"10.1001/jamaoncol.2021.7148","title":"Evidence-Based Clinical Practice Guidelines for Extramammary Paget Disease","year":2022,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer and Skin Lesions","field":"Medicine","cited_by":138,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Extramammary Paget's disease; Biopsy; Radiation therapy; Dermatology; Disease; Surgery; Radiology; Internal medicine","score_opus":0.6527709803475009,"score_gpt":0.6188556866096045,"score_spread":0.03391529373789637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205157273","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020521653,0.6915918,0.041489676,0.15306702,0.022851737,0.031801008,0.012566091,0.001349706,0.04323078],"genre_scores_gemma":[0.026312308,0.5186605,0.3420137,0.036479723,0.004605448,0.044619035,0.017226236,0.0003288924,0.009754271],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9504349,0.02087273,0.017823558,0.0018444182,0.008026283,0.00099808],"domain_scores_gemma":[0.8343261,0.0620424,0.030182192,0.0030818086,0.0659322,0.0044353674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.030689672,0.0030821005,0.0061332625,0.018200407,0.0025174841,0.006324503,0.01121305,0.0126530295,0.023635183],"category_scores_gemma":[0.16760957,0.0019775399,0.0095827,0.01442667,0.0022886372,0.006162292,0.005445196,0.010821174,0.010135084],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022797147,0.00028290035,0.0014654719,0.26728287,0.0013392994,0.000634862,0.0010791979,0.0023132588,0.0004278515,0.00711741,0.35894912,0.35887977],"study_design_scores_gemma":[0.0008589343,0.00013711216,0.0022910465,0.6929872,0.0028087813,0.00057264394,0.00069456175,0.001525957,0.0003896932,0.013735199,0.2838266,0.00017224636],"about_ca_topic_score_codex":0.014916337,"about_ca_topic_score_gemma":0.022143114,"teacher_disagreement_score":0.030689672,"about_ca_system_score_codex":0.012597558,"about_ca_system_score_gemma":0.043066945,"threshold_uncertainty_score":0.16230446},"labels":[],"label_agreement":null},{"id":"W4205452388","doi":"10.1001/jamaoncol.2021.6871","title":"Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Androgen deprivation therapy; Brachytherapy; External beam radiotherapy; Prostate cancer; Radiation therapy; Retrospective cohort study; Randomized controlled trial; Cohort; Internal medicine; Oncology; Urology; Surgery; Cancer","score_opus":0.02436716679589874,"score_gpt":0.3398482702062112,"score_spread":0.3154811034103125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205452388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94829094,0.042736925,0.0036745002,0.0015029544,0.0002498118,0.00041522822,0.00033052702,0.000035348257,0.0027637423],"genre_scores_gemma":[0.99656075,0.0013454838,0.0013492873,0.0002834516,0.000104347055,0.00012101157,0.00008597363,0.0000059482923,0.000143899],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960424,0.0027456349,0.0003799136,0.0003265448,0.00035117287,0.00015433122],"domain_scores_gemma":[0.99423945,0.0031446805,0.0017498311,0.00025139804,0.00015953383,0.00045504898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073120724,0.00022155281,0.00077242963,0.0002698347,0.00018787784,0.0010755371,0.00043100346,0.0004052003,0.002245548],"category_scores_gemma":[0.011277057,0.00021606166,0.0015477019,0.0002805058,0.00034921514,0.00074560614,0.0005854372,0.0007175602,0.00014566479],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25778753,0.0059741624,0.28422037,0.0048584095,0.012543259,0.00014572892,0.00042969172,0.010589674,0.016213097,0.0028774461,0.0020290436,0.40233162],"study_design_scores_gemma":[0.04718576,0.1259832,0.7570234,0.0021642921,0.024073286,0.0007800067,0.00055982714,0.012827851,0.009868851,0.007720441,0.011681455,0.0001316446],"about_ca_topic_score_codex":0.0005806095,"about_ca_topic_score_gemma":0.001365617,"teacher_disagreement_score":0.0073120724,"about_ca_system_score_codex":0.0005660429,"about_ca_system_score_gemma":0.0016224092,"threshold_uncertainty_score":0.03867042},"labels":[],"label_agreement":null},{"id":"W4205809226","doi":"10.1001/jamaoncol.2021.6590","title":"Association of Daily Sitting Time and Leisure-Time Physical Activity With Survival Among US Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":251,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Sitting; Population; Cohort study; Cohort; National Health and Nutrition Examination Survey; Gerontology; Cancer; Cancer survivor; Demography; Physical therapy; Internal medicine; Environmental health","score_opus":0.009966207491442652,"score_gpt":0.2778777303757237,"score_spread":0.26791152288428105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205809226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709,0.0012112809,0.00015941261,0.00013147849,0.000013801164,0.0000042124743,0.0009287493,0.0000073953647,0.000453665],"genre_scores_gemma":[0.9990073,0.00021634105,0.000073510295,0.000020482865,0.000016280199,0.0000054726843,0.00055732206,0.0000016191024,0.00010175397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996742,0.00008964225,0.000053078213,0.00006157403,0.00007931637,0.00004218274],"domain_scores_gemma":[0.9982535,0.00030824408,0.0009168952,0.00009880564,0.00020725183,0.00021520958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046728083,0.00020190678,0.00021153412,0.00051682,0.00016009348,0.00030984893,0.00023479978,0.0002611572,0.0014394452],"category_scores_gemma":[0.0028460706,0.00013917295,0.00039609085,0.00084160763,0.00019958674,0.0002789422,0.00032203866,0.00035727976,0.00013279491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028717759,0.000008128895,0.9984779,0.000009851247,0.00006532701,0.000008612198,0.0000128761585,0.000030536037,0.000048201055,0.000003396561,0.000078929756,0.0012275543],"study_design_scores_gemma":[0.0000020020987,0.000024323075,0.9996629,0.000004932045,0.000025802225,0.000040369843,0.000027730948,0.00011901679,0.00001596834,0.000011955162,0.00006364941,0.0000013688367],"about_ca_topic_score_codex":0.0057044793,"about_ca_topic_score_gemma":0.014298664,"teacher_disagreement_score":0.0057044793,"about_ca_system_score_codex":0.00013179592,"about_ca_system_score_gemma":0.00023800578,"threshold_uncertainty_score":0.011342585},"labels":[],"label_agreement":null},{"id":"W4210639134","doi":"10.1001/jamaoncol.2021.7639","title":"Development of an Open Database of Genes Included in Hereditary Cancer Genetic Testing Panels Available From Major Sources in the US","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health; Wellcome Trust","keywords":"Medicine; Hereditary Cancer; Genetic testing; Gene; Cancer; Database; Genetics; Bioinformatics; Computational biology; Internal medicine; Biology; Computer science","score_opus":0.042722726313453314,"score_gpt":0.3039056119699771,"score_spread":0.2611828856565238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210639134","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16211969,0.0032093355,0.16389996,0.022359949,0.0020407366,0.010511632,0.5726009,0.0239702,0.039287698],"genre_scores_gemma":[0.12345855,0.0011681501,0.2965824,0.00507044,0.0004772215,0.0038189683,0.56198466,0.0020802496,0.005359437],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9774984,0.0058365637,0.0042631673,0.0033017213,0.008025218,0.0010749723],"domain_scores_gemma":[0.8452602,0.052599356,0.013155129,0.02787094,0.052609626,0.008504779],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.03247094,0.00059421174,0.0011595732,0.008752207,0.0014269352,0.004905829,0.003184967,0.001068458,0.009692283],"category_scores_gemma":[0.08571642,0.00088172965,0.0011660069,0.00882171,0.0004932852,0.0038059202,0.0043666963,0.0026261515,0.0034377493],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031286522,0.002651136,0.13945934,0.0014820808,0.000569115,0.00053766044,0.0012927469,0.0031406907,0.011563331,0.008737313,0.3375206,0.4899175],"study_design_scores_gemma":[0.0026158865,0.0011878056,0.25799322,0.0016992622,0.00094970636,0.00090654066,0.0017477054,0.014061732,0.031663526,0.0065965857,0.6801887,0.0003893979],"about_ca_topic_score_codex":0.022642383,"about_ca_topic_score_gemma":0.020268524,"teacher_disagreement_score":0.996815,"about_ca_system_score_codex":0.0028026775,"about_ca_system_score_gemma":0.01287033,"threshold_uncertainty_score":0.1717248},"labels":[{"model":"gemma","categories":["open_science"],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"dataset","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4210689349","doi":"10.1001/jamaoncol.2021.6744","title":"Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":190,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto; Mount Sinai Hospital","funders":"Medical Research and Materiel Command; David Geffen School of Medicine, University of California, Los Angeles; European Regional Development Fund; National Cancer Institute; Medisinske fakultet, Universitetet i Oslo; Servicio Gallego de Salud; Universitätsklinikum Hamburg-Eppendorf; Scottish Government; KWF Kankerbestrijding; Det Sundhedsvidenskabelige Fakultet, Københavns Universitet; Instituto de Salud Carlos III; Freistaat Sachsen; Russian Academy of Sciences; Medical Research Council; European Commission; Canadian Institutes of Health Research; Directorate for Biological Sciences; National Institutes of Health; Université de Versailles Saint-Quentin-en-Yvelines; Universitätsklinikum Köln; Akershus Universitetssykehus; National University Health System; Agency for Science, Technology and Research; Universidad de La Sabana; Pomorski Uniwersytet Medyczny W Szczecinie; Institut Gustave-Roussy; Universität zu Köln; Fondazione Italiana per la Ricerca sul Cancro; Medizinischen Hochschule Hannover; Kreftforeningen; Institut National Du Cancer; Leids Universitair Medisch Centrum; Karolinska Institutet; Associazione Italiana per la Ricerca sul Cancro; Deutsche Krebshilfe; National Health and Medical Research Council; Universiti Malaya; Norges Forskningsråd; National Medical Research Council; Stockholms Läns Landsting; Sundhed og Sygdom, Det Frie Forskningsråd; Saint Petersburg State University; Kuopion Yliopistollinen Sairaala; University of Toronto; Pontificia Universidad Javeriana; King's College London; Gentofte Hospital; Deutsche Forschungsgemeinschaft; Deutsche Gesetzliche Unfallversicherung; Alexander von Humboldt-Stiftung; Cancerfonden; Cancer Council Victoria; University of Melbourne; Robert Bosch Stiftung; Programme Grants for Applied Research; Manchester Biomedical Research Centre; Monash University; Itä-Suomen Yliopisto; Eberhard Karls Universität Tübingen; Universiteit Leiden; Cancer Research Institute; University of Crete; Institut National de la Santé et de la Recherche Médicale; Institute of Genetics; Wellcome Trust; Agence Nationale de la Recherche; Lunds Universitet; Faculty of Health and Medical Sciences, University of Western Australia; Cancer Research UK; National University of Singapore; National Research Foundation Singapore; National Institute for Health and Care Research; NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust/Institute of Cancer Research; National Research Foundation; Chief Scientist Office, Scottish Government Health and Social Care Directorate; Bundesministerium für Bildung und Forschung; Genome Institute of Singapore; National Breast Cancer Foundation; QIMR Berghofer Medical Research Institute; Research Promotion Foundation; Engineering and Physical Sciences Research Council; Fondation de France; University of Cambridge; Government of Canada; Breast Cancer Research Trust; Fondation du cancer du sein du Québec; Duke-NUS Medical School; Huntsman Cancer Institute; Scottish Funding Council; Instituto de Investigación Sanitaria de Santiago de Compostela; Deutsches Krebsforschungszentrum; Helsingin Yliopisto; Genome Canada; University of California, San Diego; Universitetet i Oslo; University of Oxford; Cancer Council NSW; Susan G. Komen for the Cure","keywords":"Medicine; Germline; Breast cancer; Gene; Germline mutation; Cancer; Pathology; Oncology; Genetics; Internal medicine; Mutation; Biology","score_opus":0.011167600553947346,"score_gpt":0.2814819573539547,"score_spread":0.27031435680000737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210689349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987031,0.00054271694,0.00018550052,0.000014881204,0.0000027952715,0.000005489661,0.00017419166,0.0000070036544,0.00036447187],"genre_scores_gemma":[0.9993001,0.00018204688,0.00023754103,0.000011706973,0.0000044533417,0.0000039417037,0.00018256638,0.0000025978193,0.00007500201],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999688,0.0000627812,0.000054038668,0.000089214416,0.00006515784,0.0000408624],"domain_scores_gemma":[0.99872166,0.00021405425,0.0007854624,0.00008316919,0.000111079,0.00008456177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062163034,0.00022423628,0.000164723,0.0016909514,0.00029015724,0.00051009114,0.00023178583,0.00026780026,0.0017755801],"category_scores_gemma":[0.0012716304,0.00019404711,0.00027346602,0.0008209066,0.00031490417,0.00016921782,0.00040227425,0.00017082864,0.00016398833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027635106,0.000015641755,0.9812323,0.000039200077,0.00010130674,0.0012663499,0.0000954694,0.000050072762,0.014663533,0.00005096895,0.000081262086,0.002127574],"study_design_scores_gemma":[0.000015690583,0.00010700462,0.9856733,0.000017151937,0.00009205314,0.010522272,0.00022012531,0.00013117609,0.0027360013,0.00010067878,0.0003797817,0.000004853559],"about_ca_topic_score_codex":0.0007897456,"about_ca_topic_score_gemma":0.0011899673,"teacher_disagreement_score":0.0017755801,"about_ca_system_score_codex":0.00017094547,"about_ca_system_score_gemma":0.00014759281,"threshold_uncertainty_score":0.0059399605},"labels":[],"label_agreement":null},{"id":"W4211142194","doi":"10.1001/jamaoncol.2021.7643","title":"Effect of a Symptom Monitoring Intervention for Patients Hospitalized With Advanced Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Psychological intervention; Randomized controlled trial; Intervention (counseling); Population; Emergency medicine; Clinical trial; MEDLINE; Physical therapy; Internal medicine; Psychiatry","score_opus":0.006983832577466542,"score_gpt":0.32910184091148187,"score_spread":0.3221180083340153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211142194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895124,0.0036487726,0.00032392328,0.0010886529,0.00060733646,0.0029831096,0.00032858123,0.00008545322,0.0014217871],"genre_scores_gemma":[0.9923159,0.0012147553,0.0015993064,0.0006014651,0.00043927899,0.002954093,0.0002522093,0.0000069692564,0.0006160618],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9982572,0.0010517951,0.00020864954,0.00020672001,0.00011319104,0.00016251439],"domain_scores_gemma":[0.9973406,0.0010677368,0.00081084744,0.00010580318,0.00012630779,0.00054873346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017956704,0.00093988696,0.0013030054,0.0004705498,0.00051175867,0.00078748504,0.0006864046,0.0015824859,0.005960337],"category_scores_gemma":[0.00662696,0.00039844052,0.0022060238,0.00033212107,0.0005545415,0.00083639787,0.00076643116,0.0017282704,0.00029839482],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.80696106,0.055699438,0.0070342445,0.0032063273,0.001852294,0.000067790905,0.00020270518,0.00073537504,0.001285823,0.00015351108,0.001667195,0.12113425],"study_design_scores_gemma":[0.63899577,0.3257124,0.029529402,0.00050184864,0.001666648,0.000048220074,0.0001173812,0.0012020987,0.00088025536,0.00018707798,0.0011230038,0.000035883124],"about_ca_topic_score_codex":0.0015413917,"about_ca_topic_score_gemma":0.0024727795,"teacher_disagreement_score":0.005960337,"about_ca_system_score_codex":0.0008431322,"about_ca_system_score_gemma":0.0017381675,"threshold_uncertainty_score":0.019939363},"labels":[],"label_agreement":null},{"id":"W4213378853","doi":"10.1001/jamaoncol.2021.6204","title":"Breast Cancer Screening Strategies for Women With <i>ATM, CHEK2</i>, and <i>PALB2</i> Pathogenic Variants","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":87,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"CHEK2; PALB2; Medicine; Breast cancer; Mammography; Cancer; Oncology; Population; Breast cancer screening; Internal medicine; Gynecology; Environmental health; Genetics; Biology","score_opus":0.011540693307698349,"score_gpt":0.27602070455708827,"score_spread":0.2644800112493899,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213378853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98190546,0.0011865547,0.011707654,0.00094660954,0.000024484154,0.00030938728,0.0011857924,0.000052686475,0.002681427],"genre_scores_gemma":[0.99510634,0.00040579058,0.0032586402,0.00009868368,0.0000074429813,0.00018824065,0.00041292387,0.0000051132574,0.00051676674],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9984977,0.0009975329,0.00004509156,0.00018846006,0.0001450792,0.0001260244],"domain_scores_gemma":[0.9973174,0.0018632248,0.0005199064,0.00009883855,0.00012623343,0.000074382326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032606637,0.0006259397,0.00059651607,0.00051670184,0.0001719556,0.00062789745,0.0008709332,0.0006922263,0.0028680682],"category_scores_gemma":[0.009267855,0.0002769101,0.0018839559,0.00036024695,0.00029059217,0.0007996518,0.00048428812,0.0005108049,0.0001944277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025053276,0.00096058537,0.24533577,0.00063683867,0.0030382467,0.00025325085,0.00018959602,0.7073008,0.0019070337,0.0044208677,0.0013423495,0.032109294],"study_design_scores_gemma":[0.0010628047,0.008255004,0.16144143,0.00042347013,0.004151629,0.0005348123,0.0005946024,0.80685556,0.0033428958,0.009954393,0.0032821673,0.00010119964],"about_ca_topic_score_codex":0.011062771,"about_ca_topic_score_gemma":0.011991449,"teacher_disagreement_score":0.011062771,"about_ca_system_score_codex":0.0024769916,"about_ca_system_score_gemma":0.0016121062,"threshold_uncertainty_score":0.021996737},"labels":[],"label_agreement":null},{"id":"W4214616073","doi":"10.1001/jamaoncol.2021.8049","title":"Cost-effectiveness Analysis of Pertuzumab With Trastuzumab in Patients With Metastatic Breast Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; Public Health Ontario; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Pertuzumab; Medicine; Trastuzumab; Metastatic breast cancer; Breast cancer; Oncology; Internal medicine; Cost effectiveness; Population; Chemotherapy; Cancer; Environmental health","score_opus":0.048287472551245374,"score_gpt":0.3967369460307583,"score_spread":0.34844947347951294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214616073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.937216,0.04643984,0.0014274972,0.0021118922,0.00009480048,0.0011326342,0.004695158,0.000033256492,0.0068488675],"genre_scores_gemma":[0.9955825,0.0025181016,0.00056185125,0.00010283283,0.000024946328,0.00010601032,0.0008734174,0.000002687467,0.00022770444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638915,0.0020109643,0.00027448862,0.00020227865,0.0007594795,0.00036361805],"domain_scores_gemma":[0.9963643,0.0018100496,0.0009223043,0.00009713713,0.0005055652,0.00030077118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043104803,0.00076653715,0.001345032,0.001636141,0.00024638762,0.0013794322,0.000754685,0.0005338742,0.001856391],"category_scores_gemma":[0.0162096,0.00034063144,0.0038308653,0.0018985984,0.00044556765,0.00065411505,0.00069204386,0.00079332985,0.00007155372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.077892505,0.0021121036,0.40639678,0.012418874,0.045691215,0.0009752339,0.0004163165,0.2325848,0.0014067697,0.008257371,0.0062738154,0.20557429],"study_design_scores_gemma":[0.01752712,0.016250782,0.64529836,0.005247679,0.04506221,0.0015805331,0.00082177966,0.24406424,0.0013239582,0.0063952287,0.016188316,0.00023982918],"about_ca_topic_score_codex":0.17997992,"about_ca_topic_score_gemma":0.16609678,"teacher_disagreement_score":0.17997992,"about_ca_system_score_codex":0.022128168,"about_ca_system_score_gemma":0.00961209,"threshold_uncertainty_score":0.35786462},"labels":[],"label_agreement":null},{"id":"W4224213206","doi":"10.1001/jamaoncol.2022.0373","title":"Association of Pathogenic Variants in Hereditary Cancer Genes With Multiple Diseases","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":51,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"U.S. National Library of Medicine; National Institute of Allergy and Infectious Diseases; National Human Genome Research Institute; Medical Research Council","keywords":"Medicine; Phenome; Biobank; Cohort; Cancer; Genome-wide association study; Medical record; Disease; Cohort study; Internal medicine; Bioinformatics; Genetics; Genotype; Single-nucleotide polymorphism; Phenotype; Gene; Biology","score_opus":0.00853701586686538,"score_gpt":0.269700235275418,"score_spread":0.2611632194085526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224213206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941188,0.0015486031,0.00062565465,0.00029326807,0.000027080876,0.000018626635,0.0022761123,0.000019455998,0.0010723362],"genre_scores_gemma":[0.9977992,0.0003801535,0.0006587992,0.000077446246,0.000028718336,0.0000135279215,0.0008168113,0.0000062088866,0.00021906417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984072,0.00030157564,0.00021769271,0.00058254594,0.00035771006,0.00013342184],"domain_scores_gemma":[0.9970271,0.000779766,0.0016133994,0.00019497209,0.00019772524,0.00018696857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085005484,0.00039010448,0.00043658068,0.0011012906,0.0005413373,0.0005883928,0.00043432362,0.00048244942,0.003307749],"category_scores_gemma":[0.0044145207,0.00017923977,0.00041531242,0.0022185778,0.0005212255,0.00030060203,0.0006844162,0.00041826285,0.000189676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012945956,0.000023829416,0.9940163,0.00003578864,0.0002856468,0.00074774545,0.000059772356,0.00012164094,0.0009029007,0.000109395594,0.00036495936,0.0032025373],"study_design_scores_gemma":[0.0000326911,0.00006526369,0.99343526,0.000046655907,0.00025771087,0.0033852041,0.000105880994,0.00046841372,0.00070051936,0.0003691131,0.0011243726,0.000009011726],"about_ca_topic_score_codex":0.0050926814,"about_ca_topic_score_gemma":0.0076875486,"teacher_disagreement_score":0.0050926814,"about_ca_system_score_codex":0.0003562185,"about_ca_system_score_gemma":0.0005587706,"threshold_uncertainty_score":0.011065543},"labels":[],"label_agreement":null},{"id":"W4224288628","doi":"10.1001/jamaoncol.2022.0177","title":"Enabling the Sharing of Single-Dose Vials Through Risk Mitigation to Decrease Financial Toxicity","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.046409613462392904,"score_gpt":0.27278634441819033,"score_spread":0.2263767309557974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224288628","genre_codex":"other","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09117461,0.005342347,0.3753174,0.060054187,0.0021715781,0.0019538363,0.0024495756,0.011174299,0.4503621],"genre_scores_gemma":[0.7765313,0.0035412165,0.12995921,0.00586913,0.0011035792,0.00082207617,0.0009752812,0.0014065522,0.07979157],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953935,0.0021351334,0.00021496948,0.00035473314,0.0014836984,0.00041795627],"domain_scores_gemma":[0.98569214,0.0052632466,0.0022105211,0.0033777922,0.0020885326,0.0013678591],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066443505,0.00049798493,0.00036604426,0.000941325,0.0011025103,0.003502716,0.0016744742,0.0012008923,0.104176454],"category_scores_gemma":[0.03917302,0.0003217508,0.0012325746,0.00073267194,0.00084356504,0.0053863456,0.0044893436,0.0016704513,0.015332429],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008060819,0.0013873547,0.012001883,0.00039281344,0.00016803402,0.00033104446,0.00055891124,0.008627333,0.0025206364,0.038121406,0.16193207,0.77315235],"study_design_scores_gemma":[0.00079505984,0.0024015768,0.018473169,0.0017371541,0.00038505677,0.0024271472,0.0018934532,0.06859807,0.01865889,0.145807,0.73850787,0.00031557883],"about_ca_topic_score_codex":0.0019308471,"about_ca_topic_score_gemma":0.0019944003,"teacher_disagreement_score":0.104176454,"about_ca_system_score_codex":0.0012459091,"about_ca_system_score_gemma":0.0035830627,"threshold_uncertainty_score":0.34850496},"labels":[],"label_agreement":null},{"id":"W4225081539","doi":"10.1001/jamaoncol.2022.0874","title":"Concerns Remain Regarding the Association of Sitting Time and Physical Activity With Cancer Survivorship—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry","score_opus":0.021177923124891192,"score_gpt":0.3038195449455537,"score_spread":0.2826416218206625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225081539","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001030983,0.00039653687,0.00006941058,0.99034965,0.006755004,0.000009276551,0.00009011079,0.000044893804,0.0012542242],"genre_scores_gemma":[0.010415228,0.0008613739,0.00026307165,0.9649647,0.01966337,0.000049551276,0.00007121047,0.000028784638,0.0036827351],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854976,0.0004328906,0.00026501343,0.00019425184,0.00034812142,0.00021007458],"domain_scores_gemma":[0.99015653,0.0063033253,0.0005103272,0.00026224589,0.0017446023,0.0010230951],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030108728,0.0007458765,0.0010758548,0.0008144819,0.002939932,0.0019253605,0.0016497391,0.027302273,0.009594733],"category_scores_gemma":[0.023105677,0.0005896453,0.0010693739,0.0009827535,0.0017224507,0.0040996703,0.0010864105,0.022113532,0.0060704695],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006482638,0.00005259061,0.0045630313,0.000058831436,0.000020969113,0.0018245103,0.00039791685,0.000074571035,0.00015107974,0.0009751562,0.9802684,0.011548048],"study_design_scores_gemma":[0.00024252044,0.00036908817,0.021438053,0.000845571,0.00013357408,0.016171739,0.006357261,0.0017518649,0.00083205965,0.01409015,0.9374087,0.00035954628],"about_ca_topic_score_codex":0.009881581,"about_ca_topic_score_gemma":0.008993504,"teacher_disagreement_score":0.027302273,"about_ca_system_score_codex":0.002094197,"about_ca_system_score_gemma":0.0026420837,"threshold_uncertainty_score":0.032097578},"labels":[],"label_agreement":null},{"id":"W4225104640","doi":"10.1001/jamaoncol.2022.0615","title":"Assessment of Toxic Effects and Survival in Treatment Deescalation With Radiotherapy vs Transoral Surgery for HPV-Associated Oropharyngeal Squamous Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre; University of Ottawa; University of Calgary; McGill University; Princess Margaret Cancer Centre; University Health Network; University of Toronto; Health Sciences Centre; University of British Columbia; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Medicine; Clinical endpoint; Neck dissection; Radiation therapy; Internal medicine; Randomized controlled trial; Surrogate endpoint; Oncology; Quality of life (healthcare); Head and neck squamous-cell carcinoma; Chemoradiotherapy; Surgery; Cancer; Head and neck cancer","score_opus":0.020760217377520252,"score_gpt":0.3136201558589964,"score_spread":0.2928599384814761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225104640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948584,0.0018699794,0.0003951056,0.00016816796,0.00013569818,0.0015015652,0.00013419951,0.000011186083,0.00092571625],"genre_scores_gemma":[0.9959382,0.0007566339,0.0006811634,0.00019212226,0.00014025609,0.00162528,0.000112050024,0.0000037176833,0.00055068417],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99804556,0.0012602333,0.00016508663,0.0001978172,0.00017590619,0.00015539945],"domain_scores_gemma":[0.9977912,0.000798441,0.0007364754,0.0001228148,0.0001332767,0.0004178187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039869896,0.0008550394,0.0014680912,0.00034289522,0.00031050213,0.00071247417,0.000634705,0.0011405374,0.0027479788],"category_scores_gemma":[0.003332533,0.00038862106,0.0020669114,0.00034625444,0.0008206,0.0008017669,0.00045544788,0.0019221954,0.00025267026],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9233931,0.018434826,0.0068473388,0.00068495364,0.0015529931,0.000025713813,0.00008037939,0.0012183975,0.005119956,0.00015322084,0.00028055513,0.04220867],"study_design_scores_gemma":[0.26099992,0.7126539,0.017969185,0.00009622298,0.0018146606,0.00007162178,0.00007614762,0.0017039307,0.0032106494,0.0003084434,0.0010681028,0.000027193457],"about_ca_topic_score_codex":0.0006117413,"about_ca_topic_score_gemma":0.0019416367,"teacher_disagreement_score":0.0039869896,"about_ca_system_score_codex":0.0009839827,"about_ca_system_score_gemma":0.001566753,"threshold_uncertainty_score":0.021085441},"labels":[],"label_agreement":null},{"id":"W4233885426","doi":"10.1001/jamaoncol.2019.6921","title":"Error in Table 2","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; Public Health Ontario; University of Toronto","funders":"","keywords":"Medicine; Oncology; MEDLINE; Internal medicine","score_opus":0.031382739229008964,"score_gpt":0.3340743508320977,"score_spread":0.3026916116030887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233885426","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00083128293,0.0026988348,0.0039038123,0.14051963,0.5695734,0.0003068844,0.14253616,0.0035558853,0.13607414],"genre_scores_gemma":[0.0281538,0.0035302676,0.010509978,0.19829634,0.04640332,0.001407939,0.09207145,0.005853649,0.6137732],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9880775,0.0018781007,0.0017962309,0.0017996868,0.0051161367,0.0013322784],"domain_scores_gemma":[0.94521666,0.017943226,0.0034080145,0.006544558,0.025303544,0.0015840263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006468308,0.0013996343,0.0018548232,0.0039313813,0.0023218223,0.0043128897,0.002387632,0.0046067135,0.27998543],"category_scores_gemma":[0.12053336,0.00081182644,0.0021728468,0.0053530317,0.0010490653,0.0022299658,0.0022580235,0.008472079,0.20412377],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036736892,0.0000066392217,0.0002745675,0.000050971157,0.000006327051,0.00001759968,0.00000839446,0.00007038113,0.0000067655405,0.0010225282,0.9921462,0.0063529294],"study_design_scores_gemma":[0.0000984731,0.000017844672,0.0019737124,0.0005633852,0.000029343666,0.00012849832,0.0000809721,0.00024537963,0.00019234809,0.0033650512,0.9932765,0.000028522452],"about_ca_topic_score_codex":0.062025245,"about_ca_topic_score_gemma":0.05205745,"teacher_disagreement_score":0.27998543,"about_ca_system_score_codex":0.0058994917,"about_ca_system_score_gemma":0.009606326,"threshold_uncertainty_score":0.93664455},"labels":[],"label_agreement":null},{"id":"W4234731965","doi":"10.1001/jamaoncol.2019.6210","title":"Errors in Table","year":2019,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario; Women's College Hospital","funders":"","keywords":"Medicine","score_opus":0.026722874466928444,"score_gpt":0.33993577877378944,"score_spread":0.313212904306861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234731965","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000545582,0.0026487333,0.002461206,0.09780718,0.64825785,0.00035398296,0.084634356,0.002708605,0.16058259],"genre_scores_gemma":[0.017098589,0.005367362,0.0070704934,0.13830875,0.05291298,0.0013218607,0.061527424,0.0048288386,0.7115637],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9881003,0.0016710439,0.0022019064,0.0014770929,0.0052912068,0.0012585295],"domain_scores_gemma":[0.94103247,0.014366679,0.0050308765,0.0059023853,0.0316746,0.0019929188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056281295,0.0016571198,0.0020459762,0.005213246,0.0030096665,0.0044163796,0.0024177216,0.0045521595,0.29789194],"category_scores_gemma":[0.12072847,0.0009661346,0.0021642467,0.00819412,0.0011383865,0.002461489,0.0023882713,0.008568343,0.2582338],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022879494,0.000005313418,0.00014841056,0.00004173814,0.000003501644,0.000012362175,0.000007593546,0.000053613177,0.000005119365,0.00081531244,0.99417853,0.0047056973],"study_design_scores_gemma":[0.00006370436,0.000016572663,0.0012078075,0.00057962595,0.000018754517,0.00007334244,0.00008345072,0.00015688146,0.00013555378,0.0023250466,0.9953164,0.000022930028],"about_ca_topic_score_codex":0.07128433,"about_ca_topic_score_gemma":0.061733093,"teacher_disagreement_score":0.29789194,"about_ca_system_score_codex":0.0075219856,"about_ca_system_score_gemma":0.011420848,"threshold_uncertainty_score":0.9965478},"labels":[],"label_agreement":null},{"id":"W4253427595","doi":"10.1001/jamaoncol.2019.6477","title":"Errors in Figure 3","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; MEDLINE; Medical physics","score_opus":0.05283207734295908,"score_gpt":0.25011337010485657,"score_spread":0.1972812927618975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253427595","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009859354,0.0017838706,0.014326436,0.06503067,0.4267477,0.00031907132,0.075903736,0.012304968,0.40259758],"genre_scores_gemma":[0.014418629,0.0019972213,0.013939742,0.027711669,0.011941039,0.0007504963,0.052032005,0.0101308515,0.86707836],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9874917,0.0015511285,0.0012763025,0.0020093732,0.00660892,0.001062523],"domain_scores_gemma":[0.9379614,0.009892758,0.00299415,0.009826666,0.038403027,0.00092201075],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0053435653,0.0023979887,0.0017270911,0.0058040507,0.003471746,0.009993661,0.0028983017,0.005748671,0.39662164],"category_scores_gemma":[0.11791544,0.0011145545,0.0021988133,0.0077145356,0.0018378429,0.0032159905,0.004146153,0.008074016,0.4601076],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026954696,0.000007944082,0.0001300254,0.000038069276,0.0000043859886,0.000015619667,0.00002030896,0.00030259645,0.0000194798,0.003626148,0.9846662,0.011142139],"study_design_scores_gemma":[0.000029880764,0.0000076041647,0.0005431628,0.00024695328,0.000011408978,0.000030750176,0.00007939227,0.0004436568,0.00029812264,0.0037779885,0.99450797,0.000023008952],"about_ca_topic_score_codex":0.083270214,"about_ca_topic_score_gemma":0.06231489,"teacher_disagreement_score":0.39662164,"about_ca_system_score_codex":0.008498058,"about_ca_system_score_gemma":0.009663109,"threshold_uncertainty_score":0.860646},"labels":[],"label_agreement":null},{"id":"W4256052490","doi":"10.1001/jamaoncol.2019.6910","title":"Missing Panels in Figure 1","year":2020,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Diverse Scientific and Economic Studies","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Women's College Hospital","funders":"","keywords":"Medicine; MEDLINE","score_opus":0.07311079861610739,"score_gpt":0.2581189166740233,"score_spread":0.18500811805791592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256052490","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007777182,0.0018245364,0.0037662534,0.05669308,0.17063886,0.00061786576,0.18906476,0.004263965,0.5723529],"genre_scores_gemma":[0.008361339,0.0019253264,0.0071247006,0.056073107,0.011529319,0.0012231574,0.10139151,0.0051357388,0.8072359],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971221,0.000386784,0.00020059143,0.00034913607,0.0013399898,0.0006013328],"domain_scores_gemma":[0.9816907,0.0039274152,0.0007793147,0.0018777499,0.010330364,0.0013944249],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025180087,0.0012242083,0.0015387381,0.002929543,0.0022897448,0.0058266735,0.002126533,0.0041695493,0.6703486],"category_scores_gemma":[0.04512007,0.0008447289,0.0018084043,0.003854545,0.0008461081,0.0028728,0.0022766092,0.007744492,0.48289952],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001808927,0.000008589637,0.00006355836,0.000028219803,0.0000010789606,0.000008742121,0.0000043868313,0.000028437038,0.000007308984,0.0006105648,0.99512935,0.0040916386],"study_design_scores_gemma":[0.00006828192,0.000010776007,0.0012388792,0.00027677187,0.0000064575647,0.000035720826,0.000045517507,0.00009567324,0.00007062398,0.0021818127,0.9959571,0.000012406679],"about_ca_topic_score_codex":0.06272808,"about_ca_topic_score_gemma":0.080463074,"teacher_disagreement_score":0.6703486,"about_ca_system_score_codex":0.0036188613,"about_ca_system_score_gemma":0.00809102,"threshold_uncertainty_score":0.4702077},"labels":[],"label_agreement":null},{"id":"W4281554826","doi":"10.1001/jamaoncol.2022.1479","title":"Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Royal Victoria Regional Health Centre; University of British Columbia; Health Sciences Centre; Southlake Regional Health Center; Dalhousie University; Regional Municipality of Durham; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Supine position; Prone position; Randomized controlled trial; Breast cancer; Randomization; Regimen; Internal medicine; Surgery; Cancer","score_opus":0.002107120532603353,"score_gpt":0.23317745572687618,"score_spread":0.23107033519427284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281554826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951963,0.0015692045,0.00027926857,0.00024250345,0.00015945497,0.0009949717,0.0001478232,0.000013894752,0.0013966407],"genre_scores_gemma":[0.99729306,0.00066752144,0.0004839324,0.00027964672,0.00012010435,0.0006088212,0.00011335003,0.0000036841695,0.00042989946],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9991731,0.0005318486,0.000054640826,0.00007290354,0.00008416809,0.00008326291],"domain_scores_gemma":[0.99837804,0.00057343196,0.0005038311,0.00009718338,0.000074541436,0.00037304286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013982507,0.00047580193,0.00064761605,0.00017770429,0.00027921784,0.00040428663,0.0003458709,0.00053917174,0.0035224361],"category_scores_gemma":[0.0030918575,0.00021601327,0.0010519791,0.00020230739,0.00049163867,0.00035730228,0.00026309883,0.0009797628,0.0002799023],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.89010996,0.01694997,0.016973566,0.0005514048,0.0009190908,0.00004701629,0.00009558504,0.0005150457,0.008642091,0.0001168913,0.0007000254,0.0643793],"study_design_scores_gemma":[0.17895302,0.75690174,0.057314616,0.000108705965,0.0013500836,0.000107154534,0.000095885385,0.00060869695,0.0030946503,0.0001641588,0.0012778325,0.000023501758],"about_ca_topic_score_codex":0.00092161883,"about_ca_topic_score_gemma":0.003580702,"teacher_disagreement_score":0.0035224361,"about_ca_system_score_codex":0.00041307523,"about_ca_system_score_gemma":0.0010764848,"threshold_uncertainty_score":0.011783659},"labels":[],"label_agreement":null},{"id":"W4283314661","doi":"10.1001/jamaoncol.2022.2059","title":"Prophylactic Antibiotic Regimens in Tumor Resection Surgery Involving a Prosthesis—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Surgical site infection prevention","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; General surgery; Psychiatry","score_opus":0.036911608158457856,"score_gpt":0.3031570249962175,"score_spread":0.26624541683775965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283314661","genre_codex":"commentary","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003654334,0.0008077508,0.00017007606,0.98147637,0.010181545,0.000027876995,0.00010921959,0.00007729599,0.0034954834],"genre_scores_gemma":[0.030642318,0.0020261817,0.00063988497,0.9247719,0.035742324,0.00008257597,0.00012175387,0.000042618823,0.0059303334],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99886584,0.00030246147,0.00025155488,0.00013147458,0.00022291415,0.0002256894],"domain_scores_gemma":[0.99563015,0.002520691,0.00031887242,0.00012160915,0.0008357211,0.00057292747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013591665,0.0008031988,0.0008093605,0.00078804843,0.0018167909,0.0013239753,0.0012400936,0.026124336,0.0058572586],"category_scores_gemma":[0.013266358,0.0005828056,0.001070072,0.0008196317,0.0011484293,0.0026964494,0.00068465597,0.014424446,0.0040931245],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014532248,0.00013704954,0.00894397,0.0001194768,0.000034826146,0.016550435,0.00040896964,0.00034696824,0.00040938854,0.0011683055,0.9527757,0.018959502],"study_design_scores_gemma":[0.00042025922,0.0006923638,0.03529809,0.0013756155,0.00020263594,0.07482117,0.004200877,0.003766883,0.00163225,0.013033422,0.86411935,0.00043713092],"about_ca_topic_score_codex":0.0051108,"about_ca_topic_score_gemma":0.0050562313,"teacher_disagreement_score":0.026124336,"about_ca_system_score_codex":0.0022132252,"about_ca_system_score_gemma":0.0017324004,"threshold_uncertainty_score":0.01959449},"labels":[],"label_agreement":null},{"id":"W4292213007","doi":"10.1001/jamaoncol.2022.3467","title":"Caution Regarding Assessment of Toxic Effects and Survival in Treatment De-escalation With Radiotherapy vs Transoral Surgery for Human Papillomavirus–Associated Oropharyngeal Cancer—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Otorhinolaryngology; Neurology; Family medicine; MEDLINE; General surgery; Psychiatry","score_opus":0.037005986957889855,"score_gpt":0.3658940959846155,"score_spread":0.3288881090267256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292213007","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020911496,0.0016193069,0.0003942174,0.9732521,0.019857336,0.0000480169,0.00033881067,0.0000933546,0.0023056928],"genre_scores_gemma":[0.016760845,0.0011262873,0.0010112408,0.9483486,0.030160818,0.00014514415,0.00012021505,0.00006117167,0.0022657448],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98899186,0.0052970573,0.0028673904,0.0007559295,0.0016229688,0.00046481678],"domain_scores_gemma":[0.9230597,0.061406776,0.0029483528,0.0016614795,0.009261378,0.0016622386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016066788,0.0007031819,0.0013246003,0.0011657597,0.0014475238,0.0020435844,0.002567857,0.018555032,0.008466513],"category_scores_gemma":[0.1285793,0.0006841648,0.0023830056,0.0013266052,0.0021786792,0.0031365794,0.0010731402,0.018091224,0.0048961947],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049939606,0.00007186576,0.0066693933,0.00025968635,0.000119072814,0.0011908434,0.00037199666,0.00020181545,0.00026174056,0.0024437946,0.9593501,0.028560232],"study_design_scores_gemma":[0.0009649636,0.0010613537,0.024223227,0.0021382587,0.0006229171,0.010109578,0.0024986335,0.0022588677,0.0023211872,0.021746848,0.93171084,0.00034338652],"about_ca_topic_score_codex":0.007867136,"about_ca_topic_score_gemma":0.006572554,"teacher_disagreement_score":0.018555032,"about_ca_system_score_codex":0.0033278246,"about_ca_system_score_gemma":0.0025952428,"threshold_uncertainty_score":0.084970295},"labels":[],"label_agreement":null},{"id":"W4292249484","doi":"10.1001/jamaoncol.2022.3737","title":"Error in Figure 2","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine","score_opus":0.027383103168801007,"score_gpt":0.34826074588494066,"score_spread":0.32087764271613967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4292249484","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003925035,0.0011603019,0.0043316213,0.16600615,0.69674915,0.0004783286,0.026051573,0.0047948486,0.10003548],"genre_scores_gemma":[0.015807899,0.0038840596,0.017017826,0.24220401,0.10072348,0.0019637088,0.022278024,0.008049786,0.5880712],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927959,0.001271293,0.0011111354,0.0009610693,0.003207291,0.00065327104],"domain_scores_gemma":[0.94961303,0.01724649,0.0025404657,0.0039114715,0.025426378,0.0012621883],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.004589346,0.0016850518,0.0015523718,0.0035651575,0.0031813385,0.005234167,0.0033003923,0.0075432416,0.32967475],"category_scores_gemma":[0.10568777,0.0009043541,0.0022125905,0.003928053,0.0018519845,0.0035312236,0.0024306064,0.008538423,0.18226485],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024787489,0.0000045760858,0.00006080658,0.000053978765,0.0000022568825,0.000037490114,0.000013802816,0.00003201682,0.0000101405785,0.000911384,0.9940362,0.00481261],"study_design_scores_gemma":[0.00005487824,0.000008536869,0.00040040762,0.00038409614,0.000009744764,0.00018412604,0.00006799131,0.00015071215,0.00013355643,0.001670332,0.99691653,0.000019113084],"about_ca_topic_score_codex":0.03368968,"about_ca_topic_score_gemma":0.020480227,"teacher_disagreement_score":0.32967475,"about_ca_system_score_codex":0.0046743066,"about_ca_system_score_gemma":0.0063594654,"threshold_uncertainty_score":0.9561376},"labels":[],"label_agreement":null},{"id":"W4293105208","doi":"10.1001/jamaoncol.2022.3524","title":"Analysis of Quality-of-Life Outcomes by Drug Class in Cancer Clinical Trials—Reply","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.2685709622888784,"score_gpt":0.554625176787541,"score_spread":0.2860542144986626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293105208","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00081347383,0.0010097525,0.00018976127,0.9848932,0.011644732,0.000028981962,0.00060831243,0.000048858135,0.0007630042],"genre_scores_gemma":[0.008343826,0.0011406133,0.00052623125,0.95251757,0.034855157,0.0001985656,0.0002481225,0.00004262335,0.002127363],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9868836,0.0065926574,0.0025419698,0.0011431056,0.0021659818,0.0006726794],"domain_scores_gemma":[0.84918475,0.13167241,0.0032441437,0.002348795,0.010220854,0.0033289846],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019041874,0.0009455816,0.001872551,0.0014303563,0.0015714908,0.002380436,0.0020954332,0.019019736,0.007907381],"category_scores_gemma":[0.14140862,0.00076735707,0.0023757922,0.0025575138,0.0024268425,0.003370463,0.0010739992,0.020998353,0.004795395],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036357113,0.00003866585,0.0037207056,0.00021204348,0.00013802921,0.0003558834,0.0000979134,0.00014401386,0.00010388046,0.00094566966,0.977522,0.016357707],"study_design_scores_gemma":[0.0024939529,0.00089968037,0.033758212,0.0018802495,0.0008349534,0.0039771507,0.0010679577,0.0030637786,0.0011848151,0.023661045,0.9268078,0.0003704541],"about_ca_topic_score_codex":0.005283251,"about_ca_topic_score_gemma":0.005169675,"teacher_disagreement_score":0.019041874,"about_ca_system_score_codex":0.0034018573,"about_ca_system_score_gemma":0.003928994,"threshold_uncertainty_score":0.10070431},"labels":[],"label_agreement":null},{"id":"W4293105406","doi":"10.1001/jamaoncol.2022.4054","title":"Change of Article Status to Open Access","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine; Gerontology; Family medicine","score_opus":0.07316993465775118,"score_gpt":0.41230582663671117,"score_spread":0.33913589197896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293105406","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006937908,0.0013610438,0.0008785494,0.12299707,0.66544276,0.00030559985,0.0061310115,0.0017164487,0.20047374],"genre_scores_gemma":[0.0072437185,0.0029488024,0.0015442423,0.11016662,0.1147145,0.00034359898,0.004481177,0.0015725258,0.7569849],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99571216,0.0003951887,0.0005971788,0.0004210673,0.002161627,0.0007127922],"domain_scores_gemma":[0.9829562,0.00373939,0.0009635984,0.001861446,0.008072016,0.0024074502],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0044327066,0.0007087708,0.0013488207,0.0028707027,0.0025648798,0.0075995806,0.0027465562,0.008349444,0.39377508],"category_scores_gemma":[0.042484313,0.0005230832,0.0017297766,0.002813117,0.0013425837,0.0053699696,0.0024681897,0.006391887,0.2730482],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003603006,0.000023889137,0.00013940677,0.00015027866,0.0000061456612,0.00016996353,0.000027907025,0.000016615899,0.000052763087,0.0012403112,0.97984993,0.018286744],"study_design_scores_gemma":[0.000031368912,0.000014073333,0.00048817837,0.0002943546,0.0000067253704,0.00014643646,0.000059597147,0.00004223504,0.000113371425,0.0009895478,0.9977991,0.000015012579],"about_ca_topic_score_codex":0.0049709124,"about_ca_topic_score_gemma":0.0054026837,"teacher_disagreement_score":0.39377508,"about_ca_system_score_codex":0.0024894634,"about_ca_system_score_gemma":0.004074855,"threshold_uncertainty_score":0.8647063},"labels":[],"label_agreement":null},{"id":"W4294001434","doi":"10.1001/jamaoncol.2022.4267","title":"Errors in Abstract and Affiliations","year":2022,"lang":"en","type":"erratum","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Government of Ontario; Pfizer","keywords":"Medicine; George (robot); Gerontology; Art history; Art","score_opus":0.02248534637367638,"score_gpt":0.34299221898329635,"score_spread":0.32050687260961996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294001434","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012492115,0.0010657219,0.0014997689,0.1314833,0.8424078,0.00020657526,0.004487285,0.00074437883,0.017980201],"genre_scores_gemma":[0.015605901,0.007500615,0.009305979,0.2681537,0.30503425,0.0023413955,0.00967402,0.0043666125,0.37801746],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97633094,0.004528962,0.005291486,0.0021345848,0.010217768,0.0014962568],"domain_scores_gemma":[0.86801964,0.03555338,0.008188862,0.00904884,0.07563427,0.0035549805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013173656,0.001808023,0.003022041,0.0045151133,0.004933636,0.0058339313,0.0039777164,0.0074610137,0.1762653],"category_scores_gemma":[0.22607754,0.001198472,0.0020660188,0.0059730946,0.0022714443,0.00403157,0.003681866,0.012430081,0.16855642],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025192183,0.0000034285438,0.000040691502,0.000078440076,0.0000042474726,0.000055298973,0.000028103053,0.000020406465,0.000013683487,0.0009978845,0.9954016,0.003330996],"study_design_scores_gemma":[0.00004141907,0.000008890778,0.00019221753,0.00045460658,0.000014485733,0.00020860322,0.00011120074,0.000101232334,0.00017572803,0.0024198291,0.9962488,0.000023024644],"about_ca_topic_score_codex":0.007879159,"about_ca_topic_score_gemma":0.0066717467,"teacher_disagreement_score":0.1762653,"about_ca_system_score_codex":0.0062383674,"about_ca_system_score_gemma":0.009087287,"threshold_uncertainty_score":0.5896661},"labels":[],"label_agreement":null},{"id":"W4294001741","doi":"10.1001/jamaoncol.2022.3829","title":"Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":324,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Canadian Partnership Against Cancer; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Gemcitabine; FOLFIRINOX; Pancreatic cancer; Oncology; Internal medicine; Adjuvant; Adjuvant therapy; Cancer; Irinotecan; Colorectal cancer","score_opus":0.04120636559404846,"score_gpt":0.39803146526592575,"score_spread":0.3568250996718773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294001741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99419975,0.003841621,0.00019337886,0.00023994932,0.00010485229,0.00032764327,0.00037089776,0.000017097838,0.00070483744],"genre_scores_gemma":[0.99782854,0.0006504207,0.00021527761,0.00021313553,0.00009815831,0.00021649667,0.00041581,0.0000026328137,0.00035955803],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9990108,0.0005769379,0.000069484464,0.00009482792,0.000106315325,0.0001416021],"domain_scores_gemma":[0.99820685,0.00055032736,0.000628439,0.00009159019,0.00008458252,0.00043826032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030317006,0.0007386073,0.0012045027,0.00034059995,0.0003061981,0.0007334006,0.0005300814,0.0010767521,0.0016063137],"category_scores_gemma":[0.0029243438,0.00019647487,0.001693363,0.0003199159,0.0005320505,0.00070506043,0.00030875785,0.0012810237,0.00017054756],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9570971,0.005510011,0.007512902,0.00029784167,0.0011859508,0.000031304146,0.00003883934,0.0011222663,0.0009455856,0.000061878556,0.00056485686,0.02563143],"study_design_scores_gemma":[0.4383674,0.48156953,0.06913402,0.00017205522,0.0033476993,0.00013684323,0.000093406765,0.0030346552,0.00218091,0.00046599834,0.0014448172,0.000052621188],"about_ca_topic_score_codex":0.0020783846,"about_ca_topic_score_gemma":0.0050775628,"teacher_disagreement_score":0.0030317006,"about_ca_system_score_codex":0.0013925352,"about_ca_system_score_gemma":0.0013570491,"threshold_uncertainty_score":0.016033351},"labels":[],"label_agreement":null},{"id":"W4294958444","doi":"10.1001/jamaoncol.2022.3766","title":"Ensuring High-Quality Shared Decision-making for Lung Cancer Screening","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Decision aids; Quality (philosophy); Cancer; Lung cancer; Lung cancer screening; MEDLINE; Intensive care medicine; Family medicine; Alternative medicine; Oncology; Pathology; Internal medicine","score_opus":0.19054147670657437,"score_gpt":0.5235302621303454,"score_spread":0.33298878542377097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4294958444","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027169023,0.004029847,0.19265729,0.6669578,0.004687271,0.001049998,0.00014702142,0.0005787968,0.10272308],"genre_scores_gemma":[0.63941497,0.0034248463,0.25281307,0.09168418,0.0031611884,0.0013178006,0.00027459508,0.0003167252,0.0075926566],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.6982355,0.24381588,0.011048683,0.0049098474,0.030649835,0.011340215],"domain_scores_gemma":[0.69266903,0.18408668,0.027823888,0.028905323,0.03928204,0.027233003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.18856622,0.00069954613,0.000962489,0.0016542344,0.006544524,0.016489714,0.0038192514,0.0056212037,0.0064389626],"category_scores_gemma":[0.28729343,0.0006525873,0.0016887344,0.0011913974,0.009821287,0.009476064,0.022727732,0.013206706,0.0018442457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018779002,0.000801503,0.028486392,0.0013153082,0.00048948074,0.0012952843,0.043579575,0.0066546146,0.0014784437,0.25000274,0.13025042,0.53545845],"study_design_scores_gemma":[0.00023098652,0.00060914975,0.011916561,0.0045876238,0.0001456822,0.0019193876,0.030598704,0.0076207863,0.0034033852,0.5780301,0.3606068,0.00033083998],"about_ca_topic_score_codex":0.003447157,"about_ca_topic_score_gemma":0.0054451334,"teacher_disagreement_score":0.18856622,"about_ca_system_score_codex":0.007142329,"about_ca_system_score_gemma":0.05828754,"threshold_uncertainty_score":0.99724543},"labels":[],"label_agreement":null},{"id":"W4297964923","doi":"10.1001/jamaoncol.2022.4394","title":"Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Positive Living North; Kelowna General Hospital; University of British Columbia","funders":"","keywords":"SABR volatility model; Medicine; Population; Prostate cancer; Radiation therapy; Cancer; Ablative case; Breast cancer; Lung cancer; Cohort; Oncology; Internal medicine; Surgery","score_opus":0.023676599289634816,"score_gpt":0.332461060624334,"score_spread":0.30878446133469917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4297964923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911004,0.005614095,0.0002659989,0.0004710802,0.000022350841,0.00025294055,0.00050409464,0.000012490688,0.0017565753],"genre_scores_gemma":[0.9978453,0.0010491575,0.00021410681,0.00021940339,0.000035083824,0.000091438786,0.0003444554,0.0000020228604,0.00019902439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866056,0.000591269,0.00013025483,0.00015185753,0.0003636122,0.00010245038],"domain_scores_gemma":[0.99860746,0.00036905243,0.00072694477,0.00006709104,0.000104805156,0.00012465402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017283297,0.00018468875,0.00061337044,0.00030910273,0.00041835397,0.00041168675,0.00031883863,0.00026781097,0.00118077],"category_scores_gemma":[0.00326443,0.00013471604,0.0006884135,0.00080505264,0.00032208688,0.00022576975,0.00029255613,0.00037668116,0.00011572893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016766217,0.000638771,0.8474727,0.0011315583,0.0013685537,0.00016643849,0.00023033307,0.00080649636,0.0025446336,0.00009290992,0.0016741682,0.12710711],"study_design_scores_gemma":[0.0027349426,0.008704005,0.9814539,0.00019488443,0.00088777335,0.0007272364,0.00014851327,0.00057638035,0.00092541234,0.00017756684,0.0034571693,0.000012289243],"about_ca_topic_score_codex":0.008866628,"about_ca_topic_score_gemma":0.045895655,"teacher_disagreement_score":0.008866628,"about_ca_system_score_codex":0.0013167396,"about_ca_system_score_gemma":0.0019248301,"threshold_uncertainty_score":0.01763004},"labels":[],"label_agreement":null},{"id":"W4304989346","doi":"10.1001/jamaoncol.2022.4445","title":"Comparing Trial and Real-world Adjuvant Oxaliplatin Delivery in Patients With Stage III Colon Cancer Using a Longitudinal Cumulative Dose","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Oxaliplatin; Medicine; FOLFOX; Oncology; Regimen; Internal medicine; Colorectal cancer; Chemotherapy regimen; Fluorouracil; Stage (stratigraphy); Randomized controlled trial; Clinical trial; Cancer","score_opus":0.07246552915765818,"score_gpt":0.36321377675170163,"score_spread":0.29074824759404344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304989346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952009,0.00086388376,0.0018254224,0.00023594541,0.000041899453,0.00029428868,0.00094193744,0.0000125425095,0.00058320747],"genre_scores_gemma":[0.99747425,0.0001282174,0.0010209746,0.00012991115,0.00003012158,0.0004793975,0.00059975573,0.0000036228323,0.00013381414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9857663,0.010368058,0.0012774249,0.0012109339,0.0010722275,0.0003051032],"domain_scores_gemma":[0.9722835,0.009503245,0.013314345,0.0031157648,0.0010554574,0.0007276914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018004874,0.00032785672,0.0005331135,0.0006466195,0.0004483047,0.00074085145,0.0006258633,0.00054812466,0.0015533647],"category_scores_gemma":[0.041877534,0.00026607726,0.00159243,0.0011766545,0.00056893856,0.00091282243,0.0010266502,0.0007215298,0.0001654572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016608885,0.0009081766,0.9547656,0.00037483315,0.004008888,0.000025561827,0.00048724623,0.0012377856,0.00034883159,0.00048997893,0.00085217104,0.019892082],"study_design_scores_gemma":[0.0045796605,0.023960786,0.95228755,0.0002805157,0.002957233,0.0001892389,0.00067441555,0.0076134983,0.0012662823,0.0015440059,0.0045796908,0.000067107685],"about_ca_topic_score_codex":0.0024292553,"about_ca_topic_score_gemma":0.0033345306,"teacher_disagreement_score":0.018004874,"about_ca_system_score_codex":0.00094905886,"about_ca_system_score_gemma":0.0014640479,"threshold_uncertainty_score":0.09522003},"labels":[],"label_agreement":null},{"id":"W4304990118","doi":"10.1001/jamaoncol.2022.4649","title":"Association of Changes in Cancer Therapy Over 3 Decades With Risk of Subsequent Breast Cancer Among Female Childhood Cancer Survivors","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Cancer; Cumulative incidence; Internal medicine; Radiation therapy; Anthracycline; Population; Oncology; Cancer registry; Incidence (geometry); Retrospective cohort study; Cohort","score_opus":0.021371245718769395,"score_gpt":0.32633524515083273,"score_spread":0.3049639994320633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304990118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986527,0.0005187526,0.00008924858,0.000047704445,0.0000033274384,0.0000029701703,0.00044524926,0.0000033597782,0.00023664009],"genre_scores_gemma":[0.999268,0.00020056526,0.000058048237,0.0000137211355,0.000004716879,0.000004704071,0.00034368382,0.0000014260247,0.00010518579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997812,0.000055695673,0.000022135202,0.00006195302,0.00003730362,0.000041674608],"domain_scores_gemma":[0.998483,0.0002614268,0.00095518713,0.00008672338,0.0001025208,0.00011118227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005307839,0.00011689494,0.00011359082,0.00045110827,0.0001406714,0.0002842392,0.00018059347,0.00023442287,0.0010395383],"category_scores_gemma":[0.002286764,0.00013086673,0.00034624684,0.0005767637,0.000116933625,0.00021173593,0.00023994135,0.0002941921,0.0000851769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004746,0.000005300848,0.9988243,0.000003095315,0.000031477928,0.000014343856,0.000019633904,0.00006538727,0.00005689218,0.0000070039027,0.000031502073,0.00089349307],"study_design_scores_gemma":[0.0000013334327,0.000030085055,0.99956614,0.0000038374137,0.000018325165,0.00007772402,0.000040512332,0.00011253995,0.0000394628,0.000006403212,0.00010250847,0.0000012086941],"about_ca_topic_score_codex":0.008807778,"about_ca_topic_score_gemma":0.011682517,"teacher_disagreement_score":0.008807778,"about_ca_system_score_codex":0.00030902142,"about_ca_system_score_gemma":0.00030847272,"threshold_uncertainty_score":0.017513037},"labels":[],"label_agreement":null},{"id":"W4306913474","doi":"10.1001/jamaoncol.2022.5068","title":"Methodologic Concerns in Secondary Analysis of KEYNOTE-048","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.07565656600452525,"score_gpt":0.44372764315129026,"score_spread":0.368071077146765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306913474","genre_codex":"methods","genre_gemma":"commentary","domain_codex":"methods","domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":"methods","domain_consensus":"methods","prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.058694348,0.016646681,0.5915332,0.05287222,0.04703263,0.12212212,0.024584722,0.0041154874,0.08239867],"genre_scores_gemma":[0.5570795,0.0012948916,0.18014042,0.03723021,0.0039022185,0.20396082,0.002601603,0.001506598,0.01228379],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.28375316,0.6031121,0.050947316,0.0238175,0.03501846,0.003351447],"domain_scores_gemma":[0.29453242,0.6045353,0.022163555,0.058770396,0.018492457,0.0015059313],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.46973523,0.0029540593,0.004269365,0.0048997668,0.0029636458,0.007935234,0.0053054867,0.004313498,0.021007642],"category_scores_gemma":[0.7762467,0.0017704042,0.0068060006,0.006895542,0.005687239,0.005908559,0.0034053205,0.0059817303,0.004543771],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017667888,0.002435709,0.13059527,0.038857196,0.0295931,0.0049520517,0.018125812,0.006623462,0.001700065,0.1644046,0.3553839,0.22966105],"study_design_scores_gemma":[0.0116698705,0.004226129,0.06689849,0.02544879,0.013570989,0.0035330572,0.006536324,0.053276073,0.008132203,0.3069118,0.49908033,0.0007159484],"about_ca_topic_score_codex":0.0032654777,"about_ca_topic_score_gemma":0.0056957095,"teacher_disagreement_score":0.53026474,"about_ca_system_score_codex":0.0051684077,"about_ca_system_score_gemma":0.0065360935,"threshold_uncertainty_score":0.6539109},"labels":[],"label_agreement":null},{"id":"W4306915041","doi":"10.1001/jamaoncol.2022.5049","title":"Association of Long-term Outcomes With Stereotactic Radiosurgery vs Whole-Brain Radiotherapy for Resected Brain Metastasis","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Juravinski Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Radiosurgery; Quality of life (healthcare); Brain metastasis; Radiation therapy; Randomization; Randomized controlled trial; Internal medicine; Oncology; Surgery; Metastasis; Cancer","score_opus":0.032032689934869414,"score_gpt":0.339230455043574,"score_spread":0.3071977651087046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4306915041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998393,0.00092050806,0.00010414008,0.000057060686,0.000018094986,0.000063818574,0.00020101554,0.000003918529,0.00023837903],"genre_scores_gemma":[0.99922407,0.00014395452,0.000061071485,0.000045348523,0.000026366028,0.00008135293,0.00027997055,0.0000016342734,0.00013621271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99919134,0.00033603437,0.000103512335,0.00010519196,0.00014935202,0.00011459334],"domain_scores_gemma":[0.99757165,0.0007419719,0.0010045688,0.00012233685,0.00014058757,0.00041893317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016767491,0.0002584353,0.0006438642,0.0001997857,0.00021433526,0.00032976613,0.00025792795,0.0003799814,0.0012757533],"category_scores_gemma":[0.003174052,0.00011674655,0.0011961994,0.00024796257,0.00029794595,0.00033439716,0.00025476972,0.0007138644,0.00011166544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34161764,0.0044134106,0.5968467,0.0005452257,0.0055693267,0.00014424218,0.00011505715,0.0018243163,0.004392087,0.00010455023,0.000984603,0.043442868],"study_design_scores_gemma":[0.013644962,0.093430445,0.88535345,0.00006872634,0.0024347089,0.00023027125,0.00009072482,0.0015934285,0.0021710552,0.00016874468,0.00078425946,0.000029181296],"about_ca_topic_score_codex":0.001199473,"about_ca_topic_score_gemma":0.0034544214,"teacher_disagreement_score":0.0016767491,"about_ca_system_score_codex":0.0005288366,"about_ca_system_score_gemma":0.0007882257,"threshold_uncertainty_score":0.008867621},"labels":[],"label_agreement":null},{"id":"W4308027679","doi":"10.1001/jamaoncol.2022.5357","title":"Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Heart, Lung, and Blood Institute; National Institute on Aging; Loxo Oncology; EMD Serono; Genentech; Bausch Health; Ipsen; European Society for Medical Oncology; Astellas Pharma; Eisai; National Institutes of Health; Regeneron Pharmaceuticals; Natera; National Geographic Society; UroGen Pharma; ECOG-ACRIN Cancer Research Group; Seagen; Hope Foundation; Flatiron Health; Vanderbilt University; Advanced Accelerator Applications; National Cancer Institute; Gilead Sciences; Pfizer; Incyte; American Cancer Society; American College of Radiology Imaging Network; Exelixis; Sanofi; American Association for Cancer Research; Amgen; Bristol-Myers Squibb; AstraZeneca","keywords":"Medicine; Interquartile range; Immunosuppression; Cytokine storm; Internal medicine; Cancer; Intensive care unit; Regimen; Retrospective cohort study; Nivolumab; Immunotherapy; Coronavirus disease 2019 (COVID-19)","score_opus":0.021758550648267143,"score_gpt":0.39032240771732324,"score_spread":0.3685638570690561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308027679","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99770147,0.0006641488,0.0001424963,0.00017966072,0.000010907263,0.000011289032,0.0005307169,0.0000037821783,0.0007555788],"genre_scores_gemma":[0.9992737,0.0001759197,0.000083380866,0.000038200364,0.000021559303,0.000007756324,0.0003309766,0.0000012605922,0.00006734015],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994537,0.00017124343,0.00007041375,0.000105457875,0.00008737597,0.00011179213],"domain_scores_gemma":[0.998108,0.0002555385,0.0012556197,0.00007291527,0.000113526636,0.00019430538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046596685,0.00013668361,0.00028663865,0.00045723375,0.0003879988,0.0005490177,0.00017697229,0.00021507262,0.0019096106],"category_scores_gemma":[0.002141553,0.00009635199,0.00028578512,0.0010913174,0.00020946907,0.00045450692,0.00042661515,0.00045202384,0.00015654335],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035769608,0.000011160056,0.9988869,0.0000050600765,0.000014789664,0.000035929035,0.000020559752,0.000021250313,0.00007090642,0.000013713326,0.0000592876,0.00082464213],"study_design_scores_gemma":[0.0000044251306,0.00008332323,0.99859256,0.000011624594,0.0000200425,0.0004905288,0.000171619,0.00017115154,0.00007043431,0.00004453027,0.00033705676,0.0000026893247],"about_ca_topic_score_codex":0.0012490347,"about_ca_topic_score_gemma":0.0020413606,"teacher_disagreement_score":0.0019096106,"about_ca_system_score_codex":0.00023206888,"about_ca_system_score_gemma":0.0004708854,"threshold_uncertainty_score":0.0063883066},"labels":[],"label_agreement":null},{"id":"W4309183974","doi":"10.1001/jamaoncol.2022.5370","title":"Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":405,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital; Université de Sherbrooke","funders":"Houston Methodist Research Institute; University of California, San Diego; Saint Luke's Health System; Northwell Health; National Cancer Institute; University College London; Kaiser Permanente; Université de Sherbrooke; Moffitt Cancer Center; Houston Methodist Hospital; Montreal Neurological Institute and Hospital; University of California, Los Angeles; University of South Carolina; McGill University; Sylvester Comprehensive Cancer Center, University of Miami Health Systems; Tufts Medical Center; University of Miami; Hollings Cancer Center, Medical University of South Carolina; Brown University","keywords":"Medicine; Temozolomide; Internal medicine; Clinical endpoint; Placebo; Clinical trial; Oncology; Hazard ratio; Glioblastoma; Randomization; Chemotherapy; Surgery; Confidence interval; Pathology","score_opus":0.007123232567838385,"score_gpt":0.23840523519058587,"score_spread":0.23128200262274748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309183974","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990625,0.0005960714,0.00004538259,0.000041014184,0.00001702852,0.000062859785,0.000037691938,0.0000043170867,0.00013311463],"genre_scores_gemma":[0.99937975,0.00019227863,0.00009021653,0.000053096795,0.00002718071,0.00006627302,0.000098660574,9.626652e-7,0.000091634785],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9995449,0.00025082487,0.000039562234,0.00006989962,0.000040191073,0.00005461926],"domain_scores_gemma":[0.9990127,0.00024637318,0.00035515244,0.000085844906,0.00006546176,0.00023441548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001336397,0.00033376302,0.00065988937,0.0001843244,0.00014476046,0.00036280564,0.00023906675,0.0004072657,0.0007074428],"category_scores_gemma":[0.0020709569,0.0001602268,0.0006791743,0.00021508064,0.0002694052,0.0003083169,0.00026714997,0.00060594257,0.00010151273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55896723,0.013026476,0.29881996,0.0006069851,0.0018629723,0.00014815894,0.00022645488,0.0015325116,0.008945777,0.000121138495,0.0014450459,0.11429729],"study_design_scores_gemma":[0.07782204,0.4239554,0.4863842,0.00011726614,0.0018852777,0.00043096815,0.00016160149,0.0026331542,0.0042891353,0.00020885402,0.0020652309,0.00004686861],"about_ca_topic_score_codex":0.00043646918,"about_ca_topic_score_gemma":0.00088838255,"teacher_disagreement_score":0.001336397,"about_ca_system_score_codex":0.0004391705,"about_ca_system_score_gemma":0.00073053193,"threshold_uncertainty_score":0.0070676208},"labels":[],"label_agreement":null},{"id":"W4309184100","doi":"10.1001/jamaoncol.2022.5228","title":"Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors","year":2022,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":100,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute; Foundation Medicine; Genentech; Astellas Pharma; Incyte; National Center for Advancing Translational Sciences; Seagen; Gilead Sciences; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Symphogen; GlaxoSmithKline; Amgen; Pfizer","keywords":"Medicine; Prostate cancer; Oncology; Internal medicine; Avelumab; Cancer; Lung cancer; Breast cancer; Immunogenicity; Response Evaluation Criteria in Solid Tumors; Clinical endpoint; Immunotherapy; Antigen; Immunology; Phases of clinical research; Chemotherapy; Clinical trial; Pembrolizumab","score_opus":0.014103020392398594,"score_gpt":0.3020944315400396,"score_spread":0.28799141114764104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309184100","genre_codex":"empirical","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98163325,0.013738687,0.00042813085,0.00048774717,0.00012604873,0.00048805657,0.0006225888,0.00006467158,0.0024107997],"genre_scores_gemma":[0.99418384,0.0028697825,0.0006617388,0.0003516218,0.00015198415,0.00032407208,0.0006675891,0.000006166092,0.00078326004],"study_design_codex":"randomized_trial","study_design_gemma":"not_applicable","domain_scores_codex":[0.99977726,0.00010192879,0.000021065993,0.000036855585,0.000025927407,0.000036880865],"domain_scores_gemma":[0.9996835,0.00007580757,0.00010552488,0.000015042551,0.000018232064,0.00010191048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060803076,0.00034483164,0.0010982587,0.000238541,0.00014795594,0.00038715434,0.00024619506,0.00032414772,0.0017965647],"category_scores_gemma":[0.0007218908,0.00016116162,0.0006949486,0.000339656,0.00019389582,0.00036541265,0.0001714005,0.00074101525,0.00033589694],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.55390257,0.008260836,0.03562929,0.001956542,0.0022081141,0.0003728254,0.00012993708,0.0033522707,0.03837106,0.0003949514,0.006013246,0.34940842],"study_design_scores_gemma":[0.4033087,0.4561914,0.101897076,0.00029102905,0.002235507,0.0014494563,0.00010810706,0.004894293,0.009408398,0.00062239263,0.019549364,0.000044243752],"about_ca_topic_score_codex":0.00038513396,"about_ca_topic_score_gemma":0.001410323,"teacher_disagreement_score":0.0017965647,"about_ca_system_score_codex":0.00040109982,"about_ca_system_score_gemma":0.0006846726,"threshold_uncertainty_score":0.006010115},"labels":[],"label_agreement":null},{"id":"W4309827972","doi":"10.1001/jamaoncol.2022.5486","title":"Effectiveness of Adjuvant Pembrolizumab vs High-Dose Interferon or Ipilimumab for Quality-of-Life Outcomes in Patients With Resected Melanoma","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Ipilimumab; Pembrolizumab; Internal medicine; Quality of life (healthcare); Clinical endpoint; Oncology; Randomized controlled trial; Randomization; Clinical trial; Adjuvant therapy; Cancer; Immunotherapy","score_opus":0.02678739375407324,"score_gpt":0.33753905426309,"score_spread":0.31075166050901676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309827972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942075,0.0044129635,0.000097036456,0.00021457722,0.00007121907,0.00022933913,0.00019913646,0.000008986511,0.00055916054],"genre_scores_gemma":[0.99817085,0.00069404294,0.0002024978,0.00020651847,0.0000605904,0.0002478392,0.00023142983,0.0000020103978,0.00018419759],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991955,0.0005270139,0.0000625042,0.0000766174,0.000066977,0.00007138258],"domain_scores_gemma":[0.9988226,0.00045863987,0.0003496725,0.000073743926,0.00004711251,0.00024809685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023414397,0.0004527011,0.0010301704,0.00024533813,0.00021372364,0.0005372036,0.00039912673,0.0005680889,0.0018004803],"category_scores_gemma":[0.0025643762,0.00022971096,0.0021221954,0.00022470155,0.00034355457,0.0006267916,0.00028743336,0.0012544809,0.00017603807],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.88416994,0.009007816,0.019578038,0.00057919667,0.003146009,0.000038984897,0.000077559795,0.0015496921,0.002776784,0.00009031385,0.0008331484,0.078152545],"study_design_scores_gemma":[0.4520292,0.40819484,0.12518425,0.00027233612,0.0057203122,0.00014580898,0.00011214373,0.003999176,0.0021537365,0.0005388975,0.0015971576,0.000052166353],"about_ca_topic_score_codex":0.00079757423,"about_ca_topic_score_gemma":0.0022277897,"teacher_disagreement_score":0.0023414397,"about_ca_system_score_codex":0.0008361469,"about_ca_system_score_gemma":0.00089048804,"threshold_uncertainty_score":0.012382865},"labels":[],"label_agreement":null},{"id":"W4310566600","doi":"10.1001/jamaoncol.2022.5610","title":"Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":197,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Aptitude Health; Eisai; National Breast Cancer Foundation; Seagen; G1 Therapeutics; Daiichi-Sankyo; MacroGenics; Silverback Therapeutics; Puma Biotechnology; Medac; Ipsen; OncoSec Medical; Syndax Pharmaceuticals; BioMarin Pharmaceutical; Mylan; Ionis Pharmaceuticals; National Center for Advancing Translational Sciences; Teva Pharmaceutical Industries; Les Laboratories Pierre Fabre; Vertex Pharmaceuticals; Foundation Medicine; Genomic Health; Breast Cancer Research Foundation; Jounce Therapeutics; Celgene; Genentech; Veracyte; Amgen; Radius Health; Daiichi Sankyo Europe; National Cancer Institute; Gilead Sciences; Yale University; Sanofi; GlaxoSmithKline; Carrick Therapeutics; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Pfizer","keywords":"Capecitabine; Medicine; Trastuzumab; Internal medicine; Metastatic breast cancer; Placebo; Oncology; Breast cancer; Pertuzumab; Cancer; Colorectal cancer; Pathology","score_opus":0.009678729924896167,"score_gpt":0.28176592373884174,"score_spread":0.2720871938139456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310566600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854327,0.008392772,0.0002861531,0.0005602953,0.00083964417,0.0016822611,0.00057072804,0.00007207055,0.0021634295],"genre_scores_gemma":[0.99363685,0.0023312627,0.00037940472,0.00035775473,0.0004350946,0.0012468589,0.00033101864,0.000006138381,0.0012755573],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99935764,0.00030984243,0.00007120846,0.000110034416,0.000039665654,0.000111616166],"domain_scores_gemma":[0.99913126,0.0002917627,0.00022822403,0.000046392353,0.00003873067,0.00026367817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013130202,0.0010710536,0.0026133994,0.00053359393,0.00032805186,0.00097178307,0.0006088634,0.0014088765,0.0056265686],"category_scores_gemma":[0.0018304224,0.0004622247,0.0017806108,0.00046923407,0.00083254505,0.0011000948,0.00035540186,0.0019963041,0.00066210964],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97828215,0.0038294424,0.00039253687,0.0003778437,0.00048514287,0.000023962994,0.0000223352,0.00018715166,0.0018886457,0.00006329366,0.00034349377,0.014103997],"study_design_scores_gemma":[0.7791267,0.2144474,0.0029235813,0.00005381844,0.0009479325,0.000046765093,0.00002930459,0.00061774504,0.00082682824,0.0001922556,0.0007695517,0.000018211605],"about_ca_topic_score_codex":0.0005538366,"about_ca_topic_score_gemma":0.0016202211,"teacher_disagreement_score":0.0056265686,"about_ca_system_score_codex":0.0006126101,"about_ca_system_score_gemma":0.00085448474,"threshold_uncertainty_score":0.01882273},"labels":[],"label_agreement":null},{"id":"W4313278417","doi":"10.1001/jamaoncol.2022.6815","title":"Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer","year":2022,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; St. Michael's Hospital; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario","funders":"","keywords":"Medicine; Cancer; Hazard ratio; Internal medicine; Vaccination; Retrospective cohort study; Incidence (geometry); Population; Cohort; Cohort study; Immunology; Confidence interval","score_opus":0.03142714794451472,"score_gpt":0.39453593245238017,"score_spread":0.36310878450786543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4313278417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998295,0.00048951776,0.00005505956,0.0000793568,0.000006684753,0.0000065987756,0.00066561654,0.000003691953,0.00039841165],"genre_scores_gemma":[0.9993199,0.00012343928,0.000030742063,0.000015648096,0.0000065430786,0.0000025239387,0.0004223772,6.91101e-7,0.00007805543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972826,0.000038015303,0.000024663159,0.000059610695,0.00007269209,0.00007678013],"domain_scores_gemma":[0.9988617,0.00012850575,0.0005875407,0.000045308087,0.00017190182,0.00020509305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002153829,0.0001324969,0.00023159674,0.00030241354,0.0003566645,0.00037625284,0.00022940325,0.0002641774,0.0014503615],"category_scores_gemma":[0.0017122282,0.0001207849,0.0002933871,0.00071013183,0.00016162067,0.000164902,0.00025586513,0.00042958956,0.000071778966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049485257,0.0000055429555,0.99929345,0.0000045901556,0.000017472157,0.000015594394,0.000011746719,0.000015688522,0.000039497023,0.0000035431297,0.000078406185,0.00046489915],"study_design_scores_gemma":[0.000004991499,0.000035856425,0.9995604,0.000004969299,0.000012516119,0.00007476093,0.0000448163,0.00011519865,0.000017980805,0.000005418738,0.000121849596,0.000001215433],"about_ca_topic_score_codex":0.07950926,"about_ca_topic_score_gemma":0.10445094,"teacher_disagreement_score":0.07950926,"about_ca_system_score_codex":0.00077455724,"about_ca_system_score_gemma":0.0009131234,"threshold_uncertainty_score":0.15809292},"labels":[],"label_agreement":null},{"id":"W4317436361","doi":"10.1001/jamaoncol.2022.6881","title":"Long-term Trajectories of Physical Function Decline in Women With and Without Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Cancer; Breast cancer; Colorectal cancer; Cohort; Prospective cohort study; Cohort study; Endometrial cancer; Lung cancer; Internal medicine; Gerontology","score_opus":0.01936109449623488,"score_gpt":0.32873183478697526,"score_spread":0.3093707402907404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317436361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998511,0.00042035326,0.00010529152,0.000091066955,0.000004270362,0.0000059385434,0.00065393886,0.0000032139776,0.00020499116],"genre_scores_gemma":[0.998727,0.00016066324,0.000080222715,0.00002642388,0.000005045246,0.0000075689372,0.0008626955,0.0000013487023,0.00012910638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997403,0.00005589474,0.000030833053,0.00007000749,0.00004492682,0.000057954177],"domain_scores_gemma":[0.9991528,0.00014810267,0.00038689087,0.00005796079,0.000097942364,0.000156339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052088156,0.00017496107,0.00022066484,0.00044220834,0.00033907092,0.0004390259,0.00024210608,0.000327648,0.0007420781],"category_scores_gemma":[0.002643327,0.00013878333,0.00026199015,0.0007108085,0.0002229261,0.0004856893,0.00050573173,0.00044566087,0.00013117907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058909092,0.0000150751985,0.99837375,0.000004873999,0.000029131346,0.000021577818,0.000061477745,0.000051304403,0.000063493164,0.000014310979,0.000055659344,0.0012503621],"study_design_scores_gemma":[0.0000034822165,0.00007027186,0.9993794,0.0000062533436,0.000014322321,0.00008475088,0.00011409633,0.00012111844,0.00002175771,0.000035605222,0.00014652062,0.0000024112833],"about_ca_topic_score_codex":0.008239359,"about_ca_topic_score_gemma":0.01168031,"teacher_disagreement_score":0.008239359,"about_ca_system_score_codex":0.00025260376,"about_ca_system_score_gemma":0.00031619897,"threshold_uncertainty_score":0.016382813},"labels":[],"label_agreement":null},{"id":"W4318070812","doi":"10.1001/jamaoncol.2022.6911","title":"Association of Inflammatory Biomarkers With Survival Among Patients With Stage III Colon Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Inflammatory Biomarkers in Disease Prognosis","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"National Cancer Institute","keywords":"Medicine; Internal medicine; Hazard ratio; Colorectal cancer; Proportional hazards model; Cancer; Oncology; Biomarker; Prospective cohort study; Cohort; Confidence interval","score_opus":0.00977426076898849,"score_gpt":0.2715399056885958,"score_spread":0.2617656449196073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318070812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634725,0.0013124492,0.0002363159,0.00011507752,0.000014164289,0.000011632884,0.0016019392,0.000005700633,0.00035544133],"genre_scores_gemma":[0.9982344,0.00027651695,0.000118853524,0.000027270484,0.000018340132,0.000014264728,0.0011606637,0.0000014837957,0.00014831634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995956,0.00010218071,0.000054595577,0.000106056854,0.000070479175,0.000071242124],"domain_scores_gemma":[0.9983341,0.00023830269,0.0010542965,0.00008860028,0.0001250325,0.00015960512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007048404,0.00024741562,0.00027880023,0.0003677576,0.00026293332,0.00036749215,0.00020610742,0.00026288343,0.0013423446],"category_scores_gemma":[0.0019605723,0.00011623724,0.00034236818,0.0008483297,0.00019565772,0.00030406954,0.0003097922,0.0004290291,0.00014378608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026440347,0.000013178143,0.9983125,0.0000146120465,0.000053027296,0.000018338382,0.000009509619,0.000050236893,0.0001262983,0.000007451838,0.000100685436,0.0010297109],"study_design_scores_gemma":[0.000014948663,0.00012528065,0.9991315,0.000009740464,0.000042741463,0.00011140652,0.00002719755,0.00018749994,0.000074913594,0.000029229403,0.00024256246,0.000003023723],"about_ca_topic_score_codex":0.0019946652,"about_ca_topic_score_gemma":0.00404251,"teacher_disagreement_score":0.0019946652,"about_ca_system_score_codex":0.00026405024,"about_ca_system_score_gemma":0.00046315644,"threshold_uncertainty_score":0.004490614},"labels":[],"label_agreement":null},{"id":"W4318916194","doi":"10.1001/jamaoncol.2022.7143","title":"Different Ways of Traveling the Cancer Road—Daytime Running Lights at Night?","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Cancer; Oncology; Daytime; Internal medicine","score_opus":0.24392723444079104,"score_gpt":0.4474011985879096,"score_spread":0.20347396414711857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318916194","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013744907,0.028332531,0.0013820631,0.8642173,0.039619487,0.000020181038,0.000050185714,0.00006741463,0.052566074],"genre_scores_gemma":[0.27338257,0.05100133,0.0027424714,0.56447196,0.02366216,0.00009536702,0.000073153635,0.00032064694,0.08425028],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99543625,0.0029967343,0.000096581956,0.00019651357,0.00055330415,0.00072061166],"domain_scores_gemma":[0.99473816,0.0024318611,0.0004841119,0.00016849437,0.00074835087,0.001428897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030506994,0.0005788957,0.000551206,0.00039604478,0.011072536,0.008007735,0.001512319,0.007386595,0.0065216096],"category_scores_gemma":[0.012598305,0.00044716944,0.0011402039,0.00044324025,0.010853822,0.008331593,0.0054148734,0.019229457,0.0021292586],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013509353,0.00012546899,0.0018252505,0.0003719172,0.000060183276,0.0020930402,0.10367247,0.0001687391,0.00042761958,0.037216894,0.8071553,0.046748016],"study_design_scores_gemma":[0.00002710049,0.000120733275,0.00090382324,0.0004493516,0.000017775614,0.0014382468,0.17474648,0.0000550745,0.00016506956,0.005421086,0.81659836,0.000056770168],"about_ca_topic_score_codex":0.009278518,"about_ca_topic_score_gemma":0.027362812,"teacher_disagreement_score":0.011072536,"about_ca_system_score_codex":0.003100839,"about_ca_system_score_gemma":0.0042245868,"threshold_uncertainty_score":0.02249831},"labels":[],"label_agreement":null},{"id":"W4319657006","doi":"10.1001/jamaoncol.2022.7364","title":"Assessment of Phase 3 Randomized Clinical Trials Including Patients With Leptomeningeal Disease","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; St. Michael's Hospital; University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Randomized controlled trial; Breast cancer; Lung cancer; Disease; Clinical trial; Melanoma; Cancer; Internal medicine; Oncology","score_opus":0.3602542693905168,"score_gpt":0.6070659847269417,"score_spread":0.24681171533642493,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319657006","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"methods","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"methods","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033322638,0.9867798,0.0015444995,0.0010346576,0.00093055743,0.0035483502,0.0011314761,0.00005477322,0.0016436959],"genre_scores_gemma":[0.10566868,0.86961466,0.006684661,0.006011913,0.0006028031,0.0092062345,0.0012877521,0.000060640887,0.0008626722],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97226816,0.017196774,0.0069064093,0.0013087488,0.001965417,0.00035455258],"domain_scores_gemma":[0.94371104,0.045694444,0.0068622716,0.0011097913,0.0022302365,0.00039230904],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031193968,0.0015456827,0.009362212,0.0019208384,0.00046932083,0.0028733215,0.0014599458,0.0022963174,0.00788043],"category_scores_gemma":[0.096938394,0.00095989095,0.01366549,0.0023541297,0.0009542915,0.0021284018,0.0012055815,0.0024782338,0.0006580844],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01013123,0.00008406119,0.0010084559,0.80171156,0.08705496,0.000066001965,0.000114659066,0.00040494488,0.0005841868,0.00086794666,0.0036253394,0.09434664],"study_design_scores_gemma":[0.042670406,0.004365174,0.005805848,0.40105322,0.47997394,0.00039866875,0.00027891545,0.0004925729,0.0008619404,0.0040904717,0.05992426,0.00008457539],"about_ca_topic_score_codex":0.0018857025,"about_ca_topic_score_gemma":0.005539405,"teacher_disagreement_score":0.968806,"about_ca_system_score_codex":0.0023938185,"about_ca_system_score_gemma":0.0044537005,"threshold_uncertainty_score":0.16497147},"labels":[],"label_agreement":null},{"id":"W4321612529","doi":"10.1001/jamaoncol.2022.7770","title":"Exposure to US Cancer Drugs With Lack of Confirmed Benefit After US Food and Drug Administration Accelerated Approval","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Canadian Institutes of Health Research; National Institutes of Health; Astellas Pharma; Seagen; Flatiron Health; Emerson Collective; National Palliative Care Research Center; Eisai; National Comprehensive Cancer Network; F. Hoffmann-La Roche; University of Pennsylvania; Myriad Genetics; Prostate Cancer Foundation; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Cancer Care Ontario; Pfizer; Amgen; Conquer Cancer Foundation","keywords":"Medicine; Food and drug administration; Cancer drugs; Drug approval; Drug; Drug administration; Administration (probate law); Cancer; Pharmacology; Intensive care medicine; Oncology; Family medicine; Internal medicine","score_opus":0.28424878318026425,"score_gpt":0.43793605879494996,"score_spread":0.1536872756146857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321612529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"evaluation","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"evaluation","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98958206,0.0016504227,0.00034593567,0.0004589757,0.0000303311,0.00007916556,0.0049634795,0.000013321455,0.0028764205],"genre_scores_gemma":[0.9957568,0.00047078938,0.00012362102,0.00032822558,0.000041726093,0.000037595502,0.002662527,0.000004731553,0.00057395303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975957,0.0010332431,0.00038620344,0.00032482503,0.00045031175,0.00020954627],"domain_scores_gemma":[0.97212,0.0076280986,0.016868755,0.0011378349,0.0013037898,0.0009414545],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0027122214,0.00017622835,0.00040450558,0.00092295324,0.00028842408,0.00082920236,0.0002941949,0.00059340184,0.0038193532],"category_scores_gemma":[0.01811374,0.00019034998,0.001022022,0.0011885025,0.000260828,0.00062881905,0.0004948164,0.0011900341,0.00039278134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011689562,0.00026526765,0.99176824,0.000056275294,0.0005692245,0.000048242946,0.000043047603,0.00028994866,0.000091475544,0.00019113802,0.0008170391,0.004691053],"study_design_scores_gemma":[0.000059322498,0.0011700583,0.996055,0.000036382837,0.00023568266,0.00027713345,0.00008637648,0.00040174616,0.00014809221,0.00012332569,0.0013930915,0.000013794282],"about_ca_topic_score_codex":0.0063076066,"about_ca_topic_score_gemma":0.003933079,"teacher_disagreement_score":0.99728775,"about_ca_system_score_codex":0.00072500744,"about_ca_system_score_gemma":0.00065348105,"threshold_uncertainty_score":0.014343739},"labels":[],"label_agreement":null},{"id":"W4360601141","doi":"10.1001/jamaoncol.2023.0239","title":"Subcutaneous vs Intravenous Administration of Medications and Fluids for Patients With Cancer in the US and Canada","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Intravenous fluid; Administration (probate law); Cancer; Palliative care; Intensive care medicine; Intravenous drug; Emergency medicine; Anesthesia; Internal medicine; Family medicine; Nursing","score_opus":0.017500671534278495,"score_gpt":0.3596588544290456,"score_spread":0.3421581828947671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360601141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940916,0.0009933508,0.000059563485,0.0005487196,0.000017614793,0.000047232777,0.0017229054,0.00000608766,0.002512946],"genre_scores_gemma":[0.9979873,0.0006489485,0.00007168843,0.00029697656,0.0000088451025,0.000010583387,0.00062074215,0.0000041254275,0.00035086522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858284,0.00013254352,0.00012764455,0.0001515344,0.00050633104,0.00049924944],"domain_scores_gemma":[0.9955936,0.00047699217,0.0017759604,0.00007345079,0.0011574771,0.000922472],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004720049,0.00018896548,0.00034474226,0.00076503964,0.001261685,0.0010861228,0.00078164454,0.0005173225,0.0019399972],"category_scores_gemma":[0.0061281775,0.00032915082,0.00063629006,0.0028490615,0.0006600988,0.00042835035,0.00069717877,0.0008991654,0.00014694364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001720852,0.00004875407,0.99641466,0.000026643229,0.00005871623,0.00003811363,0.00027165806,0.000061589744,0.00005597636,0.00005745012,0.0006023351,0.0021920241],"study_design_scores_gemma":[0.000024439909,0.0000715323,0.9974228,0.00004125366,0.000035899848,0.000092797716,0.0014999576,0.00025281898,0.000049371007,0.000023131077,0.0004757128,0.000010259597],"about_ca_topic_score_codex":0.97414047,"about_ca_topic_score_gemma":0.9825074,"teacher_disagreement_score":0.025859535,"about_ca_system_score_codex":0.014253144,"about_ca_system_score_gemma":0.021227,"threshold_uncertainty_score":0.1034143},"labels":[],"label_agreement":null},{"id":"W4361270506","doi":"10.1001/jamaoncol.2023.0042","title":"Pathologic Complete Response and Clinical Outcomes in Patients With Localized Soft Tissue Sarcoma Treated With Neoadjuvant Chemoradiotherapy or Radiotherapy","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Cancer Foundation; McGill University","funders":"National Cancer Institute","keywords":"Medicine; Soft tissue sarcoma; Chemoradiotherapy; Radiation therapy; Internal medicine; Hazard ratio; Proportional hazards model; Oncology; Clinical trial; Sarcoma; Surgery; Soft tissue; Confidence interval; Pathology","score_opus":0.03960588045100155,"score_gpt":0.3626036190392862,"score_spread":0.3229977385882846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361270506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9984804,0.0009146663,0.00011315794,0.000064859916,0.0000070079846,0.000023607037,0.0001302712,0.000003885131,0.0002621861],"genre_scores_gemma":[0.9993284,0.00015119699,0.000094710274,0.000041081163,0.000016748681,0.00002276016,0.00025957657,0.0000010428706,0.000084521766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946207,0.00026383266,0.00006504602,0.00006917962,0.000095193216,0.000044644934],"domain_scores_gemma":[0.99800426,0.0006164968,0.0010125083,0.00008020703,0.000081914324,0.00020455482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012611318,0.00015567537,0.00040254183,0.0002749756,0.00015301004,0.00025268254,0.00021048772,0.00028966414,0.00082848687],"category_scores_gemma":[0.0028197945,0.00011252987,0.00031468266,0.00031434983,0.000275961,0.00039595587,0.0002879183,0.00031119413,0.00013232241],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008588178,0.0003032932,0.9694565,0.00008555291,0.00017209993,0.00008319431,0.000048920898,0.00043359972,0.0010413532,0.000015108852,0.00028138424,0.019490762],"study_design_scores_gemma":[0.00028637197,0.004427268,0.99313194,0.000023357657,0.000127758,0.00044502583,0.00006042209,0.0005416601,0.00048998074,0.00004425822,0.00041462772,0.0000074104114],"about_ca_topic_score_codex":0.0002944977,"about_ca_topic_score_gemma":0.0008856196,"teacher_disagreement_score":0.0012611318,"about_ca_system_score_codex":0.0002692285,"about_ca_system_score_gemma":0.00031507714,"threshold_uncertainty_score":0.006669581},"labels":[],"label_agreement":null},{"id":"W4362657172","doi":"10.1001/jamaoncol.2023.0175","title":"Association of Polycystic Ovary Syndrome With Pancreatic Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Ovarian function and disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.0157692679212009,"score_gpt":0.29071536937567954,"score_spread":0.2749461014544786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.913091,0.011097276,0.000841854,0.0060053812,0.0007554648,0.00006855104,0.0045299325,0.0001743952,0.06343622],"genre_scores_gemma":[0.99413425,0.0019921563,0.00029543386,0.00030740746,0.00023130847,0.000011900377,0.0006645944,0.000010646553,0.0023522726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996536,0.00006387734,0.000046407844,0.000056009518,0.00011356816,0.00006656651],"domain_scores_gemma":[0.9984864,0.00043009667,0.00052935246,0.00009323225,0.00012600014,0.0003349178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021039181,0.00016404166,0.00017062237,0.001374241,0.00045641224,0.00040313936,0.0001770236,0.00039879963,0.013473093],"category_scores_gemma":[0.0024688272,0.00012884078,0.0004474822,0.0013054296,0.00032725063,0.00038155352,0.00037403445,0.00089918374,0.00065765367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008075331,0.000027298891,0.982983,0.00004202772,0.000083167055,0.0050517293,0.000035430436,0.00009178884,0.00022806588,0.00018008733,0.0035837058,0.007612996],"study_design_scores_gemma":[0.00001733329,0.000043956796,0.93678427,0.000079338104,0.000089189896,0.056788944,0.00018358439,0.0004358913,0.00020860232,0.0004921592,0.0048611746,0.000015567037],"about_ca_topic_score_codex":0.0046392865,"about_ca_topic_score_gemma":0.0056504724,"teacher_disagreement_score":0.013473093,"about_ca_system_score_codex":0.00023958429,"about_ca_system_score_gemma":0.00051439804,"threshold_uncertainty_score":0.04507196},"labels":[],"label_agreement":null},{"id":"W4362657579","doi":"10.1001/jamaoncol.2023.0339","title":"Long-term Mortality in Individuals Diagnosed With Cancer During Pregnancy or Postpartum","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; University of Ottawa; Children's Hospital of Eastern Ontario; University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Alberta Health Services","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Pregnancy; Hazard ratio; Breast cancer; Cancer; Obstetrics; Proportional hazards model; Population; Retrospective cohort study; Postpartum period; Cohort study; Cohort; Gynecology; Confidence interval; Internal medicine; Environmental health","score_opus":0.12571682531697,"score_gpt":0.44491754313090254,"score_spread":0.31920071781393256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657579","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5111613,0.45303953,0.0026931488,0.0048142457,0.00047134096,0.00010250584,0.022664161,0.000069007394,0.004984761],"genre_scores_gemma":[0.9393368,0.05402498,0.0008070927,0.00067349226,0.00019097609,0.00008199292,0.0044368966,0.000009927584,0.0004378581],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986191,0.0004312456,0.0002126313,0.0002771255,0.00031262529,0.0001473357],"domain_scores_gemma":[0.99663734,0.0014680701,0.0011751181,0.00018762233,0.0004254259,0.00010630699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024656572,0.00028191227,0.0007769454,0.0009777825,0.0003269503,0.00073348795,0.0005522162,0.00048068538,0.0007246973],"category_scores_gemma":[0.006627117,0.0002210791,0.0023033011,0.0023859343,0.00027943624,0.00040593196,0.0004494431,0.0007453206,0.00007325422],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006413941,0.00002719095,0.9481132,0.0040891976,0.014799991,0.00011242254,0.00016160248,0.0007363894,0.00023530766,0.00034708704,0.0025080997,0.028228106],"study_design_scores_gemma":[0.000062759,0.00012535059,0.97667015,0.0026656198,0.012631325,0.00023488783,0.00024523478,0.0007493322,0.00018019645,0.00046529574,0.0059490786,0.000020783957],"about_ca_topic_score_codex":0.10904143,"about_ca_topic_score_gemma":0.15911913,"teacher_disagreement_score":0.10904143,"about_ca_system_score_codex":0.0012722198,"about_ca_system_score_gemma":0.001803016,"threshold_uncertainty_score":0.21681345},"labels":[],"label_agreement":null},{"id":"W4362657687","doi":"10.1001/jamaoncol.2023.0147","title":"Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":72,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Université de Montréal; University of Alberta","funders":"National Institute for Health and Care Research; Seagen; MacroGenics; Mirati Therapeutics; Kowa Company; Sanofi; EMD Serono; Rakuten Medical; Bristol-Myers Squibb; AstraZeneca; Pfizer; Coherus Biosciences","keywords":"Medicine; Nivolumab; Ipilimumab; Head and neck; Oncology; Head and neck squamous-cell carcinoma; Internal medicine; Metastatic melanoma; Basal cell; Expanded access; Head and neck cancer; Melanoma; Dermatology; Immunotherapy; Surgery; Radiation therapy; Cancer; Cancer research","score_opus":0.052095093963368706,"score_gpt":0.3452510310749039,"score_spread":0.2931559371115352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362657687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894632,0.006488556,0.00023155402,0.00042598645,0.00029805684,0.00090934755,0.0005690215,0.000045949884,0.0015682993],"genre_scores_gemma":[0.99588937,0.0014233581,0.00040981802,0.0003551958,0.00020446502,0.00054173113,0.00035462482,0.000007562454,0.0008139668],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9991837,0.00044005353,0.00005940881,0.0001256155,0.00008878595,0.00010239677],"domain_scores_gemma":[0.9986249,0.00044229327,0.00047838723,0.00007074559,0.00007545149,0.00030810217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023315384,0.00076881953,0.0018687014,0.00040240044,0.0002374892,0.0009329133,0.00078342797,0.0013112213,0.0037254517],"category_scores_gemma":[0.0026135498,0.00046412257,0.001746486,0.00031610852,0.0007171452,0.000981257,0.00037061793,0.0023343985,0.0005953251],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9309397,0.0070916326,0.0032958214,0.0009253158,0.0014455138,0.00003392239,0.000047283207,0.0009906586,0.0047179293,0.00006815811,0.00069773267,0.049746335],"study_design_scores_gemma":[0.5668279,0.4050604,0.018893171,0.00016589063,0.0027111678,0.000100688885,0.000048281254,0.0015939638,0.0028036123,0.00023267059,0.001525125,0.000037288653],"about_ca_topic_score_codex":0.0007332273,"about_ca_topic_score_gemma":0.0022505908,"teacher_disagreement_score":0.0037254517,"about_ca_system_score_codex":0.0012345855,"about_ca_system_score_gemma":0.001241795,"threshold_uncertainty_score":0.012462854},"labels":[],"label_agreement":null},{"id":"W4376604358","doi":"10.1001/jamaoncol.2023.1175","title":"American Radium Society Appropriate Use Criteria for Radiation Therapy in the Multidisciplinary Management of Thymic Carcinoma","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Thymic carcinoma; Radiation therapy; Delphi method; Consensus conference; General surgery; Medical physics; Surgery; Internal medicine; Thymoma","score_opus":0.1337509627166226,"score_gpt":0.43372906125346355,"score_spread":0.299978098536841,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376604358","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.065915436,0.44055983,0.09861765,0.19000857,0.015916124,0.010350858,0.0048372643,0.00064680167,0.17314743],"genre_scores_gemma":[0.44120237,0.10195523,0.3677655,0.04632396,0.0065453188,0.016664037,0.0072037107,0.00037375477,0.011966151],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9349554,0.031540323,0.02197666,0.0011355428,0.0092974305,0.0010946323],"domain_scores_gemma":[0.9013165,0.041632086,0.016390065,0.0034493387,0.035033207,0.0021788492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044085406,0.0007518367,0.0012056585,0.006233527,0.001909307,0.0025212083,0.0035658926,0.0037372625,0.0035530915],"category_scores_gemma":[0.09364109,0.00042490446,0.0021677362,0.004845357,0.002023295,0.0017682473,0.0033521468,0.0028225926,0.0015821817],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00057634595,0.00023166713,0.06912924,0.020068135,0.00055952964,0.006351683,0.008395635,0.0030976064,0.0058023348,0.026842592,0.29036695,0.56857824],"study_design_scores_gemma":[0.00029167646,0.00050015544,0.07941495,0.06356181,0.0007714059,0.013442009,0.0048137037,0.0047747246,0.0023979784,0.024680104,0.80503637,0.00031505353],"about_ca_topic_score_codex":0.0042962804,"about_ca_topic_score_gemma":0.0068006483,"teacher_disagreement_score":0.044085406,"about_ca_system_score_codex":0.0024775087,"about_ca_system_score_gemma":0.010263887,"threshold_uncertainty_score":0.23314863},"labels":[],"label_agreement":null},{"id":"W4378173491","doi":"10.1001/jamaoncol.2023.0983","title":"Vaccinia (Smallpox) for the Treatment of Ovarian Cancer—Turning an Old Foe Into a Friend?","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Smallpox; Neurology; Psychiatry; Vaccination; Pathology","score_opus":0.042499233787287434,"score_gpt":0.3745586490476901,"score_spread":0.33205941526040267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378173491","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005044068,0.0037858395,0.0005548875,0.9388757,0.025953174,0.00008025605,0.00007595345,0.00009761541,0.02553256],"genre_scores_gemma":[0.062313993,0.010607075,0.0016857703,0.77446556,0.053712398,0.00011281448,0.000100803976,0.000103883984,0.09689777],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99960357,0.00010428227,0.000046658428,0.000047028538,0.0001195463,0.000078934696],"domain_scores_gemma":[0.99933726,0.0003051233,0.000058430287,0.000023968583,0.000087077395,0.00018817186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059457653,0.00039261775,0.00033525837,0.00037034406,0.0017860245,0.0011317106,0.0004978767,0.008845862,0.011323573],"category_scores_gemma":[0.0040129684,0.00023890476,0.00066295045,0.0002803617,0.00095978205,0.0019193955,0.00050167425,0.009520763,0.0049154083],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011915102,0.00014289316,0.0027058106,0.00008591535,0.000016299771,0.023940843,0.00019639343,0.000103292106,0.0008551636,0.003522751,0.94181925,0.026492339],"study_design_scores_gemma":[0.00019509584,0.00032923667,0.0036133737,0.000327863,0.000032898883,0.051164117,0.00058589486,0.0009778348,0.00079814636,0.008161736,0.9337799,0.000034012228],"about_ca_topic_score_codex":0.0026670394,"about_ca_topic_score_gemma":0.0041440763,"teacher_disagreement_score":0.011323573,"about_ca_system_score_codex":0.0014003209,"about_ca_system_score_gemma":0.0009386391,"threshold_uncertainty_score":0.037881136},"labels":[],"label_agreement":null},{"id":"W4379768913","doi":"10.1001/jamaoncol.2023.1374","title":"Changes to Primary End Points in Randomized Clinical Trials on Immune Checkpoint Inhibitors in Urothelial, Renal Cell, and Lung Cancers","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Oncology; Clinical trial; Nivolumab; Immune checkpoint; Internal medicine; Endpoint Determination; Urothelial cancer; Immunotherapy; Cancer; Bladder cancer","score_opus":0.1272674042778694,"score_gpt":0.4600022332855313,"score_spread":0.33273482900766194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379768913","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":"reporting","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":"reporting","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088293786,0.9977343,0.00020967674,0.0002053976,0.00022540578,0.00015392742,0.00032542614,0.000010049415,0.00025288563],"genre_scores_gemma":[0.0347895,0.9609836,0.0011239122,0.0015213393,0.00031599408,0.00056990026,0.00049893116,0.000020767347,0.00017615098],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96930444,0.0144020235,0.010319328,0.0021560185,0.0033673753,0.00045076382],"domain_scores_gemma":[0.8933101,0.09040862,0.01156239,0.0011287624,0.0032162885,0.00037396981],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02547155,0.0013943102,0.009284206,0.004146342,0.00038529557,0.0024841216,0.0012816064,0.0016531597,0.0033234037],"category_scores_gemma":[0.10366087,0.00082566496,0.012666906,0.0045006587,0.0009315423,0.0018135917,0.0015121044,0.0021846094,0.00030092834],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002937244,0.000028175014,0.0014351077,0.8023247,0.07153202,0.000042480482,0.00012555142,0.0003053052,0.000357147,0.00044863822,0.0026325667,0.117831156],"study_design_scores_gemma":[0.004874869,0.0011998228,0.012163979,0.5006042,0.442493,0.00034840664,0.00023021684,0.0002409327,0.00073298946,0.001768233,0.035251748,0.00009157708],"about_ca_topic_score_codex":0.0025294481,"about_ca_topic_score_gemma":0.0072681396,"teacher_disagreement_score":0.9907158,"about_ca_system_score_codex":0.0024167441,"about_ca_system_score_gemma":0.0037453761,"threshold_uncertainty_score":0.13470805},"labels":[],"label_agreement":null},{"id":"W4384120373","doi":"10.1001/jamaoncol.2023.2163","title":"Management of Down Syndrome–Associated Leukemias","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Down syndrome; Myeloid leukemia; Internal medicine; Clinical trial; Leukemia; Population; Pediatrics; Oncology; Myeloid","score_opus":0.09827267579934236,"score_gpt":0.42358201095335213,"score_spread":0.3253093351540098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384120373","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45980787,0.3036222,0.055058457,0.060971595,0.004910909,0.0010636809,0.002247259,0.0010660654,0.11125203],"genre_scores_gemma":[0.890515,0.06384816,0.017090203,0.012266372,0.0022250602,0.00036173497,0.0016838346,0.00010467513,0.0119048655],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99969685,0.00008511821,0.00004930786,0.000036819387,0.00007790354,0.000053967764],"domain_scores_gemma":[0.99961734,0.00008048344,0.000085897766,0.000012706816,0.000065687665,0.0001378681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043896184,0.00034830946,0.00033146408,0.00049047807,0.0003928188,0.00043587128,0.00039604833,0.00054806826,0.002714526],"category_scores_gemma":[0.0018043683,0.000060570484,0.00028034326,0.00022701565,0.00019420871,0.00040250635,0.0007225778,0.0009568581,0.00042735823],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008483528,0.00031764497,0.08717445,0.0015591815,0.00020302345,0.038305767,0.00047055326,0.0012186968,0.014244016,0.005150071,0.0704031,0.7801052],"study_design_scores_gemma":[0.00065358786,0.0019256789,0.1127346,0.0048167137,0.00038132808,0.3035278,0.0011518642,0.0037568475,0.013911689,0.011722103,0.54534507,0.000072734954],"about_ca_topic_score_codex":0.00072005467,"about_ca_topic_score_gemma":0.00084259454,"teacher_disagreement_score":0.002714526,"about_ca_system_score_codex":0.0004695191,"about_ca_system_score_gemma":0.00064473547,"threshold_uncertainty_score":0.009080946},"labels":[],"label_agreement":null},{"id":"W4384818727","doi":"10.1001/jamaoncol.2023.2312","title":"Association of Reducing the Recommended Colorectal Cancer Screening Age With Cancer Incidence, Mortality, and Costs in Canada Using OncoSim","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services; St. Paul's Hospital; Vancouver General Hospital; Canadian Centre for Applied Research in Cancer Control; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Colorectal cancer; Cancer; Incidence (geometry); Cancer incidence; Oncology; Internal medicine","score_opus":0.05215501913569704,"score_gpt":0.35368109143153836,"score_spread":0.30152607229584133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384818727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752818,0.001277505,0.004371922,0.001744719,0.000032526954,0.0002718373,0.006811856,0.00009588207,0.010111951],"genre_scores_gemma":[0.9928954,0.00058236107,0.0030540437,0.00012469408,0.0000046393397,0.000055704077,0.0018042976,0.000010167158,0.0014687908],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992867,0.00015817289,0.000025149686,0.000070858,0.00024633898,0.00021285283],"domain_scores_gemma":[0.9982389,0.0006822576,0.0002181556,0.000053116517,0.0006327537,0.0001748545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013027337,0.00050035754,0.00033697175,0.0008290274,0.00062807783,0.00087364315,0.0008820074,0.00037447794,0.0021726266],"category_scores_gemma":[0.0065192706,0.00021019092,0.0008051083,0.001181323,0.00038331974,0.00031843458,0.00051890133,0.0006439224,0.0001009851],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011818736,0.00034915452,0.36491618,0.0005271299,0.00060116645,0.0002220659,0.00016260306,0.5606843,0.0006018566,0.008096653,0.008311845,0.05434525],"study_design_scores_gemma":[0.00032727365,0.0006640505,0.2829187,0.00023034331,0.0008058456,0.00015930358,0.0006592068,0.7006235,0.0017054366,0.0027686434,0.00906085,0.00007688241],"about_ca_topic_score_codex":0.95712703,"about_ca_topic_score_gemma":0.95925015,"teacher_disagreement_score":0.042872965,"about_ca_system_score_codex":0.03275988,"about_ca_system_score_gemma":0.0350122,"threshold_uncertainty_score":0.23769063},"labels":[],"label_agreement":null},{"id":"W4385294431","doi":"10.1001/jamaoncol.2023.1830","title":"Vigorous Intermittent Lifestyle Physical Activity and Cancer Incidence Among Nonexercising Adults","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Physical Activity and Health","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Medicine; Incidence (geometry); Physical activity; Cancer; Internal medicine; Gerontology; Physical therapy","score_opus":0.03467971875067961,"score_gpt":0.38130180971947303,"score_spread":0.34662209096879343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385294431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99758136,0.0003761182,0.00010113214,0.0000365547,0.0000060432394,0.000013577761,0.0014139861,0.0000056317153,0.00046545165],"genre_scores_gemma":[0.99824655,0.00014816348,0.000095863455,0.0000177415,0.000008561353,0.00001898519,0.0010085581,0.0000021410324,0.00045337374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99971956,0.000055636607,0.000039848543,0.00008549699,0.000058215763,0.0000413793],"domain_scores_gemma":[0.9987954,0.00016936466,0.00063852366,0.00012232174,0.00013449245,0.00013977976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050698034,0.00019216847,0.00020499752,0.0003905292,0.00019619144,0.00039106063,0.0002739044,0.00034145807,0.0017006658],"category_scores_gemma":[0.0021965893,0.0002611161,0.00038413366,0.0006672566,0.00012650038,0.00024298044,0.00031158066,0.00040179575,0.0002905354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012497827,0.000021202493,0.9989324,0.0000106170255,0.00004105517,0.000012053082,0.000021349842,0.000019549274,0.00009415834,0.00000441354,0.000054567732,0.0006637145],"study_design_scores_gemma":[0.0000036998529,0.00004301401,0.99977595,0.0000026163825,0.000015010636,0.000024561008,0.000015899088,0.00004363059,0.000013969733,0.0000037377438,0.000057222667,7.81877e-7],"about_ca_topic_score_codex":0.012642758,"about_ca_topic_score_gemma":0.015355317,"teacher_disagreement_score":0.012642758,"about_ca_system_score_codex":0.00017459577,"about_ca_system_score_gemma":0.0002028227,"threshold_uncertainty_score":0.025138378},"labels":[],"label_agreement":null},{"id":"W4385897829","doi":"10.1001/jamaoncol.2023.2934","title":"Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"National Center for Advancing Translational Sciences; National Institute of Allergy and Infectious Diseases; National Cancer Institute; National Institute on Aging","keywords":"Medicine; Internal medicine; Cancer; Retrospective cohort study; Intensive care unit; Incidence (geometry); Cancer registry; Lung cancer","score_opus":0.0641370124742738,"score_gpt":0.42488484549575817,"score_spread":0.3607478330214844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385897829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99444324,0.002602848,0.000119060795,0.00012754454,0.000017253493,0.000019014387,0.0019463361,0.0000039659917,0.0007206233],"genre_scores_gemma":[0.9977696,0.0006348063,0.00008420767,0.00004615353,0.00002848376,0.000013758197,0.0013483769,0.0000011865505,0.000073506235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99929917,0.00018264596,0.00016059422,0.00013267972,0.00014107946,0.000083809435],"domain_scores_gemma":[0.99600756,0.0005286109,0.0029654126,0.00013642451,0.00015604735,0.00020599233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006006111,0.00014569036,0.00036841838,0.00050188776,0.00018777236,0.00043982515,0.00023159698,0.00024078517,0.0014801457],"category_scores_gemma":[0.0032116678,0.00012640984,0.0004587364,0.0015283717,0.00018166321,0.00035446018,0.0003636892,0.00038315807,0.000094227085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011182703,0.0000114394625,0.9985013,0.000032815282,0.0000804106,0.000028586208,0.000012337623,0.000027524142,0.000039637747,0.0000122297315,0.00008208105,0.0010597657],"study_design_scores_gemma":[0.000013852357,0.00009950203,0.9989473,0.000033686938,0.00006113223,0.00028972945,0.00006297499,0.00011944891,0.000042508444,0.000021343421,0.00030551868,0.0000029228236],"about_ca_topic_score_codex":0.0020811795,"about_ca_topic_score_gemma":0.004502689,"teacher_disagreement_score":0.0020811795,"about_ca_system_score_codex":0.00025111422,"about_ca_system_score_gemma":0.00038375353,"threshold_uncertainty_score":0.0049515367},"labels":[],"label_agreement":null},{"id":"W4386501692","doi":"10.1001/jamaoncol.2023.2960","title":"The Global, Regional, and National Burden of Adult Lip, Oral, and Pharyngeal Cancer in 204 Countries and Territories","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":167,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"Division of Mathematical Sciences; National Heart, Lung, and Blood Institute; Endocrinology and Metabolism Research Institute, Tehran University of Medical Sciences; Leibniz-Gemeinschaft; National Health and Medical Research Council; Medical Research Council; University of Florida Health; Samsung; King Saud University; Universitätsklinikum Heidelberg; Monash University Malaysia; Fakultet Medicinskih Nauka, Univerziteta U Kragujevcu; Institute for Advanced Studies in Basic Sciences; University of Colombo; Xiamen University; National Institute for Medical Research Development; Yasuj University of Medical Sciences; University of Washington; Wuhan University; Sigrid Juséliuksen Säätiö; Guilan University of Medical Sciences; Masarykova Univerzita; Shahid Beheshti University of Medical Sciences; Hacettepe Üniversitesi; Birjand University of Medical Sciences; Zhejiang University; Kerman University of Medical Sciences; Rajarata University of Sri Lanka; Ain Shams University; Shiraz University of Medical Sciences; College of Medicine, Korea University; World Health Organization; Mazandaran University of Medical Sciences; King Abdulaziz University; Isfahan University of Medical Sciences; Pasteur Institute of Iran; Universitatea din București; Alexandria University; Università degli Studi di Padova; Korea University; Oulun Yliopisto; Pohang University of Science and Technology; University of Gondar; Massachusetts General Hospital; Lékařská fakulta, Masarykova univerzita; Radboud Universiteit; Imperial College London; Shiraz University; National Natural Science Foundation of China; Monash University; Karolinska Institutet; National Institute for Health and Care Research; University of Queensland; Amity University; Mashhad University of Medical Sciences; Public Health England; Royal College of Surgeons in Ireland; University of Leeds; Public Health Foundation of India; St. Jude Children's Research Hospital; Indian Council of Medical Research; National University of Singapore; University of Warwick; Coventry University; European Commission; National Human Genome Research Institute; Macquarie University; JSS Academy of Higher Education and Research; Dire Dawa University; Politechnika Gdańska; University of Exeter; Moderna; Kasturba Medical College, Manipal; Kermanshah University of Medical Sciences; Vanderbilt University; U.S. Department of Veterans Affairs; Rafsanjan University of Medical Sciences; Louisiana State University; Seres Therapeutics; Wellcome Trust; Johns Hopkins University; Amarin Corporation; Iran University of Medical Sciences; Bill and Melinda Gates Foundation; Instituto de Salud Carlos III; Università degli Studi di Milano; Saveetha Dental College; National Defense Medical College; Intuitive Surgical; Sveučilište u Zagrebu; Social Science Research Council; National Cancer Institute; University of South Carolina; Bournemouth University; The Wellcome Trust DBT India Alliance; Flinders University; Universidade Federal do Rio Grande do Sul; Harvard University; Università di Catania; Golestan University of Medical Sciences; Tehran University of Medical Sciences and Health Services; Anglia Ruskin University; Tehran Heart Center; National Institutes of Health; University of Veterinary and Animal Sciences; Florida Department of Health; King Abdullah University of Science and Technology; Department of Biotechnology, Ministry of Science and Technology, India; Jordan University of Science and Technology; McMaster University; School of Medicine, University of Alabama at Birmingham; Plastic Surgery Foundation","keywords":"Medicine; Cancer; MEDLINE; Family medicine; Internal medicine","score_opus":0.07646881709137004,"score_gpt":0.4355770112345375,"score_spread":0.35910819414316747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386501692","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021380082,0.9264588,0.0015660813,0.02179299,0.00068781455,0.0001103249,0.013886692,0.00007200192,0.014045287],"genre_scores_gemma":[0.15899192,0.8274476,0.0022681684,0.0029884782,0.00065677805,0.00019055509,0.0054138815,0.000022327013,0.0020204103],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979724,0.0008567357,0.00024411634,0.00015783746,0.0005921387,0.00017672914],"domain_scores_gemma":[0.9979169,0.0006089601,0.0006649793,0.000045674537,0.000636529,0.00012697309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024656642,0.00047009005,0.0008136034,0.0024261016,0.00035279407,0.0020636665,0.00053200615,0.00070906506,0.0056226486],"category_scores_gemma":[0.006146175,0.00029263395,0.0022868097,0.004751063,0.0005837612,0.0011201623,0.0014084559,0.0010955319,0.00079294597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037825928,0.00006785506,0.15499415,0.08263058,0.009865399,0.00056229986,0.00064003514,0.0048156427,0.0013570418,0.008222896,0.12227539,0.61419046],"study_design_scores_gemma":[0.00020030088,0.00043052854,0.37527534,0.114492916,0.014566645,0.0028664768,0.005106021,0.0021849761,0.0013261053,0.007740919,0.47565112,0.00015855367],"about_ca_topic_score_codex":0.0553304,"about_ca_topic_score_gemma":0.07149451,"teacher_disagreement_score":0.0553304,"about_ca_system_score_codex":0.0024165222,"about_ca_system_score_gemma":0.008429542,"threshold_uncertainty_score":0.1100167},"labels":[],"label_agreement":null},{"id":"W4386725777","doi":"10.1001/jamaoncol.2023.3495","title":"Individualized Stereotactic Ablative Radiotherapy for Lung Tumors","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; SABR volatility model; Lung cancer; Radiation therapy; Radiosurgery; Ablative case; Lung; Internal medicine; Oncology; Nuclear medicine","score_opus":0.033523061032147305,"score_gpt":0.38652899438591465,"score_spread":0.35300593335376734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386725777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97894865,0.012483201,0.0027584254,0.00025921932,0.0001558717,0.0023441878,0.00040030843,0.00011835238,0.0025317601],"genre_scores_gemma":[0.9918533,0.0024349955,0.0025309047,0.00026067978,0.00017683869,0.001797628,0.0003631572,0.000010947818,0.0005714251],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99936765,0.00028483046,0.000058337966,0.000117619464,0.000107877604,0.00006365367],"domain_scores_gemma":[0.99953663,0.000110661604,0.00018869177,0.00006069784,0.000022476803,0.000080760714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011450693,0.0004771572,0.0011322086,0.00037969067,0.00024361977,0.00029773553,0.0004686123,0.00035218368,0.0018019772],"category_scores_gemma":[0.00093307457,0.00015887523,0.000797083,0.00048183458,0.00033961618,0.0003492466,0.00024715488,0.0006871998,0.00019857954],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3279501,0.013877208,0.040596873,0.00586632,0.003018381,0.00026926099,0.00024803475,0.009755103,0.03450566,0.00094033225,0.0036473926,0.55932534],"study_design_scores_gemma":[0.3390665,0.4385926,0.17237705,0.0005739951,0.0042654495,0.001323243,0.00013386853,0.005968574,0.020818809,0.0018073999,0.014979915,0.00009256473],"about_ca_topic_score_codex":0.00051131885,"about_ca_topic_score_gemma":0.001517588,"teacher_disagreement_score":0.0018019772,"about_ca_system_score_codex":0.00047136325,"about_ca_system_score_gemma":0.0012754659,"threshold_uncertainty_score":0.0060557723},"labels":[],"label_agreement":null},{"id":"W4386909784","doi":"10.1001/jamaoncol.2023.3651","title":"Risk of Death Due to Pregnancy-Associated Cancers—More Questions Than Answers—Reply","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Psychiatry","score_opus":0.02973289275205126,"score_gpt":0.3361973467334496,"score_spread":0.3064644539813983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909784","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019634487,0.00036811008,0.00009580479,0.9811016,0.009896104,0.000024350658,0.00038854097,0.00006370307,0.0060982956],"genre_scores_gemma":[0.022320991,0.001130793,0.00044735655,0.9292373,0.024082847,0.00011040648,0.00036866867,0.000051851202,0.022249816],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99902165,0.00028140572,0.00018339523,0.00012227338,0.0002075595,0.00018362903],"domain_scores_gemma":[0.9955734,0.0023821278,0.00034215586,0.00011887167,0.0009930427,0.0005904497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012545412,0.0005864386,0.000536132,0.0006607396,0.0018661229,0.0012206377,0.0007020851,0.016485099,0.023910554],"category_scores_gemma":[0.014324771,0.00042322985,0.00088527706,0.0006340487,0.0007381081,0.0016904362,0.0006203138,0.007848489,0.011325869],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006641445,0.000042628497,0.0056136693,0.000043661963,0.000011662699,0.0010606045,0.0001464802,0.00007155698,0.00016022295,0.00051307975,0.9818325,0.010437472],"study_design_scores_gemma":[0.00025457374,0.00021635972,0.03305375,0.0007618503,0.0000759342,0.009077164,0.0026888964,0.0013417826,0.000762775,0.0070680585,0.94448227,0.00021664384],"about_ca_topic_score_codex":0.0075327395,"about_ca_topic_score_gemma":0.0053940406,"teacher_disagreement_score":0.023910554,"about_ca_system_score_codex":0.0018561576,"about_ca_system_score_gemma":0.0016794901,"threshold_uncertainty_score":0.07998878},"labels":[],"label_agreement":null},{"id":"W4386909796","doi":"10.1001/jamaoncol.2023.3352","title":"Rare Genetic Drivers of Lethal Prostate Cancer","year":2023,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada's Michael Smith Genome Sciences Centre; University of British Columbia","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; MEDLINE; Neurology; Psychiatry","score_opus":0.042841644843669154,"score_gpt":0.36716397033839254,"score_spread":0.3243223254947234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386909796","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0677433,0.0072502815,0.002175854,0.6875521,0.010005721,0.00008730066,0.0015078601,0.00052459864,0.22315301],"genre_scores_gemma":[0.6947965,0.010379869,0.003019506,0.18375185,0.04085473,0.00009783465,0.0008932093,0.00024479677,0.06596169],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995653,0.00009748201,0.00003325365,0.00006246332,0.00012429128,0.00011717704],"domain_scores_gemma":[0.99893636,0.0005159811,0.00011372644,0.000060011294,0.0001193392,0.00025456285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032389132,0.00029249978,0.00027803518,0.00074299873,0.0015693778,0.0008849166,0.00030515945,0.0032069173,0.017062949],"category_scores_gemma":[0.0037827292,0.00023458451,0.0003672048,0.0005936018,0.00058184424,0.000822792,0.00046734608,0.0035474924,0.0032219863],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108846805,0.000105279534,0.054684453,0.00012633351,0.00004760092,0.102405116,0.00042422354,0.00068701967,0.0014668669,0.01109642,0.7788745,0.049973313],"study_design_scores_gemma":[0.000103085695,0.00014985842,0.0699969,0.00063832174,0.00010410913,0.5192926,0.0021002835,0.003357423,0.0013821202,0.04644713,0.35632825,0.00009995125],"about_ca_topic_score_codex":0.006338795,"about_ca_topic_score_gemma":0.012503987,"teacher_disagreement_score":0.017062949,"about_ca_system_score_codex":0.00085925916,"about_ca_system_score_gemma":0.0010470125,"threshold_uncertainty_score":0.057081282},"labels":[],"label_agreement":null},{"id":"W4387115048","doi":"10.1001/jamaoncol.2023.3867","title":"Anti-TIGIT Antibody Tiragolumab Alone or With Atezolizumab in Patients With Advanced Solid Tumors","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); Princess Margaret Cancer Centre","funders":"Daiichi Sankyo Europe; National Center for Advancing Translational Sciences; National Cancer Institute; EMD Serono; Genentech; European Society for Medical Oncology; Servier; Yonsei University; MacroGenics; LG Chem; Regeneron Pharmaceuticals; BeiGene; F. Hoffmann-La Roche; Handok; Gilead Sciences; Yuhan; Eli Lilly and Company; AstraZeneca; Celgene; TG Therapeutics; Pfizer","keywords":"Medicine; Atezolizumab; Internal medicine; TIGIT; Tolerability; Oncology; Clinical endpoint; Clinical trial; Phases of clinical research; Antibody; Adverse effect; Immunology; Pembrolizumab; Immunotherapy; Cancer","score_opus":0.012491511114451901,"score_gpt":0.3158602043763073,"score_spread":0.3033686932618554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387115048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179274,0.0061025694,0.0002411372,0.00023095784,0.000073196614,0.000321938,0.00023819631,0.000023268793,0.00097594847],"genre_scores_gemma":[0.9969382,0.0014184064,0.0004079793,0.00026210694,0.0000900345,0.00022984932,0.00029838586,0.0000036712481,0.00035125198],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99958843,0.0002150453,0.000036635443,0.000054745862,0.000048724032,0.000056507015],"domain_scores_gemma":[0.9992879,0.00021651844,0.0002410242,0.000041853542,0.00004368463,0.00016903707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015451837,0.00044730437,0.0014617522,0.0002809201,0.00017864021,0.00050136924,0.00033943896,0.0005428536,0.0011435993],"category_scores_gemma":[0.0013234257,0.00024979157,0.0009996883,0.00036407585,0.00040399883,0.00046926987,0.00017362971,0.001194036,0.00023708084],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6957657,0.013920508,0.0569133,0.0021346405,0.002440773,0.0004374327,0.00019714041,0.0024053557,0.02450963,0.00021819603,0.003034393,0.19802295],"study_design_scores_gemma":[0.3589756,0.5064206,0.1176562,0.00018946928,0.0020840522,0.00083017565,0.00010214036,0.003079568,0.005055963,0.000345399,0.005224141,0.000036800175],"about_ca_topic_score_codex":0.00039100175,"about_ca_topic_score_gemma":0.0012989511,"teacher_disagreement_score":0.0015451837,"about_ca_system_score_codex":0.00050124666,"about_ca_system_score_gemma":0.00081522774,"threshold_uncertainty_score":0.008171856},"labels":[],"label_agreement":null},{"id":"W4387116241","doi":"10.1001/jamaoncol.2023.3809","title":"Radiotherapy Plus Cisplatin With or Without Lapatinib for Non–Human Papillomavirus Head and Neck Carcinoma","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Lapatinib; Internal medicine; Oncology; Cetuximab; Chemoradiotherapy; Progression-free survival; Radiation therapy; Clinical endpoint; Placebo; Head and neck cancer; Cancer; Randomized controlled trial; Breast cancer; Chemotherapy; Trastuzumab; Pathology","score_opus":0.05842564670006368,"score_gpt":0.3941057429627871,"score_spread":0.33568009626272344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387116241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886891,0.0038428498,0.0004943666,0.0004111215,0.00038773022,0.00410609,0.00045514508,0.00008525665,0.001528257],"genre_scores_gemma":[0.9911417,0.0018882329,0.00096385594,0.00043424964,0.0002884305,0.0032615035,0.00037433245,0.000010786122,0.001636915],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99937785,0.0003298498,0.00005451143,0.00010638725,0.00004322935,0.00008809104],"domain_scores_gemma":[0.9994048,0.00013414271,0.00014505349,0.000041345764,0.000028909835,0.00024564925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001357631,0.0011322465,0.0021072058,0.000379922,0.0003643538,0.00067044416,0.00079464976,0.0010850772,0.0055842767],"category_scores_gemma":[0.0012850423,0.0006709871,0.0010820389,0.00042142262,0.0009462748,0.0010104014,0.00043263787,0.0020489937,0.00067647884],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9311828,0.017230926,0.0020310744,0.00096188294,0.00076456106,0.000045462006,0.000053655476,0.0007416885,0.008819889,0.00012481581,0.0008645618,0.037178654],"study_design_scores_gemma":[0.74323434,0.25062242,0.0028344002,0.000039491995,0.00037905868,0.0000594139,0.000017705863,0.00041494024,0.0013593078,0.00008842747,0.00093731517,0.0000131976685],"about_ca_topic_score_codex":0.00066404976,"about_ca_topic_score_gemma":0.0022873767,"teacher_disagreement_score":0.0055842767,"about_ca_system_score_codex":0.0005757007,"about_ca_system_score_gemma":0.0014924302,"threshold_uncertainty_score":0.018681228},"labels":[],"label_agreement":null},{"id":"W4387765725","doi":"10.1001/jamaoncol.2023.4273","title":"Cancers Attributable to Infections in the US in 2017","year":2023,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Viral-associated cancers and disorders","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Institute for Clinical Evaluative Sciences; Impact; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Cancer; Merkel cell polyomavirus; Population; Incidence (geometry); Cervical cancer; Internal medicine; Helicobacter pylori; Attributable risk; Hepatitis C; Hepatitis B; Immunology; Hepatitis C virus; Skin cancer; Epidemiology; Virus; Merkel cell carcinoma; Environmental health; Carcinoma","score_opus":0.0953750256596236,"score_gpt":0.43034355871528446,"score_spread":0.3349685330556609,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387765725","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011160691,0.9668493,0.0003103832,0.0011434702,0.0004266502,0.00024042197,0.017917553,0.000033582088,0.0019179429],"genre_scores_gemma":[0.17927665,0.8051292,0.0010908507,0.0016649792,0.00065491244,0.00082258286,0.010716611,0.00002761246,0.0006166839],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.993869,0.0018214657,0.0021072323,0.00049837155,0.0014920699,0.00021184607],"domain_scores_gemma":[0.99296784,0.002830608,0.002826213,0.00012632653,0.0011246889,0.00012438995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005779175,0.0011014799,0.0026314375,0.012514843,0.0002747196,0.001469201,0.00081916444,0.00088949373,0.002851859],"category_scores_gemma":[0.016749753,0.00072889007,0.007936098,0.014385973,0.00048554468,0.0013769062,0.0014114099,0.0010072873,0.00043432426],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027509993,0.000051241364,0.1601593,0.5547144,0.08858189,0.00046178757,0.00045385322,0.0017844471,0.0006017673,0.0015195693,0.026714519,0.16220622],"study_design_scores_gemma":[0.0015465193,0.0005366958,0.3373769,0.31889865,0.24150644,0.0021250166,0.0012824568,0.000929586,0.0012422005,0.0029242618,0.09148853,0.00014268728],"about_ca_topic_score_codex":0.0229316,"about_ca_topic_score_gemma":0.033426665,"teacher_disagreement_score":0.0229316,"about_ca_system_score_codex":0.0036386359,"about_ca_system_score_gemma":0.0047050486,"threshold_uncertainty_score":0.045596242},"labels":[],"label_agreement":null},{"id":"W4387949767","doi":"10.1001/jamaoncol.2023.4447","title":"Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"National Cancer Institute","keywords":"Medicine; Lung cancer screening; Ethnic group; Population; Cohort; Demography; Incidence (geometry); Cancer screening; Lung cancer; Cancer; Internal medicine; Gerontology; Environmental health","score_opus":0.036077618688851634,"score_gpt":0.3848904457327718,"score_spread":0.3488128270439202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387949767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98056453,0.0012867824,0.009373572,0.001945625,0.00013546417,0.00021429262,0.0033242449,0.00014717178,0.0030082888],"genre_scores_gemma":[0.99390066,0.00016111134,0.0032480627,0.000272956,0.000030558153,0.00009378336,0.0018307242,0.000016474512,0.00044571486],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714786,0.0019899874,0.00010655353,0.00033163466,0.00029278913,0.00013119364],"domain_scores_gemma":[0.99670154,0.001807026,0.00048813503,0.00037933898,0.0004695419,0.00015437331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008636973,0.00051616057,0.00056802173,0.0005957388,0.00034237243,0.0007828738,0.00078182225,0.00042344615,0.0018918603],"category_scores_gemma":[0.014850145,0.0002087718,0.0015639255,0.0006646728,0.00020211536,0.00046477935,0.00092658604,0.0007953164,0.00021140589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018988614,0.00081622833,0.93425494,0.0001233948,0.0015629323,0.00006229808,0.00015302114,0.025953477,0.00017493237,0.0016858568,0.0064455923,0.026868433],"study_design_scores_gemma":[0.0009538985,0.0018181137,0.4718609,0.00032327027,0.0021977264,0.00018782442,0.00032032433,0.50540847,0.00073178747,0.008332251,0.0077860793,0.00007930871],"about_ca_topic_score_codex":0.044026785,"about_ca_topic_score_gemma":0.028688317,"teacher_disagreement_score":0.044026785,"about_ca_system_score_codex":0.0010559261,"about_ca_system_score_gemma":0.0027724837,"threshold_uncertainty_score":0.087541044},"labels":[],"label_agreement":null},{"id":"W4388220040","doi":"10.1001/jamaoncol.2023.4817","title":"Derailing Carcinogens—Oncologists and the Ohio Train Derailment","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Healthcare and Environmental Waste Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Derailment; MEDLINE; Train","score_opus":0.04589094491178461,"score_gpt":0.33864314463902667,"score_spread":0.2927521997272421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388220040","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.007273719,0.002426168,0.00034391545,0.9337736,0.015409107,0.0000119969045,0.000040569525,0.00003464487,0.04068635],"genre_scores_gemma":[0.1412443,0.0057148496,0.0012908424,0.7141275,0.016578833,0.000055669996,0.00009226567,0.00008820751,0.12080756],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971968,0.000782112,0.000109860805,0.000250306,0.0006042091,0.0010567353],"domain_scores_gemma":[0.9950235,0.0009743468,0.00025924042,0.00011948208,0.0006708831,0.0029525151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031632609,0.00032722784,0.00023312584,0.00038159903,0.0093979025,0.0061734365,0.0010301317,0.011928519,0.024282603],"category_scores_gemma":[0.005477913,0.00033302375,0.0006380113,0.00027795805,0.0032083094,0.003474646,0.004342347,0.010568794,0.0023660925],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005244088,0.00024648674,0.009707751,0.00008993134,0.000020037538,0.000869984,0.0019066548,0.00023398962,0.0007245442,0.03333862,0.90376896,0.04904061],"study_design_scores_gemma":[0.00001756999,0.000101360005,0.0033727966,0.00013190141,0.0000136816825,0.00030227136,0.0052643465,0.0001716962,0.00028648952,0.004030166,0.9862752,0.000032591397],"about_ca_topic_score_codex":0.024013812,"about_ca_topic_score_gemma":0.07890029,"teacher_disagreement_score":0.024282603,"about_ca_system_score_codex":0.004066625,"about_ca_system_score_gemma":0.013808229,"threshold_uncertainty_score":0.08123338},"labels":[],"label_agreement":null},{"id":"W4389728363","doi":"10.1001/jamaoncol.2023.5410","title":"Pembrolizumab or Placebo Plus Chemotherapy With or Without Bevacizumab for Persistent, Recurrent, or Metastatic Cervical Cancer","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Carboplatin; Bevacizumab; Internal medicine; Oncology; Pembrolizumab; Population; Chemoradiotherapy; Chemotherapy; Pemetrexed; Response Evaluation Criteria in Solid Tumors; Cancer; Surgery; Cisplatin; Phases of clinical research; Immunotherapy","score_opus":0.09245552719655493,"score_gpt":0.4002722129984446,"score_spread":0.3078166858018897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389728363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9208143,0.056499857,0.0018046185,0.0011704979,0.0011105492,0.008629806,0.0029038384,0.00024240791,0.0068241046],"genre_scores_gemma":[0.9868053,0.005958062,0.00086924486,0.00066343235,0.00025118957,0.0030689589,0.00067122903,0.000012178208,0.00170042],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9989818,0.00052438973,0.00013434602,0.00015500205,0.00008851786,0.000115984716],"domain_scores_gemma":[0.99941695,0.00020542735,0.00020900571,0.000055189772,0.000032243894,0.000081190345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020355298,0.0009913344,0.002277285,0.0005723393,0.0002689758,0.00088792416,0.0006421678,0.0010152758,0.0062758736],"category_scores_gemma":[0.0025182972,0.00040876845,0.0027237507,0.00052506034,0.000559895,0.00082779274,0.00036476197,0.0014581201,0.00053127314],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.949707,0.0019589786,0.0010112864,0.0028364516,0.005341138,0.000041228737,0.000028012144,0.00036578736,0.0030237308,0.00013472527,0.00091561687,0.0346362],"study_design_scores_gemma":[0.8884962,0.08930488,0.006526736,0.00035223606,0.009055951,0.00009036556,0.000041403397,0.0006093434,0.0020317708,0.00047118939,0.0029974391,0.000022515444],"about_ca_topic_score_codex":0.00072834396,"about_ca_topic_score_gemma":0.0025070666,"teacher_disagreement_score":0.0062758736,"about_ca_system_score_codex":0.00070029555,"about_ca_system_score_gemma":0.00089048926,"threshold_uncertainty_score":0.020994842},"labels":[],"label_agreement":null},{"id":"W4390061675","doi":"10.1001/jamaoncol.2023.6060","title":"Stereotactic Radiosurgery vs Conventional Radiotherapy for Spine Metastases","year":2023,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Radiosurgery; Family medicine; Neurology; MEDLINE; Internal medicine; Psychiatry; Radiation therapy","score_opus":0.04776169589400364,"score_gpt":0.3674210172704063,"score_spread":0.3196593213764027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390061675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82837874,0.06303654,0.002944579,0.008519732,0.0062102955,0.00070810324,0.006121397,0.0005089317,0.083571576],"genre_scores_gemma":[0.9741455,0.010095754,0.0012135737,0.0018214232,0.0016067061,0.00021492301,0.0012479933,0.00012864127,0.009525581],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99964666,0.00009266748,0.000039574792,0.00005751468,0.000092364586,0.00007127791],"domain_scores_gemma":[0.9993339,0.00033664657,0.00011707452,0.000035275967,0.000031975735,0.00014514713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902371,0.00031444908,0.0007647663,0.0005113559,0.00022363034,0.00047934544,0.0005231089,0.00050744065,0.041948322],"category_scores_gemma":[0.002017773,0.00013951641,0.002086827,0.00042797113,0.0002795756,0.0008978379,0.0003486182,0.0009517274,0.0034664448],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.202375,0.0024506624,0.01683898,0.0028229961,0.0034399612,0.0005085356,0.00024321745,0.004087553,0.004713738,0.0016776627,0.05456902,0.70627266],"study_design_scores_gemma":[0.09615492,0.21675378,0.501001,0.005303487,0.015287565,0.010632891,0.0020088572,0.016806161,0.01142884,0.017058996,0.10716796,0.00039558514],"about_ca_topic_score_codex":0.0022890584,"about_ca_topic_score_gemma":0.008321864,"teacher_disagreement_score":0.041948322,"about_ca_system_score_codex":0.0007023544,"about_ca_system_score_gemma":0.000567452,"threshold_uncertainty_score":0.14033109},"labels":[],"label_agreement":null},{"id":"W4391655278","doi":"10.1001/jamaoncol.2023.6698","title":"Hyperbaric Oxygen Therapy for Management of Late Radiation Toxicity—A Honey of a Trial?","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.03683930611037208,"score_gpt":0.35554456457100986,"score_spread":0.3187052584606378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391655278","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10188262,0.4936906,0.004221929,0.28485006,0.046975955,0.0039285435,0.0024116724,0.0004080007,0.06163067],"genre_scores_gemma":[0.40130046,0.260722,0.014263458,0.23708491,0.038936827,0.006027557,0.0023753792,0.00041796864,0.038871452],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99780864,0.0014712862,0.00024426793,0.00009706767,0.00024053731,0.00013814437],"domain_scores_gemma":[0.99501365,0.0021778625,0.00081883214,0.0003969368,0.0004695709,0.0011231537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068359394,0.0005957979,0.0018980734,0.0005807357,0.0007771534,0.002896625,0.0009005947,0.0032877577,0.017673505],"category_scores_gemma":[0.009659929,0.00025270059,0.0030073468,0.000660259,0.0009972664,0.0038957405,0.00060861255,0.0053186417,0.0021214504],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07719993,0.0042397506,0.003645571,0.009567997,0.0030831564,0.0004802315,0.0005319249,0.00067702704,0.0023010853,0.00983721,0.16241431,0.72602177],"study_design_scores_gemma":[0.25670093,0.078852795,0.013360459,0.035233177,0.0049237297,0.0015037878,0.0015833667,0.0026893727,0.0016147051,0.0243618,0.5789302,0.0002457232],"about_ca_topic_score_codex":0.00070698716,"about_ca_topic_score_gemma":0.0026239005,"teacher_disagreement_score":0.017673505,"about_ca_system_score_codex":0.0006951678,"about_ca_system_score_gemma":0.0014181122,"threshold_uncertainty_score":0.059123695},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4392284556","doi":"10.1001/jamaoncol.2023.6937","title":"Bilateral Oophorectomy and All-Cause Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Public Health Ontario; McMaster University; Women's College Hospital","funders":"National Cancer Institute","keywords":"Medicine; Oophorectomy; Gynecology; Sequence (biology); BRCA2 Protein; MEDLINE; Oncology; Hysterectomy; Surgery; Mutation; Genetics; Germline mutation","score_opus":0.026749539504267124,"score_gpt":0.31194481746054104,"score_spread":0.2851952779562739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392284556","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99905187,0.00026417346,0.000052465086,0.00005849321,0.000008319823,0.0000050483886,0.00042566142,0.000002590026,0.00013137722],"genre_scores_gemma":[0.9988733,0.00015960576,0.00009265895,0.000034583,0.000014633256,0.0000094844845,0.0005685733,0.0000017541287,0.00024542917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99980325,0.00005514159,0.000013171592,0.000056589324,0.000033801796,0.000037929207],"domain_scores_gemma":[0.9991523,0.0001461219,0.00039463077,0.00008051799,0.000060009614,0.00016638161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066737045,0.0002028788,0.00021941318,0.0003565992,0.00025315132,0.0003118309,0.00024472462,0.00039781316,0.0012197852],"category_scores_gemma":[0.002083152,0.00027847398,0.0005325246,0.0005405961,0.00015343653,0.00027707015,0.00026699566,0.00044557042,0.000112965194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036246792,0.000029440682,0.99856204,0.0000063682937,0.000042751093,0.000024542933,0.000018125082,0.000027114113,0.00011964689,0.0000065810677,0.00008929624,0.0007117094],"study_design_scores_gemma":[0.00003121201,0.00014792121,0.9992124,0.0000066261828,0.000053519896,0.00010790159,0.000042353753,0.0002172245,0.00003527208,0.000016465985,0.0001269414,0.000002147226],"about_ca_topic_score_codex":0.01019079,"about_ca_topic_score_gemma":0.014772668,"teacher_disagreement_score":0.01019079,"about_ca_system_score_codex":0.00026437745,"about_ca_system_score_gemma":0.00043906504,"threshold_uncertainty_score":0.020262957},"labels":[],"label_agreement":null},{"id":"W4392548257","doi":"10.1001/jamaoncol.2023.7269","title":"Stereotactic Radiation Therapy in Early Non–Small Cell Lung Cancer and Interstitial Lung Disease","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Western University; Health Sciences Centre; Sunnybrook Health Science Centre; University of Alberta; Princess Margaret Cancer Centre; Centre Hospitalier de l’Université de Montréal; University of Toronto; London Health Sciences Centre","funders":"","keywords":"Medicine; SABR volatility model; Lung cancer; Interstitial lung disease; Radiation therapy; Internal medicine; Population; Clinical endpoint; Surgery; Lung; Randomized controlled trial","score_opus":0.013995637729194085,"score_gpt":0.3136319455670084,"score_spread":0.2996363078378143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392548257","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99560106,0.0027880264,0.00019313539,0.00009546818,0.000020547579,0.00019356317,0.00029070882,0.0000035413912,0.00081393914],"genre_scores_gemma":[0.9976376,0.0011010556,0.00023171355,0.00013227217,0.00006639375,0.000107720334,0.00040932867,0.0000013116636,0.00031262796],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992041,0.00031196623,0.00008768116,0.00008073131,0.00019523986,0.00012030719],"domain_scores_gemma":[0.9989882,0.00024405739,0.00050570833,0.0000497536,0.000062616986,0.00014972263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015264694,0.00024426496,0.0006569608,0.00042347945,0.00045424295,0.00048547873,0.00040192355,0.00044749628,0.0013058337],"category_scores_gemma":[0.001879115,0.00019593381,0.0007680422,0.0008161791,0.00033776154,0.00032085116,0.00037581887,0.00033724346,0.00019550312],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00523032,0.00057670363,0.96905154,0.00041093523,0.00022552187,0.0005939984,0.00010666338,0.00026494224,0.0014367253,0.00009544189,0.00031762818,0.02168956],"study_design_scores_gemma":[0.0007664933,0.009247038,0.98427075,0.00009465619,0.00025094088,0.0026834744,0.00010827399,0.00033692142,0.0005246953,0.00013234063,0.0015759628,0.000008514233],"about_ca_topic_score_codex":0.002136771,"about_ca_topic_score_gemma":0.007316466,"teacher_disagreement_score":0.002136771,"about_ca_system_score_codex":0.00067508646,"about_ca_system_score_gemma":0.0015357038,"threshold_uncertainty_score":0.008072853},"labels":[],"label_agreement":null},{"id":"W4392800293","doi":"10.1001/jamaoncol.2023.7291","title":"Noninferiority of Hypofractionated vs Conventional Postprostatectomy Radiotherapy for Genitourinary and Gastrointestinal Symptoms","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital de l'Enfant-Jésus","funders":"National Cancer Institute","keywords":"Medicine; Prostatectomy; Prostate cancer; Randomized controlled trial; Genitourinary system; Radiation therapy; Salvage therapy; Urology; Adverse effect; Prostate-specific antigen; Internal medicine; Surgery; Cancer; Chemotherapy","score_opus":0.018124961319206986,"score_gpt":0.3160372760175603,"score_spread":0.29791231469835333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392800293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912158,0.005273427,0.00034369354,0.0005153447,0.0002845317,0.0006709613,0.00021312838,0.000031256088,0.0014517995],"genre_scores_gemma":[0.99698347,0.0007700417,0.00035337076,0.00039201236,0.00022122226,0.00047383446,0.00014328698,0.000005764868,0.0006570533],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9987184,0.0007887179,0.00009361211,0.00016066522,0.00010786285,0.0001308236],"domain_scores_gemma":[0.9972959,0.0012287642,0.0007009291,0.00017070028,0.00009998412,0.0005037195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027592422,0.0006170604,0.0014618845,0.0002869405,0.00027299116,0.00070389063,0.0007816673,0.0012399341,0.005334353],"category_scores_gemma":[0.0032118966,0.0002989726,0.0018846267,0.00029220796,0.0007848682,0.00088916364,0.0003151306,0.0022093125,0.0003696141],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92839605,0.009145679,0.0049471213,0.00074083393,0.0021363066,0.000022865755,0.00006051982,0.0008895842,0.0022597811,0.00014481126,0.00053404376,0.050722484],"study_design_scores_gemma":[0.4382179,0.5240917,0.029321708,0.0001828131,0.0024318022,0.00008371415,0.000073912146,0.0015668353,0.0016340679,0.0005488061,0.0018173112,0.00002938469],"about_ca_topic_score_codex":0.00042344048,"about_ca_topic_score_gemma":0.0016374391,"teacher_disagreement_score":0.005334353,"about_ca_system_score_codex":0.000557087,"about_ca_system_score_gemma":0.0009453493,"threshold_uncertainty_score":0.017845154},"labels":[],"label_agreement":null},{"id":"W4393037627","doi":"10.1001/jamaoncol.2024.0057","title":"Neoadjuvant Chemoimmunotherapy for NSCLC","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":205,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"University of Texas MD Anderson Cancer Center; Eisai; Regeneron Pharmaceuticals; Amgen; Johns Hopkins University; AstraZeneca","keywords":"Medicine; Chemoimmunotherapy; Neoadjuvant therapy; Oncology; Internal medicine; Chemotherapy; Cancer; Cyclophosphamide; Breast cancer","score_opus":0.07003444763824695,"score_gpt":0.45243535753577946,"score_spread":0.3824009098975325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393037627","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053684586,0.9925856,0.00022719032,0.00054594333,0.0003117962,0.0001317588,0.00022375981,0.000012229815,0.0005932843],"genre_scores_gemma":[0.26088777,0.730229,0.0018600257,0.0034505054,0.0014740223,0.0007187206,0.00078421994,0.000023461722,0.00057224976],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942306,0.0036325098,0.0011230413,0.00043848975,0.00047824933,0.00009711342],"domain_scores_gemma":[0.9906425,0.0067033763,0.0020068602,0.0002186901,0.00028890587,0.00013972267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061205616,0.00095520983,0.004987227,0.0013353041,0.00030227145,0.0014800049,0.0007674555,0.0011409584,0.0036297177],"category_scores_gemma":[0.016662132,0.00046150445,0.010074672,0.0015600518,0.00046729797,0.00085134007,0.00049057696,0.0018152826,0.0002674387],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024139702,0.00029329836,0.018202467,0.38822964,0.31480655,0.00021274148,0.00012717606,0.0034027637,0.0010077234,0.0010588897,0.0072713066,0.24124768],"study_design_scores_gemma":[0.027712066,0.008417287,0.04520815,0.16371237,0.69773185,0.001084561,0.00018248112,0.0032242257,0.001632715,0.0037680045,0.047189962,0.0001363731],"about_ca_topic_score_codex":0.0015450736,"about_ca_topic_score_gemma":0.003691234,"teacher_disagreement_score":0.0061205616,"about_ca_system_score_codex":0.0013199489,"about_ca_system_score_gemma":0.0015941731,"threshold_uncertainty_score":0.032369018},"labels":[],"label_agreement":null},{"id":"W4393278281","doi":"10.1001/jamaoncol.2024.0228","title":"Comment on the Burden of Infection-Attributable Cancers in the US—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Otorhinolaryngology; Family medicine; Neurology; MEDLINE; Psychiatry","score_opus":0.03854557456724228,"score_gpt":0.2800599658136508,"score_spread":0.2415143912464085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393278281","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005658987,0.00045538633,0.00008365822,0.9769629,0.0197209,0.000016949984,0.0011513691,0.00007952603,0.0009633889],"genre_scores_gemma":[0.004603945,0.0007538191,0.0001372931,0.9720799,0.018774407,0.000072403665,0.00047192862,0.000051623316,0.003054782],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9975867,0.0005503706,0.00046485593,0.00038995795,0.0006394849,0.00036862632],"domain_scores_gemma":[0.98403823,0.009496677,0.0009032775,0.00052171806,0.003610396,0.0014298074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004292288,0.0011623312,0.0009846246,0.0013352247,0.0019630576,0.0024005668,0.0026324664,0.02763485,0.018169086],"category_scores_gemma":[0.03999503,0.00086531864,0.001735669,0.0020689406,0.0020726772,0.0048721824,0.0020205912,0.021296185,0.009843208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026819333,0.000007537842,0.0008819345,0.000046321842,0.000008434998,0.00008972516,0.000056013687,0.000036462046,0.00004608861,0.00031581387,0.99671113,0.0017736162],"study_design_scores_gemma":[0.00018451687,0.00009561569,0.014130626,0.00070674357,0.000084204505,0.001183004,0.0017185567,0.00068062864,0.0009217225,0.0047539948,0.9753244,0.00021599895],"about_ca_topic_score_codex":0.021851707,"about_ca_topic_score_gemma":0.0125383055,"teacher_disagreement_score":0.02763485,"about_ca_system_score_codex":0.0031823216,"about_ca_system_score_gemma":0.0041057803,"threshold_uncertainty_score":0.060781598},"labels":[],"label_agreement":null},{"id":"W4393931424","doi":"10.1001/jamaoncol.2024.0194","title":"Clinical Value of Molecular Targets and FDA-Approved Genome-Targeted Cancer Therapies","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Clinical trial; Personalized medicine; Targeted therapy; Cancer drugs; Oncology; Cancer; Internal medicine; Bioinformatics","score_opus":0.012530383679306862,"score_gpt":0.32397191031379474,"score_spread":0.3114415266344879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393931424","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73797584,0.18927321,0.008193817,0.009072664,0.0005257086,0.0012477211,0.028135486,0.000065443026,0.025510097],"genre_scores_gemma":[0.98818225,0.004688865,0.0018888208,0.0008295548,0.00037270456,0.0002569613,0.0033713705,0.000012243141,0.00039721365],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.96292305,0.016457643,0.008231259,0.0032967154,0.008420233,0.0006709843],"domain_scores_gemma":[0.79247904,0.0985728,0.09370025,0.005954982,0.00748615,0.0018067656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.041360494,0.00035995347,0.0010304992,0.0035128838,0.00032989882,0.0018989804,0.00072492694,0.0008027481,0.006252194],"category_scores_gemma":[0.11681944,0.00017578849,0.0023543898,0.0047853696,0.0011220365,0.0025245324,0.0013455995,0.0011092832,0.00052863784],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006978203,0.00012598632,0.893769,0.0037878407,0.00481687,0.00017767631,0.00021464296,0.0017291653,0.00047561346,0.0021994063,0.002675017,0.0830505],"study_design_scores_gemma":[0.00089377305,0.0028554476,0.9578313,0.0031608415,0.0056785108,0.001150645,0.00040098227,0.0027209788,0.0007962148,0.005127038,0.019306475,0.00007763843],"about_ca_topic_score_codex":0.0007085523,"about_ca_topic_score_gemma":0.0012769481,"teacher_disagreement_score":0.041360494,"about_ca_system_score_codex":0.0010884787,"about_ca_system_score_gemma":0.0016252099,"threshold_uncertainty_score":0.21873784},"labels":[],"label_agreement":null},{"id":"W4394727423","doi":"10.1001/jamaoncol.2024.0294","title":"American Radium Society Appropriate Use Criteria for Unresectable Locally Advanced Non–Small Cell Lung Cancer","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"G1 Therapeutics; ViewRay; National Cancer Institute; Incyte; RefleXion Medical; AstraZeneca","keywords":"Medicine; Lung cancer; Guideline; Radiation therapy; Oncology; Internal medicine","score_opus":0.045850571577881645,"score_gpt":0.4147705081213863,"score_spread":0.3689199365435047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394727423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.047469743,0.32537666,0.075410694,0.28418803,0.0151166925,0.033123784,0.014167379,0.0010018966,0.20414509],"genre_scores_gemma":[0.42194545,0.103984,0.31632093,0.06822991,0.006205932,0.04824122,0.017977893,0.00053116505,0.01656348],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.90755963,0.044823438,0.029700115,0.0016302593,0.014658427,0.001628238],"domain_scores_gemma":[0.8711773,0.04975992,0.02099799,0.0044374606,0.050499752,0.0031275416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04494085,0.0009073811,0.0018397165,0.0074033155,0.002221957,0.0029473759,0.003969122,0.004314735,0.007220988],"category_scores_gemma":[0.11810859,0.0005071522,0.0033093905,0.0060958136,0.0028333135,0.0034784689,0.0042745373,0.0041226055,0.0038249614],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005900714,0.0002452791,0.052549895,0.02893752,0.00055630505,0.003327214,0.008107317,0.0017064156,0.0040183766,0.027840775,0.48996776,0.3821531],"study_design_scores_gemma":[0.00026784005,0.00048826166,0.050542872,0.06094833,0.0006257595,0.007022173,0.005342473,0.0021284274,0.0013904904,0.027372131,0.8435248,0.00034644653],"about_ca_topic_score_codex":0.0067588617,"about_ca_topic_score_gemma":0.0088869445,"teacher_disagreement_score":0.04494085,"about_ca_system_score_codex":0.0034826845,"about_ca_system_score_gemma":0.017596416,"threshold_uncertainty_score":0.23767275},"labels":[],"label_agreement":null},{"id":"W4394727793","doi":"10.1001/jamaoncol.2024.0286","title":"Second Primary Breast Cancer in Young Breast Cancer Survivors","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Lumpectomy; Breast cancer; Cumulative incidence; Incidence (geometry); Mastectomy; Hazard ratio; Gynecology; Proportional hazards model; Young adult; Cancer; Prospective cohort study; Internal medicine; Cohort; Confidence interval","score_opus":0.0069118740200994466,"score_gpt":0.28200540740884705,"score_spread":0.2750935333887476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394727793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99820197,0.00063233735,0.0001340756,0.000085463,0.00000988676,0.000011140041,0.000482851,0.000005204236,0.0004371205],"genre_scores_gemma":[0.9988071,0.0004451612,0.00007943689,0.000040705287,0.000015418073,0.000009691886,0.00042566124,0.0000013948855,0.00017553932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998221,0.000035267127,0.000019245172,0.00004384425,0.000039147686,0.00004052363],"domain_scores_gemma":[0.9992175,0.00013299164,0.00042779747,0.00003345727,0.000058852373,0.00012947196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003678963,0.00014160309,0.00022463173,0.0005901637,0.00021243216,0.0004218195,0.00015566988,0.00025888265,0.0016725464],"category_scores_gemma":[0.0017029664,0.00013975595,0.00035820215,0.0007388945,0.0001814392,0.0003394875,0.00034257091,0.00029445306,0.00023009785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020899966,0.0000073002784,0.99775535,0.000009982696,0.000010958044,0.00007651557,0.00003810614,0.000020394376,0.00006604849,0.000010318613,0.000081439524,0.0019027904],"study_design_scores_gemma":[0.0000032103808,0.00007542706,0.99820435,0.00002054437,0.000024210254,0.0009103352,0.00019405523,0.00015946131,0.00006729061,0.000060947455,0.00027783506,0.0000022775716],"about_ca_topic_score_codex":0.0043229517,"about_ca_topic_score_gemma":0.006319962,"teacher_disagreement_score":0.0043229517,"about_ca_system_score_codex":0.00021064011,"about_ca_system_score_gemma":0.00036893258,"threshold_uncertainty_score":0.008595586},"labels":[],"label_agreement":null},{"id":"W4394760621","doi":"10.1001/jamaoncol.2023.6944","title":"MRI Surveillance and Breast Cancer Mortality in Women With <i>BRCA1</i> and <i>BRCA2</i> Sequence Variations","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Juravinski Cancer Centre; Princess Margaret Cancer Centre; Public Health Ontario; Women's College Hospital; University of Toronto","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Breast cancer; Breast MRI; Hazard ratio; Magnetic resonance imaging; Cancer registry; Proportional hazards model; Cancer; Mammography; Demography; Gynecology; Oncology; Internal medicine; Confidence interval; Radiology","score_opus":0.011956445389394997,"score_gpt":0.30190920306287955,"score_spread":0.28995275767348455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394760621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991997,0.00029635837,0.00007880023,0.00006306056,0.000004242495,0.0000033203069,0.00016768939,0.0000025122338,0.00018436424],"genre_scores_gemma":[0.9994572,0.000109609864,0.00008296559,0.000020809455,0.000009161911,0.000005754994,0.00021449194,0.0000012833231,0.00009869919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960953,0.00017155113,0.000026887756,0.000088801935,0.000051078132,0.000052118106],"domain_scores_gemma":[0.9982705,0.00047520828,0.00096250465,0.00007684605,0.00008312345,0.00013186572],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095007714,0.00013820505,0.00016482639,0.00038649002,0.00015211712,0.00027709838,0.00023689892,0.0002786963,0.00097587984],"category_scores_gemma":[0.003732144,0.00017216461,0.00041826666,0.00041697995,0.00018196712,0.0002456691,0.00023962998,0.000385243,0.000095454416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033135543,0.000021681048,0.99818283,0.000008540013,0.000053632713,0.00002066566,0.00002438233,0.00008458114,0.00006288642,0.000011409169,0.000079881494,0.0011181817],"study_design_scores_gemma":[0.000017643135,0.00023296013,0.99840766,0.000014075767,0.000068390815,0.00017291057,0.00007959953,0.0007377264,0.00008476041,0.000032663404,0.0001487976,0.0000028789157],"about_ca_topic_score_codex":0.0032176126,"about_ca_topic_score_gemma":0.0035026595,"teacher_disagreement_score":0.0032176126,"about_ca_system_score_codex":0.00027293258,"about_ca_system_score_gemma":0.000267849,"threshold_uncertainty_score":0.0063977838},"labels":[],"label_agreement":null},{"id":"W4395466551","doi":"10.1001/jamaoncol.2024.0578","title":"Omission of Axillary Dissection Following Nodal Downstaging With Neoadjuvant Chemotherapy","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":86,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"National Cancer Institute; Dipartimento di Scienze Biomediche Avanzate, Università degli Studi di Napoli Federico II","keywords":"Medicine; Axillary Lymph Node Dissection; Breast cancer; Sentinel lymph node; Biopsy; Axilla; Neoadjuvant therapy; Retrospective cohort study; Stage (stratigraphy); Surgery; Dissection (medical); Lymph node; Radiology; Cancer; Internal medicine","score_opus":0.0052991081853735935,"score_gpt":0.27903550498234436,"score_spread":0.27373639679697076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395466551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99576855,0.0016240535,0.00068667275,0.00021990536,0.000046979472,0.000019438969,0.0003271039,0.000008553981,0.0012987874],"genre_scores_gemma":[0.99890983,0.000331077,0.0002291751,0.000061001236,0.000034120738,0.000012699154,0.00029264906,0.0000026865025,0.00012668375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986345,0.00043854758,0.00017214405,0.00018113964,0.00041268396,0.0001608553],"domain_scores_gemma":[0.99372214,0.0018372545,0.003402406,0.00044860772,0.00031099672,0.00027854103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022153922,0.0001551626,0.00034201928,0.00033627165,0.00018680695,0.00043161528,0.00037184634,0.00023953858,0.0007241271],"category_scores_gemma":[0.0072799497,0.00011266601,0.00043342196,0.00056744006,0.0002940575,0.00043462758,0.00035091784,0.00043167244,0.00013465466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005876585,0.00002514204,0.9857308,0.000044405708,0.0000760727,0.00013090979,0.00003507033,0.0003709806,0.00036780952,0.0000380331,0.00019319079,0.0123999305],"study_design_scores_gemma":[0.000027672724,0.00051481323,0.9950433,0.00006595676,0.00012622299,0.0009480223,0.000091652626,0.0011049189,0.0006673689,0.00016699966,0.0012352037,0.000007876263],"about_ca_topic_score_codex":0.0013203463,"about_ca_topic_score_gemma":0.0038709296,"teacher_disagreement_score":0.0022153922,"about_ca_system_score_codex":0.0004661939,"about_ca_system_score_gemma":0.00055403484,"threshold_uncertainty_score":0.011716247},"labels":[],"label_agreement":null},{"id":"W4396577124","doi":"10.1001/jamaoncol.2024.0851","title":"Genetic Testing in Men With Metastatic Castration-Resistant Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Genetic testing; Internal medicine; Homologous recombination; Cancer; Genetics; Gene","score_opus":0.048688765978499124,"score_gpt":0.370808606759038,"score_spread":0.32211984078053885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396577124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982646,0.00044172592,0.00007191676,0.00007104969,0.0000081506005,0.000011039136,0.00040194124,0.000004492303,0.00072520354],"genre_scores_gemma":[0.9994229,0.00014303855,0.00004348096,0.000067294415,0.000009808106,0.000004043865,0.00017079047,0.0000011402851,0.00013757325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99972385,0.000083352345,0.000019818073,0.00007041465,0.00006159864,0.000040974654],"domain_scores_gemma":[0.9991585,0.00014927136,0.00043505494,0.0000459574,0.0000623553,0.0001487887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038457717,0.00016058027,0.000192454,0.00045217853,0.0003297812,0.0003840659,0.0002192488,0.00037816443,0.0015098095],"category_scores_gemma":[0.0015543286,0.00023344347,0.00024650228,0.00065888895,0.00024495574,0.0003401925,0.00027381122,0.00048308176,0.00021491089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098638695,0.0000540956,0.9982686,0.000008690771,0.000045211927,0.000055779787,0.000026433627,0.000037478647,0.00020286808,0.000021377693,0.000113958755,0.0010667722],"study_design_scores_gemma":[0.000010276296,0.00025979697,0.99869764,0.000006714276,0.00003080989,0.00048114613,0.000105648585,0.000119445016,0.00007389421,0.000024904866,0.0001862273,0.0000034591349],"about_ca_topic_score_codex":0.003748573,"about_ca_topic_score_gemma":0.00516188,"teacher_disagreement_score":0.003748573,"about_ca_system_score_codex":0.00021811454,"about_ca_system_score_gemma":0.00021551439,"threshold_uncertainty_score":0.007453501},"labels":[],"label_agreement":null},{"id":"W4396769281","doi":"10.1001/jamaoncol.2024.0591","title":"Metastatic Hormone-Sensitive Prostate Cancer and Combination Treatment Outcomes","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Oncology; Cancer; Prostate; Internal medicine; Hormone therapy; Gynecology; Breast cancer","score_opus":0.041834624394988744,"score_gpt":0.3974128393724129,"score_spread":0.35557821497742415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396769281","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23358801,0.73059195,0.0024268413,0.005452206,0.00043360313,0.00016909832,0.008206991,0.00013857732,0.018992659],"genre_scores_gemma":[0.934096,0.05854267,0.00075683516,0.00071140076,0.00057215797,0.00010225453,0.0041478546,0.000029815288,0.0010409905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979911,0.0007822298,0.00023915911,0.00032458673,0.0005677951,0.00009513763],"domain_scores_gemma":[0.9910356,0.004231013,0.0034532605,0.00025074236,0.00048386367,0.00054544286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024468352,0.00047439782,0.0012133336,0.00091061817,0.00025536455,0.0010472453,0.00044753382,0.0004616094,0.004884525],"category_scores_gemma":[0.009382763,0.0001235646,0.0023786589,0.0026347009,0.00032374222,0.0008480452,0.000634033,0.0015960261,0.00039121317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01005889,0.0003138368,0.5937965,0.013087263,0.035257712,0.00052063644,0.00024900763,0.005153851,0.00047564338,0.001503506,0.015131782,0.32445136],"study_design_scores_gemma":[0.0008970925,0.0023696495,0.94469774,0.0024095715,0.016222952,0.0034030057,0.00016539813,0.0032650318,0.00038884784,0.0053269435,0.020730643,0.00012313167],"about_ca_topic_score_codex":0.0017066249,"about_ca_topic_score_gemma":0.0020735443,"teacher_disagreement_score":0.004884525,"about_ca_system_score_codex":0.0008656263,"about_ca_system_score_gemma":0.00054431806,"threshold_uncertainty_score":0.016340315},"labels":[],"label_agreement":null},{"id":"W4396977150","doi":"10.1001/jamaoncol.2024.0836","title":"Physician and Artificial Intelligence Chatbot Responses to Cancer Questions From Social Media","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Chatbot; Social media; MEDLINE; World Wide Web; Data science","score_opus":0.23294635570343822,"score_gpt":0.501416852682031,"score_spread":0.2684704969785927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396977150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920806,0.00007329556,0.0017625039,0.0004038802,0.00004337469,0.0007333873,0.00028186024,0.00012603815,0.0044950834],"genre_scores_gemma":[0.99275863,0.000058403908,0.0032645494,0.00050664373,0.000043721153,0.0011846196,0.00023003237,0.000024628987,0.0019288626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915565,0.0060984986,0.0005112661,0.0005518171,0.00094058126,0.00034138802],"domain_scores_gemma":[0.8995277,0.07530452,0.011545813,0.0028484452,0.00738298,0.0033905706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010311745,0.00029142952,0.0002383562,0.0007260352,0.00087809726,0.0011289659,0.00039679056,0.00092056446,0.00843061],"category_scores_gemma":[0.08346083,0.00021353381,0.00028287695,0.0004374228,0.0006879242,0.0009043851,0.0016317244,0.00067571213,0.0013224139],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008076758,0.00413982,0.6054737,0.0018864737,0.00022171225,0.0011935183,0.11195476,0.0018089494,0.018235784,0.0007100123,0.015635159,0.23066331],"study_design_scores_gemma":[0.00091253355,0.010872328,0.90931636,0.00037220394,0.00016647736,0.0012879221,0.032430936,0.0069410107,0.011225259,0.00089156145,0.025427617,0.00015586421],"about_ca_topic_score_codex":0.0007928341,"about_ca_topic_score_gemma":0.0013737599,"teacher_disagreement_score":0.010311745,"about_ca_system_score_codex":0.0011589476,"about_ca_system_score_gemma":0.0009818443,"threshold_uncertainty_score":0.054534316},"labels":[],"label_agreement":null},{"id":"W4399627166","doi":"10.1001/jamaoncol.2024.1796","title":"Stereotactic Ablative Radiotherapy for Gynecological Oligometastatic and Oligoprogessive Tumors","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; McMaster University","funders":"","keywords":"Medicine; SABR volatility model; Cumulative incidence; Radiation therapy; Incidence (geometry); Radiosurgery; Retrospective cohort study; Ablative case; Cervix; Internal medicine; Surgery; Cancer; Cohort","score_opus":0.036587463691654436,"score_gpt":0.3692842752625899,"score_spread":0.33269681157093545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399627166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812121,0.016122881,0.0006515258,0.00014364006,0.000010724028,0.00004173019,0.00070389983,0.00001297855,0.0011004793],"genre_scores_gemma":[0.9972601,0.00203999,0.00016985186,0.000042208037,0.000018586925,0.000012515093,0.00032928554,0.0000021994153,0.00012520711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99926394,0.00027358776,0.00009813587,0.00010205304,0.00020177907,0.00006051894],"domain_scores_gemma":[0.99850696,0.00037740578,0.0008562746,0.00007020001,0.00011081846,0.00007828696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014269658,0.0001875902,0.00035208516,0.00081428204,0.0001613646,0.0003586756,0.000242598,0.00012787472,0.00081208686],"category_scores_gemma":[0.0028111436,0.000111564754,0.0008115388,0.0010831186,0.00022829065,0.00019082936,0.00032928263,0.00015049563,0.000056090583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007567154,0.000023101473,0.9621349,0.00030829207,0.002079234,0.00010402164,0.000040036506,0.00029672938,0.00062336546,0.000046358906,0.00021779173,0.03336943],"study_design_scores_gemma":[0.00005684516,0.00048739143,0.99507743,0.00010626984,0.0013741464,0.0010603186,0.00011831674,0.00035647457,0.00031799133,0.00007183257,0.00096964865,0.0000034216725],"about_ca_topic_score_codex":0.0062051993,"about_ca_topic_score_gemma":0.0224791,"teacher_disagreement_score":0.0062051993,"about_ca_system_score_codex":0.0006089746,"about_ca_system_score_gemma":0.00088707905,"threshold_uncertainty_score":0.0123381615},"labels":[],"label_agreement":null},{"id":"W4399854590","doi":"10.1001/jamaoncol.2024.1805","title":"Current Management of Desmoid Tumors","year":2024,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Soft tissue tumor case studies","field":"Medicine","cited_by":80,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Medicine; Guideline; MEDLINE; Randomized controlled trial; Evidence-based medicine; Cryotherapy; Radiation therapy; Clinical trial; Sarcoma; Surgery; Pathology; Alternative medicine","score_opus":0.10312701699273753,"score_gpt":0.4600195676058344,"score_spread":0.3568925506130969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399854590","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011719915,0.9702425,0.0015046301,0.017852616,0.0018588598,0.000032280906,0.00016293593,0.00004397301,0.007130201],"genre_scores_gemma":[0.022893162,0.95500106,0.004141565,0.0102671,0.005009388,0.00006599067,0.0005950177,0.00002346467,0.0020032476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99836797,0.00031178485,0.00044722322,0.00019164867,0.00060947257,0.000071876],"domain_scores_gemma":[0.99608374,0.0014589871,0.00069609,0.00007797403,0.0014713504,0.00021192628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025455905,0.0005606058,0.0009677389,0.00219071,0.0005465074,0.0018452869,0.0012371106,0.0015606715,0.003300367],"category_scores_gemma":[0.008884043,0.00023552959,0.0006944759,0.0015857861,0.0008963349,0.00248404,0.0008752984,0.0018609184,0.0017269992],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116114345,0.00004009025,0.0017554719,0.016584555,0.00016265767,0.000954302,0.00020938268,0.00046403168,0.0010670448,0.0037046038,0.08132752,0.8936142],"study_design_scores_gemma":[0.00007510552,0.00012850492,0.0029893427,0.025027622,0.00052265037,0.0071542566,0.0006296325,0.00038448177,0.00095217075,0.007679538,0.95440966,0.000047057827],"about_ca_topic_score_codex":0.0014506537,"about_ca_topic_score_gemma":0.0028781868,"teacher_disagreement_score":0.003300367,"about_ca_system_score_codex":0.0013816587,"about_ca_system_score_gemma":0.0022860167,"threshold_uncertainty_score":0.0134625435},"labels":[],"label_agreement":null},{"id":"W4400080240","doi":"10.1001/jamaoncol.2024.1841","title":"Long-Term Prospective Outcomes of Intensity Modulated Radiotherapy for Locally Advanced Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Cancer Institute","keywords":"Medicine; Common Terminology Criteria for Adverse Events; Chemoradiotherapy; Lung cancer; Radiation therapy; Hazard ratio; Internal medicine; Prospective cohort study; Oncology; Pneumonitis; Univariate analysis; Carboplatin; Multivariate analysis; Chemotherapy; Lung; Confidence interval","score_opus":0.013806438506688508,"score_gpt":0.3746829165921156,"score_spread":0.3608764780854271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400080240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942867,0.0038870282,0.0003873846,0.00012483142,0.000033816057,0.00007785303,0.0006953038,0.000008758883,0.00049842027],"genre_scores_gemma":[0.9981609,0.00032066216,0.000113872266,0.00007593765,0.00004484909,0.00006330214,0.001052573,0.0000029476646,0.00016486812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986987,0.0005998778,0.00018860408,0.00017011,0.0002378928,0.00010485863],"domain_scores_gemma":[0.9948297,0.0010656177,0.002617578,0.00039753126,0.0003678704,0.0007216566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041503273,0.00029694068,0.0006090022,0.0003042766,0.00034118976,0.0005486918,0.0004184543,0.0005192242,0.001202615],"category_scores_gemma":[0.0042441394,0.000116788644,0.0013894804,0.00041354902,0.00040065098,0.0007290068,0.0005566765,0.00079261843,0.00030760784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042648055,0.0013214728,0.90640414,0.00033733292,0.002654959,0.000084410276,0.000097167765,0.0014927781,0.0021143614,0.00006683907,0.00059419137,0.042184386],"study_design_scores_gemma":[0.0015476472,0.025768833,0.9678772,0.00007813791,0.0012261599,0.0002816504,0.000060534814,0.0007453736,0.0013205064,0.0001614559,0.00090734323,0.000025163437],"about_ca_topic_score_codex":0.0003143993,"about_ca_topic_score_gemma":0.00071283214,"teacher_disagreement_score":0.0041503273,"about_ca_system_score_codex":0.00044795335,"about_ca_system_score_gemma":0.0004236983,"threshold_uncertainty_score":0.021949291},"labels":[],"label_agreement":null},{"id":"W4400192544","doi":"10.1001/jamaoncol.2024.3196","title":"Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Prostate Cancer Canada; University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Prostate cancer; Glutamate carboxypeptidase II; Prostate; Prostate-specific antigen; Multiparametric MRI; Nuclear medicine; Cancer; Urology; Radiology; Oncology; Internal medicine","score_opus":0.05833779788555239,"score_gpt":0.38914261966567226,"score_spread":0.3308048217801199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400192544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97960794,0.012214941,0.002004115,0.001220182,0.0005572076,0.0010260793,0.0007598,0.000036379504,0.0025734424],"genre_scores_gemma":[0.9938699,0.0009925878,0.0024297282,0.00056084414,0.00023741678,0.00044915028,0.0005042702,0.000011112606,0.0009450374],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9980003,0.0013641579,0.00010017743,0.00022542676,0.00021727718,0.00009265278],"domain_scores_gemma":[0.995889,0.002082868,0.0008777301,0.00035830925,0.00033813796,0.00045405707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009905435,0.00064605946,0.0007497086,0.0003243845,0.00025655425,0.0012163132,0.000651119,0.0012540024,0.0025987136],"category_scores_gemma":[0.0068429387,0.00035691264,0.0010050294,0.0002942785,0.00046093093,0.000667931,0.0003065647,0.0009956842,0.00042930138],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.60517204,0.00313192,0.23264651,0.0008996459,0.003929417,0.00021411627,0.00017826169,0.0019149627,0.010475782,0.00050054025,0.0020067967,0.13893001],"study_design_scores_gemma":[0.12663302,0.20644647,0.58950883,0.0010002089,0.016818363,0.0013405747,0.0002781684,0.02449878,0.013790021,0.0023725298,0.016999919,0.00031310887],"about_ca_topic_score_codex":0.0010215314,"about_ca_topic_score_gemma":0.0042308583,"teacher_disagreement_score":0.009905435,"about_ca_system_score_codex":0.00058189,"about_ca_system_score_gemma":0.00096826005,"threshold_uncertainty_score":0.05238563},"labels":[],"label_agreement":null},{"id":"W4400775048","doi":"10.1001/jamaoncol.2024.2156","title":"Neoadjuvant Exercise Therapy in Prostate Cancer","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Prostate cancer; Neoadjuvant therapy; Cancer; Internal medicine; Physical therapy; Urology; Oncology; Breast cancer","score_opus":0.024639205550594956,"score_gpt":0.33112161825445274,"score_spread":0.3064824127038578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400775048","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88314635,0.10579362,0.001735893,0.0016677259,0.00042903796,0.0009123659,0.0002604059,0.00005947455,0.0059950855],"genre_scores_gemma":[0.9845457,0.012399688,0.0009286995,0.0004290994,0.00023600952,0.00060516695,0.00022841431,0.000004223183,0.000622984],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996654,0.00023375866,0.00002321574,0.000021431812,0.00003738573,0.000018763136],"domain_scores_gemma":[0.9996693,0.00013903221,0.000095190255,0.000021017166,0.000015627571,0.000059847156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006282608,0.00019388362,0.0005263742,0.00014342155,0.0001880637,0.00028014072,0.00014875193,0.00020983546,0.0018264472],"category_scores_gemma":[0.00085066864,0.000100320525,0.00026786842,0.00026449468,0.00025762615,0.00013273224,0.00021340925,0.00054573937,0.0002275353],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07376333,0.008395302,0.068474844,0.007249325,0.0011102885,0.00027298238,0.00018736639,0.0045889146,0.020825056,0.0007618253,0.0046149506,0.8097557],"study_design_scores_gemma":[0.04780664,0.40684393,0.4725432,0.0026906522,0.0015078739,0.0027619994,0.0003203291,0.006507484,0.008699921,0.0022104373,0.048028134,0.00007932997],"about_ca_topic_score_codex":0.000368237,"about_ca_topic_score_gemma":0.0013156672,"teacher_disagreement_score":0.0018264472,"about_ca_system_score_codex":0.00028453258,"about_ca_system_score_gemma":0.00060242304,"threshold_uncertainty_score":0.0061100125},"labels":[],"label_agreement":null},{"id":"W4400978609","doi":"10.1001/jamaoncol.2024.2212","title":"Bilateral Mastectomy and Breast Cancer Mortality","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Women's College Hospital; University of Toronto","funders":"","keywords":"Medicine; Breast cancer; Mastectomy; Oncology; MEDLINE; Cancer; Internal medicine; General surgery","score_opus":0.016948588401975766,"score_gpt":0.3093466901121295,"score_spread":0.29239810171015373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400978609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9785121,0.015590081,0.00040191936,0.0010817982,0.000053871743,0.000008433703,0.0008600946,0.000017874117,0.0034737345],"genre_scores_gemma":[0.9979723,0.0011738986,0.00008842032,0.000057031364,0.000049296505,0.0000024814956,0.00027778954,0.0000022840952,0.00037651474],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996985,0.000085979074,0.000024386352,0.0000598157,0.00009164129,0.000039694132],"domain_scores_gemma":[0.9985261,0.00035968312,0.00077405496,0.00007679143,0.00007482851,0.00018844962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004509159,0.00013585149,0.0001355496,0.00026836895,0.0001237076,0.0002795375,0.00018479038,0.00022520861,0.004023573],"category_scores_gemma":[0.003164754,0.000082865205,0.00035158623,0.0003249339,0.00017759233,0.00024540364,0.00031335017,0.000303215,0.0001948932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028196603,0.000019543335,0.98563623,0.00006656769,0.0001580626,0.00007652072,0.000018956345,0.00018945547,0.00018521363,0.00010727514,0.00041353895,0.012846723],"study_design_scores_gemma":[0.00001533388,0.000050516155,0.9974738,0.000035990266,0.00010113627,0.00080925296,0.000030363228,0.00031455836,0.00009306773,0.00022343936,0.00084846077,0.0000042151887],"about_ca_topic_score_codex":0.0034702402,"about_ca_topic_score_gemma":0.005197153,"teacher_disagreement_score":0.004023573,"about_ca_system_score_codex":0.00027890602,"about_ca_system_score_gemma":0.0003540598,"threshold_uncertainty_score":0.013460219},"labels":[],"label_agreement":null},{"id":"W4401214160","doi":"10.1001/jamaoncol.2024.2491","title":"Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion","year":2024,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre Hospitalier de l’Université de Montréal; Surrey Memorial Hospital; Institut universitaire de cardiologie et de pneumologie de Québec","funders":"National Cancer Institute","keywords":"Medicine; Hazard ratio; Lung cancer; Surgery; Proportional hazards model; Randomized controlled trial; Prophylactic cranial irradiation; Internal medicine; Confidence interval; Conventional PCI","score_opus":0.022005999673415263,"score_gpt":0.32201593246549237,"score_spread":0.3000099327920771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401214160","genre_codex":"empirical","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98940814,0.0070753507,0.00027612943,0.0006281414,0.00015854678,0.00061423867,0.0005746131,0.000019785875,0.0012450368],"genre_scores_gemma":[0.9971854,0.0008339287,0.00020863512,0.00044407533,0.00013207283,0.0002565277,0.00060822075,0.0000019131814,0.0003291422],"study_design_codex":"randomized_trial","study_design_gemma":"case_report","domain_scores_codex":[0.99836224,0.0011378066,0.00010641048,0.00015504457,0.00015041544,0.00008802418],"domain_scores_gemma":[0.99828184,0.0005586163,0.000661808,0.00011466736,0.00010906818,0.00027393497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039207763,0.00037717092,0.000584678,0.00016960826,0.00021219894,0.0005271851,0.00046406573,0.0005326795,0.0017628915],"category_scores_gemma":[0.00315287,0.00021027208,0.0010178685,0.00032258686,0.000467492,0.0002880281,0.00028839108,0.0007977655,0.00012402794],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.53871804,0.0035241416,0.35286584,0.0030269122,0.008503543,0.00017502133,0.000114169336,0.0013128209,0.0029201228,0.0003953902,0.006951631,0.08149245],"study_design_scores_gemma":[0.33096337,0.068436,0.57470334,0.00051614246,0.011551636,0.00045422398,0.00013929633,0.004025894,0.001850986,0.0006192575,0.006687583,0.000052345295],"about_ca_topic_score_codex":0.003034547,"about_ca_topic_score_gemma":0.011751902,"teacher_disagreement_score":0.0039207763,"about_ca_system_score_codex":0.0007269283,"about_ca_system_score_gemma":0.0011403549,"threshold_uncertainty_score":0.020735323},"labels":[],"label_agreement":null},{"id":"W4401611660","doi":"10.1001/jamaoncol.2024.3044","title":"Breast Cancer Index in Premenopausal Women With Early-Stage Hormone Receptor–Positive Breast Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Breast cancer; Oncology; Tamoxifen; Internal medicine; Exemestane; Cancer; Population; Gynecology; Letrozole","score_opus":0.006700657720811611,"score_gpt":0.27272006821835565,"score_spread":0.266019410497544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401611660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969784,0.0009615986,0.00012526248,0.0001450101,0.000030088064,0.000105484,0.000696148,0.0000047959306,0.00095328625],"genre_scores_gemma":[0.99799675,0.0002850238,0.00023743288,0.0001211774,0.00005704609,0.000096749434,0.0008894834,0.0000013458038,0.00031497638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997447,0.00008986891,0.00002424588,0.00006500798,0.000046004014,0.000030158575],"domain_scores_gemma":[0.9993799,0.00011234184,0.0002903734,0.000057789704,0.00003914534,0.00012038839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010377034,0.00021899205,0.00038352262,0.0002809533,0.00026504425,0.00038309218,0.00023665218,0.0003365494,0.0010673947],"category_scores_gemma":[0.0015513011,0.00017104085,0.0004049178,0.0004269577,0.00024050685,0.00028627188,0.00026825,0.0004731987,0.00018038902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02114425,0.00046375534,0.9633574,0.0000963268,0.00018044146,0.000066252134,0.000044678287,0.00014592514,0.0014459436,0.000059245474,0.00045059095,0.012545228],"study_design_scores_gemma":[0.0010076789,0.0057250583,0.9905364,0.000022495444,0.00028159874,0.00025327783,0.00006086585,0.00036528133,0.000554293,0.00014653312,0.0010396617,0.0000067941924],"about_ca_topic_score_codex":0.00091628794,"about_ca_topic_score_gemma":0.001995135,"teacher_disagreement_score":0.0010673947,"about_ca_system_score_codex":0.00024721213,"about_ca_system_score_gemma":0.00039287214,"threshold_uncertainty_score":0.0054879785},"labels":[],"label_agreement":null},{"id":"W4402269149","doi":"10.1001/jamaoncol.2024.3645","title":"Inpatient Care and Outcomes Among People With Cancer Experiencing Homelessness","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Propensity score matching; Context (archaeology); Cohort; Odds; Odds ratio; Logistic regression; Cancer; Acute care; Retrospective cohort study; Inpatient care; Emergency medicine; Health care; Demography; Family medicine; Internal medicine","score_opus":0.025883592885836065,"score_gpt":0.4118331775147838,"score_spread":0.38594958462894774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402269149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978089,0.00036752396,0.000087509135,0.00017022935,0.000015418449,0.0000160427,0.0008357709,0.000004942892,0.00069367356],"genre_scores_gemma":[0.9990747,0.00011591081,0.000039895902,0.000035095807,0.000013100845,0.000008040412,0.0006576831,8.3109524e-7,0.000054776516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99955696,0.00012194763,0.00005914936,0.00006578882,0.000091574846,0.00010451675],"domain_scores_gemma":[0.9984971,0.00010909347,0.0010167558,0.00004893669,0.00012911987,0.00019891067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005426446,0.00013046141,0.00019399218,0.00048951124,0.0003288218,0.00042692677,0.00022475363,0.00016688192,0.001401274],"category_scores_gemma":[0.0033845827,0.000086116524,0.00034287202,0.000885615,0.00018966841,0.00036067946,0.00059257867,0.0003954907,0.00008600779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026942571,0.000027876826,0.99781656,0.000011528003,0.000029427094,0.000019878922,0.000040096635,0.000025723813,0.000016814914,0.00001739626,0.00019328737,0.0017745014],"study_design_scores_gemma":[0.000003190192,0.000050147028,0.9994685,0.000014694518,0.000014512979,0.000065783,0.00012456712,0.00009667079,0.0000135437585,0.00003147115,0.00011541204,0.0000014924549],"about_ca_topic_score_codex":0.0071643554,"about_ca_topic_score_gemma":0.010457607,"teacher_disagreement_score":0.0071643554,"about_ca_system_score_codex":0.0003253502,"about_ca_system_score_gemma":0.00037299006,"threshold_uncertainty_score":0.014245331},"labels":[],"label_agreement":null},{"id":"W4402638354","doi":"10.1001/jamaoncol.2024.3089","title":"Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I Non–Small Cell Lung Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Hôpital Charles-Le Moyne; Western University; University of Alberta; University of Calgary; Centre Hospitalier de l’Université de Montréal; Saint John Regional Hospital; Hôpital Notre-Dame; NOSM University; Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Saskatchewan Cancer Agency; CancerCare Manitoba; Windsor Regional Hospital; Hôpital Maisonneuve-Rosemont; Juravinski Cancer Centre; University of Manitoba; University of Saskatchewan; Queen's University; McMaster University; Dalhousie University; Hamilton Health Sciences; Kingston Health Sciences Centre; McGill University Health Centre","funders":"","keywords":"Medicine; Stage (stratigraphy); Radiation therapy; Oncology; Lung cancer; Cancer; Stereotactic radiotherapy; Radiosurgery; Internal medicine; Radiology","score_opus":0.019904746270256672,"score_gpt":0.3522619082532794,"score_spread":0.33235716198302273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402638354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767045,0.012100557,0.00079826935,0.00070794206,0.00041104868,0.0055618514,0.00064144307,0.000055804845,0.0030186924],"genre_scores_gemma":[0.9935475,0.0021777207,0.0010966554,0.00042115143,0.00014603267,0.0016229759,0.00020908161,0.0000059495433,0.0007729498],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9975817,0.0014517446,0.00022149585,0.00021229134,0.00038167028,0.00015105857],"domain_scores_gemma":[0.99757713,0.0009758561,0.0008498202,0.00008590438,0.00018514319,0.00032612355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004679259,0.00077763863,0.0013653238,0.0004605374,0.00037123854,0.0006468999,0.0008633964,0.0010744762,0.0038518822],"category_scores_gemma":[0.00528189,0.00024694807,0.0022596463,0.0005569174,0.00081752054,0.00047289365,0.00034309307,0.0013673499,0.0002264277],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8563773,0.006271642,0.0068648723,0.005255874,0.0058191787,0.000040588646,0.00024545012,0.0022872894,0.0049202936,0.0004492844,0.0009816723,0.110486425],"study_design_scores_gemma":[0.5216728,0.40208855,0.05082903,0.0011844715,0.010345626,0.00008626278,0.00018278217,0.003367883,0.004711563,0.00097215804,0.0044967313,0.00006217478],"about_ca_topic_score_codex":0.014574522,"about_ca_topic_score_gemma":0.04372904,"teacher_disagreement_score":0.014574522,"about_ca_system_score_codex":0.003361305,"about_ca_system_score_gemma":0.004159466,"threshold_uncertainty_score":0.028979361},"labels":[],"label_agreement":null},{"id":"W4402859895","doi":"10.1001/jamaoncol.2024.4214","title":"Meta-Analysis Methods for Neoadjuvant Chemoimmunotherapy for Non–Small Cell Lung Cancer—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Chemoimmunotherapy; Neoadjuvant therapy; Lung cancer; Oncology; Meta-analysis; Internal medicine; Cancer; Immunotherapy; Breast cancer","score_opus":0.08003539863057527,"score_gpt":0.4520882897463271,"score_spread":0.3720528911157518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402859895","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000993073,0.052729093,0.003586744,0.86343616,0.076874144,0.000073992895,0.0014127094,0.00017855644,0.00071544125],"genre_scores_gemma":[0.02331524,0.017202713,0.005554739,0.830048,0.119531564,0.00031791627,0.0005067576,0.00030867383,0.003214387],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.967702,0.022626847,0.00468573,0.0026386671,0.00189607,0.00045062523],"domain_scores_gemma":[0.69086796,0.27799407,0.0049708174,0.0090990495,0.014895837,0.002172307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0572897,0.0016249424,0.004554563,0.001593444,0.001057959,0.0028035692,0.0036466555,0.010895193,0.008224803],"category_scores_gemma":[0.25290322,0.0014308875,0.0073850155,0.0021130133,0.0026198134,0.004037119,0.0019944068,0.024011299,0.002350901],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001665684,0.000063359104,0.005397828,0.0040596374,0.0098948395,0.00055557763,0.00033042426,0.0007128256,0.00036754005,0.0026137652,0.9322766,0.04206185],"study_design_scores_gemma":[0.012576607,0.0009999534,0.027055742,0.00926021,0.037684493,0.0033847122,0.001493962,0.007835008,0.0021115139,0.08576685,0.8106115,0.0012195264],"about_ca_topic_score_codex":0.011456635,"about_ca_topic_score_gemma":0.017736241,"teacher_disagreement_score":0.0572897,"about_ca_system_score_codex":0.0019175282,"about_ca_system_score_gemma":0.004660013,"threshold_uncertainty_score":0.30298054},"labels":[],"label_agreement":null},{"id":"W4403097507","doi":"10.1001/jamaoncol.2024.4318","title":"Fracture Risk Prediction Using the Fracture Risk Assessment Tool in Individuals With Cancer","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"CancerCare Manitoba; University of Manitoba; University of Alberta","funders":"Medical Research Council","keywords":"Medicine; FRAX; Hip fracture; Cohort; Cohort study; Population; Internal medicine; Retrospective cohort study; Cancer; Cancer registry; Bone mineral; Osteoporosis; Physical therapy; Osteoporotic fracture; Environmental health","score_opus":0.024422698011788185,"score_gpt":0.4089161564127661,"score_spread":0.38449345840097787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883355,0.003167819,0.0015147976,0.0007879627,0.00007234983,0.00011932772,0.002403742,0.000050865594,0.0030496477],"genre_scores_gemma":[0.9958334,0.0005370153,0.0019411215,0.00008198784,0.000029008408,0.000042718722,0.0012225173,0.0000033975596,0.00030879484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990415,0.0002813598,0.00010840686,0.00010621664,0.0003680376,0.00009451501],"domain_scores_gemma":[0.9985085,0.0003409238,0.00048253842,0.000057681696,0.00046920855,0.0001410816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015855536,0.00040394664,0.00046936178,0.0018995545,0.00040944506,0.0007931643,0.0004866797,0.0005193952,0.00093227305],"category_scores_gemma":[0.008629587,0.00017661897,0.0006140387,0.002077153,0.00019772856,0.00034835574,0.00046377012,0.0006009214,0.00029010774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058339,0.000023087972,0.992912,0.000018600105,0.00006156658,0.000026422089,0.000033616612,0.00014989961,0.000028458659,0.000016981794,0.0005965393,0.0060745403],"study_design_scores_gemma":[0.00003333588,0.000158495,0.99291444,0.00010126928,0.00013592668,0.00031312235,0.00015978912,0.004566946,0.00012673796,0.00015912639,0.0013120968,0.000018706725],"about_ca_topic_score_codex":0.05157047,"about_ca_topic_score_gemma":0.077619925,"teacher_disagreement_score":0.05157047,"about_ca_system_score_codex":0.00070044806,"about_ca_system_score_gemma":0.0011345451,"threshold_uncertainty_score":0.10254061},"labels":[],"label_agreement":null},{"id":"W4403097680","doi":"10.1001/jamaoncol.2024.4330","title":"Biomarkers to Inform Prognosis and Treatment for Unresectable or Metastatic GEP-NENs","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Lawson Health Research Institute; University of Toronto; Western University; Fluidigm (Canada); Princess Margaret Cancer Centre; University of Calgary; Impact; University of British Columbia; Ottawa Hospital; BC Cancer Agency","funders":"","keywords":"Medicine; MEDLINE; Neuroendocrine tumors; Grading (engineering); Randomized controlled trial; Evidence-based medicine; Internal medicine; Oncology; Intensive care medicine; Family medicine; Alternative medicine; Pathology","score_opus":0.08450052173136242,"score_gpt":0.43317302473165814,"score_spread":0.34867250300029573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0023487809,0.8858195,0.0069049723,0.09421099,0.0042725555,0.0008850986,0.0009143734,0.00010311633,0.004540568],"genre_scores_gemma":[0.04495669,0.84700185,0.06586117,0.034186646,0.0030938026,0.0018228977,0.0015129051,0.000053748925,0.0015102519],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9636178,0.018367268,0.009013126,0.0014653029,0.006898615,0.0006379285],"domain_scores_gemma":[0.83833283,0.11625917,0.016524423,0.0022913844,0.024791243,0.0018009192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.04517886,0.0019099887,0.0036637867,0.008122918,0.00090398325,0.0048933746,0.0026899062,0.0065692603,0.0030879944],"category_scores_gemma":[0.16602267,0.0009249758,0.005331161,0.0035896488,0.00138925,0.005597256,0.002427071,0.00597361,0.0012939083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005790193,0.00024117199,0.007110159,0.25967157,0.005020638,0.0005566534,0.0011667617,0.0018473391,0.0015433963,0.006675412,0.08816252,0.62742543],"study_design_scores_gemma":[0.00044806828,0.00032702592,0.0071903383,0.67774254,0.011712702,0.0009843819,0.0013563008,0.0019909483,0.0012146919,0.01424198,0.28256708,0.00022385869],"about_ca_topic_score_codex":0.005075277,"about_ca_topic_score_gemma":0.008105269,"teacher_disagreement_score":0.04517886,"about_ca_system_score_codex":0.004218267,"about_ca_system_score_gemma":0.015827747,"threshold_uncertainty_score":0.23893148},"labels":[],"label_agreement":null},{"id":"W4403097762","doi":"10.1001/jamaoncol.2024.4327","title":"Ensuring Safety and Consistency in Artificial Intelligence Chatbot Responses—Reply","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Chatbot; Medicine; Consistency (knowledge bases); Natural language processing; Artificial intelligence; Computer science","score_opus":0.18665603076798565,"score_gpt":0.4587237640772963,"score_spread":0.27206773330931067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403097762","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036313338,0.0003434283,0.00023471894,0.9904603,0.008035388,0.000013371977,0.00006300126,0.000037158763,0.00044946995],"genre_scores_gemma":[0.002917942,0.0003240048,0.0003017785,0.98935086,0.0055232723,0.00005147139,0.000026452128,0.000015911324,0.0014883034],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99268156,0.0016085427,0.0012402999,0.0017161928,0.0018321845,0.0009212389],"domain_scores_gemma":[0.9377299,0.04003584,0.0019142178,0.0014279301,0.015053216,0.0038389487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009941876,0.00079640123,0.0010802287,0.0010848953,0.00519646,0.0046422007,0.0026916808,0.049996424,0.006884987],"category_scores_gemma":[0.09008393,0.0011176139,0.0012559963,0.000989674,0.005096019,0.005388944,0.0030661733,0.0582448,0.0054367036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011006685,0.00005167578,0.0014292995,0.00011008019,0.000054953525,0.0004662747,0.00092782336,0.000118353506,0.0004602071,0.0027299689,0.98589665,0.007644724],"study_design_scores_gemma":[0.0003288653,0.00018334668,0.007975443,0.0008833207,0.00024555775,0.0013947089,0.006247964,0.0011155203,0.0018689717,0.01464699,0.9646704,0.00043899525],"about_ca_topic_score_codex":0.019281907,"about_ca_topic_score_gemma":0.024013964,"teacher_disagreement_score":0.049996424,"about_ca_system_score_codex":0.005858891,"about_ca_system_score_gemma":0.009724393,"threshold_uncertainty_score":0.05257827},"labels":[],"label_agreement":null},{"id":"W4403299266","doi":"10.1001/jamaoncol.2024.4376","title":"Endometrial Cancer Classification and Management in the Molecular Subtyping Era","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Subtyping; Endometrial biopsy; Endometrial cancer; POSTMENOPAUSAL BLEEDING; Adenocarcinoma; Biopsy; Gynecology; Vaginal bleeding; Oncology; Internal medicine; Cancer; Pregnancy","score_opus":0.04884621008771139,"score_gpt":0.3767754390035115,"score_spread":0.3279292289158001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403299266","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65134907,0.16141097,0.0025251014,0.1393257,0.0049877353,0.00011801966,0.00096275756,0.000093751856,0.039226893],"genre_scores_gemma":[0.9288195,0.050370622,0.0037544302,0.0098590115,0.0044228737,0.000051471172,0.0006773909,0.000025545916,0.002019184],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99940586,0.00016236071,0.00008089529,0.000054980184,0.00014532838,0.00015050331],"domain_scores_gemma":[0.9991829,0.00019879536,0.0001626139,0.000030866744,0.0002194818,0.0002053383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010856697,0.00016174308,0.00029293878,0.0010262389,0.00069704495,0.0008317814,0.00039873426,0.00082236476,0.0008360907],"category_scores_gemma":[0.0044987937,0.00018573792,0.00026130938,0.00089554006,0.0003555664,0.0010081384,0.0006508249,0.001195043,0.00029972862],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038485418,0.000120461395,0.64265144,0.0001886204,0.00006736058,0.011995081,0.0007123811,0.0007421953,0.0022833224,0.0023955079,0.058814198,0.27964464],"study_design_scores_gemma":[0.00007959231,0.00028835647,0.8097327,0.0022621243,0.00016909526,0.084372856,0.0052912724,0.0036335336,0.00089336646,0.0059640775,0.087224066,0.000089036774],"about_ca_topic_score_codex":0.006124926,"about_ca_topic_score_gemma":0.015832547,"teacher_disagreement_score":0.006124926,"about_ca_system_score_codex":0.00075706246,"about_ca_system_score_gemma":0.0008668074,"threshold_uncertainty_score":0.01217854},"labels":[],"label_agreement":null},{"id":"W4403299677","doi":"10.1001/jamaoncol.2024.4354","title":"Ninth Version of the AJCC and UICC Nasopharyngeal Cancer TNM Staging Classification","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Nasopharyngeal carcinoma; Cancer; Stage (stratigraphy); AJCC staging system; Cancer staging; Internal medicine; Oncology; Radiation therapy; Staging system","score_opus":0.03465590052636265,"score_gpt":0.3610580777752746,"score_spread":0.32640217724891196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403299677","genre_codex":"dataset","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18572159,0.1076089,0.101448104,0.03966959,0.030786442,0.015106637,0.32353258,0.002536101,0.19359],"genre_scores_gemma":[0.373671,0.034022626,0.17147052,0.0050662872,0.0040760874,0.013749971,0.34535468,0.00060683937,0.051982056],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970156,0.0007976241,0.0006333189,0.00020134772,0.0011238395,0.00022818535],"domain_scores_gemma":[0.9948926,0.0003794262,0.0010373846,0.00026023522,0.0031345696,0.0002957035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005216811,0.00069736387,0.0009075099,0.004842895,0.00072606636,0.0013377074,0.0012397717,0.0005330858,0.006177604],"category_scores_gemma":[0.010146979,0.00022808484,0.0010726311,0.004454423,0.00059939874,0.00075777626,0.0013281526,0.0018414004,0.0023421114],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047925243,0.00009320853,0.19898377,0.0019611905,0.00028499213,0.00040723305,0.00043315953,0.0014019813,0.0015501176,0.004886566,0.5336711,0.2558473],"study_design_scores_gemma":[0.00020299209,0.0002952135,0.3261753,0.0028676218,0.0004045829,0.0017530341,0.0007897001,0.0030965768,0.0007317719,0.0044422583,0.6591315,0.00010943128],"about_ca_topic_score_codex":0.027724836,"about_ca_topic_score_gemma":0.036609083,"teacher_disagreement_score":0.027724836,"about_ca_system_score_codex":0.0022905816,"about_ca_system_score_gemma":0.008369844,"threshold_uncertainty_score":0.055126905},"labels":[],"label_agreement":null},{"id":"W4403485115","doi":"10.1001/jamaoncol.2024.4381","title":"Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Ifosfamide; Lenvatinib; Internal medicine; Etoposide; Clinical endpoint; Oncology; Response Evaluation Criteria in Solid Tumors; Clinical trial; Surgery; Phases of clinical research; Chemotherapy; Cancer","score_opus":0.008763653281383671,"score_gpt":0.26912362336592016,"score_spread":0.2603599700845365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403485115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9699617,0.025417848,0.00017476165,0.0008673473,0.00013273135,0.00058978796,0.0009955008,0.00002829093,0.0018320603],"genre_scores_gemma":[0.98420966,0.010599817,0.0009190053,0.0011603233,0.00020105272,0.00076838006,0.0013365725,0.000007682635,0.0007974667],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9996092,0.00017149236,0.000043262375,0.000056136174,0.000055538967,0.000064428605],"domain_scores_gemma":[0.9992747,0.00012529622,0.00025501993,0.000019870055,0.000041599385,0.0002835659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009297547,0.00032680135,0.0013686325,0.0002357046,0.00022744616,0.00042858027,0.00028308443,0.0005746596,0.0012060599],"category_scores_gemma":[0.0010455517,0.00022890946,0.0007999017,0.0004921038,0.00036143375,0.00044066214,0.00036265628,0.0012550643,0.00022307856],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36448437,0.010115003,0.270506,0.004172724,0.004007399,0.0017322245,0.0005990205,0.0031804426,0.009216188,0.0010393083,0.015805095,0.31514212],"study_design_scores_gemma":[0.25506932,0.29545757,0.38415754,0.0019751627,0.0047742873,0.005199591,0.0008688929,0.0019765748,0.004863751,0.00092840474,0.044651546,0.000077355886],"about_ca_topic_score_codex":0.0017218802,"about_ca_topic_score_gemma":0.0077039646,"teacher_disagreement_score":0.0017218802,"about_ca_system_score_codex":0.00085463346,"about_ca_system_score_gemma":0.0020393333,"threshold_uncertainty_score":0.0062007904},"labels":[],"label_agreement":null},{"id":"W4403940424","doi":"10.1001/jamaoncol.2024.4899","title":"metastatic","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Organometallic Complex Synthesis and Catalysis","field":"Chemistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine","score_opus":0.025878173892400845,"score_gpt":0.2974916556019802,"score_spread":0.2716134817095794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403940424","genre_codex":"other","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":"other","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013881605,0.0035069238,0.0007092844,0.007113135,0.003481576,0.00011920532,0.0034045991,0.0005068867,0.9797703],"genre_scores_gemma":[0.013454491,0.003895613,0.00063583214,0.009042847,0.0018873027,0.00010697147,0.0031919417,0.00022724153,0.9675578],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998431,0.000016386402,0.0000065315503,0.000030931,0.00005762015,0.00004541887],"domain_scores_gemma":[0.99968624,0.000032955963,0.000018025272,0.000028761755,0.00006697725,0.00016713577],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00016637016,0.0005498504,0.0003122923,0.0007382621,0.00067778915,0.0011535584,0.0005456793,0.0007174067,0.5947014],"category_scores_gemma":[0.0010041944,0.00014688032,0.0004183432,0.0005067282,0.00026740658,0.0005723256,0.0011231081,0.0013167107,0.29129913],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006916923,0.000035335528,0.0005107318,0.00012427778,0.000009173537,0.0006056374,0.000017855607,0.00006819135,0.00043943353,0.0036309336,0.89446115,0.10002811],"study_design_scores_gemma":[0.000032886957,0.000019398476,0.0005226908,0.00007785876,0.0000075434905,0.0009891832,0.000018299916,0.000049398463,0.00014464701,0.0013690426,0.99676573,0.000003237368],"about_ca_topic_score_codex":0.0020033943,"about_ca_topic_score_gemma":0.0061247433,"teacher_disagreement_score":0.4052986,"about_ca_system_score_codex":0.00066681736,"about_ca_system_score_gemma":0.00087423564,"threshold_uncertainty_score":0},"labels":[],"label_agreement":null},{"id":"W4405062157","doi":"10.1001/jamaoncol.2024.5381","title":"Estimation of Cancer Deaths Averted From Prevention, Screening, and Treatment Efforts, 1975-2020","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Cancer Institute; National Institutes of Health","keywords":"Medicine; Breast cancer; Cervical cancer; Colorectal cancer; Cancer prevention; Cancer; Population; Prostate cancer; Psychological intervention; Cancer registry; Gynecology; Oncology; Internal medicine; Environmental health","score_opus":0.058527763615800234,"score_gpt":0.3975389296846087,"score_spread":0.33901116606880843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405062157","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8812381,0.004371988,0.06474444,0.0011824458,0.00009553103,0.00042600147,0.032737926,0.00050820987,0.0146954255],"genre_scores_gemma":[0.978869,0.001163431,0.007873947,0.00012740558,0.000020847006,0.00023586812,0.009407412,0.00001791375,0.0022840651],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99930656,0.0003204506,0.000049435013,0.00011631124,0.00011717151,0.00009002618],"domain_scores_gemma":[0.9983479,0.0009566217,0.00029869034,0.00007625212,0.0002378047,0.000082794664],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024297347,0.0006704927,0.00040651535,0.0014820548,0.00015684306,0.00064662745,0.0006713728,0.0005615933,0.0021697546],"category_scores_gemma":[0.006650245,0.000295001,0.0013595024,0.00092906575,0.00022917213,0.0006918325,0.00056139764,0.00038328615,0.00046648883],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025841242,0.000075444026,0.13286975,0.0002952252,0.000715533,0.000090494505,0.00006495475,0.8400466,0.00029874654,0.0035292462,0.001865225,0.019890338],"study_design_scores_gemma":[0.00012882226,0.0006332297,0.19517079,0.00036563256,0.0009313024,0.00028762312,0.00043099304,0.7840697,0.0018060766,0.0072898646,0.008794455,0.00009153825],"about_ca_topic_score_codex":0.05240241,"about_ca_topic_score_gemma":0.026035577,"teacher_disagreement_score":0.05240241,"about_ca_system_score_codex":0.0038469762,"about_ca_system_score_gemma":0.0023629824,"threshold_uncertainty_score":0.10419476},"labels":[],"label_agreement":null},{"id":"W4405566423","doi":"10.1001/jamaoncol.2024.5403","title":"Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Princess Margaret Cancer Centre; Hamilton Health Sciences; University Health Network; University of Toronto; Centre Hospitalier de l’Université de Montréal","funders":"National Cancer Institute","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Clinical endpoint; Hazard ratio; Adverse effect; Oncology; Randomized controlled trial; Liver function; Progression-free survival; Radiation therapy; Confidence interval; Chemotherapy","score_opus":0.04433366409207469,"score_gpt":0.2965384348592674,"score_spread":0.2522047707671927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405566423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919308,0.0056137694,0.00034734386,0.0005088281,0.00021318918,0.00055213226,0.00018023589,0.000022337314,0.0006313004],"genre_scores_gemma":[0.9973634,0.0012163529,0.0002911476,0.0001889923,0.00012034157,0.00040734754,0.00011457508,0.000003415003,0.00029456045],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99928206,0.00044422163,0.00006340976,0.00007070571,0.00006295532,0.00007677178],"domain_scores_gemma":[0.9991309,0.0002891745,0.0003238616,0.000034679484,0.000032608852,0.0001887397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021648286,0.00057032355,0.0015095631,0.0002854077,0.00018779437,0.00053427665,0.00044330634,0.00066663336,0.0031745383],"category_scores_gemma":[0.0017564907,0.00026196093,0.0015788587,0.0003451869,0.00042126517,0.0005613102,0.00033029722,0.0010385906,0.00035953574],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91116995,0.0046102577,0.006426784,0.0010039298,0.0019420463,0.000059842485,0.00007275224,0.0019735661,0.0045056925,0.00018430568,0.00076064933,0.06729027],"study_design_scores_gemma":[0.52964395,0.42353797,0.031630687,0.00022088992,0.0034935616,0.00026858467,0.00014327714,0.004715832,0.003571404,0.00082675647,0.0019059307,0.00004106764],"about_ca_topic_score_codex":0.0005639588,"about_ca_topic_score_gemma":0.001910055,"teacher_disagreement_score":0.0031745383,"about_ca_system_score_codex":0.00078687636,"about_ca_system_score_gemma":0.001005321,"threshold_uncertainty_score":0.011448801},"labels":[],"label_agreement":null},{"id":"W4405615932","doi":"10.1001/jamaoncol.2024.5661","title":"Government Funding for the Development of Enzalutamide","year":2024,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Enzalutamide; Medicine; Government (linguistics); Drug development; Family medicine; Cancer; Drug; Prostate cancer; Pharmacology; Internal medicine","score_opus":0.07835133754982908,"score_gpt":0.40447987717722983,"score_spread":0.32612853962740074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405615932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":"incentives","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":"incentives","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8768311,0.005448785,0.0006310558,0.009768799,0.00027743177,0.0001937233,0.029199032,0.00012081494,0.07752931],"genre_scores_gemma":[0.9836811,0.0017820273,0.00032944643,0.00085266784,0.000107685024,0.00012662106,0.005598902,0.000020846173,0.0075006266],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968395,0.001158255,0.00024170087,0.00019578854,0.0009534608,0.0006111552],"domain_scores_gemma":[0.9883759,0.0018135781,0.0067999326,0.0006005087,0.0014246413,0.0009855195],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0019500729,0.00014961968,0.00017871159,0.0012511017,0.0007397464,0.0011708444,0.0004899486,0.00050673325,0.0070861215],"category_scores_gemma":[0.00964608,0.00016928319,0.00026952592,0.0027138263,0.00038487813,0.00048991246,0.0006163656,0.0008841614,0.0011000596],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013687378,0.00033368537,0.91506404,0.00031937103,0.00020125983,0.00043791815,0.00029575432,0.00030537494,0.0007339115,0.00531716,0.025038091,0.0505848],"study_design_scores_gemma":[0.00013226495,0.00036965442,0.93208545,0.00019441615,0.00013808289,0.0009563537,0.000615362,0.00033893654,0.00068068487,0.0003848772,0.06408817,0.000015764726],"about_ca_topic_score_codex":0.023295825,"about_ca_topic_score_gemma":0.027164007,"teacher_disagreement_score":0.9980499,"about_ca_system_score_codex":0.0021730277,"about_ca_system_score_gemma":0.0056925127,"threshold_uncertainty_score":0.04632044},"labels":[],"label_agreement":null},{"id":"W4405989572","doi":"10.1001/jamaoncol.2024.5627","title":"Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Cancer Institute","keywords":"Medicine; Brentuximab vedotin; Bendamustine; Internal medicine; Nivolumab; Oncology; Young adult; Cohort; Pediatrics; Hodgkin lymphoma; Cancer; Lymphoma; Rituximab","score_opus":0.008159520686991968,"score_gpt":0.2401589212079284,"score_spread":0.23199940052093643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989572","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932549,0.0045657265,0.0003380354,0.0001989967,0.0000323587,0.00036486957,0.00030674768,0.0000142605695,0.00092408934],"genre_scores_gemma":[0.9959246,0.0015680616,0.0009369331,0.00038965698,0.00005354042,0.0003468812,0.0005091804,0.000003870031,0.0002671907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967647,0.0001446671,0.000030362706,0.000049649803,0.00004361094,0.00005520968],"domain_scores_gemma":[0.9995968,0.000070600414,0.00014333398,0.000024683348,0.000028276318,0.00013639379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009166119,0.00020478516,0.00042539323,0.00017402253,0.00019950893,0.00036650183,0.00027760424,0.00026769252,0.0011630999],"category_scores_gemma":[0.0008946796,0.000097760414,0.00043749326,0.00020809172,0.00020643193,0.00035808384,0.00030504516,0.0004228407,0.00016171194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.059923634,0.0065798387,0.59759164,0.0012306152,0.0012370645,0.00056577614,0.0004029362,0.0024582993,0.009472424,0.0005379714,0.004077405,0.3159224],"study_design_scores_gemma":[0.027826065,0.11322738,0.8336763,0.00054135284,0.0012915251,0.0021902109,0.000683165,0.0019292282,0.004264601,0.00051911623,0.013823996,0.000027088325],"about_ca_topic_score_codex":0.001133101,"about_ca_topic_score_gemma":0.0048758783,"teacher_disagreement_score":0.0011630999,"about_ca_system_score_codex":0.00054184475,"about_ca_system_score_gemma":0.0012098512,"threshold_uncertainty_score":0.004847586},"labels":[],"label_agreement":null},{"id":"W4405989592","doi":"10.1001/jamaoncol.2024.5648","title":"Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma","year":2025,"lang":"en","type":"letter","venue":"JAMA Oncology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"National Cancer Institute","keywords":"Medicine; Salvage therapy; Hodgkin lymphoma; Lymphoma; Radiation therapy; Chemotherapy; Oncology; Clinical trial; Internal medicine; Surgery","score_opus":0.015207195881695454,"score_gpt":0.2821397839153472,"score_spread":0.2669325880336518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405989592","genre_codex":"empirical","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.529104,0.061611947,0.0016526907,0.27873895,0.019422794,0.001154801,0.0090232035,0.00024703157,0.099044584],"genre_scores_gemma":[0.75946367,0.0116376635,0.0012384631,0.20121947,0.0076410216,0.0010992227,0.0033741642,0.00004707353,0.01427941],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99894434,0.0007382838,0.000060764298,0.00006187342,0.000114534974,0.00008021017],"domain_scores_gemma":[0.9975598,0.0015245699,0.00031333423,0.00008710949,0.00014064384,0.00037452427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001052903,0.00016779524,0.00044541265,0.00014493286,0.00030586086,0.00046523922,0.00038966886,0.0018293033,0.0042905966],"category_scores_gemma":[0.0047670826,0.000081965045,0.0005452187,0.00025680926,0.00034752503,0.00034578616,0.00022932714,0.0015974066,0.00071709056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13165496,0.0035252618,0.040743165,0.0019100289,0.0014364047,0.0027768107,0.00023775625,0.0019055885,0.003374655,0.0052692494,0.39722717,0.40993896],"study_design_scores_gemma":[0.26896083,0.060389042,0.124203004,0.0021411916,0.0024308856,0.0073472364,0.00056571845,0.0040466045,0.008013641,0.012661916,0.50911176,0.00012819051],"about_ca_topic_score_codex":0.00075911224,"about_ca_topic_score_gemma":0.003562553,"teacher_disagreement_score":0.0042905966,"about_ca_system_score_codex":0.00079780916,"about_ca_system_score_gemma":0.00080677174,"threshold_uncertainty_score":0.014353514},"labels":[],"label_agreement":null},{"id":"W4407768026","doi":"10.1001/jamaoncol.2024.7012","title":"Improving the Clinical Utility of FRAX in Patients With Cancer—The Need for More Detailed Analysis—Reply","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Medical Imaging Techniques and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba; University of Manitoba; University of Alberta","funders":"","keywords":"Medicine; FRAX; Intensive care medicine; Medical physics; MEDLINE; Oncology; Internal medicine","score_opus":0.030155862172930707,"score_gpt":0.41060784987947435,"score_spread":0.38045198770654365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407768026","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038548248,0.002467103,0.000168866,0.9798993,0.016437823,0.000014379091,0.00013298226,0.00003492795,0.00045920725],"genre_scores_gemma":[0.002105538,0.0015006142,0.00035952014,0.9738511,0.021074055,0.00003124016,0.000049543913,0.000020726417,0.0010076844],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99633056,0.0011277054,0.0008829739,0.0005575917,0.00079464616,0.00030649448],"domain_scores_gemma":[0.9685554,0.020223502,0.001403811,0.0009131955,0.0066942736,0.002209774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007593947,0.00087965856,0.0021912782,0.0010400148,0.002170459,0.002939651,0.0024418624,0.035376973,0.0036040123],"category_scores_gemma":[0.05010702,0.00094225776,0.0014390609,0.0012300859,0.0033020095,0.0044058193,0.0019409215,0.053021528,0.003242112],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016503897,0.000046806108,0.0026215077,0.00014322491,0.00005795458,0.00046674255,0.00015849333,0.00010185119,0.0003640936,0.0014875404,0.9826822,0.011704469],"study_design_scores_gemma":[0.00039263585,0.00022954463,0.010735158,0.00091973896,0.00020556262,0.002566632,0.0015496317,0.0007125207,0.0013385996,0.009287679,0.9716864,0.0003758905],"about_ca_topic_score_codex":0.009199752,"about_ca_topic_score_gemma":0.011110465,"teacher_disagreement_score":0.035376973,"about_ca_system_score_codex":0.0027113107,"about_ca_system_score_gemma":0.003638458,"threshold_uncertainty_score":0.040161073},"labels":[],"label_agreement":null},{"id":"W4408405629","doi":"10.1001/jamaoncol.2025.0029","title":"Veliparib Plus Temozolomide for <i>MGMT</i>-Methylated Glioblastoma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Veliparib; Temozolomide; Medicine; Glioblastoma; Oncology; O-6-methylguanine-DNA methyltransferase; Cancer research; Internal medicine; Methylation; Genetics; Methyltransferase; Poly ADP ribose polymerase; DNA","score_opus":0.0164503816226078,"score_gpt":0.3369605497561127,"score_spread":0.3205101681335049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408405629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9468269,0.022913098,0.001740882,0.003884015,0.00078201,0.00027273872,0.0015907966,0.00035782089,0.021631729],"genre_scores_gemma":[0.9900523,0.0042859386,0.0007398583,0.0011624878,0.00014669732,0.00007190051,0.0010111512,0.00003810063,0.0024916125],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9999424,0.000010152468,0.0000055740766,0.000008738664,0.000008117429,0.000024924402],"domain_scores_gemma":[0.999925,0.000012143567,0.000020030964,0.0000053710564,0.000006257235,0.000031266016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012524062,0.00019056135,0.0004608547,0.00015527541,0.00018869668,0.00032820387,0.0002529057,0.00019729315,0.0023761177],"category_scores_gemma":[0.00041129568,0.00008272278,0.0004600449,0.0002161472,0.00011836261,0.0002499705,0.00019448982,0.0007124484,0.00042245493],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.058720145,0.0010655923,0.015247154,0.0015036865,0.0012907509,0.0036345462,0.00013645891,0.0044129053,0.025470942,0.0029830006,0.042303167,0.8432317],"study_design_scores_gemma":[0.07777352,0.090071835,0.28539127,0.0024283398,0.006716256,0.054507837,0.0010902641,0.027175285,0.081760734,0.027418602,0.34526512,0.00040098018],"about_ca_topic_score_codex":0.0015753335,"about_ca_topic_score_gemma":0.005766769,"teacher_disagreement_score":0.0023761177,"about_ca_system_score_codex":0.0007458463,"about_ca_system_score_gemma":0.00054943335,"threshold_uncertainty_score":0.007948875},"labels":[],"label_agreement":null},{"id":"W4409148665","doi":"10.1001/jamaoncol.2025.0329","title":"Chromosome 1p Loss and 1q Gain for Grading of Meningioma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Meningioma and schwannoma management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Medicine; Meningioma; CDKN2A; Grading (engineering); Internal medicine; CDKN2B; Proportional hazards model; Oncology; Concordance; Cohort; Pathology; Cancer; Biology","score_opus":0.022009808259677036,"score_gpt":0.339073733570681,"score_spread":0.31706392531100397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409148665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769767,0.006121248,0.0044276444,0.0012853661,0.00020025963,0.00019723877,0.005337067,0.00010398174,0.0053504524],"genre_scores_gemma":[0.9953849,0.0007261955,0.0019886706,0.000058863894,0.00006495773,0.000030053041,0.0011948501,0.0000104096525,0.00054115674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99925333,0.000205927,0.000107980646,0.0001250579,0.00025197474,0.000055797227],"domain_scores_gemma":[0.998262,0.00029505198,0.0007812908,0.000149018,0.00028667433,0.00022598293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017105442,0.0004985197,0.00025380962,0.00263909,0.00032227117,0.0006572126,0.0005820575,0.00023123335,0.0020954392],"category_scores_gemma":[0.004282824,0.00012483822,0.00040044173,0.0016340868,0.00043044525,0.0004751538,0.00053216744,0.00039530755,0.00029040358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001517718,0.000009010015,0.988366,0.000044965127,0.00006324347,0.000121179946,0.00004400544,0.00020331926,0.000877279,0.000074888616,0.0008452647,0.009199085],"study_design_scores_gemma":[0.00001394192,0.00013250226,0.9945279,0.000076678145,0.00009442131,0.00073287723,0.00011407145,0.0012766828,0.0007058983,0.00022915566,0.0020839218,0.000012081639],"about_ca_topic_score_codex":0.016343938,"about_ca_topic_score_gemma":0.03302527,"teacher_disagreement_score":0.016343938,"about_ca_system_score_codex":0.0008072808,"about_ca_system_score_gemma":0.0011516063,"threshold_uncertainty_score":0.032497644},"labels":[],"label_agreement":null},{"id":"W4409329509","doi":"10.1001/jamaoncol.2025.0519","title":"Local Control and Extended Survival in Locally Advanced Hepatocellular Carcinoma—Reply","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Oncology; Internal medicine; MEDLINE","score_opus":0.02245679219716079,"score_gpt":0.27309288930963216,"score_spread":0.25063609711247137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409329509","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011063229,0.00605666,0.00008278211,0.9647451,0.026925657,0.000009790812,0.00028517033,0.00001564818,0.0007729096],"genre_scores_gemma":[0.01455841,0.01001003,0.00025783063,0.8802785,0.09096462,0.00007164288,0.000392664,0.000026116144,0.0034402064],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993456,0.00019726106,0.00014489907,0.000121145305,0.00011025978,0.00008075128],"domain_scores_gemma":[0.9936668,0.0039747297,0.00041637864,0.00018613737,0.0010371023,0.000718824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023399722,0.0005249162,0.0012566353,0.0006043501,0.0010253033,0.0015233975,0.0013433242,0.010627278,0.00411906],"category_scores_gemma":[0.013554522,0.00049016863,0.00073027087,0.0011538886,0.001114701,0.002954207,0.0010589584,0.024417737,0.0022062704],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031089384,0.000055010623,0.0050892513,0.00016869072,0.00007549073,0.00036781686,0.00009350549,0.00013090347,0.00013936037,0.0009700971,0.9776545,0.0149444435],"study_design_scores_gemma":[0.0010169218,0.00038746296,0.036682222,0.00084818195,0.00044240296,0.0031498368,0.0023212011,0.0009407366,0.0006881586,0.011477642,0.9417391,0.00030605946],"about_ca_topic_score_codex":0.0062773842,"about_ca_topic_score_gemma":0.01019781,"teacher_disagreement_score":0.010627278,"about_ca_system_score_codex":0.0015658134,"about_ca_system_score_gemma":0.0021294258,"threshold_uncertainty_score":0.01377964},"labels":[],"label_agreement":null},{"id":"W4409329675","doi":"10.1001/jamaoncol.2025.0473","title":"National Cancer System Characteristics and Global Pan-Cancer Outcomes","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"National Cancer Institute","keywords":"Medicine; Demography; Population; Per capita; Human Development Index; Gross domestic product; Cancer; Gross national income; Gerontology; Environmental health; Human development (humanity); Economic growth; Internal medicine","score_opus":0.02895249680210092,"score_gpt":0.3086793287352443,"score_spread":0.27972683193314335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409329675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90499866,0.0026494293,0.0018365167,0.0026788723,0.00009727622,0.00023207367,0.073004894,0.00019633818,0.014305849],"genre_scores_gemma":[0.9884494,0.0002183217,0.0004258565,0.000114967275,0.00003045969,0.00012209792,0.010180944,0.000022862414,0.00043503317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990294,0.0002626933,0.0001326119,0.00018056952,0.00021868969,0.00017606244],"domain_scores_gemma":[0.99332666,0.0011036429,0.0035153115,0.0003654737,0.0008881142,0.0008007563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019848428,0.0002504273,0.00040113615,0.0022563923,0.0005939866,0.00087010866,0.00044671778,0.00030393738,0.0074012764],"category_scores_gemma":[0.008364356,0.00011656845,0.000664815,0.006211883,0.00037943377,0.00088400726,0.001103927,0.00071895035,0.0005340167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029585313,0.000009324243,0.99691087,0.000040834002,0.00006956067,0.000010620811,0.000037919453,0.00026819887,0.000013167324,0.0001070134,0.0012234952,0.0012794546],"study_design_scores_gemma":[0.000005183591,0.00004438412,0.9962734,0.000030895353,0.00005668949,0.00009406645,0.00019537061,0.00058030465,0.00003633789,0.00019507998,0.002479894,0.000008364484],"about_ca_topic_score_codex":0.021540063,"about_ca_topic_score_gemma":0.028865954,"teacher_disagreement_score":0.021540063,"about_ca_system_score_codex":0.0012642648,"about_ca_system_score_gemma":0.0016639488,"threshold_uncertainty_score":0.042829394},"labels":[],"label_agreement":null},{"id":"W4409994539","doi":"10.1001/jamaoncol.2025.0908","title":"Modeling Population-Level Impacts of Cell-Free DNA Screening for Colorectal Cancer in Canada","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Paul's Hospital; Providence Health Care; BC Cancer Agency; Alberta Health Services; University of Calgary","funders":"","keywords":"Medicine; Colorectal cancer; Colonoscopy; Population; Cell-free fetal DNA; Cancer; Colorectal cancer screening; Internal medicine; Oncology; Demography; Environmental health","score_opus":0.016289173855125932,"score_gpt":0.2875883100314656,"score_spread":0.2712991361763397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409994539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95952874,0.0010128384,0.0074414182,0.002766683,0.00008382609,0.00029540286,0.014775884,0.00017124119,0.013923941],"genre_scores_gemma":[0.9889864,0.00046405863,0.0030787971,0.00022853301,0.000011685104,0.00010572536,0.0025675162,0.000023532544,0.004533809],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992207,0.00018906241,0.000023343297,0.00014014207,0.00009790934,0.0003288285],"domain_scores_gemma":[0.99720156,0.001136275,0.00029148205,0.00007173782,0.0009029809,0.00039602903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012987215,0.0010186669,0.0008692133,0.0011754776,0.0011657209,0.001545681,0.0026170376,0.0015893537,0.0050085774],"category_scores_gemma":[0.0059148413,0.0007191981,0.0016673291,0.0018002242,0.0010127989,0.0004996391,0.0010246744,0.0013212828,0.00026483988],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013786553,0.000063144245,0.031850964,0.000040798586,0.00013469397,0.00011993887,0.00005767768,0.9616787,0.00010179886,0.0021369678,0.0016629329,0.0020145173],"study_design_scores_gemma":[0.00018516078,0.00009247419,0.016069923,0.00003692259,0.00019208007,0.00004476129,0.00026037626,0.9797917,0.00010928863,0.001322054,0.0018544903,0.000040696425],"about_ca_topic_score_codex":0.9833294,"about_ca_topic_score_gemma":0.96140945,"teacher_disagreement_score":0.04124859,"about_ca_system_score_codex":0.04124859,"about_ca_system_score_gemma":0.035880648,"threshold_uncertainty_score":0.29928088},"labels":[],"label_agreement":null},{"id":"W4410932301","doi":"10.1001/jamaoncol.2025.1002","title":"Overall Survival and Quality-of-Life Superiority in Modern Phase 3 Oncology Trials","year":2025,"lang":"en","type":"review","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Internal medicine; Clinical trial; End point; Oncology","score_opus":0.26053154335615336,"score_gpt":0.5225963334631009,"score_spread":0.2620647901069475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410932301","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.069396146,0.7954806,0.077457376,0.020069277,0.006052057,0.0154810585,0.004121372,0.0004020309,0.011540033],"genre_scores_gemma":[0.85305583,0.054861527,0.062409684,0.009859588,0.0037343914,0.013271658,0.0017456064,0.00019793588,0.00086379104],"study_design_codex":"meta_analysis","study_design_gemma":"systematic_review","domain_scores_codex":[0.47929397,0.40486905,0.07880734,0.012278767,0.02377049,0.000980409],"domain_scores_gemma":[0.2573676,0.62248224,0.08893448,0.017612185,0.012370381,0.0012331501],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.314125,0.0021775684,0.008530438,0.0041851364,0.00091827754,0.0060056765,0.0019148835,0.0042384504,0.0077351797],"category_scores_gemma":[0.5416508,0.0012007527,0.015368508,0.00590026,0.003718623,0.0075219492,0.0024872194,0.0041943933,0.0005723117],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042615917,0.0004635387,0.07335936,0.30393216,0.30647394,0.00048207407,0.0012129748,0.003406664,0.002015033,0.009381059,0.011488846,0.24516837],"study_design_scores_gemma":[0.06505587,0.017872592,0.1333406,0.1898,0.413188,0.002202144,0.0013671622,0.019947268,0.0054298346,0.074289314,0.07679782,0.0007093789],"about_ca_topic_score_codex":0.0005867427,"about_ca_topic_score_gemma":0.001324135,"teacher_disagreement_score":0.314125,"about_ca_system_score_codex":0.0024227467,"about_ca_system_score_gemma":0.0033404278,"threshold_uncertainty_score":0.845806},"labels":[],"label_agreement":null},{"id":"W4411046343","doi":"10.1001/jamaoncol.2025.1340","title":"Body Mass Index, Physical Activity, and Subsequent Neoplasm Risk Among Childhood Cancer Survivors","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Medicine; Body mass index; Cancer; Cohort; Cohort study; Pediatrics; Cancer registry; Internal medicine; Young adult","score_opus":0.013623695164829579,"score_gpt":0.3325704076860578,"score_spread":0.3189467125212282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411046343","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99828064,0.00026778015,0.00012041331,0.000050615,0.0000038158632,0.0000057631337,0.00097364065,0.0000051659554,0.0002923094],"genre_scores_gemma":[0.9984479,0.00020467599,0.000122821,0.0000111118525,0.000004462216,0.0000075767866,0.0009919682,0.0000021127241,0.0002075149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998313,0.000034217053,0.00001629282,0.000038160782,0.000046966685,0.000033013595],"domain_scores_gemma":[0.99917114,0.00013310793,0.00044451558,0.00006642496,0.0000793577,0.000105554616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043543478,0.00019463472,0.00014516506,0.0005148751,0.0002110283,0.00035658816,0.00021504452,0.00017816204,0.0012780196],"category_scores_gemma":[0.0018899335,0.0001533131,0.0003828271,0.0007631763,0.00013462768,0.00019772534,0.00030703447,0.0003050312,0.00012445917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002146164,0.000007158223,0.99932444,0.0000031688178,0.000020658912,0.000009624087,0.000011477151,0.000041309926,0.00003494322,0.000004979092,0.000032542,0.0004883626],"study_design_scores_gemma":[0.000001650816,0.00003440834,0.99941623,0.000005057937,0.000022040938,0.000064786684,0.00003901963,0.00023589323,0.000038738945,0.00000859887,0.00013242685,0.0000010216237],"about_ca_topic_score_codex":0.01844541,"about_ca_topic_score_gemma":0.033670157,"teacher_disagreement_score":0.01844541,"about_ca_system_score_codex":0.0002825721,"about_ca_system_score_gemma":0.0004838869,"threshold_uncertainty_score":0.03667605},"labels":[],"label_agreement":null},{"id":"W4412003127","doi":"10.1001/jamaoncol.2025.1891","title":"First-Line Therapy For Advanced Non–Clear Cell Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Oncology; Renal cell carcinoma; Meta-analysis; Cochrane Library; Observational study; MEDLINE; Clinical trial; Immunotherapy; Atezolizumab; Nivolumab; Cancer","score_opus":0.020000997743431965,"score_gpt":0.3031120302561916,"score_spread":0.28311103251275965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412003127","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018569619,0.9958275,0.0002409754,0.000548075,0.00018622023,0.0001516098,0.0006337659,0.000006891525,0.0005479339],"genre_scores_gemma":[0.08860827,0.90429455,0.0022163065,0.0014432775,0.0008769466,0.00055032264,0.0015334472,0.000009785426,0.00046707838],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9928479,0.0033018824,0.0019909425,0.00053877203,0.0011906954,0.00012974504],"domain_scores_gemma":[0.9786164,0.013450471,0.0058901184,0.0003057938,0.0015119748,0.00022512754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010377011,0.00071430195,0.0051041045,0.004022203,0.0002885649,0.0018196278,0.0009775087,0.0010704232,0.004575332],"category_scores_gemma":[0.021521026,0.00030664072,0.004838771,0.004483391,0.0004223957,0.0016127664,0.0005819987,0.0010524488,0.0005051286],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022135002,0.000070937254,0.0076718107,0.7036268,0.024308676,0.00023416385,0.00013179344,0.0005513877,0.00070865883,0.00081236596,0.007630613,0.25203928],"study_design_scores_gemma":[0.0046209837,0.0031369976,0.046413686,0.66981906,0.14076458,0.0027437403,0.0006246493,0.0014750795,0.002254001,0.0033088536,0.12467635,0.00016211359],"about_ca_topic_score_codex":0.003309801,"about_ca_topic_score_gemma":0.009502891,"teacher_disagreement_score":0.010377011,"about_ca_system_score_codex":0.0019093797,"about_ca_system_score_gemma":0.0039522583,"threshold_uncertainty_score":0.054879487},"labels":[],"label_agreement":null},{"id":"W4413043431","doi":"10.1001/jamaoncol.2025.2361","title":"Bacterial Decolonization With Mupirocin Ointment for Acute Radiation Oral Mucositis Prevention","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Oral health in cancer treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mucositis; Nasopharyngeal carcinoma; Mupirocin; Radiation therapy; Head and neck cancer; Internal medicine; Surgery; Quality of life (healthcare); Gastroenterology; Methicillin-resistant Staphylococcus aureus; Staphylococcus aureus","score_opus":0.021398022668147963,"score_gpt":0.41643659211267603,"score_spread":0.3950385694445281,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413043431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900988,0.0075958176,0.00048423494,0.0001435627,0.000076712,0.0009861995,0.0000770104,0.000029145982,0.0005085979],"genre_scores_gemma":[0.993755,0.00336924,0.0013467883,0.00015557805,0.00006631682,0.00071241567,0.000078171535,0.0000033188082,0.0005130899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980634,0.00007718538,0.00002468198,0.000026013635,0.000035411893,0.000030388146],"domain_scores_gemma":[0.9997619,0.00004436487,0.00009474368,0.000014094537,0.00002014172,0.000064715954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065122754,0.00036397937,0.0007890828,0.00029000128,0.0002142682,0.0002296271,0.00027938,0.0003745808,0.001610575],"category_scores_gemma":[0.00046461655,0.0001345122,0.0006693466,0.00023279489,0.0002920804,0.00023482395,0.00019597064,0.00055642636,0.00010905507],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3055265,0.039936543,0.012531098,0.006821137,0.0014940791,0.0002449105,0.00020696149,0.0010784606,0.10912235,0.00024071983,0.0015228377,0.5212744],"study_design_scores_gemma":[0.17046355,0.71119225,0.0789407,0.00052612915,0.0017783891,0.00044852935,0.00013149642,0.002084325,0.02807556,0.00015115527,0.006167832,0.00004009091],"about_ca_topic_score_codex":0.0004332592,"about_ca_topic_score_gemma":0.0015304077,"teacher_disagreement_score":0.001610575,"about_ca_system_score_codex":0.00020805838,"about_ca_system_score_gemma":0.00057578436,"threshold_uncertainty_score":0.0053879023},"labels":[],"label_agreement":null},{"id":"W4413375901","doi":"10.1001/jamaoncol.2025.2590","title":"Predicting Chronic Kidney Disease After Cisplatin Treatment Using Population-Level Data","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Chemotherapy-induced organ toxicity mitigation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Institute for Clinical Evaluative Sciences; Princess Margaret Cancer Centre; University Health Network; Ontario Institute for Cancer Research","funders":"National Cancer Institute","keywords":"Medicine; Kidney disease; Internal medicine; Cohort; Population; Retrospective cohort study; Renal function; Incidence (geometry); Environmental health","score_opus":0.06722165293175308,"score_gpt":0.375462238814315,"score_spread":0.3082405858825619,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413375901","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9839893,0.00044449742,0.0040543657,0.00048756893,0.00002695706,0.00006631837,0.009924996,0.0000738797,0.0009322457],"genre_scores_gemma":[0.9941121,0.00013526833,0.0011365095,0.000053073632,0.000016320748,0.000025324878,0.0044037136,0.000004886265,0.00011286937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871814,0.00038249575,0.00013339416,0.0003723413,0.00028141044,0.00011226949],"domain_scores_gemma":[0.9916317,0.0029593683,0.0028506822,0.00082091545,0.0013057712,0.0004315872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033909678,0.0004140401,0.000460083,0.001257516,0.00033806224,0.0010264791,0.0006402206,0.0004562235,0.0009094692],"category_scores_gemma":[0.014521508,0.00021203997,0.0008426769,0.0020081822,0.000347366,0.0005612714,0.00058518344,0.0007115514,0.00021923479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002292854,0.000007894889,0.99773127,0.000006242733,0.000080468366,0.000010574176,0.000009921342,0.0010507172,0.000019591687,0.000016285989,0.00019123571,0.0008529022],"study_design_scores_gemma":[0.000017507882,0.00008119863,0.9766632,0.000021948057,0.0001386906,0.00011881799,0.00007153526,0.021742027,0.00011575607,0.00020069582,0.00081537553,0.000013358205],"about_ca_topic_score_codex":0.10995539,"about_ca_topic_score_gemma":0.12017144,"teacher_disagreement_score":0.10995539,"about_ca_system_score_codex":0.0014308173,"about_ca_system_score_gemma":0.0024318104,"threshold_uncertainty_score":0.21863079},"labels":[],"label_agreement":null},{"id":"W4413375935","doi":"10.1001/jamaoncol.2025.2738","title":"Impact of a Weight Loss Intervention on 1-Year Weight Change in Women With Stage II/III Breast Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Risks and Factors","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Victoria; University of British Columbia; University of Toronto; Mount Sinai Hospital","funders":"National Cancer Institute","keywords":"Medicine; Breast cancer; Weight change; Weight loss; Body mass index; Obesity; Population; Randomized controlled trial; Cancer; Internal medicine; Overweight; Physical therapy; Gynecology","score_opus":0.015166605637391705,"score_gpt":0.3595881782400391,"score_spread":0.3444215726026474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413375935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556184,0.0009245875,0.0002858414,0.0005208416,0.00014445234,0.0008876315,0.00024518403,0.000071624505,0.0013581045],"genre_scores_gemma":[0.9953864,0.00054559024,0.001191814,0.00047151296,0.000100576224,0.0012670205,0.0002846893,0.0000074560257,0.00074489403],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99949455,0.00024483306,0.000036907408,0.000071870556,0.000067365894,0.00008445218],"domain_scores_gemma":[0.9991805,0.0003022966,0.00021304202,0.000048232305,0.00004349811,0.00021240297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012092637,0.00045550082,0.00070765143,0.00027073667,0.00027655653,0.00030448523,0.00040932195,0.00074366323,0.00437401],"category_scores_gemma":[0.0039605107,0.0001645081,0.0012974321,0.00020281342,0.00024558385,0.00034043228,0.00055846263,0.0009945475,0.00028080362],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3255607,0.101477295,0.02379513,0.0021089925,0.0018546233,0.00009588001,0.00035949057,0.0035158657,0.004678114,0.00016213124,0.0032065762,0.53318524],"study_design_scores_gemma":[0.19538873,0.48543838,0.30258492,0.0006363625,0.002782696,0.00012049113,0.0002786553,0.00639736,0.0026343346,0.000457432,0.003224902,0.000055763147],"about_ca_topic_score_codex":0.0031853877,"about_ca_topic_score_gemma":0.00439572,"teacher_disagreement_score":0.00437401,"about_ca_system_score_codex":0.0005473945,"about_ca_system_score_gemma":0.001033333,"threshold_uncertainty_score":0.014632463},"labels":[],"label_agreement":null},{"id":"W4414123226","doi":"10.1001/jamaoncol.2025.3153","title":"Patient-Reported Outcomes as Prognostic Indicators for Overall Survival in Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer survivorship and care","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre; BC Cancer Agency; University of Toronto","funders":"","keywords":"Overall survival; Cancer; Risk stratification; MEDLINE; Survival analysis; Cancer survival; Prognostic model; Proportional hazards model","score_opus":0.021739823009151598,"score_gpt":0.36028717613197114,"score_spread":0.3385473531228195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414123226","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022030647,0.9947641,0.0007399906,0.00075571233,0.00033562252,0.00026762256,0.000581818,0.000009745457,0.00034232225],"genre_scores_gemma":[0.16199112,0.82295173,0.006845926,0.0024871211,0.0013295617,0.002947325,0.0011228645,0.000026011625,0.00029829235],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9249046,0.05113582,0.01353766,0.0029493687,0.00702347,0.00044901468],"domain_scores_gemma":[0.8161028,0.1491458,0.026690606,0.002220335,0.005432814,0.00040774554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.044243764,0.001574918,0.006881959,0.006403885,0.0003729195,0.0035262622,0.001631499,0.002246203,0.0024361496],"category_scores_gemma":[0.15741922,0.00075950805,0.013823042,0.008819113,0.0012592773,0.0028804974,0.0011482243,0.0028222827,0.00025010185],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022138574,0.00008209052,0.01989449,0.7554872,0.10057929,0.00008502241,0.00032635656,0.0012724685,0.00020137368,0.0019247832,0.003579422,0.11435364],"study_design_scores_gemma":[0.003170299,0.0020277407,0.053867348,0.6092957,0.29235893,0.00048866594,0.00045950635,0.0023420881,0.0006002897,0.005080447,0.030058093,0.00025098416],"about_ca_topic_score_codex":0.0028250404,"about_ca_topic_score_gemma":0.00554131,"teacher_disagreement_score":0.044243764,"about_ca_system_score_codex":0.0025256204,"about_ca_system_score_gemma":0.004331607,"threshold_uncertainty_score":0.2339862},"labels":[],"label_agreement":null},{"id":"W4414508430","doi":"10.1001/jamaoncol.2025.3700","title":"Ribociclib Plus Endocrine Therapy in Hormone Receptor–Positive/ <i>ERBB2</i> -Negative Early Breast Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"BC Cancer Agency; College of Medicine, Seoul National University; University of California, Los Angeles; Instituto de Investigación Sanitaria Gregorio Marañón; Peter MacCallum Cancer Centre; Chinese Academy of Medical Sciences; Seoul National University Hospital; Universidad Complutense de Madrid; Seoul National University; Peking Union Medical College; University of Washington; University of Texas MD Anderson Cancer Center; Novartis Pharmaceuticals Corporation; Cancer Research Institute","keywords":"Endocrine system; Breast cancer; Hormone receptor; Cancer; Hormone therapy; Hormone","score_opus":0.012892989743431714,"score_gpt":0.33173204803363404,"score_spread":0.3188390582902023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414508430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844732,0.009040643,0.00048470587,0.0005373657,0.00017266361,0.0022376543,0.0005080536,0.000046614972,0.0024991492],"genre_scores_gemma":[0.9927798,0.0029047881,0.0009404393,0.00051411707,0.00019539568,0.0011756787,0.00045890777,0.0000072585904,0.0010236556],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988788,0.00079205167,0.000077803124,0.0000871657,0.000070336406,0.00009381242],"domain_scores_gemma":[0.9990477,0.00029241072,0.00027814857,0.000058657308,0.000041015097,0.00028203963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024374537,0.00065737887,0.0015073803,0.00039698236,0.00024166306,0.0006770932,0.0006078065,0.0005584339,0.0028324784],"category_scores_gemma":[0.0018293642,0.00029241113,0.0013355451,0.00049671467,0.0006276305,0.0007140182,0.00042324903,0.001505765,0.00028994793],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.91987616,0.009375879,0.0045793913,0.00093369436,0.0016228525,0.000094271636,0.000056697325,0.0009950192,0.005620647,0.0001720191,0.0006557079,0.056017775],"study_design_scores_gemma":[0.69430923,0.2874337,0.011558996,0.00012578849,0.0016681625,0.0001713697,0.000054887976,0.00063818373,0.0015014701,0.00028281286,0.0022336887,0.000021606842],"about_ca_topic_score_codex":0.0006745816,"about_ca_topic_score_gemma":0.004695927,"teacher_disagreement_score":0.0028324784,"about_ca_system_score_codex":0.000786551,"about_ca_system_score_gemma":0.0017020775,"threshold_uncertainty_score":0.012890637},"labels":[],"label_agreement":null},{"id":"W4414756817","doi":"10.1001/jamaoncol.2025.3458","title":"The Breakup Letter","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Educational Leadership and Practices","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ovarian Cancer Canada","funders":"","keywords":"","score_opus":0.043577352084523256,"score_gpt":0.440078787668521,"score_spread":0.39650143558399775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756817","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000307628,0.00077083125,0.000072463525,0.86627567,0.124294065,0.000022700488,0.000041842035,0.000045931614,0.00816895],"genre_scores_gemma":[0.0021960228,0.0003497077,0.000056738565,0.9390327,0.028671019,0.000032017964,0.000024224733,0.00003125003,0.029606389],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950616,0.0009008155,0.00035398453,0.00074027193,0.0015852969,0.0013580988],"domain_scores_gemma":[0.98757786,0.004618956,0.0005912564,0.00066952273,0.002902219,0.0036401842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040246737,0.00096250826,0.001389884,0.00090235675,0.007077082,0.00778054,0.0023940783,0.06337237,0.03515858],"category_scores_gemma":[0.04292134,0.0010256721,0.0020498645,0.0005786672,0.002992897,0.0033666703,0.0033797447,0.06186425,0.02365006],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016432132,0.000011515968,0.00012857378,0.000010271351,0.000005945293,0.00026376045,0.000031770145,0.000009497237,0.00003788193,0.00070823805,0.99683666,0.0019394421],"study_design_scores_gemma":[0.000052682546,0.00004077671,0.0007967859,0.00016108748,0.000017228738,0.0004375203,0.00041768354,0.00008552044,0.00013040361,0.0028463856,0.9949768,0.00003705616],"about_ca_topic_score_codex":0.0072016385,"about_ca_topic_score_gemma":0.01440363,"teacher_disagreement_score":0.06337237,"about_ca_system_score_codex":0.004661172,"about_ca_system_score_gemma":0.006930262,"threshold_uncertainty_score":0.11761713},"labels":[],"label_agreement":null},{"id":"W4414756848","doi":"10.1001/jamaoncol.2025.3746","title":"Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Public Works and Government Services Canada; Centre Integre de Sante et de Services Sociaux de Laval; Hôpital Charles-Le Moyne; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Prostatectomy; Radiation therapy; Prostate-specific antigen; Prostate cancer; Salvage therapy; Glutamate carboxypeptidase II","score_opus":0.018358800683848365,"score_gpt":0.32015336691437063,"score_spread":0.30179456623052225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414756848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958919,0.0012991546,0.00030643225,0.00015001235,0.00008761407,0.0010802234,0.00014384398,0.000030151912,0.0010105735],"genre_scores_gemma":[0.99733245,0.00049330085,0.0006088267,0.00017195517,0.00016021718,0.00072930875,0.00015896384,0.0000034092154,0.0003415513],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99933785,0.00032709603,0.000055072313,0.0001293804,0.000057925212,0.000092771734],"domain_scores_gemma":[0.9992373,0.00016237202,0.0003202365,0.000067733155,0.000021153193,0.00019124804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014559452,0.0006296712,0.0013451563,0.00026235834,0.00013907492,0.0004305339,0.00044844425,0.00046082944,0.0032847093],"category_scores_gemma":[0.0014866507,0.00029359528,0.001006365,0.00025489094,0.0005031224,0.00039313495,0.00032458064,0.00088608096,0.00029318017],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8840173,0.011647191,0.015512564,0.0007960488,0.0015297983,0.00007286151,0.00009268768,0.0025025662,0.0073975394,0.00023266241,0.0008440561,0.075354606],"study_design_scores_gemma":[0.42651615,0.47838297,0.083632454,0.00017109826,0.0020892008,0.00029422002,0.00005968397,0.002209449,0.0038103214,0.00046328205,0.0023343377,0.000036902245],"about_ca_topic_score_codex":0.0003629667,"about_ca_topic_score_gemma":0.0010826178,"teacher_disagreement_score":0.0032847093,"about_ca_system_score_codex":0.00047406284,"about_ca_system_score_gemma":0.000839346,"threshold_uncertainty_score":0.010988474},"labels":[],"label_agreement":null},{"id":"W4416194118","doi":"10.1001/jamaoncol.2025.4543","title":"Immune Checkpoint Inhibitor–Associated Cardiovascular Toxic Effects","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; Toronto General Hospital; Population Health Research Institute","funders":"","keywords":"Myocarditis; Pericarditis; Cardiotoxicity; Disease; Cancer; Acute pericarditis; Heart disease","score_opus":0.008894360964312868,"score_gpt":0.2788533286064106,"score_spread":0.26995896764209776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416194118","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32258567,0.5240242,0.012368506,0.043132722,0.0036303594,0.0008387984,0.0018801681,0.0006763618,0.0908632],"genre_scores_gemma":[0.9101248,0.06295728,0.0024361678,0.013128444,0.0044075754,0.00012787776,0.00095191365,0.000047966234,0.0058179996],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99917704,0.00022477556,0.00011287861,0.000092404785,0.0002709964,0.00012184329],"domain_scores_gemma":[0.99790454,0.00068277423,0.0007835895,0.00009200704,0.00032984387,0.00020725645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007288782,0.00027886507,0.00045055585,0.0002081566,0.0002862113,0.00057694677,0.00023031604,0.000588247,0.004738653],"category_scores_gemma":[0.0031327517,0.000071059505,0.00061294733,0.0002268867,0.0002891898,0.00040803125,0.0003597797,0.0016787386,0.00068543485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029833384,0.00046254313,0.17881025,0.0040016277,0.001295695,0.021622134,0.0002867045,0.0017967048,0.013748975,0.004738791,0.06028473,0.7099685],"study_design_scores_gemma":[0.0013638885,0.004240718,0.34042594,0.005215749,0.002545245,0.19999418,0.00055614975,0.0052300044,0.015544851,0.01339949,0.41132766,0.00015613463],"about_ca_topic_score_codex":0.00038529222,"about_ca_topic_score_gemma":0.00067726104,"teacher_disagreement_score":0.004738653,"about_ca_system_score_codex":0.00045532786,"about_ca_system_score_gemma":0.00046068977,"threshold_uncertainty_score":0.015852392},"labels":[],"label_agreement":null},{"id":"W4416424420","doi":"10.1001/jamaoncol.2025.4800","title":"Optimal Duration of Androgen Deprivation Therapy With Definitive Radiotherapy for Localized Prostate Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; McGill University Health Centre; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Prostate cancer; Androgen deprivation therapy; Radiation therapy; Duration (music); Androgen; MEDLINE","score_opus":0.021694330905656836,"score_gpt":0.33790397822259133,"score_spread":0.3162096473169345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416424420","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04776242,0.945005,0.0027377969,0.0012648577,0.00059775147,0.0004503626,0.00070672063,0.000043448144,0.0014315879],"genre_scores_gemma":[0.7840677,0.2022104,0.0075083184,0.0026173098,0.0009095113,0.001247029,0.0008744349,0.00003933957,0.000525825],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99137866,0.0054431,0.0015577977,0.0007183022,0.00070128875,0.0002009546],"domain_scores_gemma":[0.9876258,0.008308303,0.0031182854,0.00036645922,0.0002696628,0.00031156087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010629173,0.00060904166,0.005327814,0.0010520488,0.00020399374,0.0017314473,0.0011072747,0.0011996021,0.0026269797],"category_scores_gemma":[0.02019541,0.00042219344,0.009469982,0.0012598208,0.00052826863,0.0017569212,0.00060055783,0.0015317876,0.0002079277],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11426003,0.0012662588,0.022050641,0.30309427,0.20064741,0.0001701384,0.00033778063,0.013420556,0.0029249864,0.0021731802,0.0047319685,0.3349228],"study_design_scores_gemma":[0.114057176,0.049535967,0.09620255,0.14070632,0.5282453,0.0010150347,0.000679851,0.008249889,0.004122496,0.013907795,0.042935323,0.00034232487],"about_ca_topic_score_codex":0.001535823,"about_ca_topic_score_gemma":0.0028740375,"teacher_disagreement_score":0.010629173,"about_ca_system_score_codex":0.0012994213,"about_ca_system_score_gemma":0.0021962037,"threshold_uncertainty_score":0.05621314},"labels":[],"label_agreement":null},{"id":"W4416998993","doi":"10.1001/jamaoncol.2025.5144","title":"Predictive Role of Circulating Tumor DNA in Stage III Colon Cancer Treated With Celecoxib","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôtel-Dieu de Québec","funders":"","keywords":"Circulating tumor DNA; Colorectal cancer; Celecoxib; Circulating tumor cell; Stage (stratigraphy); Cancer","score_opus":0.005151098990225925,"score_gpt":0.26069703864595867,"score_spread":0.25554593965573275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416998993","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963084,0.0017093635,0.00029922885,0.00014751297,0.000028397135,0.000026056914,0.00076192396,0.000009302279,0.0007097142],"genre_scores_gemma":[0.99899215,0.00017415735,0.00022407225,0.0000438717,0.000021349226,0.000012063406,0.00040141487,0.0000017497158,0.00012925945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960905,0.00015521761,0.000053062606,0.00007828993,0.00007174989,0.000032657517],"domain_scores_gemma":[0.99753773,0.0007714087,0.0011905483,0.000121519326,0.00012937564,0.00024941948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008473937,0.00018122014,0.00025897892,0.00040220254,0.0001422539,0.00038022024,0.00017996108,0.0002895504,0.0014589826],"category_scores_gemma":[0.0038668846,0.000098093136,0.00040072817,0.00052649993,0.00021659734,0.00020626292,0.00017115881,0.00042017427,0.00012241353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036526418,0.000049184233,0.9895717,0.000041359017,0.0001156987,0.000046846377,0.000013634659,0.00016048978,0.00088890706,0.000014918341,0.00014588812,0.0052985884],"study_design_scores_gemma":[0.00017644692,0.00075279025,0.99669814,0.000022490587,0.00017263558,0.00018235708,0.000027741728,0.00075250526,0.0006200758,0.00006232372,0.00052777893,0.000004780264],"about_ca_topic_score_codex":0.0010422921,"about_ca_topic_score_gemma":0.0023396136,"teacher_disagreement_score":0.0014589826,"about_ca_system_score_codex":0.00023679054,"about_ca_system_score_gemma":0.00032602556,"threshold_uncertainty_score":0.0048807263},"labels":[],"label_agreement":null},{"id":"W4417246830","doi":"10.1001/jamaoncol.2025.5234","title":"Stroke in Patients With Cancer—Time Is Brain","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotchkiss Brain Institute; Alberta Cancer Foundation; University of Calgary","funders":"","keywords":"Stroke (engine); MEDLINE; Acute stroke; Ischemic stroke; Central nervous system disease","score_opus":0.0055103377443961946,"score_gpt":0.28357903293255493,"score_spread":0.27806869518815874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417246830","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013553828,0.012609479,0.0005225546,0.94009185,0.024358736,0.000010692425,0.000090113164,0.000044020213,0.020917106],"genre_scores_gemma":[0.046249427,0.03362621,0.0024776815,0.8237441,0.07389562,0.00005771257,0.00023302324,0.000100364756,0.019615833],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9986804,0.00039499963,0.00020344184,0.0001573092,0.00039564937,0.00016822228],"domain_scores_gemma":[0.9937273,0.0021519715,0.000550279,0.00036059518,0.0016919053,0.0015179244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020976148,0.00028944662,0.0007084193,0.0006023906,0.0019057964,0.003158567,0.0011122709,0.0054870727,0.0097665675],"category_scores_gemma":[0.012278074,0.00018846634,0.0007816684,0.0005628518,0.0024763036,0.0038393037,0.0012334771,0.014732246,0.0037547483],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019026696,0.00017143808,0.004948662,0.0003490399,0.00006338765,0.00058628654,0.00057913293,0.00011175919,0.00053682184,0.03448313,0.8617967,0.096183434],"study_design_scores_gemma":[0.00018350423,0.0002771645,0.007556138,0.0012170486,0.00013246539,0.0011111741,0.0012204081,0.0001606826,0.0003202294,0.03287989,0.9548882,0.000053136777],"about_ca_topic_score_codex":0.01091778,"about_ca_topic_score_gemma":0.029384559,"teacher_disagreement_score":0.01091778,"about_ca_system_score_codex":0.001954968,"about_ca_system_score_gemma":0.006273457,"threshold_uncertainty_score":0.032672465},"labels":[],"label_agreement":null},{"id":"W4417468103","doi":"10.1001/jamaoncol.2025.5364","title":"Glucagon-Like Peptide-1 Receptor Agonists and Cancer","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Cancer; Agonist; Receptor; Clinical trial; Immunotherapy","score_opus":0.013714749655027057,"score_gpt":0.3210673079292796,"score_spread":0.30735255827425256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417468103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02289258,0.8635831,0.000059487993,0.06525575,0.0042940946,0.000013863907,0.0006243151,0.000012727211,0.043264043],"genre_scores_gemma":[0.2335626,0.73040706,0.00023836787,0.013888426,0.011713234,0.000036123092,0.0006578705,0.0000072700686,0.009489064],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995921,0.0001851008,0.000034452063,0.000018277924,0.00011688988,0.00005321181],"domain_scores_gemma":[0.99857676,0.00061292533,0.00042158578,0.000024453208,0.0001016661,0.00026253145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006664787,0.00012142916,0.00035452354,0.0006716567,0.0003142066,0.0011664946,0.00019450595,0.0009246195,0.008326851],"category_scores_gemma":[0.0034756234,0.00011612346,0.00038901338,0.0016562224,0.00024739958,0.00046182214,0.00038692245,0.0014562559,0.0007697362],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034617027,0.0009026146,0.1330392,0.0038589751,0.0009841325,0.0014059534,0.00017352194,0.00094353454,0.00039415545,0.012981001,0.2410602,0.60079503],"study_design_scores_gemma":[0.0009663622,0.0011410695,0.4664048,0.00476761,0.00089430844,0.003918988,0.0009588085,0.0005192017,0.00018551746,0.01607797,0.5041049,0.000060404716],"about_ca_topic_score_codex":0.0050738947,"about_ca_topic_score_gemma":0.011583525,"teacher_disagreement_score":0.008326851,"about_ca_system_score_codex":0.0008356825,"about_ca_system_score_gemma":0.001602092,"threshold_uncertainty_score":0.027856112},"labels":[],"label_agreement":null},{"id":"W4417474102","doi":"10.1001/jamaoncol.2025.5376","title":"Enhancing Clinical Cancer Research Through Sharing of Data and Biospecimens","year":2025,"lang":"en","type":"article","venue":"JAMA Oncology","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vector Institute; Structural Genomics Consortium; Princess Margaret Cancer Centre; University of Toronto; University Health Network","funders":"","keywords":"Data sharing; Clinical trial; Quality (philosophy); MEDLINE; Patient data; Stakeholder; Data quality; Stakeholder engagement","score_opus":0.13940819094857965,"score_gpt":0.5028676831765788,"score_spread":0.36345949222799917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417474102","genre_codex":"commentary","genre_gemma":"methods","domain_codex":"methods","domain_gemma":"reproducibility","model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":"reproducibility","domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019065058,0.09766735,0.2712951,0.5172033,0.008375237,0.02031356,0.0033347672,0.001114777,0.061630912],"genre_scores_gemma":[0.27745265,0.05250451,0.46424153,0.138061,0.012535901,0.043634497,0.00439085,0.0007646897,0.006414351],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.14147599,0.7659516,0.04179571,0.014832548,0.03246324,0.0034810645],"domain_scores_gemma":[0.0667839,0.70061755,0.060952667,0.13265994,0.028201623,0.0107843885],"candidate_categories":["metaresearch","open_science"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.64308155,0.0016177039,0.0041090474,0.009614418,0.005163279,0.02178927,0.011296241,0.01157181,0.012534321],"category_scores_gemma":[0.7605795,0.0028693571,0.005262225,0.011443464,0.02039346,0.038777802,0.06435832,0.014496902,0.0048181457],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017120446,0.0006444447,0.02417673,0.02831806,0.0030122376,0.0005886499,0.01067683,0.004039141,0.001483993,0.13215373,0.05067223,0.7425219],"study_design_scores_gemma":[0.0023254165,0.0026082976,0.018787554,0.07377083,0.001650658,0.0013946326,0.009653239,0.003068574,0.0032716976,0.25559238,0.6273667,0.0005099455],"about_ca_topic_score_codex":0.0024377098,"about_ca_topic_score_gemma":0.0024944164,"teacher_disagreement_score":0.9887038,"about_ca_system_score_codex":0.011052349,"about_ca_system_score_gemma":0.0913276,"threshold_uncertainty_score":0.44014406},"labels":[],"label_agreement":null}]}